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1 Surprises and discoveries in visible-light photocatalysis 
1.1 Introduction to the visible-light photocatalysis: 
The development of safer and sustainable methods for organic synthesis is one of the important 
goals of modern chemical research era. In fact, a number of classical, as well as some current 
synthetic methodologies, use toxic and explosive reagents at enforced reaction conditions. On the 
other hand, more than hundred years ago, an Italian photochemist, Giacomo Ciamician
[1]
 (a nine-
time Nobel Prize nominee)
 
recognized that sunlight could be used as a renewable, unlimited, 
safer, and cleaner energy source for the organic syntheses (Figure 1.1). 
 
Figure 1.1: Visible-light mediated organic synthesis is an old idea: This photograph is from the 
balcony of Giacomo Ciamician’s laboratory (1913). 
He predicted for the first time the bright future of photochemistry owing to the vast natural 
abundance of solar energy. He wrote: “On the arid lands there will spring up industrial colonies 
without smoke and without smokestacks; forests of glass tubes will extend over the plains and 
glass buildings will rise everywhere; inside of these will take place the photochemical processes 
that hitherto have been the guarded secret of the plants, but that will have been mastered by 
human industry which will know how to make them bear even more abundant fruit than nature, 
for nature is not in a hurry and mankind is. And if in a distant future the supply of coal becomes 
completely exhausted, civilization will not be checked by that, for life and civilization will 
continue as long as the sun shines”[1] 
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To that end, intensive research works have been committed to originate photoredox catalysts that 
are able to absorb visible-light and to promote the desired chemical transformations between 
small organic molecules. Indeed, visible-light photocatalysis technology has recently received 
remarkable recognition from synthetic chemists because of its prevalent applications in organic 
synthesis and its significance for sustainable developments in chemistry.
[2,3,4]
 
In our day-to-day life, a number of important processes involve photochemistry. The primary 
example is photosynthesis, in which most plants use the sunlight to convert CO2 and H2O into 
glucose and releases molecular oxygen as a by-product. Not only plants but human being also 
relies on photochemistry for the generation of Vitamin D with sunlight. The Grotthuss-Draper 
law states that “only the light that is absorbed by a system or molecule can bring about a 
photochemical change or photochemical reaction.” The Stark-Einstein law says that “every 
photon that is absorbed will cause a chemical or physical reaction.”  
Upon absorbing photons directly from the light source, the reactant molecule is excited to the 
new energy maxima, which is typically called as an excited state. If the reactant molecule is 
unable to absorb the required photon or if the required light source of a particular wavelength is 
not available then a “photosensitizer” is employed, which absorbs the photon and transfer the 
energy to the reactant. This process is known as “photosensitization”. The reverse process is 
called “quenching”  when a photoexcited state is deactivated by a chemical compound.  
In principle, inorganic metal complexes and organic dyes are employed as photosensitizers (or 
photocatalysts).
[3]
 The most commonly employed photocatalysts are poly-pyridyl or 
phenanthroline based complexes of [Ru], [Ir], or [Cu]: such as, [Ru(bpy)3Cl2], fac-[Ir(ppy)3], 
[Ir(ppy)2(dtb-bpy)PF6], [Ir{dF(CF3)ppy}2(dtb-bpy)PF6], [Cu(dap)2Cl] etc. (Figure 1.2). 
Besides inorganic compounds, organic compounds
[4,5]
 are also used as a visible-light 
photocatalyst, a few of these are eosin Y, flavin, fluorescein, 9,10-dicyanoanthracene, rose 
Bengal, Rhodamine 6G etc. These complexes absorb visible-light of the electromagnetic 
spectrum to give stable, long-lived photoexcited states. Typically, the lifetime of the excited 
species is sufficiently longer [Table 1.1; e.g. 2300 ns for Ir[dF(CF3)ppy]2(dtbbpy)PF6] that it may 
engage in bimolecular electron-transfer reactions in competition with deactivation pathways.  
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Figure 1.2: Some typical photoredox catalysts. 
Entry Photocatalyst 
E1/2 
(M*/M
+
) 
(V) 
E1/2 
(M
+
/M) 
(V) 
Excitation 
λmax (nm) 
Excited state 
lifetime, τ (ns) 
1 Ru(bpy)3
2+
 -0.81 +1.29 437 1100 
2 Ru(phen)3
2+
 −0.87 +1.26 422 500 
3 Ir[dF(CF3)ppy]2(dtbbpy)
+
 −0.89 +1.69 380 2300 
4 fac-Ir(ppy)3 −1.73 +0.77 375 1900 
5 Ir(ppy)2(dtbbpy)
+
 −0.96 +1.21 - 557 
6 Cu(dap)2
+
 −1.43 +0.62 437 270 
Table 1.1 Redox potentials and selected photophysical properties of commonly used visible-light 
photocatalysts. All potentials are given in volts versus the SCE.
[3]
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Although most of these species are poor single-electron oxidants and reductants in their ground 
states; however, upon excitation they become very potent single-electron-transfer reagents. More 
importantly, the conversion of these bench stable, benign catalysts to redox-active species upon 
irradiation with simple household light-bulbs or LED’s represents a remarkably chemoselective 
trigger to induce unique and valuable catalytic processes. 
In many instances, the photocatalytic reactions occur at milder reaction conditions, typically at 
room temperature. However, a key challenge for these photochemical reactions is the 
regeneration of the metal complexes or the catalytic cycle. For this, external stoichiometric 
reagents are often applied, and in some cases, they may be replaced by simple oxidants or 
reductants, such as air (oxygen) or amines. In this fashion, besides providing alternate ways for 
established transformations that allow a broadening of the substrate scope and improvement of 
reaction conditions, also innovative transformations become possible. Undoubtedly, using 
visible-light as the ultimate renewable energy resource in combination with catalytic amounts of 
metal complexes or organic dyes is attractive for developing sustainable chemical 
transformations.  
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1.2 Principal modes of activation in visible-light photocatalysis: 
1.2.1 An electron transfer: Oxidative or reductive quenching cycles: 
In principle, the visible-light photocatalysis operates through two different activation modes: an 
electron transfer and energy transfer. The principal mode of action in visible-light photocatalysis 
is to induce an electron transfer to or from a substrate, thus generating radical anions or cations 
of the substrates, which are often occurred through the extrusion of a leaving group to overall 
form a neutral radical as the reactive species that typically initiates a chemical transformation. 
Further manipulation of these reactive intermediates can result in a number of synthetically 
useful bond forming reactions in a controllable manner. 
The commonly established mechanism of a metal-based photocatalyzed (electron transfer) 
reaction is presented in a Latimer-diagram (Figure 1.3). As mentioned, the exceptional property 
of the typical
 
photocatalyst (PC) is to absorb the (visible) light to generate a high energy excited 
singlet state (PC*) through a metal-to-ligand charge transfer (MLCT). Then this singlet excited 
state undergoes rapid intersystem crossing (ISC) to give the lowest energy triplet MLCT state, 
which usually has a longer lifetime (Table 1.1) and is capable to perform a single electron 
transfer (SET) or photoinduced electron transfer (PET) process more efficiently as compared to 
their ground states.  
The redox transformations of PC* occurs either by oxidative or by reductive quenching cycles. 
In the oxidative quenching cycle, PC* functions as a reductant, reducing some electron acceptor 
by a SET process. The products of this SET event are the radical anion and the oxidized form of 
the employed photocatalyst. In general, this oxidized species is a strong oxidant and may accept 
an electron from some donor (typically from a substrate itself) to give the radical cation and 
regenerate the photocatalytic cycle. A compound that gains an electron from PC* is said to be an 
oxidative quencher of the photocatalyst; common oxidative quenchers are viologens, 
polyhalomethanes, dinitro- and dicyanobenzenes, or aryldiazonium salts etc. 
On the other hand, in the reductive quenching cycle, PC* functions as an oxidant, accepting an 
electron from sacrificial electron donors to give the reduced form of PC. This intermediate is a 
good reductant and may donate an electron to afford the ground-state species of PC. The most 
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common reductive quenchers are tertiary amines (e.g. NEt3, DIPEA etc). To determine whether a 
reductive or oxidative quenching cycle is operative in a particular reaction, fluorescence 
quenching (or Stern−Volmer) studies are commonly employed. This technique examines the 
competition between two deactivation pathways of the photoexcited state: i.e. excited state 
quenching via electron transfer or by emission process. 
 
Figure 1.3: General presentation of electron transfer process (PC = photocatalyst; Q = quencher; 
A = acceptor; D = donor, blue: oxidative quenching cycle; green: reductive quenching cycle). 
1.2.2 Energy transfer: A sensitization 
The second mode of action is that a photosensitizer transfers energy to a substrate if electron 
transfer process is thermodynamically unfavorable or redox potential differences between 
reacting substrates and photocatalysts are considerably high (Figure 1.4).
[6]
 
 
Figure 1.4 General presentation of energy transfer process. 
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Certainly, this mode of sensitization has a long tradition for synthetic photochemistry. However, 
most of the traditional processes suffer from major drawbacks: such as the use of high energy 
UV-light, the use of stoichiometric amounts of sensitizers, longer reaction times, etc. In recent 
times, the combination of high power visible-light emitting LED’s and the discovery of new 
photocatalysts, which can carry out energy transfer processes much more efficiently, hence hold 
the promise for new transformations to be discovered. 
1.2.3 Energy transfer followed by an electron transfer: A Photocascade Process 
Another mode of action in visible-light photocatalysis is that a photosensitizer transfers energy to 
a substrate if electron transfer process for the first step is thermodynamically unfavorable or in 
other words, the redox potential differences between reacting substrates and photocatalysts are 
very high. After the first step of sensitization, the substrate could undergo subsequent 
transformation to form either a stable intermediate or a first step product. At this stage, this 
intermediate or product is typically within the reach of redox potentials of the employed 
photocatalyst, which could subsequently undergo the SET process with the same photocatalyst to 
form a final product (Figure 1.5). This process is also called as a photocascade process.
[7]
 
Although, this mode has not been widely applied thus far, however, it certainly holds promise for 
the future advancements and also needs further mechanistic investigations. 
 
Figure 1.5: General presentation of dual energy- and electron transfer photocascade process. 
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1.3 Aim of the work and outcomes:  
In this regard, I was mainly involved on to develop visible-light photocatalyzed methods in 
organic synthesis. On that way, along with the introduction of new and mild transformations, I 
have also recognized practical alternatives to the established classical procedures, which were 
traditionally operated either by UV-light or by using hazardous/toxic reagents such as n-
Bu3SnH/AIBN in stoichiometric amounts at elevated temperature conditions.  
In addition, I have also noticed several unique and unprecedented activation modes due to the 
involvement of highly reactive radical intermediates. Most of the times, the surprising reactions 
are fascinating and it often leads to the meaningful discoveries in science. However, some 
reactions also led to the complex reaction mixtures. Despite its apparent randomness, the beauty 
of identified transformations is well-defined and organized. This has been proved by carrying out 
several experimental and spectroscopic investigations.  
In photochemical reactions, several reactive radical intermediates are involved, thus predicting 
the plausible reaction mechanisms for new reactions is a challenging task. Nevertheless, I have 
tried my best to penetrate light into all the possible dark corners of the reaction, to understand the 
mode of action of a photocatalyst in the preliminary as well as in the later stages, and to identify 
or characterize the key intermediates involved. Finally, to find suitable applications of these new 
reactions and to introduce an efficient method for organic synthesis were the key parameters in 
my doctoral work. Arguably, the disclosed reactions are certainly difficult (impossible in most of 
the cases!) to accomplish by applying other non-photochemical methods. 
Overall, the major part of my doctoral work is a result of unexpected findings; therefore, I 
summarized my thesis with the title: “Surprises and discoveries in Visible-Light Photocatalysis.” 
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2 Shining visible-light on C-X bonds 
2.1 Introduction:  
The development of catalytic systems for the activation of C-X bonds has been a long-standing 
goal in organic synthesis.
[1] 
 In particular, the cross coupling reactions, such as the Stille,
[2]
 the 
Kumada,
[3]
 the Suzuki-Miyaura,
[4]
 the Negishi
[5]
 coupling or cross-coupling of organolithium 
reagents,
[6]
 are vastly developed and extensively applied in organic chemistry. Among them, the 
Ar-X (aryl halides) or Alk-X (alkyl halides) activation is one of the popular classes of activation 
in organic synthesis by both, classical
[1]
 as well as by visible-light photocatalysis.
[7]
 However, on 
the other hand, the activation of vinyl-X (vinyl halides) is also a close topic of interest, though it 
is less studied and yet underdeveloped area.
[8]
 Nevertheless, in few cases, the synthetic utility of 
vinyl halides is established in radical
[9]
 as well as in classical
[10]
 reactions. 
2.2 Generation of vinyl radicals and their applications: 
In radical reactions, the ‘vinyl radical’ formation is the principal step upon extrusion of the 
leaving group from vinyl halides.
[11]
 Due to their high reactivity, vinyl radicals have been utilized 
in many valuable transformations in synthetic organic chemistry as well as in practical 
applications.
[12,13] 
Since the pioneering work of Stork et al,
[14]
 vinyl radical reactions have 
emerged as a versatile tool in synthetic organic chemistry.
[12,13] 
Thermal vinyl radical generation 
from vinyl halides is traditionally carried out using tributyltin hydride (n-Bu3SnH) and a radical 
initiator, such as AIBN.
[9,15]
 Furthermore, the vinyl radical formation by electrochemical 
processes
[16]
 or by photolysis of vinyl halides
[17]
 is also well established in the literature. Though 
there are several other routes exists in literature for accessing this radical,
[18] 
however, the 
photochemical processes are rare.
[19]
 
 
Scheme 2.1: Visible-light triggered synthesis of alkynes from vic-dibromoalkenes. 
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In 2011, Reiser et al have noticed reductive debromination
[20]
 of vic-dibromoalkene 1 to 
corresponding alkyne 2 (Scheme 2.1), thus, they envisioned a visible-light triggered route to 
access vinyl radicals 2. Typically, the photochemical activation of vinyl halides is difficult, 
requiring either an extended π-system or weak bonds as found in vinyl iodides (Scheme 2.2).[11]  
 
Scheme 2.2: Visible-light triggered synthesis of alkenes from vinyl-iodides. 
Furthermore, they also found that
 -bromochalcones 11 can be coupled with a broad variety of 
electron rich heteroarenes 12
[21]
 or alkenes 15
[22]
 give rise to polycyclic scaffolds (Schemes 2.3).  
 
Scheme 2.3: Visible-light triggered synthesis polycyclic compounds from vinyl-bromides. 
The vinyl radicals 13 were engaged in a cascade cyclization with heteroarenes in an 
intermolecular fashion forming novel scaffolds such as naphtho[2,1-b]furans, 3H-
benzo[e]indoles and related heterocycles. The overall transformation is characterized by three-
Chapter 2: Shining visible-light on C-X bonds 
12 
 
fold C-H activation. The reaction was compatible to a broad variety of heteroarenes, ranging 
from furans, benzofurans to pyrroles, in protected or unprotected form, as well as indoles. 
2.3 Conclusion and outlook: 
The outlined work has been proved that the possibility of engaging vinyl-radical as a key 
intermediate in several organic transformations. In order to broaden the scope of C-X bond 
activation strategy, to understand reaction mechanisms in more details, and to highlight the 
importance of vinyl-radicals in organic synthesis, further work needs to be done. 
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3 Visible-light promoted generation of α-ketoradicals from vinyl-bromides 
and molecular oxygen: An unprecedented synthesis of indenones and 
dihydroindeno[1,2-c]chromenes 
3.1 Abstract: 
Ortho-alkynylated α-bromocinnamates have been efficiently converted either to indenones or to 
dihydroindeno[1,2-c]chromenes by a visible-light mediated photocascade reaction with 
molecular oxygen. The one-step strategy features two key photochemical steps, i.e. molecular 
oxygen triggered unprecedented activation of vinyl bromides to generate α-ketoradicals and the 
ortho-hydroxylation of an arene moiety in the later step. 
3.2 Introduction: 
Visible-light photoredox catalysis not only offers unprecedented pathways to the established 
reactions but holds the promise to arrive at new bond forming transformations owing to the 
range of functional group compatibility under the mild reaction conditions.
[1]
 In general, 
reduction potentials of the vinyl bromides are much higher than the typical photocatalysts in 
their excited states.
[2,3,4]
 Thus, [Ru] or [Ir]-based photocatalysts generally do not possess a 
sufficient excited-state reduction potential for the SET process, and ultimately form a “vinyl 
radical” after bromide extrusion by an oxidative quenching cycle. In contrast, by employing the 
reductive quenching cycle in the presence of sacrificial electron donor such as amine for the 
activation of vinyl bromides only results in simple dehalogenations.
[4,5]
 
 
Scheme 3.1: Synthesis of Indenones and Dihydroindeno[1,2-c]chromenes. 
This chapter has been published:  
S. K. Pagire, P. Kreitmeier, O. Reiser, Angew. Chem. Int. Ed., 2017, 56, 10928-10932; 
Angew. Chem., 2017, 129, 11068-11072. 
S.K.P., P.K., and O.R. wrote the manuscript. 
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Alternatively, the substrates can also be activated directly by energy transfer from the excited 
state photocatalysts.
[6]
 In line with such an activation principle, we report here an unprecedented 
photochemical activation of vinyl bromides by employing ortho-alkynylated -bromocinnamates 
1 and molecular oxygen to give rise to indenones 2 or to dihydroindeno[1,2-c]chromenes 3 
(Scheme 3.1), based on the electronic prerequisites of the substrates. As the key step in this 
process, the formation α-ketoradicals from the vinyl bromides is proposed, which is 
unambiguously supported by detailed mechanistic investigations and control experiments (vide 
infra). 
3.3 Results and discussion: 
We bagan our investigations by exposing 1a (Ered = –1.38 V vs. SCE, see experimental section) 
in an oxygen atmosphere to irradiation with 5 mol % [Ir{dF(CF3)ppy}2(dtb-bpy)]PF6
[7] 
(EIr(IV)/Ir(III)* = –0.89 V vs. SCE; excited state life-time () = 2300 ns),
[3] 
[dF(CF3)ppy = 2-(2,4-
difluorophenyl)-5-trifluoromethylpyridine, dtb-bpy = 4,4’-di-tert-butyl-2,2’-dipyridyl]) in 
anhydrous DMF with blue light (LED455) indeed resulted in a fruitful transformation, leading to 
the formation of 2a and 3a in acceptable yields (Table 3.1, entry 1). In contrast, in the absence of 
oxygen, only E/Z-isomerization was observed (Table 3.1, entry 2), which is in accordance with 
the proposed activation (vide infra) of vinyl bromides 1 via a diradical intermediate generated by 
a triplet sensitization process.
[8]
 Furthermore, other iridium photocatalysts such as [Ir(ppy)2(dtb-
bpy)]PF6
[9]
 (EIr(IV)/Ir(III)* = –0.96 V vs. SCE,  = 557 ns) [ppy = 2-phenylpyridine, dtb-bpy = 4,4’-
di-tert-butyl-2,2’-dipyridyl] and neutral fac[Ir(ppy)3]
[10]
 (EIr(IV)/Ir(III)* = –1.73 V vs. SCE,  = 1900 
ns) [ppy = 2-phenylpyridine], gave a similar results, however, the product yields were 
comparatively lower (Table 3.1, entries 3, 4).  
We emphasize, in all the cases, we noted a deep blood-red coloring of the reaction mixture 
during the course of the photo-irradiation, which probably blocking the photo-process. This 
could be explained by the incomplete conversion and long reaction time of the overall reactions. 
Lowering the catalyst concentration from 5 mol % to 1 mol % (Table 3.1, entry 5) gave almost 
the same results, suggesting that catalyst deactivation was not the limiting feature of the reaction. 
A significant enhancement in yield was observed upon carrying out the reaction at elevated 
temperature (60 °C), which was found to be the best parameter in combination with 2 mol % 
catalyst loading (Table 3.1, entry 6). Not surprisingly, in the absence of the iridium catalyst or 
light, no conversion of 1a was observed (Table 3.1, entries 7, 8). 
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Next, by employing other photocatalysts such as [Ru(bpy)3Cl2]
[11]
 (ERu(III)/Ru(II)* = –0.81 V vs. 
SCE,  = 1100 ns) (bpy = 2,2’-bipyridine), Eosin Y,[12] and [Cu(dap)2Cl]
[13]
 (ECu(II)/Cu(I)* = –1.43 
V vs. SCE,  = 270 ns) [dap = 2,9-bis(p-anisyl)-1,10-phenanthroline], gave rise to low yields of 
2a/3a (Table 3.1, entries 9-11). As expected, a reductive quenching experiment by adding a 
tertiary amine as a sacrificial electron donor (e.g. diisopropylethylamine, DIPEA) (Table 3.1, 
entry 14), thus utilizing strong ground state reduction potentials of [Ir{dF(CF3)ppy}2(dtb-
bpy)]PF6 (EIr(III)/Ir(II) = –1.37 V vs. SCE), only resulted in direct dehalogenation (99%). 
3.4 Synthesis of 2a and 3a: Catalyst screening and reaction optimization 
 
Entry Photocatalyst (mol %) 
Temperature 
(
o
C) 
Yield (%)
[b]
 
2a 3a 
01 [Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (5) rt 16 41 
02
[c,d]
 [Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (5), no O2 rt - - 
03 [Ir(ppy)2(dtb-bpy)]PF6 (5) rt 10 22 
04 fac[Ir(ppy)3] (5) rt 14 33 
05 [Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (1) rt 17 38 
06 [Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (2) 60 20 61 
07 [Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (1), dark rt - - 
08 No Catalyst rt - - 
09 Ru(bpy)3Cl2 (5) rt 5 26 
10 Eosin Y (5), 530 nm rt 3 8 
11 [Cu(dap)2Cl] (5), 530 nm rt - - 
12 Rose Bengal (5), 530 nm rt - - 
13 ZnCl2/porphyrin (5), 530 nm rt - - 
14
[e]
 [Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (5), DIPEA rt - - 
Table 3.1: Reaction Conditions: [a] Substrate 1a (0.5 mmol), photocatalyst (1-5 mol %), O2, DMF, 72 h, rt, 60 
oC, 
LED455. [b] Isolated yields. [c] Under nitrogen. [d] E/Z-isomerization of 1a, Z/E = 81:19 (before irradiation) to Z/E = 
50:50 (after irradiation). [e] Dehalogenation product was identified by crude 1H-NMR analysis. 
Chapter 3: Visible-light promoted generation of α-ketoradicals from vinyl-bromides and 
molecular oxygen: An unprecedented synthesis of indenones and dihydroindeno[1,2-
c]chromenes 
17 
 
 
3.5 Substrate scope: 
By applying the optimized reaction conditions (Table 3.1, entry 6), a variety of ortho-
alkynylated α-bromocinnamates 1 (mostly employed as E/Z mixtures) was subsequently 
examined (Table 3.2-3.4). To our surprise, a pronounced electronic effect was observed, which 
eventually determined the overall course of the reaction: Thus, α-bromocinnamates bearing +I 
(inductive donor) or +M (mesomeric/resonance donor) substituents yielded exclusively 
indenones 2b-k (Table 3.2). In contrast, derivatives with only electron withdrawing substituents 
gave rise to dihydroindeno[1,2-c]chromenes 3b-h (Table 3.3). However, an ortho substituent R
1
 
overrides the electronic preference (cf. 2l, Table 3.2 and 3i, Table 3.3). As expected, a mixture of 
both products 2 and 3 was observed for neutral or electronically unbiased substrates 1 (Table 
3.4). Noteworthy, carrying out the reaction in a rotating film reactor dramatically enhanced the 
rate of the reaction (from 72 h / 60 °C to 24 h / 25 °C, See experimental section for more 
experimental details) due to the availability of larger surface area of the resulting reaction 
mixture that was exposed under the visible-light irradiation and to the oxygen atmosphere (cf 
Table 3.2-3.4). Furthermore, performing the reaction in the advanced micro(flow)reactor 
technique,
[14]
 provides good yields also in a very short reaction times (Tables 3.2 and 3.3; also 
see the experimental section for detailed experimental set-ups).  
3.5.1 Electron rich substrates: 
 
Table 3.2: Substrate scope: Electron rich systems. 
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3.5.2 Electron deficient substrates: 
 
Table 3.3: Substrate scope: Electron deficient substrates. 
3.5.3 Electron unbiased substrates: 
 
Table 3.4: Substrate scope: Electron unbiased substrates. 
Tables 3.2-3.4: Reaction Conditions: [a] Substrate 1 (0.5 mmol, 1.0 equiv), photocatalyst (2 mol %), O2 at 60 
oC, 
in DMF, 72 h, LED455, isolated yields of separated 2 and 3 are stated. [b] Reaction performed on rotating film 
reactor [c] 2.0 mmol scale reaction. [d] Reaction performed on micro(flow)reactor with 1 mol % photocatalyst, 40 
min at room temperature (or 15 min at 60 oC). Compound color is mentioned in parentheses. 
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3.6 Proposed reaction mechanism: 
As can be seen from the product structures; apparently, the mechanistic picture of this 
transformation looks complex and certainly points towards several unique photocatalytic steps 
(Figure 3.1). The Stern-Volmer or fluorescence quenching studies (see experimental section for 
more details) revealed that the starting material 1a strongly interacts with the excited 
photocatalysts. As mentioned earlier, a direct photoelectron transfer from the Ir(III)-catalyst to 1 
is thermodynamically unfavorable due to the large difference in reduction potentials of substrates 
1 and the employed photocatalyst (e.g. 1a: Ered = -1.38 V vs. SCE > Ir-F: -0.89 V vs. SCE).  
By considering the experimental evidences, we propose the generation of a more stable diradical 
species I* (or a triplet excited state)
[8,15]
 upon vinyl bromide 1 excitation by energy transfer from 
the excited *Ir(III)-catalyst. Noteworthy, the [2+2]-cycloaddition of 1 was not observed of these 
bromine centered diradicals in contrast to the non-brominated analog (Scheme 3.3). Instead, I* 
loses bromine radical (Br•) to form the subsequent vinyl radical II. Evidence for generation of II 
is found by carrying out a trapping experiment with TEMPO giving rise to 9 as well as the 5-
exo-trig cyclization reaction of 4 to 5 (Scheme 3.2). In support, the ESR spectra also provides a 
broad signal of single radical species (ge = 1.984) under inert atmospheric conditions at low 
temperature (See experimental section for ESR spectra). 
Surprisingly, a direct 5-exo-dig or 6-endo-dig cyclization of II was not feasible, probably due to 
two main reasons: either an unfavorable orientation of the reacting groups (see experimental 
section for the crystal structure of 1c) or problem with the resulting radical termination. 
Nevertheless, the vinyl radical intermediate II is capable of adding on to the molecular oxygen 
gives rise to intermediate III, which should collapse to the -ketoradical IV as a key 
intermediate. In support of this conclusion, the independent generation of IV from 8 by PET in 
the presence of oxygen indeed gives rise to 2a and 3a (Scheme 3.4). It should be noted that the 
conversion of 8 to 2a and 3a requires stoichiometric amounts of photocatalyst since the 
photoredox cycle cannot be closed in the absence of a sacrificial electron donor.  
However, in the presence of DIPEA provides a direct reduced product. The α-ketoradical IV then 
undergoes 5-endo-dig cyclization
[16]
 and eventually trapped by the second molecule of the 
molecular oxygen to access V. Finally, elimination of a water molecule subsequently leads to the 
desired indenones 2. Evidently, an isotope labeling experiment with pure 
18
O2 and a mixture of  
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18/16
O2 proved that the oxygen atoms incorporated into the indenones 2 indeed originated from 
two different molecules of molecular oxygen (Scheme 3.6). Indenones 2 having electron 
accepting substituents in the aromatic ring undergoes a facile 6π-electrocyclization, leading to 
dihydroindeno[1,2-c]chromenes 3 (Scheme 3.5). Independent experiments under visible-light 
irradiation/photocatalyst or IV irradiation in the presence of oxygen (Scheme 3.5) with indenone 
2 showed the possibility of the 6π-electrocyclization reaction.[17] Though, the yields obtained by 
the independent process were low as compared to starting from the corresponding compounds 1.  
 
Figure 3.1: Proposed reaction mechanism. 
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3.7 Control experiments: 
3.7.1 Without a double bond: The evidence for a vinyl radical formation 
 
Scheme 3.2: Synthesis of indenones via vinyl radical intermediate. 
3.7.2 Without a bromine: The evidence for a diradical formation 
 
Scheme 3.3: Synthesis of cyclobutanes via diradical intermediate. 
3.7.3 Direct synthesis of 2a and 3a: The evidence for α-ketoradical formation 
 
Scheme 3.4: Synthesis of 2a and 3a via α-ketoradical intermediate. 
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3.7.4 Direct synthesis of 3 from 2: An evidence for 6π-electrocyclization 
 
Scheme 3.5: Synthesis of 3a / 3k from 2a / 2n via 6π-electrocyclization. 
Conditions A: Substrate 2 (0.25 mmol, 1.0 equiv), [Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (2 mol %), O2, at 60 
oC, in 
DMF, 72 h, LED455. Conditions B: Substrate 2 (0.25 mmol, 1.0 equiv), UV-Light (125 W Hg-lamp, λ > 300 nm), 
O2, at 60 
oC, in anhydrous DMF, 72 h. 
3.7.5 Isotope labeling experiments: 
The 
18
O2 labeling experiments (Scheme 3.6, a) revealed that the termination of the 
electrocyclization by the introduction of a hydroxyl group also was ultimately derived from 
molecular oxygen. In addition, the mixed experiment (Scheme 3.6, b) disclosed the information 
of involvement of three different oxygen molecules (see also a detailed information in 
experimental section).
[12,18]
 
a. Pure 
18
O2 experiment: 
 
b. Mix 
18
O2 / 
16
O2 experiment: 
 
Scheme 3.6: Oxygen labeling experiments: Synthesis of 2a / 2a’ and 3a / 3a’. 
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3.8 Conclusion: 
To conclude, we have shown a novel strategy for the generation of -ketoradicals from vinyl 
bromides and molecular oxygen by energy transfer process operated by an Ir-F photocatalyst 
under the mild reaction conditions. The resulting vinyl radical II from a diradical intermediate 
upon bromine extrusion could be engaged in a productive reaction cascades with up to three 
different oxygen molecules, leading to the complex molecular architectures in a single 
photochemical step. We emphasize here, this reaction could also be performed in the micro-flow 
or rotating film reactors in the short reaction time. Furthermore, the newly obtained tetracyclic 
compounds could also serve as valuable building blocks in medicinal chemistry. Since, these 
type of compounds having a heteroatom impregnated into the [6-5-6]-ABC skeleton are already 
advertised as taiwaniaquinoids related scaffolds by Panda et al,
[19]
 which are closely related to 
the naturally occurring family of Taiwaniaquinoids possessing a common [6-5-6]-abeo-abietane 
carbon architecture with broad biological activities.
[20]
 However, we admit that the electronic 
effect preference for electron deficient starting materials 1 to preferentially undergo the direct 
cyclization to 3 rather than to 2 has been unfortunately remained unclear at this point. 
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3.9 Experimental section: 
3.9.1 General information: 
Unless otherwise stated, all commercial chemical materials were used as received without further 
purification. All reactions were performed using common dry, inert atmosphere techniques. The 
blue light irradiation was done using blue light emitting diodes (700 mA, λmax = 455 nm) 
produced by Oslon SSL. All the reactions were monitored by TLC and visualized by a dual short 
(254 nm) / long (366 nm) wavelength UV lamp. Analytical thin layer chromatography was 
performed on Merck TLC aluminum sheets silica gel 60 F 254. Purifications by column 
chromatography were performed on silica gel (0.063-0.200 mm). UV-Visible spectra were 
measured on Varian Cary 50 spectrophotometer. Melting points were recorded on Stanford 
Research Systems OptiMelt MPA 100 Automated melting point system. All products were 
characterized by appropriate techniques such as 
1
H-NMR, 
19
F-NMR, 
31
P-NMR,
 13
C-NMR, FT-
IR and HRMS analysis. FT-IR (Cary 630) spectroscopy was carried out on a spectrometer, 
equipped with a Diamond Single Reflection ATR-System. NMR spectra were recorded on 
Bruker Avance 300, 400, or 600 MHz spectrometers. Chemical shifts for 
1
H-NMR were reported 
as δ, parts per million, relative to the signal of CHCl3 at 7.26 ppm. Chemical shifts for 
13
C-NMR 
were reported as δ, parts per million, relative to the signal of CHCl3 at 77.2 ppm and TMS as an 
internal standard. Coupling constants (J) are given in Hertz (Hz). The following notations 
indicate the multiplicity of the signals: s = singlet, bs = broad singlet, d = doublet, t = triplet, q = 
quartet, dd = doublet of doublets, td = triplet of doublets, and m = multiplet. Mass spectra were 
recorded at the Central Analytical Laboratory at the University of Regensburg on Agilent 
Technologies 6540 UHD Accurate-Mass Q-TOF LC/MS. THF was dried by distilling over KOH 
followed by stored on sodium metal wire under a nitrogen atmosphere. DMF was dried with 
distillation on calcium hydride then stored on activated molecular sieves (4 Å) under nitrogen. 
UV–Visible and fluorescence measurements were performed with Varian Cary 50 UV/Vis-
spectrophotometer and FluoroMax-4 spectrofluorometer, respectively. The ESR experiment was 
done on Magnettech MiniScope MS400 instrument having MW frequency 9.20-9.60 GHz 
(sensitivity: MS400: 8*10^9 Spins/0.1 mT) and Modulation Frequency 100 kHz (Field 
Modulation and Field stability was 5 μT – 0.7 mT and 1.5 μT/min, 15 μT/h, respectively). 
Electrochemical (cyclic voltammetry) studies were carried out under argon atmosphere. The 
measurements were performed in DMF containing 0.1 M tetra-n-butylammonium 
tetrafluoroborate using ferrocene/ferrocenium (Fc/Fc+) as an internal reference. A glassy carbon 
electrode (working electrode), platinum wire counter electrode, and Ag quasi-reference electrode 
were employed. (Note: this information is applicable to all the following chapters).   
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3.9.2 General procedure (GP-1) for Sonogashira coupling: 
 
To a solution of the corresponding 2-bromobenzaldehyde derivative (2.00 mmol, 1.00 equiv), 
PdCl2 (PPh3)2 (2.00 mol %), and CuI (1.00 mol %) in degassed NEt3 (20 mL) was added the 
appropriate acetylene (2.40 mmol, 1.20 equiv). The resulting mixture was heated under nitrogen 
atmosphere at 60 °C for 6-24 h, gradually the reaction turned dark. The progress of the reaction 
was monitored by TLC. After complete consumption of the starting material, resulting mixture 
was diluted with 15 mL of EtOAc and filtered through the pad of celite. The filtrate was 
evaporated under reduced pressure and the pure compound was isolated through silica gel 
column chromatography using Hexanes/EtOAc as a solvent system. 
 
2-(2-Phenylethynyl)benzaldehyde (S1a): 
Following GP-1, S1a was prepared from 2-bromobenzaldehyde (5.0 g, 27.03 
mmol). Purification of the crude product by column chromatography 
(Hexanes: EtOAc, 10:1, Rf = 0.53) afforded S1a as a brown oil (4.35 g, 78% 
yield). 
1
H-NMR (300 MHz, CDCl3): δ 10.66 (s, 1H), 7.95 (d, J = 7.8, 1H), 7.67 – 7.60 (m, 1H), 7.59 – 
7.53 (m, 3H), 7.49 – 7.42 (m, 1H), 7.41 – 7.36 (m, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 191.75, 135.84, 133.84, 133.25, 131.72, 129.12, 128.66, 128.57, 
127.28, 126.91, 122.34, 96.37, 84.92. 
The obtained data is in accordance with the literature data.
[21]
 
 
5-Methoxy-2-(2-phenylethynyl)benzaldehyde (S1b): 
Following GP-1, S1b was prepared from 2-bromo-5-methoxybenzaldehyde 
(500 mg, 2.33 mmol). Purification of the crude product by column 
chromatography (Hexanes: EtOAc, 10:1, Rf = 0.51) afforded S1b as a brown 
solid (522 mg, 95% yield). 
 
Chapter 3: Experimental section 
26 
 
 
1
H-NMR (300 MHz, CDCl3): δ 10.59 (s, 1H), 7.57 – 7.48 (m, 3H), 7.40 (d, J = 2.8 Hz, 1H), 
7.35 (dd, J = 6.1, 2.6 Hz, 3H), 7.12 (dd, J = 8.6, 2.8 Hz, 1H), 3.85 (s, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 191.63, 159.80, 137.19, 134.58, 131.54, 128.78, 128.53, 122.67, 
121.76, 119.62, 109.82, 94.87, 84.86, 55.66. 
The obtained data is in accordance with the literature data.
[21] 
 
4,5-Methylenedioxy-2-(2-phenylethynyl)benzaldehyde (S1c): 
Following GP-1, S1c was prepared from 6-bromobenzo[d][1,3]dioxole-5-
carbaldehyde (500 mg, 2.18 mmol). Purification of the crude product by 
column chromatography (Hexanes: EtOAc, 4:1, Rf = 0.58) afforded S1c as a 
white solid (540 mg, 99% yield).
 
1
H-NMR (300 MHz, CDCl3): δ 10.49 (s, 1H), 7.60 – 7.48 (m, 2H), 7.42 – 7.32 (m, 4H), 7.03 (s, 
1H), 6.09 (s, 2H). 
13
C-NMR (75 MHz, CDCl3): δ 190.08, 152.42, 148.73, 132.13, 131.60, 129.01, 128.55, 123.66, 
122.33, 112.01, 106.11, 102.44, 95.16, 84.77. 
The obtained data is in accordance with the literature data.
[21]
 
4,5-Dimethoxy-2-(2-phenylethynyl)benzaldehyde (S1d): 
Following GP-1, S1d was prepared from 2-bromo-4,5-
dimethoxybenzaldehyde (500 mg, 2.04 mmol). Purification of the crude 
product by column chromatography (Hexanes: EtOAc, 9:1, Rf = 0.49) 
afforded S1d as a brown solid (532 mg, 98% yield). 
1
H-NMR (300 MHz, CDCl3): δ 10.47 (s, 1H), 7.58 – 7.48 (m, 3H), 7.38 (s, 1H), 7.37 – 7.33 (m, 
3H), 7.01 (s, J = 1H), 3.95 (s, 3H), 3.92 (s, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 190.41, 153.61, 149.71, 131.56, 130.13, 128.90, 128.53, 122.46, 
121.55, 114.26, 108.16, 94.99, 84.86, 56.21.
 
The obtained data is in accordance with the literature data.
[21]
 
4,5-dimethoxy-2-((4-nitrophenyl)ethynyl)benzaldehyde (S1e): 
Following GP-1, S1e was prepared from 2-bromo-4,5-
dimethoxybenzaldehyde (335 mg, 1.36 mmol). Purification of the crude 
product by column chromatography (Hexanes: EtOAc, 4:1, Rf = 0.29) 
afforded S1e as a yellow solid (378 mg, 89% yield).  
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1
H-NMR (300 MHz, CDCl3): δ 10.46 (s, 1H), 8.30 – 8.20 (m, 2H), 7.73 – 7.64 (m, 2H), 7.44 (s, 
1H), 7.08 (s, 1H), 4.01 (s, 3H), 3.98 (s, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 189.79, 153.69, 150.51, 147.33, 132.29, 130.55, 129.35, 123.83, 
119.92, 114.45, 108.56, 92.78, 90.06, 56.44, 56.26. 
IR (neat, cm
-1
): 2927, 1683, 1588, 1562, 1505, 1463, 1434, 1397, 1339, 1304, 1288, 1255, 
1215, 1188, 1158, 1084, 1027, 994, 890, 871, 853, 824, 800, 775, 745, 684, 656. 
HRMS (ESI): exact m/z calculated for C17H14NO5 (M+H)
+
: 312.0866; Found: 312.087 (M+H)
+
. 
Mp: 147-149 
o
C (decomposed). 
 
2-(Phenylethynyl)nicotinaldehyde (S1f): 
Following GP-1, S1f was prepared from 2-bromonicotinaldehyde (500 mg, 
2.69 mmol). Purification of the crude product by column chromatography 
(Hexanes: EtOAc, 4:1, Rf = 0.32) afforded S1f as a brown solid (506 mg, 91% 
yield). 
1
H-NMR (300 MHz, CDCl3): δ 10.64 (s, 1H), 8.79 (s, 1H), 8.18 (dd, J = 7.9, 1.7 Hz, 1H), 7.67 
– 7.56 (m, 2H), 7.44 – 7.31 (m, 4H). 
13
C-NMR (75 MHz, CDCl3): δ 190.81, 154.51, 146.06, 134.82, 132.20, 131.84, 129.89, 128.62, 
123.28, 121.24, 96.07, 84.72. 
The obtained data is in accordance with the literature data.
[22] 
 
5-nitro-2-(phenylethynyl)benzaldehyde (S1g): 
Following GP-1, S1g was prepared from 2-bromo-5-nitrobenzaldehyde 
(300 mg, 1.30 mmol). Purification of the crude product by column 
chromatography (Hexanes: EtOAc, 4:1, Rf = 0.47) afforded S1g as a yellow 
solid (281 mg, 86% yield). 
1
H-NMR (300 MHz, CDCl3): δ 10.63 (s, 1H), 8.73 (d, J = 2.4 Hz, 1H), 8.40 (dd, J = 8.5, 2.5 
Hz, 1H), 7.81 (d, J = 8.5 Hz, 1H), 7.63 – 7.55 (m, 2H), 7.50 – 7.35 (m, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 189.33, 147.23, 136.44, 134.39, 132.40, 132.02, 130.18, 128.77, 
127.70, 122.65, 121.21, 101.69, 83.66. 
The obtained data is in accordance with the literature data.
[23] 
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4-Methyl-2-(2-phenylethynyl)benzaldehyde (S1h):
 
Following GP-1, S1h was prepared from 2-bromo-4-methylbenzaldehyde 
(500 mg, 2.51 mmol). Purification of the crude product by column 
chromatography (Hexanes: EtOAc, 10:1, Rf = 0.57) afforded S1h as a pale 
yellow solid (403 mg, 73% yield). 
1
H-NMR (300 MHz, CDCl3): δ 10.55 (s, 1H), 7.80 (d, J = 8.0 Hz, 1H), 7.55 – 7.47 (m, 2H), 
7.40 (s, 1H), 7.37 – 7.30 (m, 3H), 7.19 (d, J = 7.9 Hz, 1H), 2.36 (s, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 190.24, 143.79, 132.62, 132.52, 130.61, 128.61, 127.94, 127.46, 
126.26, 125.79, 121.37, 94.80, 84.08, 20.54. 
The obtained data is in accordance with the literature data.
[21] 
 
5-Fluoro-2-(2-phenylethynyl)benzaldehyde (S1i): 
Following GP-1, S1i was prepared from 2-bromo-5-fluorobenzaldehyde (500 
mg, 2.46 mmol). Purification of the crude product by column chromatography 
(Hexanes : EtOAc, 3:1, Rf = 0.39) afforded S1i as a pale yellow solid (480 
mg, 87% yield). 
1
H-NMR (300 MHz, CDCl3): δ 10.57 (d, J = 3.2 Hz, 1H), 7.65 – 7.57 (m, 2H), 7.53 (ddd, J = 
5.0, 3.8, 2.6 Hz, 2H), 7.39 – 7.35 (m, 3H), 7.31 – 7.23 (m, 1H). 
13
C-NMR (75 MHz, CDCl3): δ 190.49, 162.40 (d, J = 252.7 Hz), 137.77 (d, J = 6.7 Hz), 135.28 
(d, J = 7.6 Hz), 131.67, 129.21, 128.60, 123.03 (d, J = 3.4 Hz), 122.13, 121.41 (d, J = 22.8 Hz), 
113.72 (d, J = 23.0 Hz), 96.06, 83.85. 
19
F-NMR (282 MHz, CDCl3): δ -109.40.  
The obtained data is in accordance with the literature data.
[21]
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3.9.3 Synthesis of 2-ethynylbenzaldehyde:
[24,25] 
 
A dry round-bottomed flask was charged with 2-bromobenzaldehyde (10.0 g, 54.0 mmol, 1.00 
equiv), CuI (0.103 g, 0.54 mmol, 0.01 equiv) and [Pd(PPh3)2Cl2] (0.759 g, 1.08 mmol, 0.02 
equiv). 100 mL of NEt3 and trimethylsilylacetylene (6.36 g, 64.08 mmol, 1.20 equiv) were added 
to the reaction mixture. The solution was degassed and allowed to stir at 60 
o
C for 24 h. The 
reaction mixture was then concentrated. The pure S1aa was isolated by flash column 
chromatography (10:1 Hexanes: EtOAc, Rf = 0.61) as a brown solid (8.89 g, 43.94 mmol, 75% 
yield); S1aa was then treated with K2CO3 (182 mg, 1.32 mmol, 3.00 mol %) in methanol (130 
mL) for 1 h at room temperature. The pure compound S1ab was isolated through silica gel 
column chromatography (hexanes: EtOAc = 4:1, Rf = 0.46) as a white solid (5.67 g, 99% yield). 
 
2-((trimethylsilyl)ethynyl)benzaldehyde (S1aa): 
1
H-NMR (300 MHz, CDCl3): δ 10.51 (s, 1H), 7.90 – 7.82 (m, 1H), 7.56 – 7.45 
(m, 2H), 7.39 (m, 1H), 0.24 (s, 9H). 
13
C-NMR (75 MHz, CDCl3): δ 192.10, 136.37, 133.91, 133.72, 129.06, 
127.09, 127.02, 102.64, 100.27, -0.19. 
The obtained data is in accordance with the literature data.
[24,25]
 
 
2-ethynylbenzaldehyde (S1ab): 
1
H-NMR (300 MHz, CDCl3): δ 10.51 (s, 1H), 7.93 – 7.87 (m, 1H), 7.62 – 7.50 (m, 
2H), 7.45 (t, J = 7.5 Hz, 1H), 3.42 (s, 1H). 
13
C-NMR (75 MHz, CDCl3): δ 191.47, 136.55, 133.93, 133.75, 129.25, 127.27, 
125.51, 84.28, 79.21. 
The obtained data is in accordance with the literature data.
[24,25]
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3.9.4 General procedure (GP-2) for Sonogashira coupling: 
 
To the solution of appropriate halobenzene (iodo/bromo) derivatives (2.00 mmol, 1.00 equiv), 
[Pd(PPh3)2Cl2] (0.02 equiv), CuI (0.01 equiv) in degassed NEt3 (20 mL), added the solution of 2-
ethynylbenzaldehyde S1ab (2.00 mmol, 1.00 equiv). The mixture was stirred for 4-24 h at 60 
o
C. 
After completion of the reaction, the mixture was diluted with 15 mL of EtOAc and filtered 
through the pad of celite. The filtrate was evaporated under reduced pressure, and the pure 
compound was isolated through silica gel column chromatography using Hexanes/EtOAc as a 
solvent system. 
2-((4-methoxyphenyl)ethynyl)benzaldehyde (S1j): 
Following GP-2, S1j was prepared from 1-iodo-4-methoxybenzene (468 
mg, 2.0 mmol). Purification of the crude product by column 
chromatography (Hexanes: EtOAc, 95:5, Rf = 0.3) afforded S1j as a white 
solid (387 mg, 82% yield). 
 
1
H-NMR (300 MHz, CDCl3): δ 10.65 (s, 1H), 7.97 – 7.90 (m, 1H), 7.65 – 7.56 (m, 2H), 7.55 – 
7.46 (m, 3H), 7.46 – 7.38 (m, 1H), 6.94 – 6.88 (m, 2H), 3.84 (s, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 191.94, 160.25, 135.64, 134.06, 133.82, 133.26, 133.06, 128.26, 
127.22, 114.21, 96.62, 83.81, 55.38. 
The obtained data is in accordance with the literature data.
[26]
 
 
2-((4-chlorophenyl)ethynyl)benzaldehyde (S1k): 
Following GP-2, S1k was prepared from 1-chloro-4-iodobenzene (476 
mg, 2.0 mmol). Purification of the crude product by column 
chromatography (Hexanes: EtOAc, 9:1, Rf = 0.6) afforded S1k as a white 
solid (456 mg, 95% yield). 
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1
H-NMR (300 MHz, CDCl3): δ 10.57 (s, 1H), 7.91 (ddd, J = 7.7, 1.3, 0.6 Hz, 1H), 7.62 – 7.51 
(m, 2H), 7.48 – 7.39 (m, 3H), 7.35 – 7.28 (m, 2H). 
13
C-NMR (75 MHz, CDCl3): δ 191.53, 135.85, 135.21, 133.86, 133.26, 132.91, 128.91, 127.48, 
126.43, 120.83, 95.09, 85.89. 
The obtained data is in accordance with the literature data.
[27]
 
 
2-((4-bromophenyl)ethynyl)benzaldehyde (S1l): 
Following GP-2, S1l was prepared from 1-bromo-4-iodobenzene (565 mg, 
2.0 mmol). Purification of the crude product by column chromatography 
(Hexanes: EtOAc, 9:1, Rf = 0.55) afforded S1l as a pale yellow solid (453 
mg, 80% yield). 
1
H-NMR (300 MHz, CDCl3): δ 10.57 (s, 1H), 7.94 – 7.89 (m, 1H), 7.63 – 7.52 (m, 2H), 7.51 – 
7.42 (m, 3H), 7.42 – 7.36 (m, 2H). 
13
C-NMR (75 MHz, CDCl3): δ 191.49, 135.87, 133.85, 133.26, 133.09, 131.87, 128.90, 127.50, 
126.40, 123.47, 121.30, 95.14, 86.06. 
The obtained data is in accordance with the literature data.
[28]
 
 
2-(p-tolylethynyl)benzaldehyde (S1m): 
Following GP-2, S1m was prepared from 1-iodo-4-methylbenzene (436 mg, 
2.0 mmol). Purification of the crude product by column chromatography 
(Hexanes: EtOAc, 9:1, Rf = 0.63) afforded S1m as a yellow solid (344 mg, 
78% yield). 
1
H-NMR (300 MHz, CDCl3): δ 10.66 (s, 1H), 7.95 (dd, J = 7.8, 0.9 Hz, 1H), 7.60 (dtd, J = 9.1, 
7.7, 1.3 Hz, 2H), 7.50 – 7.38 (m, 3H), 7.19 (d, J = 7.9 Hz, 2H), 2.39 (s, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 191.89, 139.43, 135.76, 133.82, 133.17, 132.41, 131.62, 129.33, 
128.45, 127.21, 119.26, 96.68, 84.34, 21.63. 
The obtained data is in accordance with the literature data.
[28]
 
 
2-((4-isopropylphenyl)ethynyl)benzaldehyde (S1n): 
Following GP-2, S1n was prepared from 1-iodo-4-isopropylbenzene (492 
mg, 2.0 mmol). Purification of the crude product by column 
chromatography (Hexanes: EtOAc, 95:5, Rf = 0.53) afforded S1n as a 
yellow viscous oil (461 mg, 93% yield). 
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1
H-NMR (300 MHz, CDCl3): δ 10.64 (s, 1H), 7.92 (d, J = 9.7 Hz, 1H), 7.61 (ddd, J = 7.8, 1.4, 
0.5 Hz, 1H), 7.54 (td, J = 7.5, 1.4 Hz, 1H), 7.50 – 7.45 (m, 2H), 7.44 – 7.37 (m, 1H), 7.25 – 7.20 
(m, 2H), 2.91 (hept, J = 6.9 Hz, 1H), 1.24 (d, J = 6.9 Hz, 6H). 
13
C-NMR (75 MHz, CDCl3): δ 190.79, 149.19, 134.68, 132.72, 132.09, 130.65, 127.35, 126.09, 
125.64, 118.54, 95.63, 83.18, 33.09, 22.70. 
IR (neat, cm
-1
): 2959, 2214, 1695, 1595, 1509, 1461, 1412, 1263, 1192, 1088, 1051, 1017, 834, 
760, 700. 
HRMS (ESI): exact m/z calculated for C18H17O (M+H)
+
: 249.1273; Found: 249.1268 (M+H)
+
. 
 
2-((4-(tert-butyl)phenyl)ethynyl)benzaldehyde (S1o): 
Following GP-2, S1o was prepared from 1-(tert-butyl)-4-iodobenzene 
(520 mg, 2.0 mmol). Purification of the crude product by column 
chromatography (Hexanes: EtOAc, 95:5, Rf = 0.59) afforded S1o as a 
white solid (445 mg, 85% yield). 
1
H-NMR (300 MHz, CDCl3): δ 10.69 (s, 1H), 7.96 (dd, J = 7.8, 0.9 Hz, 1H), 7.66 – 7.55 (m, 
2H), 7.55 – 7.49 (m, 2H), 7.47 – 7.39 (m, 3H), 1.35 (s, 9H). 
13
C-NMR (75 MHz, CDCl3): δ 190.70, 151.39, 134.67, 132.68, 132.08, 130.37, 127.33, 126.08, 
124.47, 118.20, 95.57, 83.24, 33.80, 30.05.  
The obtained data is in accordance with the literature data.
[29]
 
 
2-((2-formylphenyl)ethynyl)benzonitrile (S1p): 
Following GP-2, S1p was prepared from 2-iodobenzonitrile (458 mg, 2.0 
mmol). Purification of the crude product by column chromatography 
(Hexanes: EtOAc, 4:1, Rf = 0.51) afforded S1p as a white solid (291 mg, 
63% yield). 
1
H-NMR (300 MHz, CDCl3): δ 10.65 (s, 1H), 7.94 (d, J = 7.7 Hz, 1H), 7.74 – 7.68 (m, 1H), 
7.68 – 7.63 (m, 2H), 7.62 – 7.55 (m, 2H), 7.47 (m, 2H). 
13
C-NMR (75 MHz, CDCl3): δ 191.29, 136.15, 133.93, 133.86, 132.81, 132.61, 132.42, 129.66, 
129.11, 127.55, 126.37, 125.26, 117.53, 115.39, 91.81, 91.29. 
The obtained data is in accordance with the literature data.
[30]
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2-((4-nitrophenyl)ethynyl)benzaldehyde (S1q): 
Following GP-2, S1q was prepared from 1-bromo-4-nitrobenzene (404 
mg, 2.0 mmol). Purification of the crude product by column 
chromatography (Hexanes: EtOAc, 4:1, Rf = 0.5) afforded S1q as a 
yellow solid (386 mg, 77% yield). 
1
H-NMR (300 MHz, CDCl3): δ 10.58 (s, 1H), 8.27 – 8.20 (m, 2H), 7.99 – 7.93 (m, 1H), 7.74 – 
7.67 (m, 2H), 7.63 (ddd, J = 9.1, 6.0, 1.2 Hz, 2H), 7.56 – 7.48 (m, 1H). 
13
C-NMR (75 MHz, CDCl3): δ 190.97, 147.47, 136.07, 133.94, 133.56, 132.48, 129.68, 129.17, 
127.96, 125.18, 123.80, 93.82, 89.98. 
The obtained data is in accordance with the literature data.
[27] 
 
2-((4-(trifluoromethyl)phenyl)ethynyl)benzaldehyde (S1r): 
Following GP-2, S1r was prepared from 1-bromo-4-
(trifluoromethyl)benzene (450 mg, 2.0 mmol). Purification of the crude 
product by column chromatography (Hexanes: EtOAc, 9:1, Rf = 0.61) 
afforded S1r as a light brown solid (383 mg, 70% yield). 
1
H-NMR (300 MHz, CDCl3): δ 10.59 (s, 1H), 7.93 (dt, J = 7.7, 3.8 Hz, 1H), 7.67 – 7.54 (m, 
6H), 7.50 – 7.43 (m, 1H). 
13
C-NMR (75 MHz, CDCl3): δ 190.18, 134.93, 132.80, 132.36, 130.88, 128.16, 126.55, 124.49, 
124.44, 124.39, 124.34, 93.49, 86.14. 
19
F-NMR (282 MHz, CDCl3): δ -63.35. 
The obtained data is in accordance with the literature data.
[28] 
 
Methyl 4-((2-formylphenyl)ethynyl)benzoate (S1s): 
Following GP-2, S1s was prepared from methyl 4-iodobenzoate (524 
mg, 2.0 mmol). Purification of the crude product by column 
chromatography (Hexanes: EtOAc, 9:1, Rf = 0.52) afforded S1s as a 
white solid (383 mg, 73% yield).  
 
1
H-NMR (300 MHz, CDCl3): δ 10.59 (s, 1H), 8.04 – 7.98 (m, 2H), 7.93 (dd, J = 8.0, 1.0 Hz, 
1H), 7.65 – 7.53 (m, 4H), 7.46 (dt, J = 7.7, 3.9 Hz, 1H), 3.90 (s, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 191.40, 166.41, 135.96, 133.89, 133.40, 131.64, 130.25, 129.69, 
129.16, 127.55, 126.94, 126.11, 95.27, 87.68, 52.37. 
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IR (neat, cm
-1
): 1717, 1689, 1590, 1558, 1542, 1508, 1438, 1402, 1393, 1261, 1191, 1144, 
1105, 1014, 854, 824, 805, 763, 690. 
HRMS (ESI): exact m/z calculated for C17H13O3 (M+H)
+
: 265.0859; Found: 265.0843 (M+H)
+
. 
Mp: 122-124 
o
C (decomposed). 
 
2-((4-(2-methyl-1,3-dioxolan-2-yl)phenyl)ethynyl)benzaldehyde (S1t): 
Following GP-2, S1t was prepared from 2-(4-iodophenyl)-2-methyl-1,3-
dioxolane (580 mg, 2.0 mmol). Purification of the crude product by 
column chromatography (Hexanes: EtOAc, 4:1, Rf = 0.31) afforded S1t as 
a pale yellow solid (519 mg, 89% yield). 
 
1
H-NMR (300 MHz, CDCl3): δ 10.57 (s, 1H), 7.87 (dd, J = 7.8, 0.7 Hz, 1H), 7.56 (ddd, J = 8.0, 
4.4, 1.0 Hz, 1H), 7.52 – 7.41 (m, 5H), 7.41 – 7.34 (m, 1H), 4.05 – 3.91 (m, 2H), 3.78 – 3.64 (m, 
2H), 1.60 (s, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 191.62, 144.45, 135.83, 133.80, 133.24, 131.62, 128.66, 127.28, 
126.81, 125.58, 121.83, 108.54, 96.14, 85.04, 64.54, 27.46. 
IR (neat, cm
-1
): 2895, 1695, 1590, 1508, 1475, 1443, 1400, 1370, 1238, 1192, 1095, 1033, 945, 
872, 818, 759, 707. 
HRMS (ESI): exact m/z calculated for C19H17O3 (M+H)
+
: 293.1172; Found: 293.1188 (M+H)
+
. 
Mp: 75-77 
o
C (decomposed). 
 
2-((4-(1,3-dioxolan-2-yl)phenyl)ethynyl)benzaldehyde (S1u): 
Following GP-2, S1u was prepared from 2-(4-bromophenyl)-1,3-
dioxolane (458 mg, 2.0 mmol). Purification of the crude product by 
column chromatography (Hexanes: EtOAc, 4:1, Rf = 0.43) afforded S1u 
as a white solid (439 mg, 79% yield). 
 
1
H-NMR (300 MHz, CDCl3): δ 10.64 (s, 1H), 7.94 (dt, J = 14.0, 3.8 Hz, 1H), 7.69 – 7.35 (m, 
7H), 5.83 (s, 1H), 4.19 – 3.96 (m, 4H).  
13
C-NMR (75 MHz, CDCl3): δ 191.67, 138.86, 135.85, 133.84, 133.28, 131.72, 128.75, 127.31, 
126.70, 123.13, 103.17, 96.01, 85.41, 65.39. 
IR (neat, cm
-1
): 1692, 1595, 1561, 1509, 1476, 1449, 1386, 1267, 1203, 1166, 1073, 1017, 969, 
939, 861, 827, 760, 704. 
HRMS (ESI): exact m/z calculated for C18H15O3 (M+H)
+
: 279.1016; Found: 279.1006 (M+H)
+
. 
Mp: 60-62 
o
C (decomposed). 
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4-((2-formylphenyl)ethynyl)benzonitrile (S1v) 
Following GP-2, S1v was prepared from 4-bromobenzonitrile (500 mg, 
2.75 mmol). Purification of the crude product by column chromatography 
(Hexanes: EtOAc, 9:1, Rf = 0.31) afforded S1v as a pale yellow solid (514 
mg, 81% yield). 
1
H-NMR (300 MHz, CDCl3): δ 10.59 (s, 1H), 7.97 (ddd, J = 7.7, 1.3, 0.6 Hz, 1H), 7.71 – 7.59 
(m, 6H), 7.52 (tdd, J = 7.1, 1.7, 0.8 Hz, 1H). 
13
C-NMR (75 MHz, CDCl3): δ 191.07, 136.05, 133.92, 133.50, 132.24, 132.21, 129.54, 127.88, 
127.22, 125.39, 118.33, 112.36, 94.10, 89.14.  
The obtained data is in accordance with the literature data.
[31] 
 
(E)-2-styrylbenzaldehyde (S1w):
[32]
 
The mixture of 2-bromobenzaldehyde (1.0 g, 5.4 mmol), styrene (5.6 g, 54 
mmol), potassium phosphate, (1.72 g, 8.1 mmol), Pd(OAc)2 (0.121 g, 0.054 
mmol) and N,N-dimethylacetamide (15 mL) was added to a 100 mL Schlenk 
flask under nitrogen atmosphere and stirred at 140 
o
C for 16 hours. Brine solution (60 mL) was 
added to the reaction mixture and extracted by ethyl acetate (30 mL x 3). The combined organic 
layer was dried over anhydrous Na2SO4. After the solvent was removed under reduced pressure, 
Purification of the crude product by column chromatography (Hexanes: EtOAc, 9:1, Rf = 0.33) 
afforded S1w as a pale yellow oil (0.785 g, 69% yield). 
1
H-NMR (300 MHz, CDCl3): δ 10.32 (s, 1H), 8.07 (d, J = 16.2 Hz, 1H), 7.85 (dd, J = 7.7, 1.3 
Hz, 1H), 7.73 (d, J = 7.7 Hz, 1H), 7.59 (dt, J = 9.9, 2.1 Hz, 3H), 7.48 – 7.28 (m, 4H), 7.07 (d, J = 
16.2 Hz, 1H). 
13
C-NMR (75 MHz, CDCl3): δ 192.83, 140.03, 136.99, 134.08, 133.86, 133.01, 132.50, 128.90, 
128.44, 127.74, 127.28, 127.11, 124.87. 
The obtained data is in accordance with the literature data.
[32]  
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3.9.5 Bromination of triethyl phosphonoacetate:
[33] 
 
Triethyl dibromophosphonoacetate (2ab): A solution of sodium hydroxide (20 g, 500.0 mmol, 
10.00 equiv) in H2O (60 mL) was prepared in a 500-mL, three-necked, round-bottomed flask 
fitted with a thermometer and a dropping funnel. The solution was cooled to 0 
o
C in an ice-salt 
bath, and bromine (40 g, 12.81 mL, 250.0 mmol, 5.00 equiv) was slowly added with stirring over 
25 min at a rate such that, the temperature did not exceed over 10 
o
C. Triethyl phosphonoacetate 
2aa (12 g, 53.5 mmol, 1.00 equiv) was added over 3 min to the freshly prepared, stirred sodium 
hypobromite (NaOBr) solution cooled in an ice-salt bath. Then the mixture was immediately 
extracted with chloroform (3 x 70 mL). The chloroform extracts were washed with water (2 x 20 
mL) and dried over Na2SO4 and the solvent was removed in vacuo. The residue was partitioned 
between hexane (300 mL) and H2O (2 x 5 ml), and the hexane extracts were again dried over 
Na2SO4. After removing the solvents in vacuo provided 2ab 19.01 g (93%) as a pure product.  
1
H-NMR (300 MHz, CDCl3): δ 4.40-4.20 (m, 6H), 1.39-1.22 (m, 9H) 
13
C-NMR (75 MHz, CDCl3): δ 163.70, 66.39, 66.30, 64.56, 47.97, 45.86, 16.41, 16.34, 13.69. 
31
P-NMR (121 MHz, CDCl3): δ 8.34. 
Triethyl Bromophosphonoacetate (2ac): To triethyl dibromophosphonoacetate 2ab (18 g, 47 
mmol, 1.00 equiv) dissolved in EtOH (50 mL) was added with cooling (ice bath) a solution of 
9.56 g (42.40 mmol, 0.90 equiv) of SnCl2.2H2O in H2O (100 mL). The temperature was 
maintained below 10 
o
C. When the addition was complete (20 min), the reaction mixture was 
stirred for an additional 5 min at room temperature and then extracted with chloroform (3 x 75 
mL). The chloroform extracts were dried over Na2SO4, and the solvent was removed in vacuo. 
The desired product was isolated by partitioning the crude residue between hexane (150 mL) and 
H2O (4 x 50 mL). The aqueous fractions were combined and re-extracted with chloroform (3 x 
75 mL). The chloroform extracts were dried over Na2SO4 and evaporated at reduced pressure to 
provide 10 g (72%) of pure triethyl bromophosphonoacetate 2ac.  
1
H-NMR (300 MHz, CDCl3): δ 4.40 – 4.18 (m, 7H), 1.44 – 1.24 (m, 9H). 
13
C-NMR (75 MHz, CDCl3): δ 165.05, 64.67, 64.59, 63.11, 36.78, 34.85, 16.39, 16.31, 13.92. 
31
P-NMR (121 MHz, CDCl3): δ 13.17. 
The obtained data is in accordance with the literature data.
[33]
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3.9.6 General procedure (GP-3) for the preparation of α-bromocinnamates: 
 
Potassium tert-butoxide (1.50 mmol, 1.50 equiv) was slowly added to triethyl 
bromophosphonoacetate 2ac (1.50 mmol, 1.50 equiv) in anhydrous THF (15 mL) under a 
positive nitrogen atmosphere at 0 
o
C. The resulting mixture allowed stirring for 1 h, followed by 
slow addition of desired aldehyde S1 (1.00 mmol, 1.00 equiv) in 3 mL THF over 5 min, the 
resulting mixture stirred under an inert atmosphere for 2 h at 0 
o
C. The progress of the reaction 
monitored by TLC analysis (staining with 2, 4-DNP / KMnO4); after complete consumption of 
the starting material, the reaction was quenched by adding saturated ammonium chloride solution 
(10 mL) and extracted with ethyl acetate (10 mL x 3). Combined organic layer was washed with 
brine (20 mL), dried over anhydrous Na2SO4, and concentrated in vacuo. Purification of the 
crude product by silica gel column chromatography using Hexanes/EtOAc solvent system 
afforded pure α-bromocinnamates. 
Ethyl 2-bromo-3-(2-(phenylethynyl)phenyl)acrylate (1a): 
Following GP-3, 1a was prepared from S1a (1.65 g, 8.0 mmol). Purification 
of the crude product by column chromatography (Hexanes: EtOAc, 95:5, Rf 
= 0.48) afforded 1a as a yellow viscous oil (2.49 g, 88% yield, Z:E = 82:18).  
 
1
H-NMR (300 MHz, CDCl3, Z isomer, major): δ 8.76 (s, 1H), 8.20 – 8.13 (m, 1H), 7.63 – 7.50 
(m, 3H), 7.44 – 7.27 (m, 5H), 4.38 (q, J = 7.1 Hz, 2H), 1.39 (t, J = 7.1 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3, Z isomer, major): δ 163.20, 139.51, 135.66, 132.15, 131.61, 
129.64, 128.85, 128.78, 128.47, 127.95, 124.66, 122.81, 115.07, 96.21, 87.09, 62.87, 14.28. 
IR (neat, cm
-1
): 2983, 2215, 1720, 1599, 1493, 1468, 1443, 1367, 1230, 1193, 1092, 1035, 985, 
914, 871, 836, 752, 688, 630, 536, 497. 
HRMS (ESI): exact m/z calculated for C19H16BrO2 (M+H)
+
: 355.0328; Found: 355.0331 
(M+H)
+
. 
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Ethyl 2-bromo-3-(5-methoxy-2-(phenylethynyl)phenyl)acrylate (1b): 
Following GP-3, 1b was prepared from S1b (308 mg, 1.30 mmol). 
Purification of the crude product by column chromatography (Hexanes: 
EtOAc, 9:1, Rf = 0.32) afforded 1b as a brown solid (466 mg, 93% yield. 
Z:E = 99:01).  
1
H-NMR (300 MHz, CDCl3, Z isomer, major): δ 8.75 (s, 1H), 7.76 (d, J = 2.6 Hz, 1H), 7.57 – 
7.50 (m, 3H), 7.38 – 7.31 (m, 3H), 6.95 (dd, J = 8.6, 2.7 Hz, 1H), 4.38 (q, J = 7.1 Hz, 2H), 3.87 
(s, 3H), 1.38 (t, J = 7.1 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3, Z isomer, major): δ 163.15, 159.03, 139.32, 136.89, 133.43, 
131.38, 128.40, 123.15, 117.09, 116.09, 115.13, 113.92, 94.76, 87.05, 62.90, 55.54, 14.26. 
IR (neat, cm
-1
): 2973, 1718, 1595, 1494, 1474, 1441, 1292, 1218, 1165, 1099, 1030, 902, 833, 
752, 688, 720, 688. 
HRMS (ESI): exact m/z calculated for C20H18BrO3 (M+H)
+
: 385.0434; Found: 385.0432 
(M+H)
+
. 
Mp: 48-50 
o
C (decomposed). 
 
Ethyl 2-bromo-3-(6-(phenylethynyl)benzo[d][1,3]dioxol-5-yl)acrylate (1c): 
Following GP-3, 1c was prepared from S1c (250 mg, 1.0 mmol). 
Purification of the crude product by column chromatography (Hexanes: 
EtOAc, 4:1, Rf = 0.62) afforded 1c as a brown solid (369 mg, 92% yield, 
Z:E = 82:18). 
1
H-NMR (300 MHz, CDCl3, Z isomer, major): δ 8.79 (s, 1H), 7.86 (s, 1H), 7.59 – 7.49 (m, 
2H), 7.39 – 7.31 (m, 3H), 7.03 (s, 1H), 6.06 (s, 2H), 4.36 (q, J = 7.1 Hz, 2H), 1.36 (t, J = 7.1 Hz, 
3H). 
13
C-NMR (75 MHz, CDCl3, Z isomer, major): δ 163.35, 148.85, 147.67, 138.87, 131.44, 
130.31, 128.63, 128.44, 122.83, 120.14, 112.99, 111.59, 108.61, 102.07, 95.49, 87.09, 62.79, 
14.28. 
IR (neat, cm
-1
): 2981, 2906, 1706, 1598, 1503, 1476, 1455, 1393, 1358, 1329, 1248, 1219, 
1135, 1033, 986, 932, 890, 748, 681, 573, 550, 505, 486. 
HRMS (ESI): exact m/z calculated for C20H16BrO4 (M+H)
+
: 399.0226; Found: 399.0231 
(M+H)
+
. 
Mp: 119-121 
o
C (decomposed). 
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Ethyl 2-bromo-3-(4,5-dimethoxy-2-(phenylethynyl)phenyl)acrylate (1d): 
Following GP-3, 1d was prepared from S1d (266 mg, 1.0 mmol). 
Purification of the crude product by column chromatography (Hexanes: 
EtOAc, 4:1, Rf = 0.52) afforded 1d as a brown solid (377 mg, 91% yield, 
Z:E = 84:16).  
1
H-NMR (300 MHz, CDCl3, Z isomer, major): δ 8.82 (s, 1H), 7.98 (s, 1H), 7.59 – 7.49 (m, 
2H), 7.40 – 7.30 (m, 3H), 7.06 (s, 1H), 4.35 (q, J = 7.1 Hz, 2H), 3.94 (s, 3H), 3.93 (s, 3H), 1.37 
(t, J = 7.1 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3, Z isomer, major):
 δ 163.41, 150.15, 148.63, 138.69, 131.41, 
128.44, 122.93, 118.94, 114.01, 112.27, 111.16, 95.27, 87.12, 62.77, 56.05, 14.29. 
IR (neat, cm
-1
): 1703, 1592, 1506, 1463, 1335, 1291, 1254, 1209, 1167, 1091, 1029, 1001, 967, 
892, 858, 759, 695, 635, 530, 503. 
HRMS (ESI): exact m/z calculated for C21H20BrO4 (M+H)
+
: 415.0539; Found: 415.0539 
(M+H)
+
.  
Mp: 80-82 
o
C. 
 
Ethyl 2-bromo-3-(4,5-dimethoxy-2-((4-nitrophenyl)ethynyl)phenyl)acrylate (1e): 
Following GP-3, 1e was prepared from S1e (311 mg, 1.0 mmol). 
Purification of the crude product by column chromatography (Hexanes: 
EtOAc, 4:1, Rf = 0.33) afforded 1e as a yellow solid (400 mg, 87% 
yield, Z:E = 99:01).  
1
H-NMR (300 MHz, CDCl3, Z isomer, major): δ 8.75 (s, 1H), 8.21 (d, J = 8.8 Hz, 2H), 7.96 (s, 
1H), 7.67 (d, J = 8.8 Hz, 2H), 7.07 (s, 1H), 4.37 (q, J = 7.1 Hz, 2H), 3.95 (s, 3H), 3.95 (s, 3H), 
1.38 (t, J = 7.1 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3, Z isomer, major): δ 163.28, 150.17, 149.49, 147.03, 138.19, 
131.99, 129.88, 129.31, 123.75, 117.36, 114.17, 112.85, 111.26, 93.30, 92.46, 62.90, 56.12, 
14.34. 
IR (neat, cm
-1
): 2206, 1704, 1589, 1491, 1450, 1403, 1333, 1235, 1212, 1168, 1091, 1034, 987, 
894, 850, 781, 748, 686, 581, 575, 503, 415. 
HRMS (ESI): exact m/z calculated for C21H19BrNO6 (M+H)
+
: 460.039; Found: 460.0389 
(M+H)
+
.  
Mp: 140-142 
o
C (decomposed). 
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Ethyl 2-bromo-3-(2-(phenylethynyl)pyridin-3-yl)acrylate (1f): 
Following GP-3, 1f was prepared from S1f (207 mg, 1.0 mmol). Purification 
of the crude product by column chromatography (Hexanes: EtOAc, 4:1, Rf = 
0.6) afforded 1f as a brown solid (316 mg, 89% yield, Z:E = 99:01).. 
 
1
H-NMR (300 MHz, CDCl3, Z isomer, major): δ 8.70 (s, 1H), 8.63 (dd, J = 4.8, 1.6 Hz, 1H), 
8.47 (ddd, J = 8.1, 1.6, 0.6 Hz, 1H), 7.67 – 7.59 (m, 2H), 7.44 – 7.30 (m, 4H), 4.40 (q, J = 7.1 
Hz, 2H), 1.40 (t, J = 7.1 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3, Z isomer, major): δ 162.66, 150.51, 143.63, 137.05, 136.25, 
132.29, 132.14, 129.57, 128.52, 122.18, 121.75, 117.33, 96.18, 86.54, 63.13, 14.24. 
IR (neat, cm
-1
): 2991, 2219, 1712, 1599, 1549, 1492, 1443, 1413, 1361, 1237, 1152, 1094, 
1034, 988, 902, 861, 836, 806, 759, 688, 640, 545, 501. 
HRMS (ESI): exact m/z calculated for C18H15BrNO2 (M+H)
+
: 356.0281; Found: 356.0285 
(M+H)
+
.  
Mp: 78-80 
o
C 
 
Ethyl 2-bromo-3-(5-nitro-2-(phenylethynyl)phenyl)acrylate (1g): 
Following GP-3, 1g was prepared from S1g (281 mg, 1.0 mmol). 
Purification of the crude product by column chromatography (Hexanes: 
EtOAc, 9:1, Rf = 0.47) afforded 1e as a yellow solid (332 mg, 83% yield, 
E:Z = 95:05). 
1
H-NMR (300 MHz, CDCl3, E isomer, major): δ 8.19 (d, J = 2.2 Hz, 1H), 8.13 (dd, J = 8.5, 
2.3 Hz, 1H), 7.68 (s, 1H), 7.63 (d, J = 8.5 Hz, 1H), 7.55 – 7.49 (m, 2H), 7.39 – 7.33 (m, 3H), 
4.15 (q, J = 7.1 Hz, 2H), 1.10 (t, J = 7.1 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3, E isomer, major): δ 162.84, 146.54, 138.42, 137.78, 132.65, 
132.01, 129.72, 128.87, 128.66, 123.28, 123.16, 121.71, 117.00, 100.16, 85.91, 62.90, 13.70. 
IR (neat, cm
-1
): 2984, 2208, 1709, 1600, 1575, 1513, 1497, 1465, 1435, 1338, 1285, 1267, 
1227, 1186, 1113, 1074, 1029, 983 912, 847, 823, 753, 735, 683, 658, 570, 531, 476, 418. 
HRMS (ESI): exact m/z calculated for C19H14BrNNaO4 (M+Na)
+
: 421.9998; Found: 421.9999 
(M+Na)
+
.  
Mp: 65-67
 o
C. 
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Ethyl 2-bromo-3-(4-methyl-2-(phenylethynyl)phenyl)acrylate (1h): 
Following GP-3, 1h was prepared from S1h (220 mg, 1.0 mmol). 
Purification of the crude product by column chromatography (Hexanes: 
EtOAc, 9:1, Rf = 0.56) afforded 1h as a yellow oil (306 mg, 83% yield, Z:E 
= 80:20). 
1
H-NMR (300 MHz, CDCl3, Z isomer, major): δ 8.76 (s, 1H), 8.12 (d, J = 8.1 Hz, 1H), 7.57 – 
7.50 (m, 2H), 7.41 (s, 1H), 7.37 – 7.31 (m, 3H), 7.20 (d, J = 8.1 Hz, 1H), 4.35 (q, J = 7.1 Hz, 
2H), 2.35 (s, 3H), 1.36 (t, J = 7.1 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3, Z isomer, major): δ 162.25, 139.05, 138.26, 131.66, 131.61, 
131.46, 130.51, 127.85, 127.65, 127.63, 127.37, 126.84, 123.75, 121.80, 112.94, 94.78, 86.15, 
61.70, 20.27, 13.21. 
IR (neat, cm
-1
): 2976, 2207, 1720, 1598, 1492, 1442, 1366, 1228, 1195, 1094, 1034, 982, 880, 
841, 814, 752, 688. 
HRMS (ESI): exact m/z calculated for C20H17BrNaO2 (M+Na)
+
: 391.0304; Found: 391.0307 
(M+Na)
+
. 
 
Ethyl 2-bromo-3-(5-fluoro-2-(phenylethynyl)phenyl)acrylate (1i): 
Following GP-3, 1i was prepared from S1i (505 mg, 2.25 mmol). 
Purification of the crude product by column chromatography (Hexanes: 
EtOAc, 9:1, Rf = 0.38) afforded 1i as a brown oil (756 mg, 90% yield, Z:E 
= 81:19). 
1
H-NMR (300 MHz, CDCl3, Z isomer, major):
 δ 8.72 (s, 1H), 7.94 (dd, J = 10.0, 2.7 Hz, 1H), 
7.61 – 7.51 (m, 2H), 7.40 – 7.30 (m, 4H), 7.16 – 7.03 (m, 1H), 4.38 (q, J = 7.1 Hz, 2H), 1.39 (t, J 
= 7.1 Hz, 1H).  
13
C-NMR (75 MHz, CDCl3, Z isomer, major): δ 162.90, 160.04, 138.24, 137.69, 133.91, 
132.53, 131.54, 129.24, 128.82, 128.48, 122.63, 117.21, 115.78, 95.87, 86.10, 63.02, 14.23. 
19
F-NMR (282 MHz, CDCl3): δ -110.10 (Z); -111.19 (E). 
IR (neat, cm
-1
): 2983, 1724, 1596, 1571, 1495, 1475, 1443, 1367, 1244, 1205, 1158, 1095, 
1035, 989, 871, 822, 752, 722, 688, 638, 527, 495. 
HRMS (ESI): exact m/z calculated for C19H15BrFO2 (M+H)
+
: 373.0234; Found: 373.0237 
(M+H)
+
. 
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Ethyl 2-bromo-3-(2-((4-methoxyphenyl)ethynyl)phenyl)acrylate (1j): 
Following GP-3, 1j was prepared from S1j (236 mg, 1.0 mmol). 
Purification of the crude product by column chromatography (Hexanes: 
EtOAc, 95:5, Rf = 0.3) afforded 1j as a red solid (327 mg, 85% yield, Z:E 
= 73:27). 
 
1
H-NMR (300 MHz, CDCl3, Z isomer, major): δ 8.78 (s, 1H), 8.21 – 8.14 (m, 1H), 7.60 – 7.23 
(m, 5H), 6.93 – 6.80 (m, 2H), 4.38 (q, J = 7.1 Hz, 2H), 3.81 (s, 3H), 1.39 (t, J = 7.1 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3, Z isomer, major): δ 163.21, 160.27, 160.04, 139.62, 135.33, 
134.07, 133.13, 131.91, 129.68, 128.81, 127.57, 125.13, 114.18, 114.12, 96.51, 85.98, 81.32, 
73.07, 62.85, 55.33, 14.32. 
IR (neat, cm
-1
): 2980, 2211, 1714, 1605, 1569, 1509, 1461, 1287, 1243, 1175, 1090, 1025, 985, 
889, 861, 824, 754, 689. 
HRMS (ESI): exact m/z calculated for C20H17BrNaO3 (M+Na)
+
: 407.0253; Found: 407.0254 
(M+Na)
+
. 
Mp: 95-97 
o
C (decomposed). 
 
Ethyl 2-bromo-3-(2-((4-chlorophenyl)ethynyl)phenyl)acrylate (1k): 
Following GP-3, 1k was prepared from S1k (430 mg, 1.78 mmol). 
Purification of the crude product by column chromatography (Hexanes: 
EtOAc, 9:1, Rf = 0.6) afforded 1k as a light brown solid (592 mg, 85% yield, 
Z:E = 91:09).  
1
H-NMR (300 MHz, CDCl3, Z isomer, major):
 δ 8.67 (s, 1H), 8.16 – 8.06 (m, 1H), 7.57 – 7.50 
(m, 1H), 7.46 – 7.40 (m, 2H), 7.38 – 7.33 (m, 2H), 7.32 – 7.25 (m, 2H), 4.33 (q, J = 7.1 Hz, 2H), 
1.34 (t, J = 7.1 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3, Z isomer, major): δ 163.16, 139.35, 135.70, 134.80, 132.79, 
132.14, 129.64, 128.87, 128.83, 128.16, 124.26, 121.30, 115.14, 94.97, 88.01, 62.89, 14.29. 
IR (neat, cm
-1
): 2972, 2927, 1723, 1614, 1489, 1389, 1231, 1085, 1034, 984, 863, 816, 750; 
HRMS (ESI): exact m/z calculated for C19H14BrClNaO2 (M+Na)
+
: 410.9758; Found: 410.9758 
(M+Na)
+
. 
Mp: 55-57 
o
C (decomposed). 
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Ethyl 2-bromo-3-(2-((4-bromophenyl)ethynyl)phenyl)acrylate (1l): 
Following GP-3, 1l was prepared from S1l (320 mg, 1.12 mmol). 
Purification of the crude product by column chromatography (Hexanes: 
EtOAc, 9:1, Rf = 0.52) afforded 1l as a brown solid (445 mg, 91% yield, 
Z:E = 76:24).  
1
H-NMR (300 MHz, CDCl3, Z isomer, major):
 δ 8.71 (s, 1H), 8.19 – 8.12 (m, 1H), 8.18 – 8.11 
(m, 1H), 7.61 – 7.56 (m, 1H), 7.53 – 7.47 (m, 2H), 7.44 – 7.37 (m, 4H), 4.38 (q, J = 7.1 Hz, 2H), 
1.38 (t, J = 7.1 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3, Z isomer, major): δ 163.15, 139.34, 135.71, 132.98, 132.14, 
131.75, 129.64, 128.88, 128.19, 124.24, 123.05, 121.76, 115.16, 95.02, 88.19, 62.89, 14.30.  
IR (neat, cm
-1
): 2975, 2928, 1714, 1606, 1488, 1391, 1364, 1338, 1284, 1220, 1108, 1068, 
1026, 1007, 885, 864, 815, 790, 745. 
HRMS (ESI): exact m/z calculated for C19H14Br2NaO2 (M+Na)
+
: 454.9253; Found: 454.9253 
(M+Na)
+
. 
Mp: 58-60 
o
C (decomposed). 
 
Ethyl 2-bromo-3-(2-(p-tolylethynyl)phenyl)acrylate (1m): 
Following GP-3, 1m was prepared from S1m (418 mg, 1.89 mmol). 
Purification of the crude product by column chromatography (Hexanes: 
EtOAc, 9:1, Rf = 0.56) afforded 1m as a brown oil (623 mg, 89% yield, Z:E 
= 80:20). 
1
H-NMR (300 MHz, CDCl3, Z isomer, major): δ 8.75 (s, 1H), 8.18 – 8.10 (m, 1H), 7.61 – 7.54 
(m, 1H), 7.42 (dd, J = 8.8, 5.8 Hz, 2H), 7.40 – 7.33 (m, 2H), 7.19 – 7.11 (m, 2H), 4.36 (q, J = 7.1 
Hz, 2H), 1.37 (t, J = 7.1 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3, Z isomer, major): δ 163.21, 139.59, 139.00, 135.54, 132.05, 
131.51, 129.61, 129.22, 128.82, 127.72, 124.92, 119.74, 114.95, 96.50, 86.51, 62.83, 21.60, 
14.29. 
IR (neat, cm
-1
): 2976, 2212, 1720, 1608, 1601, 1510, 1468, 1366, 1229, 1034, 982, 868, 839, 
814, 756 
HRMS (ESI): exact m/z calculated for C20H17BrNaO2 (M+Na)
+
: 391.0304; Found: 391.0311 
(M+Na)
+
. 
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Ethyl 2-bromo-3-(2-((4-isopropylphenyl)ethynyl)phenyl)acrylate (1n): 
Following GP-3, 1n was prepared from S1n (350 mg, 1.4 mmol). 
Purification of the crude product by column chromatography (Hexanes: 
EtOAc, 9:1, Rf = 0.43) afforded 1n as a yellow viscous oil (473 mg, 84% 
yield, Z:E = 77:23). 
1
H-NMR (300 MHz, CDCl3, Z isomer, major): δ 8.75 (s, 1H), 8.18 – 8.08 (m, 1H), 7.62 – 7.53 
(m, 1H), 7.52 – 7.43 (m, 2H), 7.41 – 7.34 (m, 2H), 7.26 – 7.16 (m, 2H), 4.37 (q, J = 7.1 Hz, 2H), 
2.91 (hept, J = 6.9 Hz, 1H), 1.37 (t, J = 7.1 Hz, 3H), 1.24 (d, J = 6.9 Hz, 6H). 
13
C-NMR (75 MHz, CDCl3, Z isomer, major): δ 163.22, 149.89, 139.62, 135.57, 132.07, 
131.63, 129.61, 128.82, 127.72, 126.61, 124.94, 120.11, 114.94, 96.53, 86.44, 62.84, 34.17, 
23.83, 14.29. 
IR (neat, cm
-1
): 2959, 2214, 1722, 1610, 1509, 1464, 1412, 1334, 1230, 1092, 1036, 831, 752; 
HRMS (ESI): exact m/z calculated for C22H21BrNaO2 (M+Na)
+
: 419.0617; Found: 419.0621 
(M+Na)
+
. 
 
Ethyl 2-bromo-3-(2-((4-(tert-butyl)phenyl)ethynyl)phenyl)acrylate (1o): 
Following GP-3, 1o was prepared from S1o (350 mg, 1.34 mmol). 
Purification of the crude product by column chromatography (Hexanes: 
EtOAc, 9:1, Rf = 0.32) afforded 1o as a yellow oil (472 mg, 86% yield, Z:E 
= 80:20). 
1
H-NMR (300 MHz, CDCl3, Z isomer, major): δ 8.75 (s, 1H), 8.18 – 8.10 (m, 1H), 7.62 – 7.55 
(m, 1H), 7.53 – 7.44 (m, 2H), 7.40 – 7.25 (m, 4H), 4.36 (q, J = 7.1 Hz, 2H), 1.37 (t, J = 7.1 Hz, 
4H), 1.32 (s, 9H). 
13
C-NMR (75 MHz, CDCl3, Z isomer, major): δ 162.13, 151.04, 138.54, 134.51, 131.00, 
130.28, 128.51, 127.74, 126.63, 124.38, 123.85, 118.71, 113.85, 95.39, 85.42, 61.75, 33.80, 
30.11, 13.20. 
IR (neat, cm
-1
): 2960, 2214, 1722, 1609, 1508, 1466, 1392, 1364, 1247, 1191, 1088, 1028, 832, 
800, 758, 699. 
HRMS (ESI): exact m/z calculated for C23H24BrO2 (M+H)
+
: 411.0954; Found: 411.0955 
(M+H)
+
. 
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Ethyl 2-bromo-3-(2-((2-cyanophenyl)ethynyl)phenyl)acrylate (1p): 
Following GP-3, 1p was prepared from S1p (215 mg, 0.93 mmol). 
Purification of the crude product by column chromatography (Hexanes: 
EtOAc, 9:1, Rf = 0.27) afforded 1p as a pale yellow solid (279 mg, 79% 
yield, Z:E = 85:15).  
 
1
H-NMR (300 MHz, CDCl3, Z isomer, major):
 
 δ 8.69 (s, 1H), 8.13 – 8.08 (m, 1H), 7.73 – 7.64 
(m, 3H), 7.59 (tt, J = 7.7, 1.8 Hz, 1H), 7.50 – 7.38 (m, 3H), 4.38 (q, J = 7.1 Hz, 2H), 1.38 (t, J = 
7.1 Hz, 3H). 
 
13
C-NMR (75 MHz, CDCl3, Z isomer, major): δ 163.13, 139.06, 136.15, 133.00, 132.72, 
132.45, 132.41, 129.57, 128.95, 128.72, 126.73, 123.06, 117.38, 116.02, 115.10, 93.27, 91.53, 
62.89, 14.23. 
IR (neat, cm
-1
): 2976, 2227, 1714, 1592, 1486, 1442, 1389, 1366, 1330, 1284, 1218, 1098, 
1036, 980, 902, 874, 839, 753. 
HRMS (ESI): exact m/z calculated for C20H15BrNO2 (M+H)
+
: 380.0281; Found: 380.0284 
(M+H)
+
.  
Mp: 91-93 
o
C (decomposed). 
 
Ethyl 2-bromo-3-(2-((4-nitrophenyl)ethynyl)phenyl)acrylate (1q): 
Following GP-3, 1q was prepared from S1q (251 mg, 1.0 mmol). 
Purification of the crude product by column chromatography (Hexanes: 
EtOAc, 4:1, Rf = 0.47) afforded 1q as a yellow solid (324 mg, 81% yield, 
Z:E = 99:01).  
1
H-NMR (300 MHz, CDCl3, Z isomer, major): δ 8.66 (s, 1H), 8.23 – 8.15 (m, 2H), 8.15 – 8.07 
(m, 1H), 7.69 – 7.61 (m, 2H), 7.61 – 7.55 (m, 1H), 7.41 (pd, J = 7.4, 1.5 Hz, 2H), 4.35 (q, J = 7.1 
Hz, 2H), 1.36 (t, J = 7.1 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3, Z isomer, major): δ 163.07, 147.25, 138.98, 136.16, 132.45, 
132.28, 129.01, 128.99, 123.75, 123.26, 115.59, 93.90, 92.12, 62.99, 14.30. 
IR (neat, cm
-1
): 2985, 2213, 1721, 1589, 1511, 1469, 1445, 1367, 1340, 1231, 1195, 1104, 
1032, 849, 748, 684. 
HRMS (ESI): exact m/z calculated for C19H14BrNNaO4 (M+Na)
+
: 421.9998; Found: 421.9997 
(M+Na)
+
. 
Mp: 104-106 
o
C 
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Ethyl 2-bromo-3-(2-((4-(trifluoromethyl)phenyl)ethynyl)phenyl)acrylate (1r): 
Following GP-4, 1r was prepared from S1r (330 mg, 1.2 mmol). 
Purification of the crude product by column chromatography (Hexanes: 
EtOAc, 9:1, Rf = 0.67) afforded 1r as a brown viscous oil (465 mg, 91% 
yield, Z:E = 76:24). 
1
H-NMR (300 MHz, CDCl3, Z isomer, major):
 δ 8.73 (s, 1H), 8.20 – 8.14 (m, 1H), 7.70 – 7.59 
(m, 5H), 7.43 (tt, J = 8.9, 3.0 Hz, 1H), 7.36 – 7.30 (m, 1H), 4.39 (q, J = 7.1 Hz, 2H), 1.39 (t, J = 
7.1 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3, Z isomer, major): δ 162.05, 138.13, 134.90, 133.18, 131.25, 
128.58, 127.85, 127.47, 126.48, 125.56, 124.33 (q, J = 3.8 Hz), 122.73, 114.30, 93.42, 88.25, 
61.85, 13.20. 
19
F-NMR (282 MHz, CDCl3, Z isomer): δ -63.30. 
IR (neat, cm
-1
): 2962, 1722, 1612, 1470, 1404, 1319, 1251, 1165, 1122, 1062, 1014, 839, 800, 
758, 697. 
HRMS (ESI): exact m/z calculated for C20H14BrF3NaO2 (M+Na)
+
: 445.0021; Found: 445.0024 
(M+Na)
+
. 
 
Methyl 4-((2-(2-bromo-3-ethoxy-3-oxoprop-1-en-1-yl)phenyl)ethynyl)benzoate (1s): 
Following GP-3, 1s was prepared from S1s (370 mg, 1.4 mmol). 
Purification of the crude product by column chromatography (Hexanes: 
EtOAc, 9:1, Rf = 0.26) afforded 1s as a brown solid (509 mg, 88% yield, 
Z:E = 72:28). 
 
1
H-NMR (300 MHz, CDCl3, Z isomer, major): δ 8.68 (s, 1H), 8.15 – 8.09 (m, 1H), 8.02 – 7.96 
(m, 2H), 7.60 – 7.52 (m, 3H), 7.41 – 7.34 (m, 2H), 4.34 (q, J = 7.1 Hz, 2H), 3.88 (s, 3H), 1.34 (t, 
J = 7.1 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3, Z isomer, major): δ 166.48, 163.11, 139.21, 135.91, 132.31, 
131.48, 129.66, 129.60, 128.91, 128.47, 128.01, 127.45, 123.96, 115.37, 95.20, 89.89, 62.93, 
52.33, 14.30; IR (neat, cm
-1
): 2958, 2926, 1715, 1704, 1602, 1462, 1447, 1428, 1271, 1244, 
1189, 1105, 1031, 979, 959, 791, 886, 857, 838, 761, 749, 693. 
HRMS (ESI): exact m/z calculated for C21H17BrNaO4 (M+Na)
+
: 435.0202; Found: 435.0209 
(M+Na)
+
.  
Mp: 77-79 
o
C (decomposed). 
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Ethyl 3-(2-((4-acetylphenyl)ethynyl)phenyl)-2-bromoacrylate (1t): 
Following GP-3, 1t was prepared from S1t (266 mg, 0.91 mmol). The 
crude product treated with aq. HCl (1 M, 10 mL) and reaction mixture was 
neutralized with saturated sodium bicarbonate solution. The crude product 
purified by column chromatography (Hexanes: EtOAc, 9:1, Rf = 0.13) 
afforded 1t as a yellow solid (285 mg, 79% yield, Z:E = 85:15). 
1
H-NMR (300 MHz, CDCl3, Z isomer, major):
 δ 8.70 (s, 1H), 8.17 – 8.10 (m, 1H), 7.95 – 7.87 
(m, 2H), 7.63 – 7.57 (m, 3H), 7.44 – 7.34 (m, 2H), 4.36 (q, J = 7.1 Hz, 2H), 2.58 (s, 3H), 1.37 (t, 
J = 7.1 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3, Z isomer, major): δ 197.22, 163.05, 139.14, 136.50, 135.86, 
132.31, 131.67, 129.67, 128.88, 128.52, 128.34, 127.58, 123.91, 115.31, 95.21, 90.22, 62.91, 
26.66, 14.31. 
IR (neat, cm
-1
): 2973, 1722, 1683, 1598, 1557, 1468, 1424, 1402, 1259, 1217, 1109, 1028, 988, 
955, 901, 868, 831, 753, 726. 
HRMS (ESI): exact m/z calculated for C21H18BrO3 (M+H)
+
: 397.0434; Found: 397.044 (M+H)
+
. 
Mp: 89-91 
o
C (decomposed). 
 
Ethyl 2-bromo-3-(2-((4-formylphenyl)ethynyl)phenyl)acrylate (1u): 
Following GP-3, 1u was prepared from S1u (935 mg, 3.36 mmol). The 
crude product treated with aq. HCl (1 M, 10 mL) and reaction mixture was 
neutralized with saturated sodium bicarbonate solution. The crude product 
purified by column chromatography (Hexanes: EtOAc, 4:1, Rf = 0.6) 
afforded 2u as a yellow solid (879 mg, 68% yield, Z:E = 80:20).  
1
H-NMR (300 MHz, CDCl3, Z isomer, major):
 δ 9.96 (s, 1H), 8.66 (s, 1H), 8.14 – 8.06 (m, 
1H), 7.84 – 7.78 (m, 2H), 7.68 – 7.59 (m, 2H), 7.58 – 7.52 (m, 1H), 7.43 – 7.31 (m, 2H), 4.33 (q, 
J = 7.1 Hz, 2H), 1.33 (t, J = 7.1 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3, Z isomer, major): 
13C δ 191.37, 163.06, 139.09, 135.98, 135.72, 
132.38, 132.08, 129.64, 128.93, 128.69, 123.72, 115.43, 95.04, 90.91, 62.94, 14.30. 
IR (neat, cm
-1
): 2984, 2864, 1722, 1694, 1598, 1561, 1468, 1445, 1387, 1278, 1239, 1199, 
1167, 1113, 1091, 1031, 987, 889, 822, 744, 689. 
HRMS (ESI): exact m/z calculated for C20H16BrO3 (M+H)
+
: 383.0277; Found: 383.0279 
(M+H)
+
. 
Mp 68-70 
o
C (decomposed). 
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Ethyl 2-bromo-3-(2-((4-cyanophenyl)ethynyl)phenyl)acrylate (1v): 
Following GP-3, 1v was prepared from S1v (495 mg, 2.14 mmol). 
Purification of the crude product by column chromatography (Hexanes: 
EtOAc, 9:1, Rf = 0.42) afforded 1v as a light brown solid (667 mg, 82% 
yield, Z:E = 70:30). 
1
H-NMR (300 MHz, CDCl3, Z isomer, major):
 
 δ 8.68 (s, 1H), 8.14 (dt, J = 4.4, 2.6 Hz, 1H), 
7.69 – 7.58 (m, 5H), 7.43 (td, J = 7.0, 1.6 Hz, 1H), 7.36 – 7.29 (m, 1H), 4.38 (q, 7.1 Hz, 2H), 
1.38 (t, J = 7.1 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3, Z isomer):  δ 163.07, 139.37, 139.03, 136.06, 132.39, 132.15, 
132.05, 129.67, 128.62, 128.05, 127.69, 123.41, 118.43, 115.48, 111.94, 94.14, 91.26, 62.94, 
14.28. 
IR (neat, cm
-1
): 2985, 2227, 1715, 1602, 1502, 1468, 1444, 1387, 1367, 1219, 1091, 1031, 984, 
836, 753. 
HRMS (ESI): exact m/z calculated for C20H15BrNO2 (M+H)
+
: 380.0281; Found: 380.0287 
(M+H)
+
. 
Mp: 85-87 
o
C (decomposed). 
 
Ethyl-2-bromo-3-(2-((E)-styryl)phenyl)acrylate (4): 
Following GP-3, 4 was prepared from S1w (416 mg, 2.00 mmol). 
Purification of the crude product by column chromatography (Hexanes: 
EtOAc, 9:1, Rf = 0.42) afforded 4 as a yellow oil (657 mg, 92% yield, Z:E = 
77:23). 
1
H-NMR (300 MHz, CDCl3, Z isomer, major): δ 8.47 (s, 1H), 7.70 (ddd, J = 8.5, 5.5, 1.9 Hz, 
1H), 7.59 – 7.51 (m, 2H), 7.46 – 7.30 (m, 2H), 7.29 – 7.18 (m, 1H), 7.06 (dd, J = 16.1, 2.3 Hz, 
1H), 4.41 (q, J = 7.1 Hz, 2H), 1.42 (t, J = 7.1 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3, Z isomer, major): δ 162.98, 140.84, 137.05, 136.67, 132.91, 
132.35, 129.56, 129.22, 128.78, 128.15, 127.17, 126.82, 126.23, 125.64, 116.54, 62.87, 14.27; 
IR (neat, cm
-1
): 2981, 1719, 1608, 1493, 1472, 1447, 1390, 1366, 1327, 1234, 1218, 1201, 
1092, 1031, 960, 860, 756, 689. 
HRMS (ESI): exact m/z calculated for C19H18BrO2 (M+H)
+
: 357.0485; Found: 357.0485 
(M+H)
+
. 
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Ethyl (E)-3-(2-(phenylethynyl)phenyl)acrylate (6): 
Following GP-3, 6 was prepared from S1a (412 mg, 2.0 mmol), 
triethylphosphonoacetate (672 mg, 3 mmol), and KO
t
-Bu (336 mg, 3 
mmol). Purification of the crude product by column chromatography 
(Hexanes: EtOAc, 95:05, Rf = 0.32) afforded 6 as a light yellow oil 
(518 mg, 94% yield, E:Z = 99:01). 
1
H-NMR (300 MHz, CDCl3, E isomer, major): δ 8.34 (d, J = 16.1 Hz, 1H), 7.69 – 7.53 (m, 
4H), 7.43 – 7.29 (m, 5H), 6.58 (d, J = 16.1 Hz, 1H), 4.30 (q, J = 7.1 Hz, 2H), 1.37 (t, J = 7.1 Hz, 
3H). 
13
C-NMR (75 MHz, CDCl3, E isomer, major): δ 166.93, 142.51, 135.78, 132.80, 131.69, 
129.80, 128.74, 128.62, 128.51, 126.26, 124.09, 122.96, 119.84, 95.66, 87.15, 60.61, 14.40. 
The obtained data is in accordance with the literature data.
[34]
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3.9.7 Reduction potentials of α-bromocinnamates: 
The redox potentials of the α-bromocinnamates were measured in DMF containing 0.1 M tetra-
n-butylammonium tetrafluoroborate as an electrolyte using ferrocene/ferrocenium (Fc/Fc+) as an 
internal reference. A glassy carbon electrode (working electrode), platinum wire counter 
electrode, and Ag quasi-reference electrode were employed. All values are given vs. Saturated 
Calomel Electrode (SCE). The scan rate was 50 mV S
-1
. 
α-Bromocinnamates Reduction potential (V) 
1a -1.38 
1b -1.37 
1c -1.40 
1d -1.43 
1e -1.06 
1f -1.25 
1g -0.93 
1h -1.40 
1i -1.28 
1j -1.04 
1k -1.32 
1l -1.32 
1m -1.36 
1n -1.38 
1o -1.39 
1p -1.24 
1q -1.04 
1r -1.29 
1s -1.29 
1t -1.25 
1u -1.23 
1v -1.27 
4 -1.51 
Table 3.5: Redox potentials of the α-bromocinnamate ethyl esters vs SCE.  
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3.9.8 General procedure (GP-4) for visible-light photocatalysis: 
 
To a oven dried 10/25 mL three-necked flask was charged with 1 (0.50 mmol, 1.00 equiv) and 
[Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (5.6 mg, 0.01 equiv, 1.00 mol %) in 3 mL anhydrous DMF. The 
reaction mixture was bubbled with oxygen balloon for 30 min, the flask was closed under 
positive oxygen atmosphere, and the reaction mixture was vigorously stirred (~1000 rpm) at 60 
o
C with internal irradiation of blue light (LED 455 nm). After 36 h, additional photocatalyst (5.6 
mg, 1.00 mol %) was added to the reaction mixture under positive oxygen flow; after 72 h, 
distilled water (20 mL) was added to dilute the reaction mixture, the resulting dark red coloured 
mixture then transferred to the separatory funnel and extracted with ethyl acetate (3 x 10 mL). 
The combined organic layer was washed with brine (15 ml) and dried over Na2SO4. The residue 
was purified by flash column chromatography (SiO2) with Hexanes/EtOAc as a solvent system. 
 
 
Figure 3.2: Reaction setup for photocatalytic oxidation reaction. 
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3.9.9 General procedure (GP-5): Photocatalysis with rotating film reactor: 
A solution of 0.50 mmol 1 in 2 ml DMF and [Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (5.6 mg, 0.01 
equiv, 1.00 mol %) catalyst is slowly rotated in presence of oxygen atmosphere with an external 
irradiation of blue light for 24 h. Then distilled water (20 mL) was added to dilute the reaction 
mixture, the resulting dark red coloured mixture then transferred to the separatory funnel and 
extracted with ethyl acetate (3 x 10 mL). The combined organic layer was washed with brine (15 
ml) and dried over Na2SO4. The resulting residue was purified by flash column chromatography 
(SiO2) with Hexanes/EtOAc as solvent system. 
 
Figure 3.3: Rotating film reactor setup for photocatalytic oxidation reaction. 
Ethyl 2-oxo-2-(1-oxo-2-phenyl-1H-inden-3-yl)acetate (2a): 
Following GP-4, 2a was prepared from 1a (177 mg, 0.50 mmol). 
Purification of the crude product by column chromatography (Hexanes: 
EtOAc, 9:1, Rf = 0.55) afforded 2a as a light red solid (30 mg, 20% 
yield); GP-5: (33 mg, 22% yield). 
1
H-NMR (300 MHz, CDCl3): δ 7.56 (t, J = 6.6 Hz, 2H), 7.46 – 7.33 (m, 6H), 7.31 – 7.24 (m, 
1H), 3.74 (q, J = 7.2 Hz, 2H), 0.94 (t, J = 7.2 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 195.64, 186.22, 160.97, 143.62, 142.50, 141.92, 134.82, 130.44, 
129.84, 129.57, 129.49, 129.19, 128.71, 124.42, 122.90, 62.66, 13.47. 
IR (neat, cm
-1
): 3059, 2923, 1722, 1661, 1594, 1564, 1445, 1371, 1285, 1247, 1209, 1180, 
1106, 1083, 1039, 1010, 958, 909, 864, 847, 801, 784, 754, 719, 699, 673. 
HRMS (ESI): exact m/z calculated for C19H15O4 (M+H)
+
: 307.0965; Found: 307.0969 (M+H)
+
. 
Mp: 98-100 
o
C (decomposed). 
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Ethyl 2-(5-methoxy-1-oxo-2-phenyl-1H-inden-3-yl)-2-oxoacetate (2b): 
Following GP-4, 2b was prepared from 1b (192 mg, 0.50 mmol). 
Purification of the crude product by column chromatography (Hexanes: 
EtOAc, 9:1, Rf = 0.49) afforded 2b as a light red solid (104 mg, 62% yield). 
1
H-NMR (300 MHz, CDCl3): δ 7.57 (d, J = 8.1 Hz, 1H), 7.47 – 7.37 (m, 5H), 7.16 (t, J = 9.3 
Hz, 1H), 6.71 (dd, J = 8.1, 2.2 Hz, 1H), 3.88 (s, 3H), 3.76 (q, J = 7.2 Hz, 2H), 0.98 (t, J = 7.2 Hz, 
3H). 
13
C-NMR (75 MHz, CDCl3): δ 193.68, 186.07, 165.32, 161.10, 145.26, 144.04, 141.48, 130.46, 
129.92, 129.75, 128.64, 126.54, 121.79, 112.15, 111.05, 62.59, 55.96, 13.46. 
IR (neat, cm
-1
): 2926, 2854, 1739, 1706, 1689, 1665, 1597, 1544, 1526, 1491, 1468, 1447, 
1431, 1368, 1340, 1286, 1259, 1213, 1172, 1107, 1081, 1042, 1016, 935, 879, 863, 846, 804, 
781, 756, 734, 694, 666. 
HRMS (ESI): exact m/z calculated for C20H17O5 (M+H)
+
: 337.1071; Found: 337.1076 (M+H)
+
. 
Mp: 88-90 
o
C (decomposed). 
 
Ethyl 2-oxo-2-(5-oxo-6-phenyl-5H-indeno[5,6-d][1,3]dioxol-7-yl)acetate (2c): 
Following GP-4, 2c was prepared from 1c (200 mg, 0.50 mmol). Purification 
of the crude product by column chromatography (Hexanes: EtOAc, 9:1, Rf = 
0.45) afforded 2c as a dark brown solid (112 mg, 64% yield).  
1
H-NMR (300 MHz, CDCl3): δ 7.43 – 7.36 (m, 3H), 7.36 – 7.31 (m, 2H), 7.13 (s, 1H), 7.04 (s, 
1H), 6.03 (s, 1H), 3.72 (q, J = 7.2 Hz, 2H), 0.95 (t, J = 7.2 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 193.95, 185.96, 161.19, 152.79, 148.22, 142.15, 141.57, 139.57, 
130.38, 129.80, 129.59, 128.63, 123.10, 105.86, 105.45, 102.50, 62.61, 13.45. 
IR (neat, cm
-1
): 2918, 1746, 1709, 1670, 1581, 1499, 1471, 1371, 1356, 1294, 1254, 1195, 
1103, 1065, 1029, 1010, 928, 895, 874, 834, 787, 740, 694. 
HRMS (ESI): exact m/z calculated for C20H15O6 (M+H)
+
: 351.0863; Found: 351.0868 (M+H)
+
. 
Mp: 114-116 
o
C (decomposed). 
 
Ethyl 2-(5,6-dimethoxy-1-oxo-2-phenyl-1H-inden-3-yl)-2-oxoacetate (2d): 
Following GP-4, 2d was prepared from 1d (207 mg, 0.50 mmol). 
Purification of the crude product by column chromatography (Hexanes: 
EtOAc, 9:1, Rf = 0.43) afforded 2d as a dark brown solid (124 mg, 68% 
yield). 
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1
H-NMR (300 MHz, CDCl3): δ 7.46 – 7.40 (m, 3H), 7.39 – 7.35 (m, 2H), 7.21 (s, 1H), 7.18 (s, 
1H), 3.98 (s, 3H), 3.91 (s, 3H), 3.75 (q, J = 7.2 Hz, 2H), 0.97 (t, J = 7.2 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 194.76, 186.25, 161.23, 153.85, 149.42, 142.25, 141.86, 137.70, 
130.32, 129.78, 128.62, 121.33, 108.06, 107.04, 62.57, 56.53, 56.38, 13.45. 
IR (neat, cm
-1
): 2976, 2942, 1743, 1700, 1659, 1580, 1486, 1467, 1443, 1414, 1368, 1352, 
1292, 1238, 1219, 1192, 1128, 1089, 1037, 1020, 893, 790, 754, 729, 695. 
HRMS (ESI): exact m/z calculated for C21H19O6 (M+H)
+
: 367.1176; Found: 367.1179 (M+H)
+
. 
Mp: 148-150 
o
C (decomposed). 
 
Ethyl 2-(5,6-dimethoxy-2-(4-nitrophenyl)-1-oxo-1H-inden-3-yl)-2-oxoacetate (2e): 
Following GP-4, 1e was prepared from 1e (230 mg, 0.50 mmol). 
Purification of the crude product by column chromatography (Hexanes: 
EtOAc, 4:1, Rf = 0.19) afforded 1e as a dark brown solid (82 mg, 40% 
yield); (decomposed); GP-5: (100 mg, 49% yield). 
1
H-NMR (600 MHz, CDCl3): δ 8.27 (d, J = 8.7 Hz, 2H), 7.55 (d, J = 8.7 Hz, 2H), 7.20 (s, 1H), 
7.16 (s, 1H), 3.99 (s, 3H), 3.93 (s, 3H), 3.88 (q, J = 7.2 Hz, 2H), 1.07 (t, J = 7.2 Hz, 3H). 
13
C-NMR (151 MHz, CDCl3): δ 193.48, 185.48, 160.62, 154.12, 150.16, 148.33, 144.61, 
138.46, 136.91, 136.04, 130.53, 123.61, 121.19, 108.35, 107.34, 63.02, 56.60, 56.45, 13.57. 
IR (neat, cm
-1
): 2925, 2854, 1743, 1709, 1689, 1581, 1520, 1497, 1460, 1343, 1297, 1259, 
1219, 1132, 1102, 1038, 1012, 865, 847, 800, 782, 763, 736, 692. 
HRMS (ESI): exact m/z calculated for C21H18NO8 (M+H)
+
: 412.1027; Found: 412.1028 
(M+H)
+
. 
Mp: 130-132 
o
C 
 
Ethyl 2-(2-(4-methoxyphenyl)-1-oxo-1H-inden-3-yl)-2-oxoacetate (2f): 
Following GP-4, 2f was prepared from 1j (192 mg, 0.50 mmol). 
Purification of the crude product by column chromatography (Hexanes: 
EtOAc, 9:1, Rf = 0.51) afforded 2f as a red solid (107 mg, 64% yield).  
1
H-NMR (300 MHz, CDCl3): δ 7.58 – 7.54 (m, 2H), 7.42 (td, J = 7.6, 1.1 Hz, 1H), 7.38 – 7.32 
(m, 2H), 7.29 – 7.21 (m, 1H), 6.95 – 6.89 (m, 2H), 3.82 (q, , J = 7.2 Hz, 2H), 3.81 (s, 3H), 0.99 
(t, J = 7.2 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 196.20, 186.31, 161.73, 161.31, 142.86, 141.79, 141.74, 134.84, 
131.62, 129.20, 129.11, 124.31, 122.66, 122.20, 114.31, 62.62, 55.47, 13.54. 
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IR (neat, cm
-1
): 2957, 2927, 2848, 1734, 1715, 1672, 1597, 1505, 1556, 1370, 1344, 1290, 
1246, 1172, 1107, 1041, 1021, 948, 909, 853, 831, 814, 790, 750, 730, 711, 654. 
HRMS (ESI): exact m/z calculated for C20H17O5 (M+H)
+
: 337.1071; Found: 337.1072 (M+H)
+
. 
Mp: 70-72 
o
C (decomposed). 
 
Ethyl 2-(2-(4-chlorophenyl)-1-oxo-1H-inden-3-yl)-2-oxoacetate (2g): 
Following GP-4, 2g was prepared from 1k (194 mg, 0.50 mmol). 
Purification of the crude product by column chromatography (Hexanes: 
EtOAc, 9:1, Rf = 0.49) afforded 2g as a light red solid (97 mg, 57% yield).  
1
H-NMR (300 MHz, CDCl3): δ 7.56 (ddd, J = 13.2, 6.8, 3.9 Hz, 2H), 7.43 (td, J = 7.5, 1.2 Hz, 
1H), 7.40 – 7.26 (m, 5H), 3.84 (q, J = 7.2 Hz, 2H), 1.01 (t, J = 7.2 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 195.27, 185.92, 160.87, 143.98, 142.29, 140.35, 136.81, 134.93, 
131.06, 129.70, 129.06, 129.02, 127.97, 124.55, 122.99, 62.87, 13.53. 
IR (neat, cm
-1
): 2959, 2918, 2850, 1718, 1691, 1591, 1544, 1488, 1456, 1397, 1370, 1346, 
1300, 1255, 1213, 1174, 1099, 1035, 1002, 949, 905, 729, 792, 754, 729, 706, 658. 
HRMS (ESI): exact m/z calculated for C19H14ClO4 (M+H)
+
: 341.0575; Found: 341.058 (M+H)
+
.  
Mp: 105-107 
o
C (decomposed). 
 
Ethyl 2-(2-(4-bromophenyl)-1-oxo-1H-inden-3-yl)-2-oxoacetate (2h): 
Following GP-4, 2h was prepared from 1l (217 mg, 0.50 mmol). 
Purification of the crude product by column chromatography (Hexanes: 
EtOAc, 9:1, Rf = 0.5) afforded 2h as a yellow solid (87 mg, 45% yield).  
1
H-NMR (300 MHz, CDCl3): δ 7.60 – 7.51 (m, 4H), 7.44 (td, J = 7.5, 1.1 Hz, 1H), 7.30 (td, J = 
7.6, 0.9 Hz, 1H), 7.26 – 7.21 (m, 2H), 3.85 (q, J = 7.2 Hz, 2H), 1.01 (t, J = 7.2 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 195.18, 185.92, 160.86, 144.01, 142.29, 140.39, 134.94, 131.97, 
131.23, 129.71, 129.07, 128.40, 125.15, 124.56, 123.00, 62.89, 13.53. 
IR (neat, cm
-1
): 2975, 2929, 1717, 1675, 1595, 1575, 1486, 1453, 1392, 1376, 1151, 1253, 
1214, 1151, 1105, 1039, 1008, 847, 834, 795, 751, 729, 703, 679, 659. 
HRMS (ESI): exact m/z calculated for C19H13BrNaO4 (M+Na)
+
: 406.9889; Found: 406.9894 
(M+Na)
+
. 
Mp: 98-100 
o
C (decomposed). 
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Ethyl 2-oxo-2-(1-oxo-2-(p-tolyl)-1H-inden-3-yl)acetate (2i): 
Following GP-4, 2i was prepared from 1m (184 mg, 0.50 mmol). 
Purification of the crude product by column chromatography (Hexanes: 
EtOAc, 9:1, Rf = 0.53) afforded 2i as a red viscous oil (94 mg, 59% yield). 
1
H-NMR (300 MHz, CDCl3): δ 7.58 – 7.52 (m, 2H), 7.40 (td, J = 7.6, 1.0 Hz, 1H), 7.23 (dt, J = 
12.0, 7.7 Hz, 5H), 3.76 (q, J = 7.2 Hz, 2H), 2.34 (s, 3H), 0.94 (t, J = 7.2 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 195.88, 186.29, 161.12, 142.84, 142.66, 142.10, 141.03, 134.79, 
129.85, 129.44, 129.29, 129.23, 126.77, 124.33, 122.76, 62.59, 21.55, 13.44. 
IR (neat, cm
-1
): 2975, 2932, 2873, 1719, 1675, 1596, 1509, 1459, 1374, 1286, 1244, 1179, 
1104, 1040, 1010, 909, 855, 791, 752, 727, 710. 
HRMS (ESI): exact m/z calculated for C20H17O4 (M+H)
+
: 321.1121; Found: 321.1122 (M+H)
+
. 
 
Ethyl 2-(2-(4-isopropylphenyl)-1-oxo-1H-inden-3-yl)-2-oxoacetate (2j): 
Following GP-4, 2j was prepared from 1n (198 mg, 0.50 mmol). 
Purification of the crude product by column chromatography (Hexanes: 
EtOAc, 9:1, Rf = 0.5) afforded 2j as a red solid (99 mg, 57% yield). 
1
H-NMR (300 MHz, CDCl3): δ 7.61 (dd, J = 6.6, 1.1 Hz, 2H), 7.46 (td, J = 7.6, 1.1 Hz, 1H), 
7.37 – 7.25 (m, 5H), 3.78 (q, J = 7.2 Hz, 2H), 2.94 (hept, J = 6.9 Hz, 1H), 1.25 (d, J = 6.9 Hz, 
6H), 0.94 (t, J = 7.2 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 195.93, 186.28, 161.15, 151.86, 142.89, 142.70, 142.20, 134.79, 
129.98, 129.29, 129.25, 127.16, 126.89, 126.59, 124.34, 122.80, 62.55, 34.19, 23.76, 13.40. 
IR (neat, cm
-1
): 2964, 2927, 2871, 1742, 1714, 1678, 1596, 1502, 1457, 1368, 1288, 1244, 
1210, 1179, 1105, 1037, 1011, 948, 907, 850, 797, 752, 717, 654. 
HRMS (ESI): exact m/z calculated for C22H20NaO4 (M+Na)
+
: 371.1254; Found: 371.1257 
(M+H)
+
. 
Mp: 76-78 
o
C (decomposed). 
 
Ethyl 2-(2-(4-(tert-butyl)phenyl)-1-oxo-1H-inden-3-yl)-2-oxoacetate (2k): 
Following GP-4, 2k was prepared from 1o (205 mg, 0.50 mmol). 
Purification of the crude product by column chromatography (Hexanes: 
EtOAc, 9:1, Rf = 0.51) afforded 2k as a red solid (94 mg, 52% yield). 
1
H-NMR (300 MHz, CDCl3): δ 7.60 – 7.55 (m, 2H), 7.46 – 7.39 (m, 3H), 7.33 – 7.21 (m, 3H), 
3.73 (q, J = 7.2 Hz, 2H), 1.28 (s, 9H), 0.89 (t, J = 7.2 Hz, 3H). 
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13
C-NMR (75 MHz, CDCl3): δ 195.97, 186.27, 161.16, 154.08, 142.93, 142.70, 142.19, 134.80, 
129.70, 129.30, 129.26, 126.79, 125.76, 124.37, 122.82, 62.56, 34.97, 31.12, 13.39. 
IR (neat, cm
-1
): 2958, 2927, 2864, 1741, 1713, 1684, 1596, 1502, 1458, 1396, 1365, 1288, 
1246, 1218, 1178, 1117, 1097, 1042, 1009, 952, 906, 856, 800, 756, 722, 657. 
HRMS (ESI): exact m/z calculated for C23H23O4 (M+H)
+
: 363.1591; Found: 363.1597 (M+H)
+
. 
Mp: 73-75 
o
C (decomposed). 
 
Ethyl 2-(2-(2-cyanophenyl)-5,6-dimethoxy-1-oxo-1H-inden-3-yl)-2-oxoacetate (2l): 
Following GP-4, 2l was prepared from 1p (190 mg, 0.50 mmol). 
Purification of the crude product by column chromatography (Hexanes: 
EtOAc, 4:1, Rf = 0.4) afforded 2l as a yellow solid (92 mg, 56% yield). 
1
H-NMR (300 MHz, CDCl3): δ 7.79 (dd, J = 7.7, 0.9 Hz, 1H), 7.73 – 7.63 (m, 3H), 7.54 (dtd, J 
= 12.8, 7.6, 1.3 Hz, 2H), 7.38 (ddd, J = 8.4, 6.8, 0.8 Hz, 2H), 3.83 (q, J = 7.2 Hz, 2H), 1.10 (t, J 
= 7.2 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 193.60, 184.84, 160.88, 146.23, 141.73, 139.15, 134.95, 133.33, 
133.27, 132.55, 131.12, 130.31, 130.05, 128.92, 124.96, 124.02, 117.25, 113.31, 62.88, 13.60; 
IR (neat, cm
-1
): 2929, 2225, 1719, 1687, 1597, 1562, 1544, 1487, 1376, 1286, 1257, 1209, 
1177, 1094, 1031, 1008, 852, 754, 719, 692. 
HRMS (ESI): exact m/z calculated for C20H14NO4 (M+H)
+
: 332.0917; Found: 332.0919 
(M+H)
+
. Mp 115-117 
o
C (decomposed). 
 
Ethyl 2-(6-methyl-1-oxo-2-phenyl-1H-inden-3-yl)-2-oxoacetate (2m): 
Following GP-4, 2m was prepared from 1h (184 mg, 0.50 mmol). 
Purification of the crude product by column chromatography (Hexanes: 
EtOAc, 9:1, Rf = 0.48) afforded 2m as a red viscous oil (53 mg, 33% 
yield); (GP-7, Setup-B, 58 mg, 36% yield). 
1
H-NMR (300 MHz, CDCl3): δ 7.36 (m, 7H), 7.22 (m, 1H), 3.74 (q, J = 7.2 Hz, 2H), 2.34 (s, 
3H), 0.94 (t, J = 7.2 Hz, 3H. 
13
C-NMR (75 MHz, CDCl3): δ 194.92, 185.26, 160.01, 142.84, 140.33, 138.85, 138.71, 133.79, 
129.21, 128.73, 128.66, 128.49, 127.60, 124.33, 121.68, 61.55, 20.33, 12.40. 
IR (neat, cm
-1
): 2925, 1734, 1715, 1673, 1595, 1476, 1444, 1371, 1255, 1218, 1114, 1042, 
1024, 938, 885, 860, 835, 791, 753, 737, 695. 
HRMS (ESI): exact m/z calculated for C20H17O4 (M+H)
+
: 321.1121; Found: 321.1125 (M+H)
+
. 
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Ethyl 2-(5-fluoro-1-oxo-2-phenyl-1H-inden-3-yl)-2-oxoacetate (2n): 
Following GP-4, 2n was prepared from 1i (186 mg, 0.50 mmol). Purification 
of the crude product by column chromatography (Hexanes: EtOAc, 9:1, Rf = 
0.46) afforded 2n as a light red solid (35 mg, 22% yield).  
1
H-NMR (300 MHz, CDCl3):
 δ 7.59 (dd, J = 8.1, 5.1 Hz, 1H), 7.46 – 7.32 (m, 6H), 6.98 – 6.90 
(m, 1H), 3.74 (q, J = 7.2 Hz, 2H), 0.96 (t, J = 7.2 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3):
 δ 193.71, 185.82, δ 166.89 (d, J = 257.0 Hz), 160.95, 145.64 (d, J 
= 10.6 Hz), 143.52, 141.42, 130.79, 129.94, 129.28, 128.76, 126.36 (d, J = 10.2 Hz), 125.06, 
115.40 (d, J = 23.3 Hz), 111.98 (d, J = 26.6 Hz), 62.73, 13.45. 
19
F-NMR (282 MHz, CDCl3): δ -101.28. 
IR (neat, cm
-1
): 2923, 2852, 1742, 1720, 1676, 1597, 1461, 1444, 1371, 1254, 1214, 1174, 
1103, 1072, 1037, 1016, 950, 868, 838, 822, 804, 788, 753, 732, 693, 657. 
HRMS (ESI): exact m/z calculated for C19H12FO4 (M+H)
+
: 325.0871; Found: 325.0878 
(M+H)
+
. 
 
Mp: 104-106 
o
C (decomposed). 
 
Ethyl 6-hydroxy-11-oxo-6,11-dihydroindeno[1,2-c]chromene-6-carboxylate (3a): 
Following GP-4, 3a was prepared from 1a (177 mg, 0.50 mmol). Purification 
of the crude product by column chromatography (Hexanes: EtOAc, 4:1, Rf = 
0.37) afforded 3a as a red solid (98 mg, 61% yield). GP-5: (101 mg, 63% 
yield). 
1
H-NMR (300 MHz, CDCl3): δ 8.18 (dd, J = 7.7, 1.5 Hz, 1H), 7.55 – 7.50 (m, 1H), 7.38 – 7.20 
(m, 3H), 7.07 (td, J = 7.6, 1.2 Hz, 1H), 6.99 (dd, J = 8.2, 0.8 Hz, 1H), 6.91 (dd, J = 4.3, 3.5 Hz, 
1H), 5.22 (bs, 1H), 4.38 (q, J = 7.1 Hz, 2H), 1.25 (t, J = 7.1 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 194.28, 168.52, 150.70, 142.27, 140.80, 134.16, 131.31, 130.37, 
129.13, 126.75, 124.64, 123.69, 122.55, 120.12, 116.25, 114.84, 93.79, 64.15, 13.94. 
IR (neat, cm
-1
): 3341, 2972, 1744, 1703, 1624, 1594, 1562, 1490, 1457, 1370, 1293, 1263, 
1232, 1214, 1169, 1122, 1091, 1057, 1032, 994, 854, 746, 708, 680. 
HRMS (ESI): exact m/z calculated for C19H15O5 (M+H)
+
: 323.0914; Found: 323.0917 (M+H)
+
.  
Mp: 157-159 
o
C (decomposed). 
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Ethyl 6-hydroxy-11-oxo-6,11-dihydrochromeno[3',4':3,4]cyclopenta[1,2-b]pyridine-6-
carboxylate (3b): 
Following GP-4, 3b was prepared from 1f (178 mg, 0.50 mmol). Purification 
of the crude product by column chromatography (Hexanes: EtOAc, 4:1, Rf = 
0.26) afforded 3b as a red solid (88 mg, 55% yield). 
1
H-NMR (300 MHz, CDCl3): δ 8.52 (d, J = 4.1 Hz, 1H), 8.25 (dd, J = 7.7, 1.5 Hz, 1H), 7.40 – 
7.28 (m, 2H), 7.23 (dd, J = 7.5, 5.1 Hz, 1H), 7.13 (dd, J = 10.9, 4.2 Hz, 1H), 7.05 (d, J = 7.6 Hz, 
1H), 5.33 (bs, 1H), 4.42 (q, J = 7.1 Hz, 2H), 1.29 (t, J = 7.1 Hz, 3H). 
13
C-NMR (151 MHz, CDCl3): δ 192.77, 167.95, 151.12, 150.94, 149.20, 140.41, 136.85, 
131.13, 126.75, 126.29, 125.98, 125.06, 122.80, 116.43, 113.91, 93.47, 64.26, 13.96. 
IR (neat, cm
-1
): 3399, 2956, 2922, 2852, 1762, 1735, 1576, 1460, 1415, 1367, 1329, 1296, 
1256, 1222, 1173, 1147, 1133, 1106, 1063, 1029, 1011, 977, 948, 912, 889, 848, 801, 756, 720, 
701, 677, 657. 
HRMS (ESI): exact m/z calculated for C18H14NO5 (M+H)
+
: 324.0866; Found: 324.0873 
(M+H)
+
.  
Mp: 147-149 
o
C (decomposed). 
 
Ethyl 6-hydroxy-8-nitro-11-oxo-6,11-dihydroindeno[1,2-c]chromene-6-carboxylate (3c): 
Following GP-4, 3c was prepared from 1g (200 mg, 0.50 mmol). 
Purification of the crude product by column chromatography (Hexanes: 
EtOAc, 4:1, Rf = 0.42) afforded 3c as a brown solid (69 mg, 38% yield);  
1
H-NMR (600 MHz, CDCl3): δ 8.18 (dd, J = 7.9, 1.6 Hz, 2H), 7.70 (dd, J = 12.5, 4.8 Hz, 2H), 
7.37 – 7.32 (m, 1H), 7.11 (dd, J = 11.0, 4.1 Hz, 1H), 7.03 (d, J = 8.2 Hz, 1H), 5.17 (s, 1H), 4.42 
(q, J = 7.1 Hz, 2H), 1.28 (t, J = 7.1 Hz, 3H). 
13
C-NMR (151 MHz, CDCl3): δ 191.77, 167.67, 151.76, 151.06, 142.51, 140.69, 135.51, 
131.50, 129.05, 125.15, 124.93, 123.73, 122.85, 116.54, 114.77, 114.01, 93.61, 64.50, 13.97. 
IR (neat, cm
-1
): 3393, 3099, 2921, 2852, 1755, 1713, 1612, 1591, 1536, 1449, 1375, 1341, 
1305, 1256, 1217, 1122, 1084, 1067, 1040, 1002, 951, 898, 869, 843, 827, 791, 763, 735, 719, 
687. 
HRMS (ESI): exact m/z calculated for C19H17N2O7 (M+NH4)
+
: 385.103; Found: 385.103 
(M+NH4)
+
.  
Mp: 202-204 
o
C (decomposed). 
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Ethyl 6-hydroxy-3-nitro-11-oxo-6,11-dihydroindeno[1,2-c]chromene-6-carboxylate (3d): 
Following GP-4, 3d was prepared from 1q (200 mg, 0.50 mmol). 
Purification of the crude product by column chromatography (Hexanes: 
EtOAc, 4:1, Rf = 0.3) afforded 3d as a dark brown solid (75 mg, 41% yield). 
1
H-NMR (600 MHz, CDCl3): δ 8.35 (d, J = 8.5 Hz, 1H), 7.95 (dd, J = 8.5, 2.2 Hz, 1H), 7.86 (d, 
J = 2.2 Hz, 1H), 7.60 (d, J = 7.1 Hz, 1H), 7.41 (td, J = 7.7, 1.0 Hz, 1H), 7.36 – 7.33 (m, 1H), 
7.00 (d, J = 7.3 Hz, 1H), 5.32 (s, 1H), 4.41 (q, J = 7.1 Hz, 2H), 1.26 (t, J = 7.1 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 193.08, 167.72, 150.76, 148.30, 145.76, 139.78, 134.53, 131.18, 
130.38, 124.94, 124.17, 121.04, 120.63, 117.68, 111.85, 94.16, 64.64, 13.94. 
IR (neat, cm
-1
): 3466, 2924, 2854, 1759, 1701, 1587, 1517, 1457, 1417, 1378, 1339, 1295, 
1252, 1228, 1161, 1127, 1084, 1066, 1040, 1010, 951, 851, 833, 799, 774, 753, 739, 711, 683. 
HRMS (ESI): exact m/z calculated for C19H17N2O7 (M+NH4)
+
: 385.103; Found: 385.1034 
(M+NH4)
+
.  
Mp: 175-177 
o
C (decomposed). 
 
Ethyl 6-hydroxy-11-oxo-3-(trifluoromethyl)-6,11-dihydroindeno[1,2-c]chromene-6-
carboxylate (3e): 
Following GP-4, 3e was prepared from 1r (211 mg, 0.50 mmol). 
Purification of the crude product by column chromatography (Hexanes: 
EtOAc, 4:1, Rf = 0.48) afforded 3e as a red solid (91 mg, 47% yield), (GP-7, 
Setup B: 100 mg, 52% yield).  
1
H-NMR (300 MHz, CDCl3): δ 8.24 (d, J = 8.0 Hz, 1H), 7.54 – 7.49 (m, 1H), 7.33 (td, J = 7.7, 
1.2 Hz, 1H), 7.29 – 7.24 (m, 2H), 7.21 (d, J = 4.0 Hz, 1H), 6.92 (d, J = 7.1 Hz, 1H), 5.30 (bs, 
1H), 4.34 (q, J = 7.1 Hz, 2H), 1.21 (t, J = 7.1 Hz, 2H). 
13
C-NMR (75 MHz, CDCl3): δ 193.56, 168.03, 150.56, 144.38, 140.16, 134.34, 132.02, 131.58, 
131.21, 129.83, 125.60, 125.40, 124.99, 123.95, 120.63, 119.21 (q, J = 7.7 Hz), 117.87, 113.47 
(q, J = 8.5 Hz), 93.97, 64.42, 13.91. 
19
F-NMR (282 MHz, CDCl3): δ -63.39. 
IR (neat, cm
-1
): 3339, 2925, 1765, 1698, 1619, 1593, 1562, 1509, 1456, 1424, 1389, 1325, 
1254, 1219, 1166, 1114, 1066, 1053, 997, 939, 875, 853, 833, 801, 769, 748, 716, 701, 682, 659. 
HRMS (ESI): exact m/z calculated for C20H13F3NaO5 (M+H)
+
: 413.0607; Found: 413.0609 
(M+H)
+
.  
Mp: 145-147 
o
C (decomposed). 
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6-ethyl 3-methyl 6-hydroxy-11-oxo-6,11-dihydroindeno[1,2-c]chromene-3,6-dicarboxylate 
(3f): 
Following GP-4, 3f was prepared from 1s (206 mg, 0.50 mmol). 
Purification of the crude product by column chromatography (Hexanes: 
EtOAc, 4:1, Rf = 0.25) afforded 3f as a yellow solid (104 mg, 55% yield); 
GP-5: (116 mg, 62% yield). 
1
H-NMR (300 MHz, CDCl3): δ 8.24 (d, J = 8.1 Hz, 1H), 7.73 (dd, J = 8.1, 1.6 Hz, 1H), 7.65 (d, 
J = 1.4 Hz, 1H), 7.58 – 7.53 (m, 1H), 7.37 (td, J = 7.7, 1.2 Hz, 1H), 7.32 – 7.28 (m, 1H), 6.97 (d, 
J = 7.1 Hz, 1H), 5.26 (bs, 1H), 4.38 (q, J = 7.1 Hz, 2H), 3.91 (s, 3H), 1.24 (t, J = 7.1 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 193.69, 168.15, 166.38, 150.46, 144.53, 140.29, 134.31, 131.42, 
131.29, 129.77, 126.00, 124.42, 123.90, 123.67, 120.64, 118.84, 117.37, 93.89, 64.30, 52.37, 
13.93. 
IR (neat, cm
-1
): 3356, 2955, 2927, 1746, 1721, 1701, 1603, 1558, 1491, 1458, 1434, 1416, 
1370, 1285, 1254, 1219, 1136, 1095, 1056, 1000, 927, 888, 855, 836, 803, 761, 734, 710, 686. 
HRMS (ESI): exact m/z calculated for C21H17O7 (M+H)
+
: 381.0969; Found: 381.0968 (M+H)
+
. 
Mp: 156-158 
o
C (decomposed). 
 
Ethyl 3-acetyl-6-hydroxy-11-oxo-6,11-dihydroindeno[1,2-c]chromene-6-carboxylate (3g): 
Following GP-4, 3g was prepared from 1t (198 mg, 0.50 mmol). 
Purification of the crude product by column chromatography (Hexanes: 
EtOAc, 4:1, Rf = 0.2) afforded 3g as a red solid (109 mg, 60% yield).  
1
H-NMR (600 MHz, CDCl3): δ 8.28 (d, J = 8.0 Hz, 1H), 7.67 (dd, J = 8.0, 1.6 Hz, 1H), 7.59 – 
7.56 (m, 2H), 7.40 – 7.36 (m, 1H), 7.30 (t, J = 7.4 Hz, 1H), 6.97 (d, J = 7.3 Hz, 1H), 5.21 (s, 
1H), 4.39 (q, J = 7.1 Hz, 2H), 2.59 (s, 3H), 1.25 (t, J = 7.1 Hz, 1H). 
13
C-NMR (151 MHz, CDCl3): δ 197.00, 193.61, 168.23, 150.66, 144.64, 140.37, 138.15, 
134.30, 131.36, 129.81, 126.01, 124.63, 123.91, 122.56, 120.63, 118.95, 115.95, 93.87, 64.36, 
26.70, 13.92. 
IR (neat, cm
-1
): 3216, 2924, 2854, 1743, 1716, 1686, 1664, 1602, 1557, 1457, 1413, 1357, 
1319, 1277, 1248, 1232, 1181, 1160, 1092, 1066, 1044, 1012, 967, 921, 884, 850, 825, 798, 757, 
736, 710, 691. 
HRMS (ESI): exact m/z calculated for C21H17O6 (M+H)
+
: 365.102; Found: 365.1026 (M+H)
+
. 
Mp: 176-178 
o
C (decomposed). 
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Ethyl 3-formyl-6-hydroxy-11-oxo-6,11-dihydroindeno[1,2-c]chromene-6-carboxylate (3h): 
Following GP-4, 3h was prepared from 1u (764 mg, 2.0 mmol). 
Purification of the crude product by column chromatography (Hexanes: 
EtOAc, 4:1, Rf = 0.24) afforded 3h as a brown red solid (404 mg, 58% 
yield); GP-5: (113 mg, 65% yield on 0.50 mmol scale). 
1
H-NMR (300 MHz, CDCl3): δ 9.90 (s, 1H), 8.30 (d, J = 7.9 Hz, 1H), 7.56 – 7.50 (m, 2H), 7.44 
(d, J = 1.3 Hz, 1H), 7.34 (td, J = 7.7, 1.2 Hz, 1H), 7.30 – 7.21 (m, 1H), 6.95 (d, J = 7.1 Hz, 1H), 
5.38 (bs, 1H), 4.35 (q, J = 7.1 Hz, 2H), 1.21 (t, J = 7.1 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 193.49, 191.35, 167.99, 151.03, 145.31, 140.11, 137.32, 134.40, 
131.27, 130.03, 125.79, 125.09, 124.42, 123.99, 120.85, 120.33, 116.43, 93.97, 64.39, 13.93. 
IR (neat, cm
-1
): 3412, 2925, 2853, 1757, 1740, 1695, 1602, 1557, 1509, 1458, 1424, 1375, 
1322, 1274, 1234, 1172, 1145, 1089, 1068, 1043, 1001, 956, 916, 882, 850, 830, 798, 771, 753, 
731, 715, 675. 
HRMS (ESI): exact m/z calculated for C20H15O6 (M+H)
+
: 351.0863; Found: 351.0867 (M+H)
+
. 
Mp: 172-174 
o
C (decomposed). 
 
Ethyl 3-cyano-6-hydroxy-11-oxo-6,11-dihydroindeno[1,2-c]chromene-6-carboxylate (3i): 
Following GP-4, 3i was prepared from 1v (190 mg, 0.50 mmol). Purification 
of the crude product by column chromatography (Hexanes: EtOAc, 4:1, Rf = 
0.26) afforded 3i as a yellow solid (83 mg, 48% yield). 
1
H-NMR (600 MHz, CDCl3): δ 8.29 (d, J = 8.0 Hz, 1H), 7.59 – 7.57 (m, 1H), 7.39 (td, J = 7.7, 
1.1 Hz, 1H), 7.35 (dd, J = 8.0, 1.5 Hz, 1H), 7.34 – 7.31 (m, 1H), 7.25 (d, J = 1.4 Hz, 1H), 6.98 
(d, J = 7.3 Hz, 1H), 5.31 (bs, 1H), 4.40 (q, J = 7.1 Hz, 2H), 1.26 (t, J = 7.1 Hz, 3H). 
13
C-NMR (151 MHz, CDCl3): δ 193.16, 167.77, 150.46, 145.20, 139.89, 134.43, 131.19, 
130.16, 126.23, 125.22, 125.19, 124.07, 120.85, 119.68, 119.15, 118.29, 112.91, 93.98, 64.55, 
13.91. 
IR (neat, cm
-1
): 3370, 2922, 2852, 2233, 1749, 1719, 1602, 1547, 1457, 1412, 1311, 1289, 
1265, 1244, 1146, 1134, 1092, 1054, 1001, 859, 826, 796, 774, 755, 734, 713, 685. 
HRMS (ESI): exact m/z calculated for C20H14NO5 (M+H)
+
: 348.0866; Found: 348.0867 
(M+H)
+
.  
Mp: 131-133 
o
C (decomposed). 
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Ethyl 6-hydroxy-9-methyl-11-oxo-6,11-dihydroindeno[1,2-c]chromene-6-carboxylate (3j): 
Following GP-4, 3j was prepared from 1h (184 mg, 0.50 mmol). 
Purification of the crude product by column chromatography (Hexanes: 
EtOAc, 4:1, Rf = 0.53) afforded 3j as a red solid (67 mg, 40% yield); (GP-7, 
Setup B, 73 mg, 44% yield).
 
1
H-NMR (600 MHz, CDCl3): δ 8.17 (dd, J = 7.7, 1.4 Hz, 1H), 7.35 (s, 1H), 7.28 – 7.23 (m, 
1H), 7.12 (d, J = 7.4 Hz, 1H), 7.06 (dd, J = 10.9, 4.1 Hz, 1H), 6.98 (d, J = 8.2 Hz, 1H), 6.80 (d, J 
= 7.4 Hz, 1H), 5.08 (bs, 1H), 4.36 (q, J = 7.1 Hz, 2H), 2.34 (s, 3H), 1.25 (t, J = 7.1 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 194.56, 168.59, 150.53, 142.67, 139.59, 137.90, 134.02, 131.69, 
130.07, 126.17, 124.84, 124.48, 122.50, 119.93, 116.20, 115.02, 93.79, 64.10, 21.47, 13.95. 
IR (neat, cm
-1
): 3374, 2924, 2854, 1740, 1704, 1606, 1443, 1366, 1260, 1230, 1213, 1127, 
1100, 1056, 1033, 1000, 902, 861, 845, 827, 786, 749, 724, 696. 
HRMS (ESI): exact m/z calculated for C20H17O5 (M+H)
+
: 337.1071; Found: 337.1077 (M+H)
+
.  
Mp: 140-142 
o
C (decomposed). 
 
Ethyl 8-fluoro-6-hydroxy-11-oxo-6,11-dihydroindeno[1,2-c]chromene-6-carboxylate (3k): 
Following GP-4, 3k was prepared from 1i (186 mg, 0.50 mmol). 
Purification of the crude product by column chromatography (Hexanes: 
EtOAc, 4:1, Rf = 0.4) afforded 3k as a red solid (86 mg, 51% yield).
 
1
H-NMR (600 MHz, CDCl3): δ 8.17 (dd, J = 7.7, 1.5 Hz, 1H), 7.52 (dd, J = 8.0, 5.1 Hz, 1H), 
7.32 – 7.27 (m, 1H), 7.07 (td, J = 7.6, 0.9 Hz, 1H), 6.99 (d, J = 8.2 Hz, 1H), 6.90 – 6.84 (m, 1H), 
6.64 (dd, J = 8.1, 2.1 Hz, 1H), 5.10 (bs, 1H), 4.38 (q, J = 7.1, 2H), 1.26 (t, J = 7.1 Hz, 3H). 
13
C-NMR (151 MHz, CDCl3): δ 192.41, 168.21, 166.40 (d, J = 179.1 Hz), 150.94, 144.00 (d, J 
= 10.23 Hz), 139.95 (d, J = 2.78 Hz, 130.81, 128.32, 127.13, 125.51 (d, J = 10.1 Hz), 124.81, 
122.64, 116.30, 114.63, 114.51 (J = 8.5 Hz), 109.09 (d, J = 26.22 Hz), 93.69, 64.27, 13.94. 
19
F-NMR (282 MHz, CDCl3): δ -103.41. 
IR (neat, cm
-1
): 3412, 2923, 2853, 1763, 1702, 1590, 1461, 1361, 1237, 1220, 1191, 1147, 
1121, 1094, 1061, 1035, 1007, 972, 946, 875, 857, 840, 816, 784, 757, 728, 709. 
HRMS (ESI): exact m/z calculated for C19H13FNaO5 (M+Na)
+
: 363.0639; Found: 363.064 
(M+Na)
+
. 
Mp: 117-119 
o
C (decomposed). 
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Ethyl 1-benzylidene-1H-indene-2-carboxylate (5): 
Following GP-4, 5 was prepared from 4 (178 mg, 0.50 mmol) and 
[Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (5.6 mg, 1 mol %) in DMF (2 mL) under 
nitrogen atmosphere. Purification of the crude product by column 
chromatography (Hexanes: EtOAc, 9:1, Rf = 0.61) afforded 5 as a yellow oil 
(113 mg, E/Z = 1:1, 82% yield). 
1
H-NMR (300 MHz, CDCl3, isolated isomer): δ 8.35 (s, 1H), 7.93 – 7.87 (m, 1H), 7.82 (d, J = 
7.9 Hz, 1H), 7.78 (s, 1H), 7.59 – 7.46 (m, 2H), 7.42 – 7.27 (m, 4H), 7.21 (s, 1H), 4.10 (q, J = 7.1 
Hz, 2H), 0.99 (t, J = 7.1 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3, isolated isomer): δ 168.78, 141.69, 138.80, 134.33, 131.60, 
130.87, 129.65, 129.59, 128.60, 128.19, 128.03, 127.82, 127.40, 127.06, 126.72, 61.08, 13.74. 
IR (neat, cm
-1
): 2980, 1711, 1629, 1595, 1490, 1444, 1365, 1274, 1212, 1193, 1134, 1086, 
1016, 894, 863, 762, 747, 697. 
HRMS (ESI): exact m/z calculated for C19H16O2 (M)
+
: 276.1145; Found: (M)
+
: 276.1146. 
 
Diethyl (1S,2S,3R,4R)-3,4-bis(2-(phenylethynyl)phenyl)cyclobutane-1,2-dicarboxylate (7): 
Following GP-4, 7 was prepared from 6 (138 mg, 0.50 mmol). Purification of 
the crude product by column chromatography (Hexanes: EtOAc, 9:1, Rf = 
0.37) afforded 7 as a pale yellow oil [89 mg, 65% yield (under oxygen); 99 
mg, 73% yield (under nitrogen)]. 
1
H-NMR (300 MHz, CDCl3): δ 7.66 (d, J = 7.2 Hz, 1H), 7.52 – 7.41 (m, 3H), 7.37 – 7.30 (m, 
3H), 7.27 (td, J = 7.6, 1.4 Hz, 1H), 7.14 (td, J = 7.5, 1.2 Hz, 1H), 4.55 – 4.51 (m, 1H), 4.02 (q, J 
= 7.1 Hz, 2H), 3.57 – 3.52 (m, 1H), 1.12 (t, J = 7.1 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 172.71, 142.06, 132.60, 131.79, 129.00, 128.41, 127.08, 127.02, 
123.39, 123.05, 93.65, 88.00, 61.05, 45.52, 45.03, 14.20. 
IR (neat, cm
-1
): 2925, 2854, 1723, 1598, 1493, 1443, 1368, 1318, 1201, 1157, 1095, 1027, 914, 
855, 752, 689. 
EI-MS: exact m/z calculated for C38H33O4 (M+H)
+
: 553.2373; Found: 553.2382 (M+Na)
+
. 
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3.9.10 General procedure (GP-6) for 6π-electrocyclization: 
a. Visible-light photocatalysis:  
A solution of 2 (0.25 mmol and 2 mol % photocatalyst in 1 mL DMF) irradiated with blue light 
(λmax = 455 nm) in presence of oxygen atmosphere for 72 h at 60 oC. The distilled water (20 
mL) was added to dilute the reaction mixture, the resulting red coloured mixture then transferred 
to the separatory funnel and extracted with ethyl acetate (3 x 10 mL). The combined organic 
layer was washed with brine (15 mL) and dried over Na2SO4. The purification by flash column 
chromatography (SiO2) with Hexanes/EtOAc afforded 3. (Note: we have also conducted these 
experiments in presence of stoichiometric amount of water (for a hydroxyl source), but we did 
not get any improvement in the yields). 
b. UV-light experiment:  
Followed the same procedure as mentioned above without adding a photocatalyst. The UV-light 
irradiation was done by Philips HPK 125 instrument (125 W Hg-lamp, λ =300 nm). 
 
Conditions A: Substrate 2 (0.25 mmol, 1.0 equiv), [Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (2 mol %), O2, at 60 
oC, in 
DMF, 72 h, LED455. Conditions B: Substrate 2 (0.25 mmol, 1.0 equiv), UV-Light (125 W Hg-lamp, λ > 300 nm), 
O2, at 60 
oC, in DMF, 72 h. 
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3.9.11 General procedure (GP-7): Photocatalysis with micro(flow)reactor: 
a. Micro(flow)reactor setup-A:  
A solution of 1a (177 mg, 0.50 mmol) in 5 mL DMF and [Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (5.6 
mg, 0.01 equiv, 1.00 mol %) catalyst is pumped through a tee and mixed with a pulsed stream of 
oxygen to produce a segmented liquid-gas suspension, which flows through a glass flow reactor 
(LTF-V, channel diameter 1 mm, total volume 1.7 ml, Little Things Factory). The glass reactor 
is illuminated by 8 blue LED455. After 40 min, the distilled water (10 mL) was added to dilute 
the reaction mixture, the resulting dark red coloured mixture then transferred to the separatory 
funnel and extracted with ethyl acetate (3 x 10 mL). The combined organic layer was washed 
with brine (10 mL) and dried over Na2SO4. The residue was purified by flash column 
chromatography (SiO2) with Hexanes/EtOAc as the solvent system to give 2a (25.5 mg, 17%) 
and 3a (68 mg, 43%). The yields are low here, therefore we switched to the advanced 
micro(flow)reactor setup available in our department (see, setup-B).
[14]
 
 
Figure 3.4: Micro(flow)reaction (gas-liquid phase) setup for photocatalytic oxidation reaction. 
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Flow rate liquid phase: 0.020 mL/min 
Oxygen: a 0.1 sec. pulse every 10 seconds to produce a liquid/gas segmented flow with a liquid-
gas ratio of approx 1:2 (V/V). 
Estimated residence time: 35-40 min. 
Reaction Temperature: 20-23 
o
C 
b. Micro(flow)reactor setup-B:
[14] 
A solution of 1a (177 mg, 0.50 mmol) in 2 mL DMF and 
[Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (5.6 mg, 0.01 equiv, 1.00 mol %) catalyst is pumped through a 
tee (BOLA, F 731-02) by HPLC (Bischoff dosage pump 2250; PHPLC = 40 bar) via a capillary 
(for back-pressure build-up; Bischoff PEEK capillary 1021903PK; BPR = 12 bar) and 
subsequently mixed with a pulsed stream of oxygen (oxygen supply: Linde 4.6; oxygen pressure 
= 30 bar), to produce a segmented liquid-gas suspension, which flows through a FEP capillary.  
 
Figure 3.5: Schematic representation of Micro(flow)reaction (gas-liquid phase) setup. 
Figure 3.5: Schematic illustration of the reactor setup: [a] solvent reservoir, [b] substrate solution, [c] T valve 
(BOLA, F 731-02), [d] HPLC pump (Bischoff dosage pump 2250), [e] capillary (for back-pressure build-up; 
Bischoff PEEK capillary 1021903PK), [f] oxygen supply (Linde 4.6, upto 200 bar), [g] pressure reducing valve (GO 
regulator, TeamTrade, PR11I11ACW-111), [h] mass flow controller (Brooks SLA 5850), [i] T mixer (IDEX, P-727 
or P-632), [j] thermostat bath, [k] FEP capillary, [l] LED light source (24 × Cree Xlamp MK-R, blue light, 700 mA), 
[m] back-pressure regulator (IDEX, P-763, 100 psi), [n] collecting vessel. 
 
The reactor heated to 60 
o
C (Note: the yields were low at room temperature conditions, therefore 
we have performed this reaction at 60 
o
C) and illuminated by 24 blue LEDs. After 15 min, the 
distilled water (10 mL) was added to dilute the reaction mixture, the resulting dark red coloured 
mixture then transferred to the separatory funnel and extracted with ethyl acetate (3 x 10 mL). 
The combined organic layer was washed with brine (10 mL) and dried over Na2SO4. The residue  
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was purified by flash column chromatography (SiO2) with Hexanes/EtOAc as the solvent system 
to give 2a (28 mg, 19%) and 3a (90 mg, 57%).  
Flow rate liquid phase: 0.025 ml/min 
Oxygen: a 0.1 sec. pulse every 5 seconds to produce a liquid/gas segmented flow with a liquid-
gas ratio of approx 1:1 (V/V). 
Estimated residence time: 15 min. 
Reaction Temperature: 60 
o
C. 
 
Figure 3.6: Simplified Micro(flow)reaction (gas-liquid phase) setup. 
 
Figure 3.7: Some original photographs taken of the micro(flow)reactor setup during the 
experiments.  
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3.9.12 Oxygen labeling experiments: 
a. Pure 
18
O2 experiment: 
An oven dried 10 mL Schlenk tube equipped with a rubber septum and a magnetic stir bar was 
charged with [Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (1 mol %), α-bromocinnamate 1a (0.25 mmol, 1.0 
equiv). The flask was purged with a stream of nitrogen and 1.0 mL of dry DMF was added via 
syringe. The resultant mixture was degassed by the freeze-pump-thaw procedure (3 cycles). 
Followed by pure 
18
O2 was transferred to the reaction. The tube was sealed and externally 
irradiated with blue light. After 24 h of irradiation oxygen labeled compounds 2a and 3a were 
detected by HRMS analysis. Crude mixtures were submitted to the HRMS analysis. 
 
Scheme 3.7: Pure 
18
O2 labeling experiment. 
 
(i) HRMS Spectra of 2a’: crude reaction mixture submitted for HRMS analysis 
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(ii) HRMS Spectra of 3a’: crude reaction mixture submitted for HRMS analysis 
b. Mix 
18
O2/
16
O2 experiment: Followed the same procedure as described above: Herein, 
approximately half of the pure 
18
O2 was transferred into the reaction mixture containing 
16
O2. 
 
Scheme 3.8: Mix 
18
O2 / 
16
O2 labeling experiment. 
Compound 2a: Possible oxygen isotope incorporations 
 
Figure 3.8: Possible oxygen incorporations in 2a/2a’. 
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(iii) HRMS Spectra of 2a/2a’: crude reaction mixture submitted for HRMS analysis. 
 
Compound 3a: Possible oxygen isotope incorporations 
 
Figure 3.9: Possible oxygen incorporations in 3a/3a’. 
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(iv) HRMS Spectra of 3a/3a’: crude reaction mixture submitted for HRMS analysis. 
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3.9.13 Stern-Volmer luminescence quenching experiments: 
Stern-Volmer luminescence intensities were recorded using a FluoroMax-4 spectrofluorometer. 
All solutions were excited at (λex = 450 nm) and the emissions (λem) were recorded in the range 
of 452-750 nm.  
a. Figure 2.1.10:  
To a degassed DMF in quartz cuvettes, capped with septa, was introduced a stock solution of an 
[Ir(dF(CF3)ppy)2(dtb-bpy)PF6] photocatalyst (148.56 µM) under nitrogen (inert) atmosphere. 
This blank [Ir]-catalyst solution was excited by blue light (λex = 450 nm) at 20 
o
C (Figure 3.10, 
A). The maximum emission was recorded at λem = 476 nm with an intensity of 1.7 x 10
6
 (red 
colour plot, Figure 3.10, A). Strong changes in the luminescence intensities of 
[Ir(dF(CF3)ppy)2(dtb-bpy)PF6] was observed upon successive addition of 1a in DMF. In the 
inset, Stern-Volmer plots are shown.  
From the plot A, the following data was obtained: 
(1) Stern-Volmer constant (Ksv) = Kq0 = 968.1 ± 8.304 
(2) The fluorescence lifetime (0) = 2300 ns
[3]
 
 
b. Figure 2.1.10:  
To a non-degassed DMF in quartz cuvettes, capped with septa, was introduced a stock solution 
of an [Ir(dF(CF3)ppy)2(dtb-bpy)PF6] photocatalyst under air. The resulting blank Ir-catalyst 
solution was excited by blue light (λex = 450 nm) at 20 
o
C (Figure 3.10, B). The maximum 
emission was recorded at λem = 476 nm with an intensity of 1.0 x 10
6
 (red colour plot, Figure 
3.10, B). In this case, the intensity is slightly lower for the photocatalyst as compared to Figure 
3.10, A (under nitrogen). This is due to the quenching of the oxygen molecule present in the air. 
The oxygen quenching is also called as collision quenching typically occurred by physical 
energy transfer processes (or non-radiative transitions). However, the oxygen quenching is not as 
strong as the substrate 1a with the photocatalyst. Which is proved upon further addition of 1a to 
the [Ir(dF(CF3)ppy)2(dtb-bpy)PF6] photocatalyst solution under air at 20 
o
C (Figure 3.10, B). 
This experiment suggests, the starting material interacts strongly with the excited photocatalyst 
irrespective of the presence of oxygen molecule in the solution. In the inset, Stern-Volmer plots 
are shown. 
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From the plot B, the following data was obtained: 
(1) Stern-Volmer constant (Ksv) = Kq0 = 287.0 ± 9.032 
(2) The fluorescence lifetime (0) = 2300 ns
[3]
 
 
c. Figure 2.1.10:  
The separate oxygen quenching experiment was conducted by successive addition of an 
approximate amount of oxygen to the catalyst solutions at every 5 min until the solution gets 
saturated with oxygen (red line). After this, further quenching did not takes place. The resulting 
quenching spectra are shown in (Figure 3.10, C). Although, the quenching with oxygen was not 
as strong as the starting material but it suggested that, the oxygen molecule also takes part in the 
catalytic cycle. 
 
 
Figure 3.10: [A] Fluorescence quenching of the [Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 upon successive addition of 1a 
under nitrogen in DMF at rt.  
[B] Fluorescence quenching of the [Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 upon successive addition of 1a under air in DMF 
at rt (in the insets, Stern-Volmer plots are shown). 
[C] Fluorescence quenching of the [Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 upon successive addition of oxygen in DMF. 
  
(C) 
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3.9.14 ESR spectra of a vinyl radical: 
A solution of 1a (0.10 mmol) and [Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (5 mol %) was irradiated at 
455 nm under inert atmosphere at low temperature (using liquid nitrogen) in DMF (0.3 mL). 
After 10 min of irradiation, a vinyl radical was detected (Figure 3.11) having g-factor (ge) = 
1.984, which corresponds to the single electron. The instrument details are given below: 
Magnettech MiniScope MS400 
Power Consumption: ca. 500 VA 
Microwave (MW) Power: 100 μW-50 mW (10 μW-100 mW optional) 
Sensitivity MS400: 8*109 Spins/0.1 mT 
MW Frequency: 9,20-9,60 GHz 
Field Homogeneity: ± 5 μT sample area 
Field Range: 50 – 450 mT (optional 50 – 600 mT with water cooling) 
Field Sweep: 0 – 400 mT (optional 0 – 550 mT with water cooling) 
Sweep Time: 12 s – 34 min 
Field Stability: 1.5 μT/min, 15 μT/h 
Field Modulation: 5 μT – 0.7 mT 
Modulation Frequency: 100 kHz 
Resonator rectangular: TE102 
 
Figure 3.11: ESR spectra for vinyl radical of 1a. 
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3.9.15 Experimental procedure to trap a vinyl radical with TEMPO: 
An oven dried 10 mL Schlenk tube equipped with a rubber septum and a magnetic stir bar was 
charged with [Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (2 mol %), α-bromocinnamate 1u (0.10 mmol, 1.0 
equiv) and TEMPO (0.3 mmol, 3.0 equiv). The flask was purged with a stream of nitrogen and 
1.0 mL of dry DMF was added via syringe. The resultant mixture was degassed by the freeze-
pump-thaw procedure (3 cycles). The tube was sealed with an internal blue light irradiation set 
up. After 12 h of irradiation, TEMPO trapped compound 9 was detected by mass spectra; 
(M+H)
+
: 460.2487 (C29H34NO4). 
 
Scheme 3.9: TEMPO trapping experiment. 
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3.9.16 Synthesis of starting material precursors:
[35] 
 
a. Synthesis of ethyl 2-ethoxy-3-(2-(phenylethynyl)phenyl)oxirane-2-carboxylate (S3a):  
To a solution of sodium ethoxide, made by dissolving 0.222 g of sodium (9.64 
mmol) in 7 ml of anhydrous ethanol, was added a solution of S1a (1.00 g, 
4.84 mmol) and ethyl dichloroacetate S2a (0.890 ml, 7.26 mmol) in THF (13 
ml) at 0 °C via cannula. The suspension was then heated at reflux for 8 h. 
After removing all the solvent in vacuo, the residue was diluted with CH2Cl2 (30 ml) and washed 
with saturated NH4Cl (20 mL). The aqueous layer was extracted with CH2Cl2 (3 x 20 ml). The 
combined organic layers were dried (Na2SO4) and the solvents were evaporated in vacuo. 
Purification of the crude product by column chromatography (Hexanes: EtOAc, 9:1, Rf = 0.29) 
afforded S3a as a light yellow oil (1.50 g, 92% yield, dr = 5.18:1). 
1
H-NMR (300 MHz, CDCl3, major isomer): δ 7.56 – 7.51 (m, 1H), 7.52 – 7.44 (m, 2H), 7.41 – 
7.29 (m, 6H), 4.87 (s, 1H), 4.35 (q, J = 7.1 Hz, 2H), 3.85 (q, J = 7.1 Hz, 2H), 1.30 (t, J = 7.1 Hz, 
3H), 1.14 (t, J = 7.1 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3, major isomer): δ 167.28, 134.59, 131.83, 131.58, 128.71, 128.52, 
128.29, 128.09, 126.88, 123.01, 122.71, 95.09, 86.41, 83.21, 64.38, 63.13, 62.49, 15.17, 14.22. 
 
b. Synthesis of ethyl 3-bromo-2-oxo-3-(2-(phenylethynyl)phenyl)propanoate (8): 
To a solution of S3a (0.336 g, 1.00 mmol) in Et2O (10 ml) was added 
magnesium bromide (0.368 g, 2.00 mmol) in portions at room temperature for 
3 h. Deionized water (20 ml) was then added and the organic layer was 
separated. The aqueous layer was extracted with Et2O (3 x 20 ml). The 
combined organic layers were dried (Na2SO4) and concentrated in vacuo. Purification of the 
crude product by column chromatography (Hexanes: EtOAc, 9:1, Rf = 0.19) afforded 8 as a 
yellow oil (319 mg, 86% yield). 
1
H-NMR (300 MHz, CDCl3): δ 7.62 – 7.54 (m, 4H), 7.45 – 7.33 (m, 5H), 6.90 (s, 1H), 4.30 (qd, 
J = 7.1, 4.1 Hz, 2H), 1.28 (t, J = 7.1 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 184.51, 159.99, 135.08, 132.52, 131.82, 130.41, 129.46, 129.24, 
129.09, 128.64, 123.15, 122.61, 96.23, 86.21, 63.35, 48.49, 14.01.  
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3.9.17 Synthesis of 2a and 3a from 8: 
 
An oven dried 10 mL Schlenk tube equipped with a magnetic stir bar was charged with 
[Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (56 mg, 100 mol %), 8 (18.5 mg, 0.05 mmol, 1.0 equiv). The 
flask was purged with a stream of oxygen and 1.0 mL of dry DMF (1 mL) was added via 
syringe. The resultant mixture was bubbled by oxygen. Then, the tube was sealed under positive 
oxygen atmosphere and irradiated with blue light for 12 h. After complete consumption of the 
starting material (analyzed by TLC), the reaction mixture was diluted with EtOAc (10 mL) and 
transferred to the separatory funnel. This mixture was then washed with water (3 x 10 mL) and 
with brine solution (10 mL). The combined brine and water fractions were again washed with 
EtOAc (3 x 10 mL). The combined organic layers were dried over Na2SO4 and concentrated in 
vacuo. Purification of the crude product by column chromatography (Hexanes: EtOAc, 9:1) 
afforded 2a (4.1 mg, 27% yield) and 3a (7.6 mg, 47% yield). 
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3.10 Representative UV-Visible spectra in dilute acetonitrile: 
a. Compound 3a: (red colour) 
 
 
 
b. Compound 3c: (dark brown colour) 
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c. Compound 2b: (light red colour) 
 
 
 
d. Compound 2e: (violet colour) 
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3.11 NMR spectra: 
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3.12 Crystal data: 3a 
 
Figure 3.12: Single-crystal X-ray structure of 3a 
The recrystallization was done by 
DCM/pentane diffusion method. 
 
Crystal Data. C19H14O5, Mr = 322.30, triclinic, P-
1 (No. 2), a = 7.8329(2) Å, b = 8.2722(2) Å, c = 
11.4374(2) Å,  = 92.787(2)°,  = 95.928(2)°,  = 
93.919(2)°, V = 734.24(3) Å3, T = 123.01(10) K, 
Z = 2, Z' = 1, (CuK) = 0.882, 13287 reflections 
measured, 2918 unique (Rint = 0.0276) which 
were used in all calculations. The final wR2 was 
0.0902 (all data) and R1 was 0.0343 (I = 2(I)). 
Compound  3a  
Formula  C19H14O5  
Dcalc./ g cm-3  1.458  
/mm-1  0.882  
Formula Weight  322.30  
Colour  red  
Shape  prism  
Max Size/mm  0.19  
Mid Size/mm  0.16  
Min Size/mm  0.09  
T/K  123.01(10)  
Crystal System  triclinic  
Space Group  P-1  
a/Å  7.8329(2)  
b/Å  8.2722(2)  
c/Å  11.4374(2)  
/°  92.787(2)  
/°  95.928(2)  
/°  93.919(2)  
V/Å3  734.24(3)  
Z  2  
Z'  1  
min/°  3.892  
max/°  73.635  
Measured Refl.  13287  
Independent Refl.  2918  
Reflections Used  2647  
Rint  0.0276  
Parameters  219  
Restraints  0  
Largest Peak  0.274  
Deepest Hole  -0.203  
GooF  1.036  
wR2 (all data)  0.0902  
wR2  0.0874  
R1 (all data)  0.0378  
R1  0.0343  
 
Table 3.6: Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement Parameters (Å2×103) 
for 3a. Ueq is defined as 1/3 of the trace of the orthogonalized Uij. 
 
Atom x y z Ueq 
O2 5114.3(11) 9349.3(10) 3258.0(8) 26.3(2) 
O1 5717.4(11) 8469(1) 1384.9(8) 26.0(2) 
O3 4811.8(11) 2719.3(10) 2868.4(8) 27.8(2) 
O4 9190.9(11) 8485.5(10) 2366.5(9) 29.1(2) 
O5 8291.9(12) 10767.7(11) 3167.9(9) 35.3(2) 
C4 4173.3(15) 5815.8(14) 1380.4(11) 22.8(3) 
C2 6206.7(15) 6818.2(14) 3058.6(11) 21.9(2) 
C5 4462.1(15) 7315.3(14) 881.5(11) 23.2(3) 
C11 6660.6(15) 4623.7(14) 4214.5(11) 23.4(3) 
C3 5215.3(15) 5586.3(14) 2472.3(11) 22.4(3) 
C12 7109.9(15) 6290.2(14) 4155.3(11) 22.7(3) 
C10 5451.2(15) 4081.5(14) 3145.2(11) 23.2(3) 
C17 8027.6(16) 9404.8(14) 2756.3(11) 23.7(3) 
C1 6216.0(15) 8501.3(14) 2632.3(11) 22.9(3) 
C6 3585.0(16) 7656.4(15) -182.3(11) 26.3(3) 
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Atom x y z Ueq 
C16 7279.8(16) 3764.5(15) 5150.2(12) 26.2(3) 
C9 2954.1(16) 4666.8(15) 787.9(12) 25.9(3) 
C13 8190.0(16) 7120.1(15) 5043.4(11) 26.0(3) 
C14 8829.0(17) 6251.7(16) 5996.7(11) 28.0(3) 
C15 8385.3(17) 4613.4(16) 6050.7(12) 28.4(3) 
C7 2385.0(16) 6491.3(16) -754.9(12) 27.6(3) 
C8 2065.6(16) 5002.3(16) -273.3(12) 28.0(3) 
C18 10968.9(16) 9214.0(16) 2471.8(13) 29.6(3) 
C19 11264.1(17) 10284.7(16) 1483.8(13) 31.2(3) 
Table 3.7: Anisotropic Displacement Parameters (×104) 3a. The anisotropic displacement factor exponent 
takes the form: -22[h2a*2 × U11+ ... +2hka* × b* × U12] 
 
Atom U11 U22 U33 U23 U13 U12 
O2 23.4(4) 17.1(4) 39.0(5) 3.4(3) 5.3(4) 3.0(3) 
O1 26.1(4) 20.8(4) 29.8(5) 5.6(3) -1.4(4) -2.9(3) 
O3 26.5(5) 18.1(4) 38.5(5) 3.9(3) 1.8(4) 0.6(3) 
O4 20.0(4) 20.7(4) 47.0(6) 2.2(4) 5.5(4) 0.6(3) 
O5 28.5(5) 25.5(5) 50.7(6) -7.1(4) 6.7(4) -4.3(4) 
C4 18.6(6) 21.0(6) 29.5(6) 2.3(5) 3.8(5) 3.1(4) 
C2 18.3(5) 19.7(6) 28.5(6) 3.1(5) 4.5(5) 2.5(4) 
C5 19.5(6) 20.1(5) 30.1(6) 0.9(5) 2.7(5) 2.0(4) 
C11 19.9(6) 20.7(6) 30.4(6) 2.7(5) 5.2(5) 3.0(4) 
C3 18.7(6) 18.8(5) 30.6(6) 4.0(5) 4.9(5) 2.2(4) 
C12 19.8(6) 21.0(6) 28.6(6) 4.4(5) 5.5(5) 3.9(4) 
C10 19.4(6) 20.0(6) 31.4(6) 3.9(5) 6.3(5) 2.9(4) 
C17 22.6(6) 19.6(6) 28.7(6) 4.2(5) 0.6(5) 0.8(5) 
C1 20.3(6) 19.5(6) 28.6(6) 3.5(4) 0.2(5) 1.3(4) 
C6 24.4(6) 24.2(6) 31.1(7) 4.4(5) 3.3(5) 5.1(5) 
C16 25.3(6) 21.9(6) 32.9(7) 6.5(5) 6.6(5) 4.6(5) 
C9 22.1(6) 21.4(6) 34.3(7) 1.6(5) 3.8(5) 0.8(5) 
C13 25.8(6) 22.2(6) 30.1(6) 2.1(5) 4.0(5) 1.3(5) 
C14 26.8(6) 30.4(6) 26.5(6) 0.9(5) 2.1(5) 2.0(5) 
C15 29.0(7) 29.8(6) 27.8(6) 6.9(5) 4.5(5) 6.5(5) 
C7 22.7(6) 30.9(6) 29.3(6) 1.0(5) 0.2(5) 7.3(5) 
C8 20.5(6) 27.5(6) 35.2(7) -2.9(5) 0.9(5) 1.5(5) 
C18 18.7(6) 28.3(6) 41.7(7) 7.3(5) 1.1(5) 0.3(5) 
C19 24.0(6) 31.2(7) 39.0(7) 6.1(6) 4.0(5) 2.5(5) 
Table 3.8: Bond Lengths in Å for 3a. 
 
Atom Atom Length/Å 
O2 C1 1.3822(15) 
O1 C5 1.3822(14) 
O1 C1 1.4382(15) 
O3 C10 1.2150(15) 
O4 C17 1.3240(15) 
O4 C18 1.4700(15) 
O5 C17 1.1966(15) 
C4 C5 1.4045(17) 
C4 C3 1.4476(17) 
C4 C9 1.3979(17) 
C2 C3 1.3449(17) 
C2 C12 1.4754(17) 
C2 C1 1.4972(16) 
C5 C6 1.3853(18) 
Atom Atom Length/Å 
C11 C12 1.4059(16) 
C11 C10 1.4979(18) 
C11 C16 1.3782(18) 
C3 C10 1.5071(16) 
C12 C13 1.3763(18) 
C17 C1 1.5477(16) 
C6 C7 1.3889(18) 
C16 C15 1.4021(19) 
C9 C8 1.3854(19) 
C13 C14 1.4028(18) 
C14 C15 1.3819(19) 
C7 C8 1.3912(19) 
C18 C19 1.4961(19) 
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Table 3.9: Bond Angles in ° for 3a. 
Atom Atom Atom Angle/° 
C5 O1 C1 119.16(9) 
C17 O4 C18 116.30(10) 
C5 C4 C3 116.00(11) 
C9 C4 C5 118.56(11) 
C9 C4 C3 125.42(11) 
C3 C2 C12 111.33(10) 
C3 C2 C1 121.11(11) 
C12 C2 C1 127.42(11) 
O1 C5 C4 121.55(11) 
O1 C5 C6 116.95(11) 
C6 C5 C4 121.34(11) 
C12 C11 C10 107.99(11) 
C16 C11 C12 121.75(12) 
C16 C11 C10 130.24(11) 
C4 C3 C10 130.40(11) 
C2 C3 C4 121.54(11) 
C2 C3 C10 108.05(11) 
C11 C12 C2 107.40(11) 
C13 C12 C2 132.08(11) 
C13 C12 C11 120.51(12) 
O3 C10 C11 127.61(11) 
O3 C10 C3 127.20(12) 
C11 C10 C3 105.19(10) 
O4 C17 C1 111.83(10) 
O5 C17 O4 125.99(12) 
O5 C17 C1 122.18(11) 
O2 C1 O1 111.67(10) 
O2 C1 C2 107.65(10) 
O2 C1 C17 110.40(10) 
O1 C1 C2 110.96(10) 
O1 C1 C17 102.64(9) 
C2 C1 C17 113.55(10) 
C5 C6 C7 118.93(12) 
C11 C16 C15 117.55(11) 
C8 C9 C4 120.43(12) 
C12 C13 C14 118.03(12) 
C15 C14 C13 121.27(12) 
C14 C15 C16 120.90(12) 
C6 C7 C8 120.79(12) 
C9 C8 C7 119.94(12) 
O4 C18 C19 111.71(11) 
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Table 3.10: Hydrogen Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement 
Parameters (Å2×103) for 3a. Ueq is defined as 1/3 of the trace of the orthogonalised Uij. 
 
Atom x y z Ueq 
H2 5331 10350 3205 39 
H6 3801 8671 -515 32 
H16 6969 2639 5184 31 
H9 2733 3649 1115 31 
H13 8494 8248 5012 31 
H14 9581 6801 6617 34 
H15 8835 4055 6707 34 
H7 1775 6714 -1484 33 
H8 1239 4216 -672 34 
H18A 11772 8341 2473 36 
H18B 11215 9859 3230 36 
H19A 11001 9654 731 47 
H19B 12470 10717 1566 47 
H19C 10515 11185 1506 47 
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3.13 Crystal data: 2a 
 
 
Figure 3.13: Single-crystal X-ray structure of 
2a. 
The recrystallization was done by 
DCM/pentane diffusion method. 
 
Crystal Data. C19H14O4, Mr = 306.30, 
monoclinic, C2/c (No. 15), a = 15.1845(4) Å, b = 
14.3496(4) Å, c = 13.6636(4) Å,  = 98.670(3)°, 
 =  = 90°, V = 2943.16(15) Å3, T = 
122.99(10) K, Z = 8, Z' = 1, (MoK) = 0.097, 
20923 reflections measured, 3647 unique 
(Rint = 0.0294) which were used in all 
calculations. The final wR2 was 0.1310 (all data) 
and R1 was 0.0441 (I = 2(I)). 
Compound  2a  
Formula  C19H14O4  
Dcalc./ g cm-3  1.383  
/mm-1  0.097  
Formula Weight  306.30  
Colour  red  
Shape  prism  
Max Size/mm  0.58  
Mid Size/mm  0.26  
Min Size/mm  0.21  
T/K  122.99(10)  
Crystal System  monoclinic  
Space Group  C2/c  
a/Å  15.1845(4)  
b/Å  14.3496(4)  
c/Å  13.6636(4)  
/°  90  
/°  98.670(3)  
/°  90  
V/Å3  2943.16(15)  
Z  8  
Z'  1  
min/°  3.215  
max/°  29.177  
Measured Refl.  20923  
Independent Refl.  3647  
Reflections Used  3103  
Rint  0.0294  
Parameters  209  
Restraints  0  
Largest Peak  0.317  
Deepest Hole  -0.312  
GooF  1.127  
wR2 (all data)  0.1310  
wR2  0.1268  
R1 (all data)  0.0519  
R1  0.0441  
Table 3.11: Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement Parameters 
(Å2×103) for 2a. Ueq is defined as 1/3 of the trace of the orthogonalised Uij. 
 
Atom x y z Ueq 
O4 7910.6(7) 3065.3(7) 7356.8(7) 19.3(2) 
O2 6230.7(7) 2022.1(7) 5981.4(9) 24.4(3) 
O3 8109.4(7) 2177.2(8) 6045.2(8) 24.5(3) 
O1 5916.8(8) 6055.1(8) 6312.5(9) 28.5(3) 
C2 8000.2(10) 4442.8(10) 5537.2(10) 18.3(3) 
C10 5213.3(9) 3729.1(10) 6150.2(10) 17.6(3) 
C16 6641.2(9) 2741.1(10) 6182.1(10) 17.1(3) 
C11 6197.6(9) 3653.7(9) 6168.9(10) 16.0(3) 
C9 4994.7(10) 4672.2(10) 6206.3(10) 19.3(3) 
C14 3681.1(10) 3359.5(12) 6143.8(11) 25.1(3) 
C17 7651.7(10) 2640.8(10) 6502.1(11) 17.7(3) 
C12 4132.7(10) 4971.4(11) 6229.1(11) 23.5(3) 
C15 4554.2(10) 3061.5(11) 6114.9(11) 21.3(3) 
C3 8873.1(10) 4728.8(10) 5549.9(11) 21.2(3) 
C1 7489.4(9) 4820.0(9) 6209.1(10) 17.4(3) 
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Atom x y z Ueq 
C5 8736.3(11) 5781.1(11) 6884.5(12) 24.8(3) 
C6 7862(1) 5504.6(10) 6876.1(11) 21.4(3) 
C18 8866.6(10) 3037.9(11) 7718.2(11) 23.1(3) 
C8 5825.8(10) 5221.5(10) 6253.2(10) 19.8(3) 
C7 6570.0(9) 4516.9(10) 6213.7(10) 17.4(3) 
C13 3471.9(10) 4296.3(12) 6200.2(11) 26.5(3) 
C4 9246.0(11) 5394.6(11) 6224.4(12) 25.0(3) 
C19 8992.8(13) 3322.4(15) 8783.1(13) 36.7(4) 
Table 3.12: Anisotropic Displacement Parameters (×104) 2a. The anisotropic displacement factor exponent 
takes the form: -22[h2a*2 × U11+ ... +2hka* × b* × U12] 
 
Atom U11 U22 U33 U23 U13 U12 
O4 19.9(5) 19.8(5) 17.6(5) 0.3(4) 1.2(4) 1.0(4) 
O2 24.5(6) 17.3(5) 32.1(6) -4.0(4) 6.6(5) -2.8(4) 
O3 23.7(5) 23.5(6) 26.1(6) -4.6(4) 2.7(4) 7.2(4) 
O1 35.2(6) 16.3(5) 33.9(6) -3.3(4) 4.6(5) 3.9(4) 
C2 23.5(7) 15.0(6) 15.9(6) 1.4(5) 1.2(5) 0.1(5) 
C10 19.4(7) 20.1(7) 13.1(6) 0.8(5) 2.1(5) 2.7(5) 
C16 20.8(7) 15.8(6) 15.3(6) -0.8(5) 4.6(5) 0.0(5) 
C11 18.5(6) 16.8(7) 12.9(6) -1.1(5) 2.8(5) 1.4(5) 
C9 22.3(7) 21.9(7) 13.6(6) -0.3(5) 2.2(5) 4.0(5) 
C14 19.1(7) 34.3(8) 21.9(7) 3.4(6) 3.1(6) -1.8(6) 
C17 21.3(7) 13.4(6) 18.5(7) 2.3(5) 3.3(5) 1.3(5) 
C12 25.5(8) 27.7(8) 17.3(7) 0.8(6) 3.4(6) 9.4(6) 
C15 21.5(7) 23.2(7) 19.2(7) 1.2(6) 2.6(5) -0.8(6) 
C3 23.9(7) 20.2(7) 20.6(7) 2.1(5) 6.6(6) 0.8(6) 
C1 21.3(7) 13.7(6) 17.0(6) 1.9(5) 2.0(5) -0.1(5) 
C5 30.1(8) 21.2(7) 22.8(7) -3.6(6) 2.9(6) -7.5(6) 
C6 27.3(8) 17.9(7) 19.4(7) -2.4(5) 5.0(6) -1.5(6) 
C18 19.6(7) 24.7(7) 23.8(7) 4.2(6) -1.1(6) 0.0(6) 
C8 25.9(7) 17.9(7) 15.6(7) -0.9(5) 2.8(5) 4.0(6) 
C7 21.4(7) 16.1(6) 14.3(6) -0.6(5) 2.0(5) 1.9(5) 
C13 20.3(7) 39.2(9) 20.3(7) 3.2(6) 4.4(6) 7.1(6) 
C4 23.7(7) 25.1(8) 26.3(8) 1.2(6) 4.4(6) -5.6(6) 
C19 33.6(9) 44.0(11) 28.9(9) -8.6(8) -7.4(7) 0.1(8) 
 
Table 3.13: Bond Lengths in Å for 2a. 
 
Atom Atom Length/Å 
O4 C17 1.3233(18) 
O4 C18 1.4618(18) 
O2 C16 1.2152(17) 
O3 C17 1.2025(18) 
O1 C8 1.2054(19) 
C2 C3 1.385(2) 
C2 C1 1.397(2) 
C10 C11 1.4949(19) 
C10 C9 1.398(2) 
C10 C15 1.381(2) 
C16 C11 1.4714(19) 
C16 C17 1.538(2) 
C11 C7 1.3592(19) 
C9 C12 1.382(2) 
C9 C8 1.481(2) 
C14 C15 1.399(2) 
Atom Atom Length/Å 
C14 C13 1.386(2) 
C12 C13 1.391(2) 
C3 C4 1.388(2) 
C1 C6 1.400(2) 
C1 C7 1.4632(19) 
C5 C6 1.384(2) 
C5 C4 1.389(2) 
C18 C19 1.495(2) 
C8 C7 1.5232(19) 
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Table 3.14: Bond Angles in ° for 2a 
 
Atom Atom Atom Angle/° 
C17 O4 C18 115.69(11) 
C3 C2 C1 120.14(13) 
C9 C10 C11 108.31(12) 
C15 C10 C11 131.90(13) 
C15 C10 C9 119.77(13) 
O2 C16 C11 122.31(13) 
O2 C16 C17 116.14(12) 
C11 C16 C17 121.48(12) 
C16 C11 C10 121.29(12) 
C7 C11 C10 110.05(12) 
C7 C11 C16 128.61(13) 
C10 C9 C8 108.04(12) 
C12 C9 C10 122.36(14) 
C12 C9 C8 129.59(14) 
C13 C14 C15 121.61(15) 
O4 C17 C16 111.02(12) 
O3 C17 O4 126.50(14) 
O3 C17 C16 122.29(13) 
C9 C12 C13 117.68(15) 
C10 C15 C14 118.15(14) 
C2 C3 C4 120.41(14) 
C2 C1 C6 119.31(13) 
C2 C1 C7 120.82(13) 
C6 C1 C7 119.86(13) 
C6 C5 C4 120.51(14) 
C5 C6 C1 119.97(14) 
O4 C18 C19 107.24(13) 
O1 C8 C9 128.26(14) 
O1 C8 C7 125.65(14) 
C9 C8 C7 106.08(12) 
C11 C7 C1 131.41(13) 
C11 C7 C8 107.50(12) 
C1 C7 C8 121.08(12) 
C14 C13 C12 120.44(14) 
C3 C4 C5 119.64(14) 
Table 3.15: Hydrogen Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement 
Parameters (Å2×103) for 2a. Ueq is defined as 1/3 of the trace of the orthogonalised Uij. 
 
Atom x y z Ueq 
H2 7748 3989 5071 22 
H14 3221 2909 6124 30 
H12 3996 5616 6263 28 
H15 4690 2418 6072 26 
H3 9219 4467 5094 25 
H5 8990 6239 7345 30 
H6 7515 5779 7323 26 
H18A 9188 3471 7332 28 
H18B 9101 2401 7652 28 
H13 2873 4478 6219 32 
H4 9846 5585 6235 30 
H19A 8784 3964 8836 55 
H19B 9626 3284 9059 55 
H19C 8651 2906 9152 55 
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3.14 Crystal data: 1c 
 
  
Figure 3.14: Single-crystal X-ray structure of 1c. 
 
The recrystallization was done by DCM/pentane diffusion 
method. 
Crystal Data. C20H15BrO4, Mr = 399.23, monoclinic, Ia (No. 
9), a = 7.3822(2) Å, b = 24.5362(5) Å, c = 9.3974(2) Å,  = 
103.349(3)°,  =  = 90°, V = 1656.17(7) Å3, T = 
123.01(10) K, Z = 4, Z' = 1, (Cu K) = 3.580, 12765 
reflections measured, 3047 unique (Rint = 0.0326) which 
were used in all calculations. The final wR2 was 0.0612 
(all data) and R1 was 0.0248 (I > 2(I)). 
Compound  1c  
Formula  C20H15BrO4  
Dcalc./ g cm-3  1.601  
/mm-1  3.580  
Formula Weight  399.23  
Colour  clear colourless  
Shape  prism  
Size/mm3  0.11×0.07×0.03  
T/K  123.01(10)  
Crystal System  monoclinic  
Flack Parameter  -0.043(13)  
Hooft Parameter  -0.007(7)  
Space Group  Ia  
a/Å  7.3822(2)  
b/Å  24.5362(5)  
c/Å  9.3974(2)  
/°  90  
/°  103.349(3)  
/°  90  
V/Å3  1656.17(7)  
Z  4  
Z'  1  
Wavelength/Å  1.54184  
Radiation type  Cu K  
min/°  3.603  
max/°  73.488  
Measured Refl.  12765  
Independent Refl.  3047  
Reflections Used  2883  
Rint  0.0326  
Parameters  286  
Restraints  50  
Largest Peak  0.224  
Deepest Hole  -0.347  
GooF  1.041  
wR2 (all data)  0.0612  
wR2  0.0593  
R1 (all data)  0.0277  
R1  0.0248  
Table 3.16: Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement Parameters 
(Å2×103) for 1c. Ueq is defined as 1/3 of the trace of the orthogonalised Uij. 
 
Atom x y z Ueq 
Br(1) -1031.5(7) 9520.1(2) -254.3(6) 43.23(15) 
O(4) -883(4) 7888.4(10) 66(2) 22.0(6) 
O(1) 3031(4) 10455(1) 4381(3) 25.1(5) 
C(2) 4242(6) 9080.5(16) 5341(4) 21.8(7) 
O(3) -2058(4) 8475.3(11) -1747(3) 29.6(6) 
C(20) -1376(7) 6923.1(15) -84(5) 25.7(9) 
O(2) 5033(4) 10005.9(11) 6291(3) 26.3(5) 
C(3) 3120(5) 8785.6(15) 4179(4) 21.4(7) 
C(11) 3433(5) 7720.7(15) 4359(4) 22.3(7) 
C(7) 809(5) 8717.2(14) 1831(4) 19.5(7) 
C(8) -335(5) 8821.9(13) 547(4) 21.6(8) 
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Atom x y z Ueq 
C(4) 1893(5) 9056.8(14) 2994(4) 20.1(7) 
C(10) 3267(5) 8203.3(15) 4233(4) 22.0(7) 
C(5) 1805(5) 9632.3(14) 3007(4) 21.6(7) 
C(13) 4820(6) 6945.2(17) 5871(5) 25.1(9) 
C(16) 3246(7) 6219.4(19) 3718(5) 31.8(10) 
C(19) -1672(6) 7449.6(15) -920(4) 23.5(8) 
C(15) 4348(7) 6033.0(16) 5023(6) 34.9(12) 
C(17) 2923(6) 6769(2) 3467(5) 27.9(9) 
C(18) 4294(6) 10529.7(15) 5773(5) 26.2(8) 
C(12) 3713(5) 7142.6(13) 4558(4) 20.3(8) 
C(14) 5143(7) 6396.7(18) 6093(5) 29.6(9) 
C(9) -1198(6) 8387.7(14) -508(4) 21.7(9) 
C(6) 2916(5) 9900.9(14) 4147(4) 21.3(7) 
C(1) 4097(5) 9636.2(14) 5299(4) 20.9(7) 
Table 3.17: Anisotropic Displacement Parameters (×104) 1c. The anisotropic displacement factor exponent 
takes the form: -22[h2a*2 × U11+ ... +2hka* × b* × U12] 
 
Atom U11 U22 U33 U23 U13 U12 
Br(1) 64.5(3) 18.58(16) 33.7(2) 4.7(2) -15.06(17) -0.5(3) 
O(4) 25.6(14) 17.8(11) 19.6(16) -3.4(9) -0.8(13) -3.6(10) 
O(1) 28.1(15) 17.5(12) 26.7(14) -2(1) 0.2(11) -0.8(11) 
C(2) 19.8(18) 23.4(17) 21.4(16) 4.4(15) 2.7(13) 0.7(15) 
O(3) 36.3(17) 28.8(14) 19.2(13) 0.4(11) -2.6(11) 2.2(12) 
C(20) 30(3) 18.8(15) 26(2) -3.0(16) 0.2(16) -3.9(16) 
O(2) 27.5(14) 20.6(11) 26.1(13) -3.4(10) -3.2(10) -1.9(10) 
C(3) 20.6(19) 20.4(16) 23.7(19) 1.6(15) 6.1(14) 0.1(15) 
C(11) 21(2) 22.0(17) 22.8(16) -1.4(14) 2.6(12) -0.8(14) 
C(7) 20(2) 13.7(15) 24.9(18) 0.5(12) 4.6(14) 0.1(12) 
C(8) 25(2) 13.4(16) 25.0(19) 2.6(13) 3.0(15) 0.7(13) 
C(4) 18.9(18) 20.4(16) 20.5(16) -0.4(13) 3.3(14) -0.8(14) 
C(10) 19.5(19) 23.7(17) 21.2(16) 1.9(15) 1.4(13) 1.0(15) 
C(5) 22.5(19) 19.7(16) 22.5(17) 1.1(13) 4.8(14) 0.2(14) 
C(13) 23(2) 28(2) 22(2) -0.7(16) -1.2(16) -2.7(16) 
C(16) 37(3) 25(2) 34(2) -13.0(18) 9.0(18) -10.7(18) 
C(19) 23(2) 22.2(18) 21.1(19) -6.7(14) -2.1(16) -2.5(15) 
C(15) 40(3) 16.3(16) 51(3) 3.6(17) 17(2) -0.1(16) 
C(17) 28(2) 34(2) 19.3(19) -3.7(17) 1.2(16) -4.1(17) 
C(18) 27(2) 21.4(17) 27.2(19) -5.2(15) 0.4(17) -4.5(16) 
C(12) 20(2) 19.7(15) 21(2) 2.6(15) 3.5(17) 1.7(15) 
C(14) 29(2) 27(2) 31(2) 9.7(16) 1.8(16) 1.5(17) 
C(9) 19(2) 24.1(15) 22(3) 0.3(13) 5(2) 1.7(15) 
C(6) 22.6(19) 17.5(16) 23.4(18) 0.2(14) 4.8(14) -1.4(14) 
C(1) 17.6(19) 23.0(16) 22.4(16) -4.4(13) 5.0(14) -4.2(15) 
Table 3.18: Bond Lengths in Å for 1c. 
 
Atom Atom Length/Å 
Br(1) C(8) 1.894(3) 
O(4) C(19) 1.452(4) 
O(4) C(9) 1.337(4) 
O(1) C(18) 1.432(5) 
O(1) C(6) 1.377(4) 
C(2) C(3) 1.409(5) 
C(2) C(1) 1.368(5) 
O(3) C(9) 1.210(5) 
C(20) C(19) 1.502(5) 
O(2) C(18) 1.437(5) 
O(2) C(1) 1.368(4) 
Atom Atom Length/Å 
C(3) C(4) 1.427(5) 
C(3) C(10) 1.433(5) 
C(11) C(10) 1.194(5) 
C(11) C(12) 1.439(4) 
C(7) C(8) 1.328(5) 
C(7) C(4) 1.458(5) 
C(8) C(9) 1.494(5) 
C(4) C(5) 1.414(5) 
C(5) C(6) 1.360(5) 
C(13) C(12) 1.399(6) 
C(13) C(14) 1.374(6) 
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Atom Atom Length/Å 
C(16) C(15) 1.383(7) 
C(16) C(17) 1.379(7) 
C(15) C(14) 1.371(6) 
Atom Atom Length/Å 
C(17) C(12) 1.400(5) 
C(6) C(1) 1.385(5) 
Table 3.19: Bond Angles in ° for 1c. 
 
Atom Atom Atom Angle/° 
C(9) O(4) C(19) 114.5(3) 
C(6) O(1) C(18) 106.0(3) 
C(1) C(2) C(3) 117.5(4) 
C(1) O(2) C(18) 105.6(3) 
C(2) C(3) C(4) 121.3(3) 
C(2) C(3) C(10) 117.3(3) 
C(4) C(3) C(10) 121.5(3) 
C(10) C(11) C(12) 177.4(4) 
C(8) C(7) C(4) 134.0(3) 
C(7) C(8) Br(1) 126.4(3) 
C(7) C(8) C(9) 123.3(3) 
C(9) C(8) Br(1) 110.3(3) 
C(3) C(4) C(7) 117.3(3) 
C(5) C(4) C(3) 118.8(3) 
C(5) C(4) C(7) 124.0(3) 
C(11) C(10) C(3) 176.4(4) 
C(6) C(5) C(4) 118.0(3) 
C(14) C(13) C(12) 121.2(4) 
C(17) C(16) C(15) 121.2(4) 
O(4) C(19) C(20) 108.4(3) 
C(14) C(15) C(16) 120.0(4) 
C(16) C(17) C(12) 119.2(4) 
O(1) C(18) O(2) 108.1(3) 
C(13) C(12) C(11) 119.5(3) 
C(13) C(12) C(17) 118.6(3) 
C(17) C(12) C(11) 121.9(3) 
C(15) C(14) C(13) 119.7(4) 
O(4) C(9) C(8) 112.2(3) 
O(3) C(9) O(4) 123.7(3) 
O(3) C(9) C(8) 124.1(3) 
O(1) C(6) C(1) 109.5(3) 
C(5) C(6) O(1) 127.4(3) 
C(5) C(6) C(1) 123.0(3) 
C(2) C(1) O(2) 128.1(4) 
C(2) C(1) C(6) 121.4(4) 
O(2) C(1) C(6) 110.5(3) 
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Table 3.20: Hydrogen Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement 
Parameters (Å2×103) for 1c. Ueq is defined as 1/3 of the trace of the orthogonalised Uij. 
 
Atom x y z Ueq 
H(20A) -1890(70) 6670(20) -710(60) 25(11) 
H(18A) 3630(60) 10680(17) 6410(50) 22(10) 
H(15) 4560(80) 5680(20) 5230(60) 41(14) 
H(19A) -1010(60) 7446(16) -1690(50) 20(10) 
H(2) 5040(60) 8911(17) 6080(50) 16(10) 
H(14) 5940(80) 6240(20) 6980(60) 43(15) 
H(17) 2230(70) 6920(20) 2600(60) 36(13) 
H(20B) -120(130) 6860(30) 240(90) 90(30) 
H(13) 5250(90) 7200(20) 6610(70) 54(16) 
H(19B) -2990(70) 7531(17) -1220(50) 21(10) 
H(18B) 5230(80) 10740(20) 5500(60) 38(13) 
H(5) 1040(80) 9840(20) 2260(60) 39(13) 
H(7) 920(60) 8367(18) 1940(50) 19(10) 
H(20C) -1990(80) 6930(30) 640(70) 60(18) 
H(16) 2800(80) 6000(20) 3090(60) 45(16) 
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4 Photosensitized regioselective [2+2]-cycloaddition of cinnamates and 
related alkenes 
4.1 Abstract:  
A facile, mild and efficient method for the synthesis of substituted cyclobutane derivatives 
from cinnamates, chalcones, and styrenes has been developed by using a visible-light energy 
transfer mode. This reaction access a broad range of substituted 4-membered carbocycles in 
high yields with reasonable regio- and diastereoselectivities without providing external 
additives. We believe that the excellent regioselectivity is observed due to strong --
stacking between two distinct arene groups, whereas diastereoselectivity depends on the 
electronic effects or ortho-substitution of the arene moieties. The efficiency of the presented 
method is also demonstrated with the formal synthesis of the natural product (±)-Tanegool. 
4.2 Introduction:  
Strained 4-membered carbocycles are valuable structural building blocks, which commonly 
features in natural products (Figure 4.1). In general, they are found in insects, microbial 
species, and the plant kingdom, most of them possess a broad range of biological activities 
with potential therapeutic uses.
[1]
 In particular, cinnamic acid derived dimers, such as truxinic 
acid, piperarborenine D, or Sagerinic acid derivatives are particularly important class due to 
their attractive biological activities (Figure 4.1).
[2]
 In addition, the styrene-based naturally 
occurring cyclobutanes such as Endiandrin A, di-O-methylendiandrin A, Magnosalin (trans) 
or Andamanicin (cis) are typically used as anti-inflammatory agents, which potently bind to 
glucocorticoid receptors (GR).
[3]
 As a consequence, various atom economic methods have 
been established for the synthesis of cyclobutanes.
[4,5]
 In general, the [2+2]-cycloadditions of 
alkenes by thermal methods is uncommon,
[6]
 whereas photochemical approaches under UV-
irradiation have been established from decades.
[7]
 Recently, visible-light photocatalysis 
approach has been extensively applied for this transformation.
[8]
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Figure 4.1: Representative biologically active cyclobutanes. 
In particular, the group of Yoon has established the visible-light mediated methods for the 
synthesis of a wide range of cyclobutanes derivatives from different olefins.
[9,10]
 Despite the 
enormous development of visible-light mediated [2+2]-cycloaddition reactions, surprisingly 
the cycloaddition of cinnamates or styrenes has not been achieved efficiently so far.
[11]
 This is 
being summarized in a recent review with the following statement: Only if rendered 
intramolecular and only if the reacting centres are spatially close is a [2+2] 
photocycloaddition with cinnamates and other -arylacrylic acid derivatives possible.[4]  
Though, a number of indirect approaches have been developed for such substrates, which 
however requiring additional synthetic steps or additives: for instance, Yoon and co-workers 
have presented a stepwise method for photocycloaddition of desired cyclobutanes. They 
introduced a cleavable redox auxiliary for -unsaturated carbonyl compounds, which upon 
dimerization under visible-light provides intermediate cyclobutanes, and subsequent cleavage 
of the auxiliary affords the aimed cyclobutane carboxamides, esters, or thioesters.
[12]
 Despite 
its importance, this method requires nevertheless extra steps for the introduction and cleavage 
of such redox auxiliary. In 2015, Beeler et al developed an UV-light mediated flow-technique 
for the dimerization of cinnamates to afford ester-substituted cyclobutanes with the 
introduction of a thiourea derived catalyst (Scheme 4.2, top).
[13]
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4.3 Initial findings: Chemoselective [2+2] cycloaddition 
In recent times, we have presented that -bromocinnamates can be activated either by direct 
electron transfer
[14]
 or by a dual energy- and electron transfer photocascade
[15]
 process.
[16]
 In 
particular, the latter process of -bromocinnamate activation[16] is supposed to be initiated via 
a stabilized diradical species through energy transfer from the excited [Ir]-photocatalyst. This 
eventually cleaves off to a vinyl radical upon bromine extrusion in the presence of oxygen. 
Notably, in the absence of oxygen only E/Z-isomerisation product was observed, and in 
particular, no [2+2]-cycloadduct(s) could be isolated. 
With reference to previous chapter 3, Scheme 3.3 (see also a mechanistic discussion from 
both these chapters), when 1p was subjected under the standard reaction conditions, to our 
surprise, we only observed a [2+2]-cycloaddition product 2p (Scheme 4.1) of the -
unsaturated double bonds. Unexpectedly, the triple bonds do not interfere with the diradical 
(A*) involved, providing only the chemoselective cycloadditions. Initially, we were assuming 
a direct intramolecular cyclization of diradical on the triple bond should be the more feasible 
pathway. However, a photosensitized [2+2]-cycloaddition of -unsaturated bonds was 
turned out to be a dominating pathway. We later noticed that such cycloaddition reactions of 
corresponding cinnamate derivatives were not explored in the literature.
[4]
 
 
Scheme 4.1: Chemoselective [2+2] cycloaddition. 
Accordingly, we questioned about the utilization of such diradicals for simple cinnamates, 
and indeed, we present here the possibility of a energy transfer protocol for [2+2]-
cycloadditions. By this method, not only the synthesis of ester-substituted cyclobutanes are  
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accessed but the chalcones and styrenes derived cyclobutanes also synthesized in good to 
excellent yields and selectivities (Scheme 4.2, bottom).  
4.4 Beeler’s work: Combining UV-light and a thiourea catalyst 
 
4.5 This work: Visible-light photoredox catalysis 
 
Scheme 4.2: Representative synthesis of cyclobutanes by UV-light and visible light 
photocatalysis. 
In principle, the direct photoinduced electron transfer (PET) to cinnamates is 
thermodynamically unfavourable owing to its high reduction potential (e.g. –1.79 V vs SCE 
for 1a)
[17]
 by typical photocatalysts
[18]
 including  [Ru(bpy)3]Cl2] (–0.81 V vs SCE)
[19]
 or 
[Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (Ir-F: –0.89 V vs SCE).
[20]
 Alternatively, visible-light 
triggered photoredox catalyzed cycloadditions of these types of unsaturated carbonyl 
compounds is only feasible by triplet-sensitization or energy transfer mode.
[21]
 Noteworthy, 
the efficiency of energy transfer is solely independent of the redox potentials of the reacting 
substrates, which depends on the excited state lifetime of the photocatalysts. Thus, long-lived 
excited state photocatalysts typically provide better results. 
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4.6 Results and discussion: 
Considering these facts, we began our photochemical experiments by exploring [2+2]-
photocycloaddition of ethyl cinnamate 1a with the [Ir{dF(CF3)ppy}2(dtb-bpy)]PF6
 
photocatalyst, which having longer excited state lifetime (τ = 2300 ns)[20] under an oxygen 
atmosphere with blue light (Table 4.1, entry 1). Pleasantly, only head-to-head (-truxinate, 
trans) 2a and (-truxinate, cis) 3a isomers were obtained in a 9:1 ratio and 63% yield. The 
use of neutral fac[Ir(ppy)3] (τ = 1900 ns, entry 2) and [Ir(ppy)2(dtb-bpy)]PF6 (τ = 557 ns, 
entry 3) gave lower yields. 
4.7 Synthesis of 2a and 3a: Catalyst screening and reaction optimization 
 
Entry 
Photocatalyst 
(1.0 mol %) 
Atmosphere 
Yield  
(%)
[b]
 
d.r.
[c] 
01 [Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 O2 63 9:1 
02 fac[Ir(ppy)3] O2 44 9:1 
03 [Ir(ppy)2 (dtb-bpy)]PF6 O2 18 9:1 
04 [Cu(dap)2Cl] O2 traces - 
05 [Ru(bpy)3Cl2] O2 traces - 
06 [Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 N2 96 9:1 
07
[d,e]
 [Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 N2 78 ND
[f]
 
08 Rose bengal, 530 nm N2 - - 
09 No catalyst N2 NR
[g]
 - 
10 [Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 no light N2 NR
[g]
 - 
Table 4.1: Reaction conditions: [a] Ethyl cinnamate 1a (1.0 mmol), photocatalyst (1.0 mol %), dry DMF (2 
mL), LED455, 72 h, LED455, room temperature. [b] Isolated yields.
 [c] Determined by crude 1H-NMR analysis. 
[d] 0.5 mol % photocatalyst used. [e] Reaction time was 84 h. [f] d.r. not determined. [g] No reaction. [h] The 
optimizations are done by Santosh K. Pagire and Asik Hossain. 
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While [Cu(dap)2Cl]
[22] 
(τ = 270 ns) and [Ru(bpy)3Cl2], (τ= 1100 ns) did not provide any 
product under the identical conditions (Table 4.1, entry 4, 5). Lowering the catalyst 
concentration to 0.5 mol% (Table 4.1, entry 7) gave lower, but still respectable yields (78%). 
No reaction was observed in the presence of the typical triplet sensitizer rose bengal, 
highlighting the importance of the [Ir]-photocatalyst (Table 4.1, entry 8). The control 
experiments suggested the importance of both, [Ir]-photocatalyst and visible-light together 
(Table 4.1, entries 9, 10). Obviously, the best catalyst (Ir-F, Table 4.1, entry 1) was selected 
for next optimizations: Gratifyingly, the cycloaddition proceeded much more efficiently 
under nitrogen (N2) atmosphere (Table 4.1, entry 6), giving rise to 2a/3a (9:1) in 96% yield.  
4.8 Substrate scope: Cinnamates and Chalcones 
Having identified the best conditions (Table 4.1, entry 6), next, the substrate scope was 
examined. With the standard conditions, methyl cinnamate (1b) provided 2b/3b in 89% yield 
and 10:1 diastereoselectivity, also improving the literature report that yielded the desired 
cycloadduct in lower yields and selectivity (60%; up to 4:1, Scheme 4.2).
[13] 
Similarly, the 
cycloaddition of -methyl ethyl cinnamate (1c) provides solely the -diastereomer 2c in 88% 
yield. Moreover, para-substituted cinnamates with electron donating substituents (+I/+M) or 
weak acceptors (–I/–M) groups afford the thermodynamically favored all-trans substituted 
cyclobutanes in good yields and diastereoselectivities (2d/3d to 2h/3h, Table 4.2). 
In contrast, strong electron withdrawing groups decrease the diastereoselectivity to a great 
extent, most likely due to the destabilisation of the radical species formed as intermediates 
(see the mechanistic discussion). Notably, substitution in ortho-position of the arene moiety 
dramatically enhances the diastereoselectivity up to 20:1 (Table 4.2 and Scheme 4.1; 2n/3n 
and 2p/3p, respectively). Furthermore, relevant for naturally occurring cyclobutanes (cf. 
Figure 4.1), di- or tri-arylsubstituted cinnamates can also be engaged in photodimerization, 
providing cyclobutanes 2l/3l and 2m/3m in reasonable yields and diastereoselectivities. In 
particular, the isolated -isomer (3l) has already been recognized as a critical intermediate for 
the synthesis of lignane natural product (±)-Tanegool.
[4,23]
 Moreover, Furan, thiophene, and 
N-Boc-pyrrole substituted cinnamates were also suitable substrates,
[4,24]
 providing the desired 
head-to-head dimers 2q-s/3q-s in good yields, however, with low diastereoselectivity 
(~1.7:1). Interestingly, for the first two substrates, the unexpected head-to-tail dimers 4q, 4r 
could also be detected in minute amounts (see 
1
H-NMR in the ESI), whereas, in the case of  
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the pyrrole derivative, only the head-to-head cycloaddition product 2s/3s was obtained. The 
limitation of our method was observed for the indole derivative, it only gave corresponding 
cycloadduct product 2t in 11% yield (Table 4.2).  
 
Table 4.2: Reaction conditions:
 [a] Substrate 1 (1.0 mmol), [Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (1.0 mol %), dry 
DMF (2 mL), LED455, 72 h, LED455, room temperature, the diastereomeric ratios were determined either by 
crude 1H-NMR analysis or on the basis of yield of isolated products. [b] Reaction time was 96 h. [c] Head-to-tail 
products were detected by 1H-NMR analysis. [d] These compounds are isolated by Lukas Traub. [e] These 
compounds are isolated by Asik Hossain. [f] These compounds are isolated by Sabine Kerres. 
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Due to the fast cis/trans isomerization process (or relaxation of the excited state), the [2+2] 
photocycloaddition reactions of chalcones are relatively rare.
[25]
 Nevertheless, we were 
pleased to notice that chalcones also efficiently underwent a complete dimerization under the 
standard conditions, providing the desired products (2v/3v and 2w/3w) in good yields with 
3:1 diastereoselectivity. In addition, the -isomer of 2v could also be isolated and 
unambiguously characterised by single X-ray crystallography (Table 4.2), confirming the 
stereochemistry of a major isomer. Unfortunately, the attempted photodimerization of 
corresponding sulfone, cyano, or nitro substituted alkenes only led to the E/Z-isomerization 
of the starting materials, and no cyclobutanes could be detected. 
4.9 Substrate scope: Styrenes 
Having established a protocol for α-β-unsaturated carbonyl compounds, next, we explored 
the intermolecular [2+2] photo-dimerization of styrenes 5 by triplet sensitization,
[21]
 given the 
importance of the resulting cyclobutanes for biologically active molecules (cf. Figure 4.1). In 
literature, the intermolecular styrene cycloadditions by photochemical alkene oxidation were 
already reported under visible-light conditions, but they require the electron rich systems to 
obtain desired products.
[10,26]
 Pleasingly, in our case (Table 4.3), a range of electronically 
unbiased styrenes 5a,c-e, but also the nitro-substituted styrene 5b provided the corresponding 
head-to-head cycloadducts 6 in excellent yields. Surprisingly, the corresponding 1,2-diphenyl 
ethene (E-Stilbene) only undergoes cis/trans isomerization. 
 
Table 4.3: Reaction conditions:
 [a] Unless otherwise stated, the identical conditions from Table 4.2 were used. 
[b] These compounds are isolated by Asik Hossain. 
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4.10 [2+2] cross-cycloaddition of cinnamates 
The selective synthesis of unsymmetrical cyclobutanes derivatives is a long-standing problem 
in organic synthesis and only a few protocols are known.
[27]
 In line with our strategy, we next 
questioned if two electronically differentiated cinnamates would allow cross-cycloaddition 
beyond the statistically assumed distribution of possible products (Table 4.4). Indeed, in all 
cases tested the expected cross-coupling products were obtained; however, no acceptable bias 
towards the cross-coupled cinnamates was observed. 
 
Table 4.4: Reaction conditions:
 [a] Substrate 1 (1.0 mmol, in total), [Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (1.0 mol 
%), dry DMF (2 mL), LED455, 72 h, LED455, room temperature, the diastereomeric ratios were determined either 
by crude 1H-NMR analysis or on the basis of yield of isolated products. [b] All the cross-cycloaddition reactions 
were performed by Lukas Traub. 
4.11 Proposed reaction mechanism 
Following the underlying principle put forward by Haag and co-workers for the cycloaddition 
of cinnamates,
[28]
 we, therefore, propose that the method described here should also proceed 
by energy transfer mode through diradical formation (Figure 4.2).
[29]
 The visible-light 
excitation of the [Ir]-photocatalyst forms the excited Ir*, which transfers triplet-energy to the 
substrate 1 to form the activated diradical (triplet) species 1*, followed by coupling with 1 to 
give rise to A. In full agreement with the experimental outcomes, we reasoned, the 
regioselective (head-to-head) product formation is only possible due to the strong π-π  
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stacking of an arene moiety. However, the stereoselectivity is dependent on the stabilization 
of the adjacent benzylic radicals (Figure 4.2, A), being more influential for electron donating 
substituted substrates, which consequently undergo slower ring (as compared to the electron 
withdrawing substituents) closure that enables equilibrating A to the sterically most 
favourable all-trans arrangements. 
 
Figure 4.2: Proposed reaction mechanism. 
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4.12 Conclusion: 
To summarize, we have developed for the first time an efficient strategy for homo-
cycloaddition of cinnamates, styrenes, and chalcones which offers a range of substituted 
cyclobutanes in excellent yields with moderate to good diastereoselectivities under the 
sustainable reaction conditions. In addition, we have also shown that cross-cycloaddition also 
possible with an appropriate combination of the reactants. Moreover, the scope of this 
strategy was extended by carrying out the intramolecular and chemoselective synthesis of 
cyclobutanes. Finally, the value of this method highlighted with the formal synthesis of 
lignane natural product (±)-Tanegool. 
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4.13 Experimental section: 
4.13.1 General procedure (GP-1) for visible-light photocatalysis: 
 
An oven dried 10 mL schlenk flask was charged with olefin (1.00 mmol, 1.00 equiv) and 
[Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (11.22 mg, 0.01 equiv, 1.0 mol %) in 2.0 mL anhydrous 
DMF. The resulting suspension was deoxygenated by three freeze-pump-thaw cycles. The 
reaction mixture was irradiated with blue light emitting diode (LED, λmax = 455 nm) at room 
temperature for 72 h. Then the reaction mixture was saturated with brine (15 mL) and 
extracted with ethyl acetate (3 x 20 mL). After drying the combined organic layers on 
Na2SO4, the resulting solution was concentrated in vacuo. Purification by silica-gel column 
chromatography using hexanes and ethyl acetate as eluents afforded cycloaddition product(s). 
 
Figure 4.3: Experimental set-up the cycloaddition reaction. 
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Diethyl (1R,2R,3S,4S)-3,4-diphenylcyclobutane-1,2-dicarboxylate (2a): 
Following GP-1, 2a was prepared from ethyl cinnamate 1a (176.2 mg, 1.0 
mmol, 1.00 equiv) and [Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (11.22 mg, 0.01 equiv, 
1.0 mol %) in dry DMF (2 mL). The crude product was purified by column 
chromatography (silica gel, hexanes–EtOAc, 9:1, Rf = 0.43) to afford 2a as a 
colourless oil (153 mg, 87% yield).  
1
H-NMR (300 MHz, CDCl3): δ 7.45 – 7.06 (m, 10H), 4.22 (q, J = 7.1 Hz, 4H), 3.79 (d, J = 
9.6 Hz, 2H), 3.48 (d, J = 9.5 Hz, 2H), 1.29 (t, J = 7.1 Hz, 6H). 
13
C-NMR (75 MHz, CDCl3): δ 172.72, 141.31, 128.73, 127.19, 126.97, 61.13, 47.09, 44.95, 
14.37. 
IR (neat, cm
-1
): 3030, 2981, 2936, 1723, 1602, 1496, 1449, 1416, 1388, 1368, 1317, 1198, 
1156, 1095, 1030, 856, 751, 696. 
EI-MS: exact m/z calculated for C22H24O4 (M)
+
: 352.16691; Found: 352.16799 (M)
+
. 
 
Diethyl (1R,2S,4S)-3,4-diphenylcyclobutane-1,2-dicarboxylate (3a): 
Following GP-1, 3a was prepared from ethyl cinnamate 1a (176.2 mg, 1.0 
mmol, 1.00 equiv) and [Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (11.22 mg, 0.01 equiv, 
1.0 mol %) in dry DMF (2 mL). The crude product was purified by column 
chromatography (silica gel, hexanes–EtOAc, 9:1, Rf = 0.39) to afford 3a as a 
colourless oil (17 mg, 9% yield).  
1
H-NMR (300 MHz, CDCl3): δ 7.37 – 7.15 (m, 4H), 7.12 – 6.95 (m, 4H), 6.94 – 6.85 (m, 
2H), 4.40 – 4.32 (m, 2H), 4.16 (q, J = 7.1 Hz, 4H), 3.78 (m, 2H), 1.23 (t, J = 7.1 Hz, 6H). 
13
C-NMR (75 MHz, CDCl3): δ 172.65, 138.88, 128.15, 127.98, 126.47, 61.16, 45.00, 43.61, 
14.39. 
IR (neat, cm
-1
): 3030, 2981, 2935, 1725, 1602, 1496, 1449, 1267, 1196, 1158, 1095, 1062, 
1015, 856, 749, 696. 
EI-MS: exact m/z calculated for C22H24O4 (M)
+
: 352.16691; Found: 352.16799 (M)
+
. 
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Dimethyl (1R,2R,3S,4S)-3,4-diphenylcyclobutane-1,2-dicarboxylate (2b): 
Following GP-1, 2b was prepared from methyl cinnamate 1b (162.2 
mg, 1.0 mmol, 1.00 equiv) and [Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (11.22 
mg, 0.01 equiv, 1.0 mol %) in dry DMF (2 mL). The crude product 
was purified by column chromatography (silica gel, hexanes–EtOAc, 
9:1, Rf = 0.40) to afford 2b as a white solid (131 mg, 81% yield).  
1
H-NMR (300 MHz, CDCl3): δ 7.40 – 7.22 (m, 10H), 3.78 (m, 2H), 3.75 (s, 6H), 3.56 – 
3.50 (m, 2H). 
13
C-NMR (75 MHz, CDCl3): δ 173.12, 141.08, 128.77, 127.29, 126.96, 52.34, 47.47, 44.53; 
IR (neat, cm
-1
): 3031, 2950, 2923, 2853, 1725, 1602, 1496, 1433, 1313, 1281, 1200, 1167, 
1115, 1023, 1006, 905, 775, 753, 733, 696. 
HRMS (ESI): exact m/z calculated for C20H21O4 (M+H)
+
: 325.1434; Found: 325.1443 
(M+H)
+
. 
Mp: 69-71 
o
C (decomposed). 
 
Dimethyl (1R,2S,4S)-3,4-diphenylcyclobutane-1,2-dicarboxylate (3b): 
Following GP-1, 3b was prepared from methyl cinnamate 1b (162.2 mg, 1.0 
mmol, 1.00 equiv) and [Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (11.22 mg, 0.01 equiv, 
1.0 mol %) in dry DMF (2 mL). The crude product was purified by column 
chromatography (silica gel, hexanes–EtOAc, 9:1, Rf = 0.36) to afford 3b as a 
colourless oil (13 mg, 8% yield). 
1
H-NMR (300 MHz, CDCl3): δ 7.15 – 7.01 (m, 6H), 6.95 – 6.89 (m, 4H), 4.41 (dd, J = 3.9, 
2.3 Hz, 2H), 3.86 (dt, J = 3.3, 0.9 Hz, 2H), 3.76 (s, 6H). 
13
C-NMR (75 MHz, CDCl3): δ 173.13, 138.61, 128.17, 127.92, 126.54, 52.36, 45.08, 43.39. 
IR (neat, cm
-1
): 3029, 2951, 2923, 1726, 1602, 1496, 1434, 1367, 1270, 1200, 1163, 1062, 
1029, 967, 748, 695. 
HRMS (ESI): exact m/z calculated for C20H21O4 (M+H)
+
: 325.1434; Found: 325.1443 
(M+H)
+
. 
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Diethyl (1S,2S,3S,4S)-3,4-dimethyl-3,4-diphenylcyclobutane-1,2-dicarboxylate (2c): 
Following GP-1, 2c was prepared from ethyl (E)-3-phenylbut-2-enoate 1c 
(190.2 mg, 1.0 mmol, 1.00 equiv) and [Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (11.22 
mg, 0.01 equiv, 1.0 mol %) in dry DMF (2 mL). The crude product was 
purified by column chromatography (silica gel, hexanes–EtOAc, 9:1, Rf = 
0.56) to afford 2c as a colourless oil (167 mg, 88% yield). 
1
H-NMR (300 MHz, CDCl3): δ 7.45 – 7.27 (m, 6H), 7.21 (dd, J = 7.7, 1.7 Hz, 4H), 5.92 (d, 
J = 1.3 Hz, 2H), 4.01 (q, J = 7.1 Hz, 4H), 2.19 (d, J = 1.4 Hz, 6H), 1.09 (t, J = 7.1 Hz, 6H). 
13
C-NMR (75 MHz, CDCl3): δ 166.08, 155.57, 141.00, 128.03, 127.87, 126.95, 117.90, 
59.90, 27.31, 14.10. 
IR (neat, cm
-1
): 2979, 2937, 1722, 1705, 1638, 1600, 1575, 1492, 1441, 1373, 1273, 1227, 
1155, 1095, 1075, 1043, 954, 912, 860, 766, 696. 
EI-MS: exact m/z calculated for C24H28O4 (M)
+
: 380.19821; Found: 380.19819 (M)
+
. 
 
Diethyl (1S,2S,3R,4R)-3,4-di-m-tolylcyclobutane-1,2-dicarboxylate (2d): 
Following GP-1, 2d was prepared from ethyl (E)-3-(m-tolyl)acrylate 
1d (190.2 mg, 1.0 mmol, 1.00 equiv) and [Ir{dF(CF3)ppy}2(dtb-
bpy)]PF6 (11.22 mg, 0.01 equiv, 1.0 mol %) in dry DMF (2 mL). The 
crude product was purified by column chromatography (silica gel, 
hexanes–EtOAc, 9:1, Rf = 0.49) to afford 2d as a colourless oil (130 
mg, 68% yield). 
1
H-NMR (300 MHz, CDCl3): δ 7.24 (t, J = 7.5 Hz, 2H), 7.18 – 7.05 (m, 6H), 4.24 (q, J = 7.1 
Hz, 4H), 3.82 – 3.71 (m, 2H), 3.49 – 3.41 (m, 2H), 2.37 (s, 6H), 1.31 (t, J = 7.1 Hz, 6H). 
13
C-NMR (75 MHz, CDCl3): δ 172.79, 141.29, 138.29, 128.58, 127.91, 127.66, 124.08, 
61.06, 46.95, 45.02, 21.58, 14.35.  
IR (neat, cm
-1
): 2980, 2924, 2870, 1725, 1606, 1589, 1489, 1460, 1445, 1410, 1385, 1368, 
1310, 1197, 1156, 1095, 1021, 857, 778, 698. 
EI-MS: exact m/z calculated for C24H28O4 (M)
+
: 380.19821; Found: 380.19819 (M)
+
. 
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Diethyl (1R,2S,4S)-3,4-di-m-tolylcyclobutane-1,2-dicarboxylate (3d): 
Following GP-1, 3d was prepared from ethyl (E)-3-(m-tolyl)acrylate 
1d (190.2 mg, 1.0 mmol, 1.00 equiv) and [Ir{dF(CF3)ppy}2(dtb-
bpy)]PF6 (11.22 mg, 0.01 equiv, 1.0 mol %) in dry DMF (2 mL). The 
crude product was purified by column chromatography (silica gel, 
hexanes–EtOAc, 9:1, Rf = 0.43) to afford 3d as a colourless oil (43 mg, 
23% yield). 
1
H-NMR (300 MHz, CDCl3): δ 7.24 – 6.83 (m, 6H), 6.77 – 6.67 (m, 2H), 4.34 (dd, J = 3.9, 
2.3 Hz, 2H), 4.20 (q, J = 7.1 Hz, 4H), 3.85 – 3.78 (m, 2H), 2.19 (s, 6H), 1.29 (t, J = 7.1 Hz, 
6H). 
13
C-NMR (75 MHz, CDCl3): δ 172.71, 138.82, 137.51, 128.87, 127.92, 127.13, 125.00, 
61.09, 44.91, 43.64, 21.49, 14.38. 
IR (neat, cm
-1
): 2979, 2924, 2856, 1727, 1606, 1589, 1489, 1460, 1446, 1372, 1349, 1300, 
1274, 1198, 1159, 1095, 1066, 1024, 878, 857, 776, 698. 
EI-MS: exact m/z calculated for C24H28O4 (M)
+
: 380.19821; Found: 380.19819 (M)
+
. 
 
Diethyl (1S,2S,3R,4R)-3,4-bis(4-isopropylphenyl)cyclobutane-1,2-dicarboxylate (2e): 
Following GP-1, 2e was prepared from ethyl (E)-3-(4-
isopropylphenyl)acrylate 1e (218.3 mg, 1.0 mmol, 1.00 equiv) and 
[Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (11.22 mg, 0.01 equiv, 1.0 mol %) in 
dry DMF (2 mL). The crude product was purified by column 
chromatography (silica gel, hexanes–EtOAc, 9:1, Rf = 0.52) to afford 
2e as a colourless oil (163 mg, 75% yield). 
1
H-NMR (300 MHz, CDCl3): δ 7.32 – 7.26 (m, 4H), 7.24 – 7.18 (m, 4H), 4.23 (q, J = 7.1 
Hz, 4H), 3.84 – 3.73 (m, 2H), 3.48 – 3.40 (m, 2H), 2.92 (m, 2H), 1.31 (t, J = 7.1 6H), 1.27 (d, 
J = 6.9 Hz, 12H). 
13
C-NMR (75 MHz, CDCl3): δ 172.83, 147.67, 138.82, 126.93, 126.71, 61.03, 46.70, 45.11, 
33.88, 24.11, 14.37. 
IR (neat, cm
-1
): 2960, 2931, 2871, 1726, 1513, 1461, 1409, 1366, 1316, 1263, 1199, 1156, 
1097, 1033, 1017, 824. 
EI-MS: exact m/z calculated for C28H36O4 (M)
+
: 436.26081; Found: 436.25936 (M)
+
. 
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Diethyl (1R,2S,4S)-3,4-bis(4-isopropylphenyl)cyclobutane-1,2-dicarboxylate (3e): 
Following GP-1, 3e was prepared from ethyl (E)-3-(4-
isopropylphenyl)acrylate 1e (218.3 mg, 1.0 mmol, 1.00 equiv) and 
[Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (11.22 mg, 0.01 equiv, 1.0 mol %) in 
dry DMF (2 mL). The crude product was purified by column 
chromatography (silica gel, hexanes–EtOAc, 9:1, Rf = 0.46) to afford 
3e as a colourless oil (31 mg, 14% yield). 
1
H-NMR (300 MHz, CDCl3): δ 7.23 – 6.90 (m, 4H), 6.88 – 6.78 (m, 4H), 4.42 – 4.26 (m, 
2H), 4.19 (q, J = 7.1 Hz, 4H), 3.85 – 3.78 (m, 2H), 2.88 – 2.60 (m, 2H), 1.28 (t, J = 7.1 Hz, 
6H), 1.12 (d, J = 7.0 Hz, 12H). 
13
C-NMR (75 MHz, CDCl3): δ 172.81, 146.95, 136.29, 127.89, 126.03, 61.06, 44.75, 43.62, 
33.92, 33.74, 29.88, 24.16, 24.09, 14.39. 
IR (neat, cm
-1
): 2959, 2925, 2855, 1727, 1606, 1513, 1461, 1373, 1265, 1191, 1158, 1097, 
1056, 1017, 827. 
EI-MS: exact m/z calculated for C28H36O4 (M)
+
: 436.26081; Found: 436.25936 (M)
+
. 
 
Diethyl (1R,2R,3S,4S)-3,4-bis(4-methoxyphenyl)cyclobutane-1,2-dicarboxylate (2f): 
Following GP-1, 2f was prepared from ethyl (E)-3-(4-
methoxyphenyl)acrylate 1f (206.2 mg, 1.0 mmol, 1.00 equiv) and 
[Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (11.22 mg, 0.01 equiv, 1.0 mol %) in 
dry DMF (2 mL). The crude product was purified by column 
chromatography (silica gel, hexanes–EtOAc, 5:1, Rf = 0.40) to afford 
2f as a colourless oil (122 mg, 59% yield) and a mixture of 2f/3f as 
yellow oil (49 mg, 27% yield, 1:0.84 d.r.). 
1
H-NMR (300 MHz, CDCl3, mixture of both isomers): δ 7.24 – 7.17 (m, 2H), 6.88 – 6.81 
(m, 4H), 6.66 (d, J = 8.8 Hz, 2H), 4.29 (dd, J=4.0, 2.2, 1H), 4.19 (qd, J=7.1, 1.6, 4H), 3.79 (s, 
3H), 3.77 (d, J =1.4 Hz, 1H), 3.76 – 3.72 (m, 1H), 3.71 (d, J = 2.2 Hz, 2H), 3.64 – 3.59 (m, 
1H), 3.39 – 3.34 (m, 1H), 1.27 (td, J = 7.1, 4.5 Hz, 6H). 
1
H-NMR (300 MHz, CDCl3, trans isomer): δ 7.21 – 7.13 (m, 2H), 6.85 – 6.74 (m, 2H), 6.85 
– 6.76 (m, 2H), 4.14 (q, J = 7.1, 2H), 3.77 – 3.70 (m, 6H), 3.61 – 3.54 (m, 1H), 3.36 – 3.28 
(m, 1H), 1.21 (t, J = 7.1 Hz, 6H). 
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13
C-NMR (75 MHz, CDCl3, trans isomer): δ 172.71, 158.67, 133.38, 127.95, 113.99, 77.38, 
77.06, 76.74, 60.94, 55.29, 46.94, 45.01, 14.27. 
IR (neat, cm
-1
): 2982, 2836, 1722, 1610, 1513, 1461, 1245, 1033, 826, 731. 
HRMS (ESI): exact m/z calculated for mixture: C24H28O6 (M+H)
+
: 413.1959; Found: 
413.1959 (M+H)
+
; For trans: exact m/z calculated for C24H28O6 (M+H)
+
: 413.1959; Found: 
413.1959 (M+H)
+
; For cis: exact m/z calculated for C24H28O6 (M+H)
+
: 413.1959; Found: 
413.1961 (M+H)
+
. 
 
Diethyl-3,4-bis(4-fluorophenyl)cyclobutane-1,2-dicarboxylate (2g/3g): 
Following GP-1, 2g/3g was prepared from ethyl (E)-3-(4-
fluorophenyl)acrylate 1g (194.2 mg, 1.0 mmol, 1.00 equiv) and 
[Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (11.22 mg, 0.01 equiv, 1.0 mol %) in dry 
DMF (2 mL). The crude product was purified by column chromatography 
(silica gel, hexanes–EtOAc, 9:1, Rf = 0.20 (trans), Rf = 0.17 (cis) to afford 
mixture of 2g/3g as a white solid (139 mg, 72% yield; d.r. = 6:1). 
1
H-NMR (300 MHz, CDCl3, major isomer): δ 7.39 – 7.12 (m, 4H), 7.01 (t, J = 8.6 Hz, 4H), 
4.20 (q, J = 7.1 Hz, 4H), 3.75 – 3.55 (m, 2H), 3.47 – 3.31 (m, 2H), 1.27 (t, J = 7.1 Hz, 6H). 
13
C-NMR (75 MHz, CDCl3, major isomer): δ 172.52, 162.12 (d, 
1
JC-F = 245.5 Hz), 136.78 
(d, 
4
JC-F = 3.1 Hz), 128.51 (d, 
3
JC-F = 8.0 Hz), 115.68 (d, 
2
JC-F = 21.4 Hz), 61.29, 46.78, 
45.05, 14.38. 
19
F-NMR (282 MHz, CDCl3): δ -115.85. 
IR (neat, cm
-1
): 2989, 2944, 1718, 1601, 1509, 1473, 1447, 1393, 1368, 1300, 1215, 1196, 
1155, 1109, 1033, 1015, 965, 870, 824, 791, 671. 
EI-MS: exact m/z calculated for C22H22O4F2 (M)
+
: 388.14807; Found: 388.14844 (M)
+
. 
Mp: 60-62 
o
C (decomposed). 
 
Diethyl-3,4-bis(4-bromophenyl)cyclobutane-1,2-dicarboxylate (2h/3h): 
Following GP-1, 2h/3h was prepared from ethyl (E)-3-(4-
bromophenyl)acrylate 1h (255.1 mg, 1.0 mmol, 1.00 equiv) and 
[Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (11.22 mg, 0.01 equiv, 1.0 mol %) in dry 
DMF (2 mL). The crude product was purified by column chromatography 
(silica gel, hexanes–EtOAc, 9:1, Rf = 0.20 (trans), Rf = 0.17 (cis) to afford 
mixture of 2h/3h as a white solid (125 mg, 49% yield; d.r. = 4:1).  
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1
H-NMR (300 MHz, CDCl3, major isomer): δ 7.48 – 7.41 (m, 4H), 7.18 – 7.11 (m, 4H), 
4.20 (q, J = 7.1 Hz, 4H), 3.66 – 3.58 (m, 2H), 3.42 – 3.34 (m, 2H), 1.26 (t, J = 7.1 Hz, 6H). 
13
C-NMR (75 MHz, CDCl3, major isomer): δ 172.35, 139.85, 131.96, 128.69, 121.32, 
61.38, 46.73, 44.73, 14.39. 
IR (neat, cm
-1
): 2985, 2937, 1717, 1588, 1486, 1394, 1364, 1315, 1294, 1273, 1195, 1159, 
1111, 1070, 1006, 962, 864, 812, 755, 702. 
EI-MS: exact m/z calculated for C22H22O4Br2 (M)
+
: 507.98498; Found: 507.98582 (M)
+
.  
Mp: 92-94 
o
C (decomposed). 
 
Diethyl-3,4-bis(4-cyanophenyl)cyclobutane-1,2-dicarboxylate (2i/3i): 
Following GP-1, 2i/3i was prepared from ethyl (E)-3-(4-
cyanophenyl)acrylate 1i (201.2 mg, 1.0 mmol, 1.00 equiv) and 
[Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (11.22 mg, 0.01 equiv, 1.0 mol %) in 
dry DMF (2 mL). The crude product was purified by column 
chromatography (silica gel, hexanes–EtOAc, 5:1, Rf = 0.20) to afford a 
mixture of 2i/3i as a white solid (171 mg, 85% yield, 1.15:1 d.r.).  
1
H-NMR (400 MHz, CDCl3, trans isomer): δ 7.68 – 7.58 (m, 2H), 7.38 (d, J = 8.3 Hz, 2H), 
4.22 (qd, J = 7.1 Hz, 1.6, 2H), 3.87 – 3.74 (m, 1H), 3.59 – 3.40 (m, 1H), 1.27 (t, J = 7.1 Hz, 
3H). 
13
C-NMR (101 MHz, CDCl3, trans isomer): δ 172.71, 158.67, 133.38, 127.95, 113.99, 
77.38, 77.06, 76.74, 60.94, 55.29, 46.94, 45.01, 14.27. 
IR (neat, cm
-1
): 3064, 2989, 2229, 1715, 1607, 1506, 1372, 1312, 1200, 1163, 1014, 828; 
HRMS (ESI): exact m/z calculated for C24H22N2O4 (M+H)
+
: 403.1652; Found: 403.1652 
(M+H)
+
.  
Mp: 121-122 °C (decomposed). 
 
Diethyl (1S,2S,3R,4R)-3,4-bis(4-(methoxycarbonyl)phenyl)cyclobutane-1,2-
dicarboxylate (2j): 
Following GP-1, 2j was prepared from methyl (E)-4-(3-ethoxy-3-
oxoprop-1-en-1-yl)benzoate 1j (234.3 mg, 1.0 mmol, 1.00 equiv) and 
[Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (11.22 mg, 0.01 equiv, 1.0 mol %) in dry 
DMF (2 mL). The crude product was purified by column chromatography 
(hexanes–EtOAc, 5:1) to afford 2j as colourless oil (130 mg, 56% yield).  
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1
H-NMR (400 MHz, CDCl3): δ 7.71 (d, 2H), 6.94 (d, J = 8.4 Hz, 2H), 4.42 (dd, J = 3.9, 2.2, 
2H), 4.16 (q, J = 7.1 Hz, 2H), 3.84 (d, J = 1.6 Hz, 1H), 3.78 (s, 3H), 1.23 (t, J = 7.1 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 172.13, 166.79, 145.80, 130.07, 129.18, 126.85, 77.47, 
77.05, 76.63, 61.30, 52.17, 46.79, 44.52, 14.22.  
IR (neat, cm
-1
): 2952, 1718, 1610, 1435, 1159, 1275, 1193, 1103, 1018, 965, 857, 768, 701. 
HRMS (ESI): exact m/z calculated for C26H28O8 (M+H)
+
: 469.1857; Found: 469.1862 
(M+H)
+
. 
 
Diethyl (1R,2S,3R,4S)-3,4-bis(4-(methoxycarbonyl)phenyl)cyclobutane-1,2-
dicarboxylate (3j): 
Following GP-1, 3j was prepared from methyl (E)-4-(3-ethoxy-3-
oxoprop-1-en-1-yl)benzoate 1j (234.3 mg, 1.0 mmol, 1.00 equiv) and 
[Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (11.22 mg, 0.01 equiv, 1.0 mol %) in 
dry DMF (2 mL). The crude product was purified by column 
chromatography (silica gel, hexanes–EtOAc, 5:1) to afford 3j as 
colourless oil (79 mg, 34% yield).  
1
H-NMR (400 MHz, CDCl3): δ = 7.71 (d, 2H), 6.94 (d, J = 8.4 Hz, 2H), 4.42 (dd, J = 3.9 
Hz, 2.2, 1H), 4.16 (q, J =7.1 Hz, 2H), 3.84 (d, J = 1.6 Hz, 1H), 3.78 (s, 3H), 1.23 (t, J = 7.1 
Hz, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 172.13, 166.79, 145.80, 130.07, 129.18, 126.85, 77.47, 
77.05, 76.63, 61.30, 52.17, 46.79, 44.52, 14.22. 
IR (neat, cm
-1
): 2952, 1718, 1610,1435, 1159, 1275, 1193, 1103, 1018, 965, 857, 768, 701. 
HRMS (ESI): exact m/z calculated for C26H28O8 (M+H)
+
: 469.1857; Found: 469.1860 
(M+H)
+
. 
 
Diethyl (1S,2S,3R,4R)-3,4-bis(4-nitrophenyl)cyclobutane-1,2-dicarboxylate (2k): 
Following GP-1, 2k was prepared from ethyl (E)-3-(4-
nitrophenyl)acrylate 1k (221.2 mg, 1.0 mmol, 1.00 equiv) and 
[Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (11.22 mg, 0.01 equiv, 1.0 mol %) in 
dry DMF (2 mL). The crude product was purified by column 
chromatography (silica gel, hexanes–EtOAc, 10:1, Rf = 0.2) to afford 
2k as a orange viscous oil (115 mg, 49% yield).  
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1
H-NMR (400 MHz, CDCl3): δ 8.24 – 8.16 (m, 2H), 7.45 (d, J = 8.7 Hz, 2H), 4.24 (qd, J = 
7.1 Hz, 1.4, 2H), 3.90 – 3.81 (m, 1H), 3.53 – 3.43 (m, 1H), 1.33 – 1.23 (m, 3H). 
13
C-NMR (101 MHz, CDCl3): δ 171.61, 147.50, 147.34, 127.72, 124.17, 77.38, 77.07, 
76.75, 61.62, 46.36, 44.60, 14.22. 
IR (neat, cm
-1
): 2982, 2937, 1722, 1603, 1517, 1342, 1200, 1159, 1111, 1014, 854, 746. 
HRMS (ESI): exact m/z calculated for C22H22N2O8 (M+H)
+
: 443.1449; Found: 443.1457 
(M+H)
+
. 
 
Diethyl (1R,2S,3R,4S)-3,4-bis(4-nitrophenyl)cyclobutane-1,2-dicarboxylate (3k): 
Following GP-1, 3k was prepared from ethyl (E)-3-(4-
nitrophenyl)acrylate 1k (221.2 mg, 1.0 mmol, 1.00 equiv) and 
[Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (11.22 mg, 0.01 equiv, 1.0 mol %) in 
dry DMF (2 mL). The crude product was purified by column 
chromatography (silica gel, hexanes–EtOAc, 10:1, Rf = 0.15) to afford 
3k with impurities of 2k as orange oil. (87 mg, 37% yield).  
1
H-NMR (400 MHz, CDCl3): δ 8.01 (d, J = 8.8 Hz, 2H), 7.11 (d, J = 8.7 Hz, 2H), 4.57 (d, J 
= 6.2 Hz, 1H), 4.24 (q, J =7.1 Hz, 2H), 3.86 (dd, J = 3.7, 2.4 Hz, 1H), 1.30 (t, J = 7.1 Hz, 
3H). 
IR (neat, cm
-1
):  2982, 2937, 1722, 1603, 1517, 1342, 1200, 1159, 1111, 1014, 854, 746. 
HRMS (ESI): exact m/z calculated for C22H22N2O8 (M+H)
+
: 443.1449; Found: 443.1455 
(M+H)
+
.  
 
Dimethyl-3,4-bis(4-hydroxy-3-methoxyphenyl)cyclobutane-1,2-dicarboxylate (2l/3l): 
Following GP-1, 2l/3l was prepared from methyl (E)-3-(4-hydroxy-3-
methoxyphenyl)acrylate 1l (208.2 mg, 1.0 mmol, 1.00 equiv) and 
[Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (11.22 mg, 0.01 equiv, 1.0 mol %) in 
dry DMF (2 mL). The crude product was purified by column 
chromatography (silica gel, hexanes–EtOAc, 1:1, Rf = 0.20) to afford 
mixture of 2l/3l as a colourless oil (135 mg, 65% yield; d.r. = 2.94:1). 
1
H-NMR (300 MHz, CDCl3, major isomer): δ 6.86 (d, J = 8.2 Hz, 2H), 6.82 – 6.74 (m, 
4H), 5.65 (bs, 2H), 3.84 (s, 6H), 3.74 (s, 6H), 3.61 – 3.53 (m, 2H), 3.45 – 3.38 (m, 2H). 
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13
C-NMR (75 MHz, CDCl3, major isomer): δ 173.28, 146.70, 144.89, 133.08, 119.71, 
114.57, 109.48, 56.01, 52.36, 47.98, 44.61. 
IR (neat, cm
-1
): 3433, 2952, 2844, 1721, 1602, 1514, 1434, 1264, 1235, 1200, 1156, 1121, 
1028, 851, 812, 766, 733, 700. 
HRMS (ESI): exact m/z calculated for C22H25O8 (M+H)
+
: 417.1544; Found: 417.1546 
(M+H)
+
. 
 
Diethyl-3,4-bis(2-chloro-3,4-dimethoxyphenyl)cyclobutane-1,2-dicarboxylate (2m/3m): 
Following GP-1, 2m/3m was prepared from ethyl (E)-3-(2-chloro-3,4-
dimethoxyphenyl)acrylate 1m (270.7 mg, 1.0 mmol, 1.00 equiv) and 
[Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (11.22 mg, 0.01 equiv, 1.0 mol %) in 
dry DMF (2 mL). The crude product was purified by column 
chromatography (silica gel, hexanes–EtOAc, 4:1, Rf = 0.16 (trans), Rf 
= 0.14 (cis) to afford mixture of 2m/3m as a yellow solid (189 mg, 
70% yield; d.r. = 6:1). 
1
H-NMR (300 MHz, CDCl3, major isomer): δ 7.26 (d, J = 8.7 Hz, 2H), 6.85 (d, J = 8.7 Hz, 
2H), 4.23 – 4.19 (m, 2H), 4.16 (q, J = 7.1 Hz, 4H), 3.84 (s, 6H), 3.81 (s, 6H), 3.41 – 3.24 (m, 
2H), 1.24 (t, J = 7.1 Hz, 6H). 
13
C-NMR (75 MHz, CDCl3, major isomer): δ 172.57, 152.89, 145.37, 130.94, 128.54, 
123.17, 110.82, 61.18, 60.62, 56.15, 45.45, 43.21, 14.25. 
IR (neat, cm
-1
): 2934, 2839, 1721, 1594, 1490, 1462, 1439, 1420, 1294, 1267, 1205, 1176, 
1149, 1036, 1012, 980, 841, 807, 774, 710, 666. 
HRMS (ESI): exact m/z calculated for C26H31Cl2O8 (M+H)
+
: 541.1390; Found: 541.1403 
(M+H)
+
. 
Mp: 125-127 
o
C (decomposed).
 
 
Diethyl-3,4-bis(2-fluorophenyl)cyclobutane-1,2-dicarboxylate (2n/3n): 
Following GP-1, 2n/3n was prepared from ethyl (E)-3-(2-
fluorophenyl)acrylate 1n (194.2 mg, 1.0 mmol, 1.00 equiv) and 
[Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (11.22 mg, 0.01 equiv, 1.0 mol %) in dry 
DMF (2 mL). The crude product was purified by column chromatography 
(silica gel, hexanes–EtOAc, 9:1, Rf = 0.25 (trans), Rf = 0.20 (cis) to afford 
mixture of 2n/3n as a white solid (143 mg, 74% yield; d.r. = 5:1). 
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1
H-NMR (300 MHz, CDCl3, major isomer): δ 7.42 (td, J = 7.5, 1.7 Hz, 2H), 7.23 (tdd, J = 
7.2, 5.1, 1.8 Hz, 2H), 7.13 (tt, J = 9.0, 4.5 Hz, 2H), 7.06 – 6.98 (m, 2H), 4.20 (q, J = 7.1 Hz, 
4H), 4.13 – 4.04 (m, 2H), 3.53 – 3.43 (m, 2H), 1.26 (t, J = 7.1 Hz, 6H). 
13
C-NMR (75 MHz, CDCl3, major isomer): δ 172.35, 160.98 (d, 
1
JC-F = 246.2 Hz), 128.90 
(d, 
3
JC-F = 8.3 Hz), 128.43 (d, 
3
JC-F = 4.7 Hz), 127.57 (d, 
2
JC-F = 15.1 Hz), 124.46 (d, 
4
JC-F = 
3.6 Hz), 115.55 (d, 
2
JC-F = 22.0 Hz), 61.21, 44.84, 40.09, 14.29. 
19
F-NMR (282 MHz, CDCl3): δ -116.94. 
IR (neat, cm
-1
): 2988, 2944, 1719, 1602, 1509, 1472, 1446, 1393, 1368, 1302, 1216, 1196, 
1156, 1107, 1034, 1015, 965, 826, 807, 768, 731, 671. 
EI-MS: exact m/z calculated for C22H22O4F2 (M)
+
: 388.14807; Found: 388.14844 (M)
+
. 
Mp: 57-59 
o
C (decomposed). 
 
Diethyl-3,4-bis(2-cyanophenyl)cyclobutane-1,2-dicarboxylate (2o/3o): 
Following GP-1, 2o/3o was prepared from ethyl (E)-3-(2-
cyanophenyl)acrylate 1o (201.2 mg, 1.0 mmol, 1.00 equiv) and 
[Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (11.22 mg, 0.01 equiv, 1.0 mol %) in dry 
DMF (2 mL). The crude product was purified by column chromatography 
(silica gel, hexanes–EtOAc, 85:15, Rf = 0.40) to afford mixture of 2o/3o as a 
white solid (127 mg, 63% yield; d.r. = 7.34:1).  
1
H-NMR (300 MHz, CDCl3, major isomer): δ 7.79 (d, J = 7.5 Hz, 2H), 7.73 – 7.65 (m, 
2H), 7.59 (dd, J = 7.8, 1.1 Hz, 2H), 7.42 – 7.35 (m, 2H), 4.22 (q, J = 7.1 Hz, 4H), 4.20 – 4.15 
(m, 2H), 3.63 – 3.50 (m, 2H), 1.27 (t, J = 7.1 Hz, 6H). 
13
C-NMR (75 MHz, CDCl3, major isomer): δ 171.46, 142.92, 133.83, 133.18, 128.34, 
127.67, 117.63, 112.49, 61.74, 14.22. 
IR (neat, cm
-1
): 2988, 2931, 2222, 1715, 1597, 1473, 1446, 1369, 1320, 1255, 1218, 1193, 
1169, 1122, 1103, 1023, 970, 853, 769, 728, 676. 
EI-MS: exact m/z calculated for C24H22 N2O4 (M)
+
: 402.15607; Found: 402.15624 (M)
+
. 
Mp: 110-112 
o
C (decomposed). 
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Diethyl (1S,2S,3R,4R)-3,4-bis(2-(phenylethynyl)phenyl)cyclobutane-1,2-dicarboxylate 
(2p): 
Following GP-1, 2p was prepared from ethyl (E)-3-(2-
(phenylethynyl)phenyl)acrylate 1p (276.3 mg, 1.0 mmol, 1.00 equiv). 
Purification of the crude product by column chromatography (Hexanes: 
EtOAc, 9:1, Rf = 0.37) afforded 2p as a pale yellow oil (174 mg, 63% yield; 
d.r. = 20:1). 
1
H-NMR (300 MHz, CDCl3): δ 7.66 (d, J = 7.2 Hz, 1H), 7.52 – 7.41 (m, 3H), 7.37 – 7.30 
(m, 3H), 7.27 (td, J = 7.6, 1.4 Hz, 1H), 7.14 (td, J = 7.5, 1.2 Hz, 1H), 4.55 – 4.51 (m, 1H), 
4.02 (q, J = 7.1 Hz, 2H), 3.57 – 3.52 (m, 1H), 1.12 (t, J = 7.1 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 172.71, 142.06, 132.60, 131.79, 129.00, 128.41, 127.08, 
127.02, 123.39, 123.05, 93.65, 88.00, 61.05, 45.52, 45.03, 14.20. 
IR (neat, cm
-1
): 2925, 2854, 1723, 1598, 1493, 1443, 1368, 1318, 1201, 1157, 1095, 1027, 
914, 855, 752, 689. 
EI-MS: exact m/z calculated for C38H33O4 (M+H)
+
: 553.2373; Found: 553.2382 (M+H)
+
. 
 
Diethyl 3,4-di(furan-2-yl)cyclobutane-1,2-dicarboxylate (2r/3r) and diethyl 2,4-di(furan-
2-yl)cyclobutane-1,3-dicarboxylate (2q/3q/4q): 
Following GP-1, 2q/3q/4q was prepared from ethyl (E)-3-
(furan-2-yl)acrylate 1r (166.2 mg, 1.0 mmol, 1.00 equiv) and 
[Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (11.22 mg, 0.01 equiv, 1.0 
mol %) in dry DMF (2 mL). The crude product was purified 
by column chromatography (silica gel, hexanes–EtOAc, 5:1, Rf = 0.4-0.2) to afford 4q as 
orange oil (27 mg, 16% yield) and a mixture of 2r/3r/4r as orange oil. (88 mg, 53% yield).  
 
1
H-NMR (300 MHz, CDCl3, trans isomer): δ 7.36 (dd, J = 1.8, 0.8 Hz, 1H), 6.30 (dd, J = 
3.2, 1.9 Hz, 1H), 6.16 (dd, J = 3.2, 0.7 Hz, 1H), 4.18 (qd, J =7.1, 0.6 Hz, 2H), 3.82 – 3.72 (m, 
1H), 3.53 – 3.44 (m, 1H), 1.25 (t, J = 7.1, 3H). 
1
H-NMR (300 MHz, CDCl3, cis isomer): δ = 7.22 (dd, J = 1.8, 0.8 Hz, 1H), 6.20 (dd, J = 
3.2, 1.8 Hz, 1H), 5.94 (d, J = 2.8 Hz, 1H), 4.25 (dd, J = 3.8, 2.2, 1H), 4.18 (qd, J = 7.1, 1.5 
Hz, 2H), 3.85 (dd, J = 3.7, 2.2, 1H), 1.26 (td, J =7.1, 3.6 Hz, 3H). 
13
C-NMR (101 MHz, CDCl3, trans isomer): δ 171.88, 153.36, 142.17, 110.37, 106.58, 
77.35, 77.03, 76.71, 61.08, 43.37, 39.44, 14.19. 
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IR (neat, cm
-1
): 2982, 2941, 1800, 1726, 1372, 1200, 1096, 1014, 924, 738. 
HRMS (ESI): trans: exact m/z calculated for C18H20O6 (M+H)
+
: 333.1338; Found: 333.1334 
(M+H)
+
; cis: exact m/z calculated for C18H20O6 (M+H)
+
: 333.1338; Found: 333.1336 
(M+H)
+
; head-to-tail conformer: exact m/z calculated for C18H20O6 (M+H)
+
: 333.1338; 
Found: 333.1335 (M+H)
+
. 
Diethyl-3,4-di(thiophen-2-yl)cyclobutane-1,2-dicarboxylate (2r/3r, 4r): 
Following GP-1, 2r/3r, 4r was prepared from methyl (E)-3-(thiophen-
2-yl)acrylate (188 mg, 1.0 mmol, 1.00 equiv) and 
[Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (11.22 mg, 0.01 equiv, 1.0 mol %) in 
dry DMF (2 mL). The crude product was purified by column 
chromatography (silica gel, hexanes–EtOAc, 5:1, Rf = 0.58) to afford 
mixture of 2r/3r, 4r as a yellow oil (145.1 mg, 77% yield; d.r. = 1.8:1). 
1
H-NMR (300 MHz, CDCl3): δ 7.21 (dd, J = 4.2, 2.1 Hz, 2H, trans), 7.09 (dd, J = 5.1, 1.1 
Hz, 1H, cis), 7.04 (dd, J = 4.9, 0.8 Hz, 0.2H, head-to-tail conformer), 7.00 – 6.93 (m, 4H, 
trans), 6.85 (dd, J = 5.0, 3.5 Hz, 1H, cis), 6.81 (dd, J = 5.1, 3.6 Hz, 0.2H, head-to-tail 
conformer), 6.73 (dd, J = 3.5, 1.0 Hz, 1H, cis), 4.52 (dd, J = 3.9, 2.2 Hz, 1H, cis), 4.26 – 4.13 
(m, 7H, trans/cis), 3.88 – 3.82 (m, 2H, trans), 3.79 (dd, J = 3.7, 2.2 Hz, 1H, cis), 3.48 – 3.36 
(m, 2H, trans), 1.29 (t under t, J = 7.1, 3.8 Hz, 10H, trans/cis), 0.96 (t under t, J = 7.1, 4.9 
Hz, 0.9H, head-to-tail conformer). 
13
C-NMR (75 MHz, CDCl3, trans/cis isomer, head-to-tail conformer): δ 172.57, 171.76, 
171.68, 170.27, 143.92, 141.83, 141.35, 138.63, 127.08, 126.66,  126.62, 126.47, 126.39, 
125.46, 125.33, 124.86, 124.62, 124.50, 124.39, 77.55, 77.13, 76.70, 61.23, 61.19, 60.80, 
46.06, 45.85, 44.71, 44.63, 43.47, 42.30, 41.39, 41.02, 14.24, 14.21, 13.86. 
IR (neat, cm
-1
): 3108, 2981, 1722, 1442, 1371, 1297, 1192, 1036, 849, 790, 693. 
HRMS (ESI): trans: exact m/z calculated for C18H21S2O4 (M+H)
+
: 365.0876; Found: 
365.0880 (M+H)
+
; cis: exact m/z calculated for C18H21S2O4 (M+H)
+
: 365.0876; Found: 
365.0880 (M+H)
+
; head-to-tail conformer: exact m/z calculated for C18H21S2O4 (M+H)
+
: 
365.0876; Found: 365.0880 (M+H)
+
. 
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Dimethyl-3,4-bis(1-(tert-butoxycarbonyl)-1H-pyrrol-2-yl)cyclobutane-1,2-dicarboxylate 
(2s/3s): 
Following GP-1, 2s/3s was prepared from methyl tert-butyl (E)-2-(3-
methoxy-3-oxoprop-1-en-1-yl)-1H-pyrrole-1-carboxylate 1s (263.3 
mg, 1.0 mmol, 1.00 equiv) and [Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (11.22 
mg, 0.01 equiv, 1.0 mol %) in dry DMF (2 mL). The crude product 
was purified by column chromatography (silica gel, hexanes–EtOAc, 
5:1, Rf = 0.28) to afford mixture of 2s/3s as a yellow oil (137.5 mg, 
54% yield; d.r. = 1.38:1). 
1
H-NMR (300 MHz, CDCl3, trans isomer): δ 7.10 (dd, J = 3.3, 1.7 Hz, 2H), 5.98 (t, J = 3.4 
Hz, 2H), 5.77 (dd, J = 3.4, 1.7 Hz, 2H), 5.02 – 4.92 (m, 2H), 3.71 (s, 6H), 3.60 – 3.54 (m, 
2H), 1.53 (s, 18H). 
1
H-NMR (300 MHz, CDCl3, cis isomer): 7.13 (dd, J = 3.3, 1.8 Hz, 2H), 6.29 (dd, J = 3.3, 
1.7 Hz, 2H), 6.09 (t, J = 3.4 Hz, 2H), 4.46 – 4.40 (m, 2H), 3.68 (s, 6H), 3.34 – 3.27 (m, 2H), 
1.52 (s, 18H). 
13
C-NMR (75 MHz, CDCl3, trans/cis isomer): δ 172.84, 172.79, 149.12, 148.96, 135.31, 
133.30, 121.72 (cis), 121.64, 111.84 (cis), 110.98, 110.26 , 109.61, 83.52, 83.42, 51.99, 51.97 
(cis), 45.33 (cis), 44.05, 40.49 (cis), 38.44, 27.97, 27.92. 
IR (neat, cm
-1
): 2981, 1733, 1435, 1319, 1159, 1125, 1066, 846, 723. 
HRMS (ESI): trans: exact m/z calculated for C26H35N2O8 (M+H)
+
: 503.2388; Found: 
503.2390 (M+H)
+
; cis: exact m/z calculated for C26H35N2O8 (M+H)
+
: 503.2388; Found: 
503.2390 (M+H)
+
. 
 
Diethyl (1S,3R)-3,4-bis(1-methyl-1H-indol-3-yl)cyclobutane-1,2-dicarboxylate (2t): 
Following GP-1, 2t was prepared from methyl (E)-3-(1-methyl-1H-
indol-3-yl)acrylate 1t (233.1 mg, 1.0 mmol, 1.00 equiv) and 
[Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (11.22 mg, 0.01 equiv, 1.0 mol %) in 
dry DMF (2 mL). The crude product was purified by column 
chromatography (silica gel, hexanes–EtOAc, 5:1, Rf = 0.23) to afford 
mixture of 2t as a yellow oil (51.6 mg, 11% yield). 
1
H-NMR (300 MHz, CDCl3): δ 7.69 (dd, J = 8.0, 0.6 Hz, 1H), 7.38 – 7.04 (m, 4H), 4.32 – 
4.14 (m, 3H), 3.74 (s, J = 6.6 Hz, 3H), 3.63 – 3.57 (m, 1H), 1.29 (t, J = 7.1 Hz, 3H). 
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13
C-NMR (75 MHz, CDCl3): δ 173.41, 137.40, 127.02, 126.54, 121.73, 119.89, 119.01, 
115.51, 109.33, 77.52, 77.09, 76.67, 60.92, 45.88, 39.83, 32.72, 14.30. 
IR (neat, cm
-1
): 3049, 2978, 2929, 1710, 1613, 1550, 1472, 1371, 1315, 1244, 1203, 1177, 
1036, 834, 738. 
HRMS (ESI): exact m/z calculated for C28H30N2O4Na (M+Na)
+
: 481.2098; Found: 481.2104 
(M+Na)
+
. 
 
1,2-diphenyl-1,2,2a,5,10,12a-hexahydrobenzo[c]cyclobuta[h][1,6]dioxecine-3,12-dione 
(2u/3u): 
Following GP-1, 2u/3u was prepared from 1,2-phenylenebis(methylene) 
(2E,2'E)-bis(3-phenylacrylate) 1u (398.5 mg, 1.0 mmol, 1.00 equiv) and 
[Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (11.22 mg, 0.01 equiv, 1.0 mol %) in dry 
DMF (2 mL). The crude product was purified by column 
chromatography (silica gel, hexanes–EtOAc, 5:1, Rf = 0.3) to afford the major diastereomer 
of 2u as white solid (168 mg, 42% yield) and a mixture of both diastereomers of 2u/3u as 
colorless oil. (142 mg, 35% yield 1:1.36 d.r.).  
1
H-NMR (400 MHz, CDCl3, major isomer): δ 7.48 – 7.38 (m, 2H), 7.14 – 7.01 (m, 3H), 
6.91 (dd, J = 5.2, 3.2 Hz, 2H), 5.27 (dd, J = 109.2, 12.2 Hz, 2H), 4.46 (dd, J = 3.8, 2.3 Hz, 
1H), 3.81 (dd, J = 3.8, 2.3 Hz, 1H). 
13
C-NMR (101 MHz, CDCl3, major isomer): δ 171.47, 138.25, 135.22, 131.58, 129.27, 
128.09, 127.75, 126.45, 67.66, 44.31, 43.71. 
IR (neat, cm
-1
): 3027, 2060, 2963, 1730, 1498, 1446, 1256, 1185, 1163, 1048, 1018, 839, 
749, 697. 
HRMS (ESI) major isomer: exact m/z calculated for C26H22O4 (M+H)
+
: 399.1591; Found: 
399.1590 (M+H)
+
. Minor isomer: exact m/z calculated for C26H22O4 (M+H)
+
: 399.1591; 
Found: 399.1588 (M+H)
+
.  
Mp: 153–154 °C (decomposed). 
 
3,4-diphenylcyclobutane-1,2-diyl)bis(phenylmethanone) (2v/3v): 
Following GP-1, 2v/3v was prepared from (E)-chalcone 1v (208.2 mg, 1.0 
mmol, 1.00 equiv) and [Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (11.22 mg, 0.01 equiv, 
1.0 mol %) in dry DMF (2 mL). The crude product was purified by column 
chromatography (silica gel, hexanes–EtOAc, 9:1, Rf = 0.30 (trans), Rf = 0.15 
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(cis) to afford mixture of 2v/3v as a white solid (167 mg, 80% yield; d.r. = 3:1).  
1
H-NMR (300 MHz, CDCl3, major isomer): δ 7.81 (dt, J = 8.5, 1.7 Hz, 4H), 7.48 – 7.40 
(m, 2H), 7.33 – 7.17 (m, 14H), 4.63 – 4.57 (m, 2H), 3.99 – 3.93 (m, 2H). 
13
C-NMR (75 MHz, CDCl3, major isomer): δ 199.20, 141.55, 135.70, 133.63, 129.00, 
128.86, 128.69, 127.58, 127.37, 48.07, 47.79. 
IR (neat, cm
-1
): 2925, 1741, 1663, 1595, 1579, 1491, 1448, 1381, 1293, 1273, 1208, 1178, 
1154, 1075, 1020, 985, 910, 857, 802, 775, 749, 689, 661. 
HRMS (ESI): exact m/z calculated for C30H25O2 (M+H)
+
: 417.1849; Found: 417.1848 
(M+H)
+
. 
Mp: 54-56 
o
C (decomposed). 
 
3,4-bis(4-chlorophenyl)cyclobutane-1,2-diyl)bis(phenylmethanone) (2w/3w): 
Following GP-1, 2w/3w was prepared from (E)-3-(4-chlorophenyl)-1-
phenylprop-2-en-1-one 1w (242.7 mg, 1.0 mmol, 1.00 equiv) and 
[Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (11.22 mg, 0.01 equiv, 1.0 mol %) in 
dry DMF (2 mL). The crude product was purified by column 
chromatography [silica gel, hexanes–EtOAc, 9:1, Rf = 0.28 (trans); Rf 
= 0.17 (cis)] to afford mixture of 2w/3w as a white solid (179 mg, 74% 
yield; d.r. = 3:1).  
1
H-NMR (300 MHz, CDCl3, major isomer): δ 7.85 – 7.78 (m, 4H), 7.49 (ddd, J = 6.9, 2.4, 
1.2 Hz, 2H), 7.39 – 7.18 (m, 12H), 4.61 – 4.53 (m, 2H), 3.92 – 3.85 (m, 2H). 
13
C-NMR (75 MHz, CDCl3, major isomer): δ 198.78, 139.71, 135.45, 133.88, 133.29, 
129.10, 128.93, 128.86, 128.83, 47.57, 47.47. 
IR (neat, cm
-1
): 3058, 2927, 1733, 1670, 1636, 1594, 1579, 1559, 1488, 1446, 1403, 1373, 
1316, 1296, 1275, 1230, 1210, 1179, 1089, 1043, 1012, 934, 912, 859, 821, 701, 685.  
HRMS (ESI): exact m/z calculated for C30H23Cl2O2 (M+H)
+
: 485.1070; Found: 485.1069 
(M+H)
+
. 
Mp: 119-121 
o
C (decomposed). 
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1,2-diphenylcyclobutane (6a): 
Following GP-1, 6a was prepared from styrene 5a (104.1 mg, 1.0 mmol, 1.00 
equiv) and [Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (11.22 mg, 0.01 equiv, 1.0 mol %) 
in dry DMF (2 mL). The crude product was purified by column 
chromatography (silica gel, hexanes–EtOAc, 95:5, Rf = 0.45) to afford 
cis/trans mixture of 6a as a colourless oil (95 mg, 92% yield; trans/cis = 
2.57:1). 
1
H-NMR (300 MHz, CDCl3): δ 7.43 – 7.24 (m, 7H, trans/cis), 7.22 – 7.00 (m, 3H, 
trans/cis), 4.11 (ddd, J = 5.6, 3.9, 2.2 Hz, 2H, cis), 3.73 – 3.61 (m, 2H, trans), 2.55 (ddd, J = 
6.5, 4.2, 2.6 Hz, 2H, trans/cis), 2.47 – 2.33 (m, 4H, trans/cis), 2.31 – 2.16 (m, 4H, trans/cis). 
13
C-NMR (75 MHz, CDCl3): δ 144.71 (trans), 141.62 (cis), 128.47 (trans), 128.08 (cis), 
127.80 (cis), 126.78 (trans), 126.25 (trans), 125.67 (cis), 48.02 (trans), 45.41 (cis), 26.10 
(trans), 24.34 (cis). 
IR (neat, cm
-1
): 3059, 3026, 2940, 2866, 1685, 1600, 1493, 1446, 1028, 749, 694. 
EI-MS: exact m/z calculated for C16H16 (M)
+
: 208.12465; Found: 208.12450 (M)
+
.
 
 
1,2-bis(4-nitrophenyl)cyclobutane (6b): 
Following GP-1, 6b was prepared from 1-nitro-4-vinylbenzene 5b (149.1 mg, 
1.0 mmol, 1.00 equiv) and [Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (11.22 mg, 0.01 
equiv, 1.0 mol %) in dry DMF (2 mL). The crude product was purified by 
column chromatography (silica gel, hexanes–EtOAc, 9:1, Rf = 0.26) to afford 
cis/trans mixture of 6b as a pale yellow solid (128 mg, 86% yield; trans/cis = 
5.19:1). 
1
H-NMR (300 MHz, CDCl3): δ 8.21 – 8.11 (m, 4H, trans), 8.01 – 7.90 (m, 4H, cis), 7.42 – 
7.31 (m, 4H, trans), 7.14 – 7.05 (m, 4H, cis), 4.26 – 4.17 (m, 2H, cis), 3.77 – 3.62 (m, 2H, 
trans), 2.54 – 2.36 (m, 4H, trans/cis), 2.34 – 2.15 (m, 4H, trans/cis). 
13
C-NMR (75 MHz, CDCl3): δ 151.05 (trans), 146.84 (cis), 128.56 (cis), 127.52 (trans), 
124.06 (trans), 123.48 (cis), 47.82 (trans), 45.22 (cis), 25.92 (trans), 24.14 (cis). 
The obtained data is in accordance with literature data.
[30] 
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1,2-di-o-tolylcyclobutane (6c): 
Following GP-1, 6c was prepared from 1-methyl-2-vinylbenzene 5c (118.1 
mg, 1.0 mmol, 1.00 equiv) and [Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (11.22 mg, 
0.01 equiv, 1.0 mol %) in dry DMF (2 mL). The crude product was purified by 
column chromatography (silica gel, hexanes–EtOAc, 95:5, Rf = 0.43) to afford 
cis/trans mixture of 6c as a colourless liquid (104 mg, 88% yield; trans/cis = 
2.44:1). 
1
H-NMR (300 MHz, CDCl3): δ 7.28 – 6.93 (m, 10H, trans/cis), 4.26 – 4.17 (m, 2H, cis), 
3.97 – 3.85 (m, 2H, trans), 2.55 – 2.35 (m, 4H, trans), 2.30 (s, 3H, trans), 2.10 (s, 3H, cis), 
1.96 (dd, J = 13.7, 9.1 Hz, 1H, cis). 
13
C-NMR (75 MHz, CDCl3): δ 142.35 (trans), 139.80 (cis), 136.38 (cis), 136.08 (trans), 
130.17 (trans), 129.86 (cis), 126.83 (cis), 126.14 (trans), 126.09 (trans), 125.98 (trans), 
125.86 (cis), 125.43 (cis), 43.33 (trans), 41.67 (cis), 27.09 (trans), 24.97 (cis), 19.96 (trans), 
19.83 (cis). 
IR (neat, cm
-1
): 3019, 2965, 2943, 1686, 1602, 1488, 1458, 1378, 1031, 734. 
EI-MS: exact m/z calculated for C18H20 (M)
+
: 236.15595; Found: 236.15646 (M)
+
.
 
 
1,2-dimethyl-1,2-diphenylcyclobutane (6d): 
Following GP-1, 6d was prepared from prop-1-en-2-ylbenzene 5d (118.1 mg, 
1.0 mmol, 1.00 equiv) and [Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (11.22 mg, 0.01 
equiv, 1.0 mol %) in dry DMF (2 mL). The crude product was purified by 
column chromatography (silica gel, hexanes–EtOAc, 95:05, Rf = 0.57) to 
afford cis/trans mixture of 6d as a colourless oil (99 mg, 84% yield; trans/cis 
= 3.96:1). 
1
H-NMR (300 MHz, CDCl3): δ 7.42 – 7.36 (m, 6H, trans), 7.36 – 7.16 (m, 4H, trans), 7.03 
(d, J = 4.3 Hz, 6H, cis), 6.97 – 6.89 (m, 4H, cis), 2.90 – 2.73 (m, 2H, trans), 2.68 (dd, J = 
11.8, 6.3 Hz, 2H, cis), 2.15 – 2.01 (m, 2H, cis), 1.85 – 1.70 (m, 2H, trans), 1.65 (s, 3H, cis), 
1.17 (s, 3H, trans). 
13
C-NMR (75 MHz, CDCl3): δ 147.44 (trans), 147.25 (cis), 128.20 (trans), 127.45 (cis), 
126.79 (trans), 126.59 (cis), 125.81 (trans), 125.13 (cis), 49.25 (trans), 37.00 (cis), 29.78 
(cis), 27.33 (trans), 27.00 (trans), 26.28 (cis). 
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IR (neat, cm
-1
): 2926, 1457, 1421, 1263, 1094, 1029, 895, 804, 733, 703. 
EI-MS: exact m/z calculated for C18H20 (M)
+
: 236.15595; Found: 236.15563 (M)
+
.
 
 
3,4-dimethylcyclobutane-1,2-diyl)dibenzene (6e): 
Following GP-1, 6e was prepared from (E)-prop-1-en-1-ylbenzene 5e (118.1 
mg, 1.0 mmol, 1.00 equiv) and [Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (11.22 mg, 
0.01 equiv, 1.0 mol %) in dry DMF (2 mL). The crude product was purified by 
column chromatography (silica gel, hexanes–EtOAc, 95:05, Rf = 0.59) to 
afford cis/trans mixture of 6e as a colourless oil (94 mg, 80% yield; trans/cis 
= 3.38:1). 
1
H-NMR (300 MHz, CDCl3): δ 7.39 – 7.13 (m, 10H, trans), 7.13 – 6.90 (m, 10H, cis), 3.56 
– 3.52 (m, 2H, cis), 2.99 – 2.90 (m, 2H, trans), 1.91 (td, J = 9.4, 3.9 Hz, 2H, cis), 1.55 (s, 3H, 
cis), 1.26 (s, 3H, trans), 1.23 – 1.18 (m, 2H, trans). 
13
C-NMR (75 MHz, CDCl3): δ 143.86 (trans), 128.48 (trans), 128.22 (cis), 127.83 (cis), 
127.00 (trans), 126.24 (trans), 125.58 (cis), 52.83 (trans), 43.32 (trans), 19.15 (trans). 
IR (neat, cm
-1
): 3058, 2955, 2923, 2861, 1494, 1453, 1261, 1094, 1029, 803, 749, 698. 
EI-MS: exact m/z calculated for C18H20 (M)
+
: 236.15595; Found: 236.15556 (M)
+
. 
 
Diethyl 3-(4-methoxyphenyl)-4-phenylcyclobutane-1,2-dicarboxylate (7a): 
Following GP-1, 7a was prepared from ethyl cinnamate 1a (88.1 mg, 
0.5 mmol, 1.00 equiv), ethyl-3-(4-methoxyphenyl)acrylate 1f (103.1 
mg, 0.5 mmol, 1.00 equiv) and [Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (11.22 
mg, 0.02 equiv, 2.0 mol %) in dry DMF (2 mL). The crude product 
was purified by column chromatography (silica gel, hexanes–EtOAc, 
5:1, Rf = 0.3) to afford the desired product 7a as colorless oil (67 mg, 
35% yield), product 2f as yellow oil (46 mg, 24% yield) and product 
2a (21 mg, 11% yield) as colorless oil. 
1
H-NMR (400 MHz, CDCl3): δ 7.35 – 7.26 (m, 5H), 7.26 – 7.21 (m, 3H), 6.89 – 6.83 (m, 
2H), 4.19 (qt, J = 10.8, 5.4 Hz, 4H), 3.79 (s, 3H), 3.76 – 3.63 (m, 2H), 3.47 – 3.35 (m, 2H), 
1.27 (td, J = 7.1, 3.3 Hz, 6H). 
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13
C-NMR (101 MHz, CDCl3): δ 172.70, 172.63, 158.71, 141.27, 133.33, 128.59, 128.01, 
127.01, 126.81, 114.02, 77.37, 77.05, 76.73, 61.00, 60.96, 55.30, 47.27, 46.67, 45.27, 44.60, 
14.26. 
IR (neat, cm
-1
): 2982, 1722, 1610, 1513, 1457, 1249, 1178, 1033, 828, 701. 
HRMS (ESI): exact m/z calculated for C23H26O5 (M+H)
+
: 383.1859; Found: 383.1586 
(M+H)
+
. 
 
Diethyl 3-(4-(methoxycarbonyl)phenyl)-4-phenylcyclobutane-1,2-dicarboxylate (7b): 
Following GP-1, 7b was prepared from ethyl cinnamate 1a (88.1 mg, 
0.5 mmol, 1.00 equiv), methyl-4-(3-ethoxy-3-oxoprop-1-en-1-
yl)benzoate 1j (117.1 mg, 0.5 mmol, 1.00 equiv) and 
[Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (11.22 mg, 0.02 equiv, 2.0 mol %) in 
dry DMF (2 mL). The crude product was purified by column 
chromatography (silica gel, hexanes–EtOAc, 5:1, Rf = 0.4-0.1) to 
afford the desired product 7b (76 mg, 32% yield, 1.9:1 d.r.) and 
product 2j (25 mg, 14% yield) as colorless oils.  
1
H-NMR (400 MHz, CDCl3): δ 7.99 (d, J = 8.3 Hz, 2H), 7.32 (ddd, J = 19.6, 15.8, 7.8 Hz, 
7H), 4.26 – 4.16 (m, 4H), 3.90 (s, 3H), 3.84 – 3.71 (m, 2H), 3.51 – 3.41 (m, 2H), 1.33 – 1.22 
(m, 6H). 
13
C-NMR (101 MHz, CDCl3): δ 172.13, 166.79, 145.82, 130.08, 129.49, 129.22, 127.71, 
126.85, 77.36, 77.04, 76.73, 61.29, 52.15, 52.03, 46.82, 44.90, 44.56, 43.24, 14.23. 
IR (neat, cm
-1
): 2952, 1718, 1610, 1435, 1275, 1185, 1103, 1017, 965, 857, 767, 705. 
HRMS (ESI): exact m/z calculated for C24H26O6 (M+H)
+
: 411.1808; Found: 411.1807 
(M+H)
+
. 
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Diethyl 3-(4-cyanophenyl)-4-(4-methoxyphenyl)cyclobutane-1,2-dicarboxylate (7c): 
Following GP-1, 7c was prepared from ethyl-3-(4-
methoxyphenyl)acrylate 1f (103.1 mg, 0.5 mmol, 1.00 equiv), ethyl-3-
(4-cyanophenyl)acrylate 1i (100.6 mg, 0.5 mmol, 1.00 equiv) and 
[Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (11.22 mg, 0.02 equiv, 2.0 mol %) in 
dry DMF (2 mL). The crude product was purified by column 
chromatography (silica gel, hexanes–EtOAc, 5:1, Rf = 0.4-0.1) to 
afford the desired product 7c (111.3 mg, 54% yield, d.r. 1.75:1) and 
product 2f (26.4 mg, 13% yield, 99:1 d.r.) as white solids and product 
2i (17 mg, 14% yield, 90:1 d.r.) as colorless oil.  
1
H-NMR (400 MHz, CDCl3): δ 7.63 – 7.55 (m, 2H), 7.38 (d, J = 8.1 Hz, 2H), 7.24 – 7.16 
(m, 2H), 6.90 – 6.85 (m, 2H), 4.20 (p, J = 7.2 Hz, 4H), 3.80 (s, 3H), 3.77 – 3.56 (m, 2H), 3.44 
– 3.38 (m, 2H), 1.27 (dd, J = 13.4, 7.1, 6H). 
13
C-NMR (101 MHz, CDCl3): δ 172.3, 172.2, 159.0, 146.6, 132.5, 132.4, 127.9, 127.6, 
118.8, 114.2, 110.9, 77.4, 77.1, 76.8, 61.3, 61.2, 55.3, 46.9, 46.7, 45.4, 44.0, 14.2. 
IR (neat, cm
-1
): 2981, 2937, 2840, 229, 1718, 1610, 1513, 1245, 1178, 114, 1036, 828. 
HRMS (ESI): exact m/z calculated for C24H25NO5 (M+H)
+
: 408.1811; Found: 408.1805 
(M+H)
+
.  
Mp: 54-56 °C (decomposed). 
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4.14 NMR spectra: 
1
H-NMR: 2a/3a (mixture, before separation) 
 
13
C-NMR: 2a/3a (mixture, before separation) 
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1
H-NMR: 2a (trans, after separation) 
 
13
C-NMR: 2a (trans, after separation) 
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1
H-NMR: 3a (cis, after separation) 
13
C-NMR: 3a (cis, after separation) 
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1
H-NMR: 2b (trans, after separation)  
13
C-NMR: 2b (trans, after separation) 
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1
H-NMR: 3b (cis, after separation) 
13
C-NMR: 3b (cis, after separation) 
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1
H-NMR: 2c (trans, isomer only)  
13
C-NMR: 2c (trans, isomer only) 
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1
H-NMR: 2d/3d (mixture, before separation)  
13
C-NMR: 2d/3d (mixture, before separation)  
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1
H-NMR: 2d (trans, after separation)  
13
C-NMR: 2d (trans, after separation) 
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1
H-NMR: 3d (cis, after separation)  
13
C-NMR: 3d (cis, after separation) 
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1
H-NMR: 2e/3e (mixture, before separation)  
13
C-NMR: 2e/3e (mixture, before separation)  
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1
H-NMR: 2e (trans, after separation) 
13
C-NMR: 2e (trans, after separation)  
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1
H-NMR: 3e (cis, after separation)  
13
C-NMR: 3e (cis, after separation) 
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1
H-NMR: 2f (mixture, before seperation)  :
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1
H-NMR: 2f (trans, after seperation)  :
13
C-NMR: 2f (trans, after separation) 
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1
H-NMR: 2g (trans, after separation)   
13
C-NMR: 2g (trans, after separation)  
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19
F-NMR: 2g (trans, after separation)   
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1
H-NMR: 2h (trans, after separation)   
13
C-NMR: 2h(trans, after separation)  
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1
H-NMR: 2i/3i (mixture, before separation)   
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1
H-NMR: 2i (trans, after separation)    
13
C-NMR: 2i (trans, after separation)    
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1
H-NMR: 2j (trans, after separation)   
13
C-NMR: 2j (trans, after separation)  
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1
H-NMR: 3j (cis, after separation)   
13
C-NMR: 3j (cis, after separation)  
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1
H-NMR: 2k (trans, after separation)   
  
13
C-NMR: 2k (trans, after separation)   
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1
H-NMR: 3k (cis, after separation)   
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1
H-NMR: 2l (trans, after separation)  
13
C-NMR: 2l (trans, after separation)  
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1
H-NMR: 2m (trans, after separation)   
13
C-NMR: 2m (trans, after separation)  
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1
H-NMR: 2n (trans, after separation)   
13
C-NMR: 2n (trans, after separation)  
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19
F-NMR: 2n (trans, after separation)   
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1
H-NMR: 2o (trans, after separation)   
13
C-NMR: 2o (trans, after separation)  
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1
H-NMR: 2p (trans, after separation)   
13
C-NMR: 2p (trans, after separation)  
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1
H-NMR: 2q/3q/4q (mixture, before separation)   
1
H-NMR: 2q/3q (mixture, after separation)   
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1
H-NMR: 2q (trans, after separation)   
13
C-NMR: 2q (trans, after separation)   
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1
H-NMR: 2r/3r, 4r  
13
C-NMR: 2r/3r, 4r  
 
trans 
head-to-tail cis 
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1
H-NMR: 2s/3s 
13
C-NMR: 2s/3s  
 
cis 
cis 
trans 
trans 
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1
H-NMR: 2t (trans, after separation)  
13
C-NMR: 2t (trans, after separation) 
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1
H-NMR: 2u/3u (cis/trans)   
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1
H-NMR: 2u (major isomer)   
13
C-NMR: 2u (major isomer)   
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1
H-NMR: 2v (trans, after separation)   
13
C-NMR: 2v (trans, after separation)   
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1
H-NMR: 2w (trans, after separation)   
13
C-NMR: 2w (trans, after separation)  
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1
H-NMR: 6a (cis/trans)   
13
C-NMR: 6a (cis/trans)   
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1
H-NMR: 6b (cis/trans)   
13
C-NMR: 6b (cis/trans)  
 
Chapter 4: NMR data 
255 
 
1
H-NMR: 6c (cis/trans)   
13
C-NMR: 6c (cis/trans)   
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1
H-NMR: 6d (cis/trans)   
13
C-NMR: 6d (cis/trans)  
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1
H-NMR: 6e (cis/trans)   
13
C-NMR: 6e (cis/trans)   
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1
H-NMR: 7a (trans)  
13
C-NMR: 7a (trans)  
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1
H-NMR: 7b (trans)  
13
C-NMR: 7b (trans)   
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1
H-NMR: 7c (trans)   
13
C-NMR: 7c (trans) 
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4.15 Crystal data for 2v: 
 
 
Figure 4.4: Crystal structure of 2v 
Experimental: Single clear colourless prism-shaped crystals 
of (2v) were obtained by recrystallisation from 
DCM/pentane. A suitable crystal (0.27×0.10×0.07) mm3 was 
selected and mounted on a MITIGEN holder with inert oil on 
a SuperNova, Single source at offset, Atlas diffractometer. 
The crystal was kept at T = 123.01(10) K during data 
collection. Using Olex2 (Dolomanov et al., 2009), the 
structure was solved with the Sheldrick, 2015) structure 
solution program, using the None methods solution method. 
The model was refined with version of olex2.refine 
(Bourhis et al., 2015) using Gauss-Newton minimisation. 
Crystal Data. C30H24O2, Mr = 416.52, monoclinic, P21/c (No. 
14), a = 10.8157(1) Å, b = 9.5942(1) Å, c = 21.1289(2) Å,  = 
91.349(1)°,  =  = 90°, V = 2191.90(4) Å3, T = 123.01(10) K, 
Z = 4, Z' = 1, (Cu K) = 0.606, 49002 reflections measured, 
4378 unique (Rint = 0.0317) which were used in all 
calculations. The final wR2 was 0.0873 (all data) and R1 was 
0.0338 (I≥(I)). 
Compound  2v 
    
Formula  C30H24O2  
Dcalc./ g cm-3  1.2621  
/mm-1  0.606  
Formula Weight  416.52  
Colour  clear colourless  
Shape  prism  
Size/mm3  0.27×0.10×0.07  
T/K  123.01(10)  
Crystal System  monoclinic  
Space Group  P21/c  
a/Å  10.8157(1)  
b/Å  9.5942(1)  
c/Å  21.1289(2)  
/°  90  
/°  91.349(1)  
/°  90  
V/Å3  2191.90(4)  
Z  4  
Z'  1  
Wavelength/Å  1.54184  
Radiation type  Cu K  
min/°  4.09  
max/°  73.59  
Measured Refl.  49002  
Independent Refl.  4378  
Reflections Used  4034  
Rint  0.0317  
Parameters  288  
Restraints  0  
Largest Peak  0.2557  
Deepest Hole  -0.1984  
GooF  1.0479  
wR2 (all data)  0.0873  
wR2  0.0849  
R1 (all data)  0.0367  
R1  0.0338  
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Table 4.5: Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement Parameters 
(Å2×103) for 2v. Ueq is defined as 1/3 of the trace of the orthogonalised Uij. 
 
Atom x y z Ueq 
O(1) 2124.4(7) 9112.5(8) 5945.5(4) 30.51(19) 
O(2) 3233.2(8) 5262.6(9) 5034.9(4) 33.1(2) 
C(5) 2024.0(9) 5363.4(11) 7158.8(5) 21.1(2) 
C(3) 2450.1(9) 6193.2(11) 5986.1(5) 21.3(2) 
C(2) 3542.5(9) 7222.2(11) 6008.6(5) 21.5(2) 
C(4) 2909.1(9) 5523.5(11) 6626.5(5) 21.2(2) 
C(19) 1440.8(10) 4123.2(11) 5377.4(5) 23.1(2) 
C(12) 5194.4(9) 6212.8(11) 6843.0(5) 22.7(2) 
C(25) 4214.1(10) 9794.1(11) 5880.2(5) 24.9(2) 
C(11) 3900.2(9) 6717.2(11) 6695.6(5) 21.7(2) 
C(6) 2020.8(10) 4149.0(11) 7516.7(5) 26.6(2) 
C(1) 3206.6(10) 8745.5(11) 5943.8(5) 23.1(2) 
C(10) 1213.5(10) 6430.8(12) 7316.3(5) 25.2(2) 
C(18) 2427.1(10) 5206.7(11) 5428.6(5) 23.2(2) 
C(20) 1478.8(11) 3171.3(12) 4875.0(5) 29.1(2) 
C(24) 491.7(10) 4021.5(11) 5808.6(5) 25.2(2) 
C(23) -399(1) 2981.9(12) 5739.6(5) 28.8(2) 
C(13) 5925.2(10) 5643.5(12) 6376.5(5) 28.5(2) 
C(9) 411.4(10) 6272.1(13) 7815.1(5) 29.2(2) 
C(17) 5649.6(11) 6219.6(12) 7464.6(5) 28.5(2) 
C(7) 1217.1(11) 3995.9(13) 8017.1(5) 31.0(3) 
C(26) 5453.0(11) 9473.6(13) 6000.3(6) 31.0(3) 
C(15) 7534.3(11) 5116.4(12) 7142.4(6) 32.7(3) 
C(8) 412.5(10) 5050.6(14) 8166.3(5) 30.7(3) 
C(30) 3893.3(11) 11146.9(12) 5698.1(6) 30.7(2) 
C(16) 6816.0(11) 5669.8(13) 7611.5(6) 33.6(3) 
C(22) -357.8(11) 2057.6(12) 5239.8(6) 32.0(3) 
C(14) 7088.7(11) 5110.7(13) 6524.8(6) 32.6(3) 
C(21) 581.6(12) 2156.7(13) 4807.0(6) 34.0(3) 
C(29) 4795.9(12) 12149.4(13) 5628.4(6) 35.9(3) 
C(28) 6025.4(12) 11824.5(13) 5752.0(6) 36.4(3) 
C(27) 6351.6(11) 10494.8(14) 5941.9(6) 37.5(3) 
Table 4.6: Anisotropic Displacement Parameters (×104) 2v. The anisotropic displacement factor 
exponent takes the form: -22[h2a*2 × U11+ ... +2hka* × b* × U12] 
 
Atom U11 U22 U33 U23 U13 U12 
O(1) 22.7(4) 25.6(4) 43.2(5) 1.1(3) 0.3(3) -1.3(3) 
O(2) 34.5(4) 36.5(5) 28.6(4) -8.0(4) 9.9(3) -6.4(3) 
C(5) 19.4(5) 22.6(5) 21.3(5) -3.8(4) -0.3(4) -1.6(4) 
C(3) 19.3(5) 21.1(5) 23.7(5) -1.4(4) 1.9(4) -0.1(4) 
C(2) 18.8(5) 22.2(5) 23.4(5) -1.3(4) 2.0(4) -0.4(4) 
C(4) 20.7(5) 19.8(5) 23.3(5) -0.2(4) 2.5(4) -1.2(4) 
C(19) 24.4(5) 22.2(5) 22.6(5) 0.8(4) -3.3(4) 1.2(4) 
C(12) 21.6(5) 21.3(5) 25.3(5) -4.7(4) 0.2(4) 2.2(4) 
C(25) 25.8(5) 24.4(5) 24.4(5) -2.1(4) 0.6(4) 1.4(4) 
C(11) 20.9(5) 21.7(5) 22.6(5) -1.7(4) 2.9(4) -1.3(4) 
C(6) 30.1(6) 22.3(5) 27.3(5) -1.8(4) 0.6(4) -0.4(4) 
C(1) 22.6(5) 24.3(5) 22.4(5) -0.2(4) 0.0(4) -0.3(4) 
C(10) 24.1(5) 26.2(5) 25.4(5) 0.9(4) 2.4(4) 1.3(4) 
C(18) 23.4(5) 24.3(5) 22.0(5) 1.0(4) 0.4(4) 1.5(4) 
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Atom U11 U22 U33 U23 U13 U12 
C(20) 33.9(6) 27.5(6) 25.9(5) -0.6(5) 1.1(4) -1.6(4) 
C(24) 24.3(5) 25.1(5) 26.2(5) -0.3(4) -1.2(4) -1.3(4) 
C(23) 24.5(5) 29.1(6) 32.7(6) -1.8(4) -0.8(4) 3.2(5) 
C(13) 24.7(5) 33.1(6) 27.4(5) 2.8(4) -2.4(4) -1.9(4) 
C(9) 22.5(5) 38.7(6) 26.6(5) 3.3(5) 2.4(4) -2.9(5) 
C(17) 29.4(6) 31.9(6) 24.4(5) -5.6(5) 0.9(4) 3.6(4) 
C(7) 35.7(6) 31.0(6) 26.2(5) -9.7(5) 1.1(5) 5.2(4) 
C(26) 25.7(6) 27.2(6) 39.8(6) -2.3(4) -0.4(5) 8.4(5) 
C(15) 23.7(6) 28.9(6) 45.1(7) -1.1(4) -7.2(5) 8.8(5) 
C(8) 24.3(6) 45.8(7) 22.0(5) -9.2(5) 2.3(4) 0.2(5) 
C(30) 30.0(6) 27.1(6) 34.8(6) 0.5(5) -1.2(5) 4.3(5) 
C(16) 33.9(6) 36.4(6) 30.1(6) -7.1(5) -8.8(5) 10.0(5) 
C(22) 33.0(6) 25.8(6) 36.6(6) -7.6(5) -8.2(5) 2.0(5) 
C(14) 24.8(6) 33.5(6) 39.5(6) 3.8(5) 0.2(5) -1.3(5) 
C(21) 43.9(7) 28.0(6) 29.7(6) -4.3(5) -3.9(5) -5.7(5) 
C(29) 42.1(7) 24.6(6) 40.9(7) -3.6(5) -0.1(5) 7.6(5) 
C(28) 35.3(6) 32.5(6) 41.5(7) -12.8(5) 0.2(5) 6.9(5) 
C(27) 25.8(6) 38.5(7) 48.1(7) -6.4(5) -3.0(5) 10.4(6) 
Table 4.7: Bond Lengths in Å for 2v. 
 
Atom Atom Length/Å 
O(1) C(1) 1.2224(13) 
O(2) C(18) 1.2204(13) 
C(5) C(4) 1.5018(14) 
C(5) C(6) 1.3890(15) 
C(5) C(10) 1.3935(15) 
C(3) C(2) 1.5396(14) 
C(3) C(4) 1.5681(14) 
C(3) C(18) 1.5108(14) 
C(2) C(11) 1.5699(14) 
C(2) C(1) 1.5114(14) 
C(4) C(11) 1.5732(14) 
C(19) C(18) 1.4916(15) 
C(19) C(20) 1.4016(15) 
C(19) C(24) 1.3919(15) 
C(12) C(11) 1.5066(14) 
C(12) C(13) 1.3896(15) 
C(12) C(17) 1.3919(15) 
C(25) C(1) 1.4915(15) 
C(25) C(26) 1.3923(16) 
C(25) C(30) 1.3952(16) 
C(6) C(7) 1.3923(16) 
C(10) C(9) 1.3890(15) 
C(20) C(21) 1.3796(17) 
C(24) C(23) 1.3919(15) 
C(23) C(22) 1.3805(17) 
C(13) C(14) 1.3872(16) 
C(9) C(8) 1.3871(17) 
C(17) C(16) 1.3955(17) 
C(7) C(8) 1.3761(18) 
C(26) C(27) 1.3876(17) 
C(15) C(16) 1.3799(19) 
C(15) C(14) 1.3805(17) 
C(30) C(29) 1.3807(17) 
C(22) C(21) 1.3862(18) 
C(29) C(28) 1.3846(18) 
Atom Atom Length/Å 
C(28) C(27) 1.3807(18) 
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Table 4.8: Bond Angles in ° for 2v. 
 
Atom Atom Atom Angle/° 
C(6) C(5) C(4) 120.22(9) 
C(10) C(5) C(4) 121.29(9) 
C(10) C(5) C(6) 118.47(10) 
C(4) C(3) C(2) 90.51(7) 
C(18) C(3) C(2) 115.11(8) 
C(18) C(3) C(4) 114.53(8) 
C(11) C(2) C(3) 90.17(7) 
C(1) C(2) C(3) 115.76(8) 
C(1) C(2) C(11) 115.83(8) 
C(3) C(4) C(5) 119.59(8) 
C(11) C(4) C(5) 116.74(8) 
C(11) C(4) C(3) 89.02(7) 
C(20) C(19) C(18) 118.39(10) 
C(24) C(19) C(18) 122.58(9) 
C(24) C(19) C(20) 119.03(10) 
C(13) C(12) C(11) 121.39(9) 
C(17) C(12) C(11) 119.99(10) 
C(17) C(12) C(13) 118.46(10) 
C(26) C(25) C(1) 122.45(10) 
C(30) C(25) C(1) 118.35(10) 
C(30) C(25) C(26) 119.19(10) 
C(4) C(11) C(2) 89.22(7) 
C(12) C(11) C(2) 119.85(8) 
C(12) C(11) C(4) 114.40(8) 
C(7) C(6) C(5) 120.77(11) 
C(2) C(1) O(1) 120.43(9) 
C(25) C(1) O(1) 120.50(10) 
C(25) C(1) C(2) 119.07(9) 
C(9) C(10) C(5) 120.55(10) 
C(3) C(18) O(2) 120.34(9) 
C(19) C(18) O(2) 120.15(10) 
C(19) C(18) C(3) 119.46(9) 
C(21) C(20) C(19) 120.37(11) 
C(23) C(24) C(19) 120.06(10) 
C(22) C(23) C(24) 120.37(11) 
C(14) C(13) C(12) 120.86(11) 
C(8) C(9) C(10) 120.39(11) 
C(16) C(17) C(12) 120.39(11) 
C(8) C(7) C(6) 120.39(11) 
C(27) C(26) C(25) 120.06(11) 
C(14) C(15) C(16) 119.38(11) 
C(7) C(8) C(9) 119.43(10) 
C(29) C(30) C(25) 120.37(11) 
C(15) C(16) C(17) 120.47(11) 
C(21) C(22) C(23) 119.87(11) 
C(15) C(14) C(13) 120.44(11) 
C(22) C(21) C(20) 120.29(11) 
C(28) C(29) C(30) 120.09(11) 
C(27) C(28) C(29) 120.03(11) 
C(28) C(27) C(26) 120.24(12) 
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Table 4.9: Hydrogen Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement 
Parameters (Å2×103) for 2v. Ueq is defined as 1/3 of the trace of the orthogonalised Uij. 
 
Atom x y z Ueq 
H(3) 1656.4(9) 6672.0(11) 6030.4(5) 25.6(3) 
H(2) 4175.4(9) 6957.9(11) 5706.7(5) 25.8(3) 
H(4) 3318.9(9) 4632.5(11) 6545.1(5) 25.5(3) 
H(11) 3645.4(9) 7405.0(11) 7009.7(5) 26.0(3) 
H(6) 2561.7(10) 3429.9(11) 7420.9(5) 31.9(3) 
H(10) 1209.7(10) 7256.4(12) 7085.6(5) 30.2(3) 
H(20) 2112.4(11) 3223.9(12) 4585.9(5) 34.9(3) 
H(24) 452.6(10) 4648.7(11) 6143.1(5) 30.3(3) 
H(23) -1025.4(10) 2909.6(12) 6031.9(5) 34.5(3) 
H(13) 5630.6(10) 5619.4(12) 5959.6(5) 34.2(3) 
H(9) -129.6(10) 6989.0(13) 7914.1(5) 35.1(3) 
H(17) 5173.7(11) 6592.9(12) 7784.0(5) 34.3(3) 
H(7) 1224.2(11) 3176.0(13) 8252.0(5) 37.1(3) 
H(26) 5678.5(11) 8574.2(13) 6119.9(6) 37.1(3) 
H(15) 8311.3(11) 4750.6(12) 7241.4(6) 39.2(3) 
H(8) -125.8(10) 4945.5(14) 8499.8(5) 36.8(3) 
H(30) 3067.0(11) 11374.7(12) 5623.2(6) 36.8(3) 
H(16) 7111.2(11) 5676.4(13) 8028.5(6) 40.3(3) 
H(22) -959.1(11) 1369.8(12) 5193.6(6) 38.4(3) 
H(14) 7571.7(11) 4747.2(13) 6205.9(6) 39.2(3) 
H(21) 607.2(12) 1536.6(13) 4469.2(6) 40.7(3) 
H(29) 4577.7(12) 13044.0(13) 5498.3(6) 43.1(3) 
H(28) 6631.7(12) 12502.3(13) 5707.0(6) 43.7(3) 
H(27) 7176.5(11) 10282.8(14) 6030.9(6) 45.0(3) 
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5 Tandem cyclization of vinyl radicals: A sustainable approach to indolines 
utilizing visible-light photocatalysis 
5.1 Abstract:  
A tin-free strategy for the synthesis of substituted indolines has been demonstrated generating 
vinyl radicals utilizing the reductive quenching cycle operated by visible-light-promoted 
photocatalysis. This method offers a robust, mild, and high yielding route to a broad range of 
indoline derivatives containing different electronic functionalities. The resultant 2,3-disubstituted 
indolines features as valuable precursors for the synthesis of a number of biologically active 
molecules, which is demonstrated with the formal synthesis of  representative examples, such as 
Furoindolines or Tryptamines etc. 
5.2 Introduction:  
Indoles are a one of the commonly occurred prevalent structural entities in a range of bioactive 
natural products, drug candidates, pharmaceutical, alkaloids, and functional materials.
[1]
 In 
particular, 2,3-disubstituted indoles are a valuable class of organic compounds, which exhibit a 
remarkable biological activities.
[2]
 For example, FGIN-1-27 (1, Figure 5.1) is recognized as an 
agonist anxiolytic drug candidate, which potently and specifically binds to the glial 
mitochondrial diazepam binding receptor complex (Ki = 4.4 nM).
[3]
 Whereas, the 2-phenyl 
tryptamine derivative 2 is a high-affinity and selective antagonist of the human 5-HT2A receptor 
(Ki = 2.7 nM).
[4]
 Furthermore, the 2-arylindole-3-acetamide derivative 3 was identified as a FPP-
competitive inhibitor of farnesyl protein transferase (IC50 = 31 nM)
[5]
 and 2-(3,5-
dimethylphenyl)tryptamine derivatives such as 4 exhibit incredible affinity for the gonadotropin-
releasing hormone (GnRH-antagonist).
[6]
 In turn, a number of elegant synthetic approaches 
targeting this class of indoles have been established over the years.
[7,8]
 Among them, the tandem 
radical cyclization via hydrogen translocation strategy (Scheme 5.2) pioneered by Parson and co-
workers
[9]
 offers an efficient and direct approach to 2,3-disubstituted benzodihydrofurans and 
indolines with the desired 3-acetic acid side chain,
[10,11]
 and subsequently, 2-arylindolin-3-
ylacetic acid esters 7 (Table 5.1-5.2).  
This chapter has been published: 
S. K. Pagire, O. Reiser, Green Chem. 2017, 19, 1721-1725. 
S.K.P. and O.R. wrote the manuscript. 
Chapter 5: Tandem cyclization of vinyl radicals: A sustainable approach to indolines utilizing 
visible-light photocatalysis 
269 
 
 
Figure 5.1 Representative biologically active 2-arylindoles. 
However, the protocols that were demonstrated for the tandem radical cyclization suffers through 
harsh reaction conditions: the high reaction temperatures (> 100 °C) and the use of super-
stoichiometric Bu3SnH (1.4 to 2 equiv)/AIBN (0.5 equiv) (Scheme 5.2), which is non-practical 
from a sustainable point of view, especially for the late-stage synthesis of pharmaceutically 
active compounds on industrial scale.  
Alternatively, visible-light photoredox catalysis offers a mild and benign route for such 
transformations. The low catalyst loading (0.3 mol %, see results and discussion) and unlimited 
source of clean light energy certainly hold promise for the future developments. Utilizing this 
technology, we intended to develop a complementary method towards 2,3-disubstituted 
indolines, which not only overcome the shortcomings of employing toxic reagents in large 
amounts but also opens new doors in organic synthesis. 
Typically, visible-light induced activation of vinyl halides and their applications in organic 
transformations has not been widely explored and only few examples are known.
[12,13,14]
 This is 
mainly due to their high redox potentials, which generally require a strongly reducing 
photocatalysts. This is mostly possible in the reductive quenching cycle to successfully generate 
a vinyl radical under extrusion of halide. However, the high reactivity such vinyl radicals results 
overall in simple reductions with efficient quenching by the sacrificial electron donor present. 
For example, our efforts to engage α-bromochalcones or α-bromocinnamates in a visible-light 
mediated C-C bond forming reactions with heteroarenes using fac[Ir(ppy)3] or 
Chapter 5: Tandem cyclization of vinyl radicals: A sustainable approach to indolines utilizing 
visible-light photocatalysis 
270 
 
[Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 in combination with amines (such as DIPEA or NEt3) as 
sacrificial electron donor were unsuccessful. Instead, a vinyl bromide reduction was efficiently 
taking place in quantitative yields (>95%), but no coupling products could be isolated (Scheme 
5.1).
[13,14]
 Nevertheless, we questioned that vinyl radicals generated from α-bromocinnamate 
derivatives by photoredox catalysis in the reductive quenching cycle might readily undergo 
hydrogen translocation from a suitable H-donor being present in the substrate itself instead of 
external reduction. This way, the productive C-C bond forming process should be possible 
(Scheme 5.2).
[15]
 
5.2.1 Previous attempts: Direct dehalogenation products 
 
Scheme 5.1: Unsuccessful attempts of C-C bond formations utilizing reductive quenching 
cycles. 
5.2.2 This attempt: Successful 1,6-HAT process  
 
Scheme 5.2: Successful tandem cyclization via 1,6-hydrogen atom translocation (HAT) strategy. 
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5.3 Results and discussion: 
Our interpretation was confirmed when α-bromocinnamate 7a did not give any cyclized product 
upon utilizing oxidative quenching conditions employing with [Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 
(Ir
4+
/Ir*
3+ 
= –0.89 V vs. SCE)[16] or [Ir(ppy)2(dtb-bpy)]PF6 (Ir
4+
/Ir*
3+ 
= –0.96 V vs. SCE)[17] as 
photocatalysts
[18]
 in DMF under blue light (λmax = 455 nm) irradiation (Table 5.1, entry 1, 2).  
5.4 Synthesis of 8a: Catalyst screening and reaction optimization 
 
Entry Photocatalyst (mol %), additive, solvent 
Time  
(h) 
Ratio 8a 
 (cis/trans)
[b]
 
Yield 
(%)
[c]
 
01
[a]
 [Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 (5), DMF 72 - - 
02 [Ir(ppy)2(dtb-bpy)]PF6 (5), DMF 72 - - 
03 [Cu(dap)2Cl] (5), DMF 72 - NR
[d]
 
04 fac[Ir(ppy)3] (5), DMF 72 - -
[e]
 
05
[f]
 fac[Ir(ppy)3] (5), DIPEA, DMF 36 81:19 71 
06 [Ir(ppy)2 (dtb-bpy)]PF6 (5), DIPEA, DMF 36 67:33 76 
07 
[Ir{dF(CF3)ppy}2 (dtb-bpy)]PF6 (5),  
DIPEA, DMF 
36 71:29 15 
08 [Ir(ppy)2 (dtb-bpy)]PF6 (1), DIPEA, DMF 36 67:33 71 
09 [Ir(ppy)2(dtb-bpy)]PF6 (1), DIPEA, MeCN 36 76:24 82 
10 [Ir(ppy)2(dtb-bpy)]PF6 (0.3), DIPEA, MeCN 48 76:24 78 
11 [Ir(ppy)2(dtb-bpy)]PF6 (0.1), DIPEA, MeCN 48 76:24 59 
12 [Ir(ppy)2(dtb-bpy)]PF6 (0.1), DIPEA, MeCN 72 76:24 61 
13 No Catalyst, DIPEA, MeCN 48 - NR
[d]
 
14 
[Ir(ppy)2(dtb-bpy)]PF6 (0.3), no light,  
DIPEA, MeCN 
48 - NR
[d]
 
Table 5.1: Reaction conditions: [a] Oxidative quenching (entries 1-4): Substrate 7a (0.5 mmol), photocatalyst (5 
mol %), anhydrous DMF (2 mL), LED455, 72 h, room temperature. [b] Cis/trans ratio was determined by 
1H-NMR. 
[c] Isolated yields. [d] No reaction (starting material recovered). [e] E/Z-isomerization. [f] Reductive quenching 
(entries 5-13): Substrate 7a (0.5 mmol), photocatalyst (0.1-5 mol %), DIPEA (1.1 mmol), anhydrous DMF or MeCN 
(2.0 mL), LED455, room temperature, 36 h-72 h. 
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This is in accordance with the cyclic voltammetry measurements, suggesting that 7a (–1.50 V vs. 
SCE, see experimental section) has a considerably higher reduction potential. Also, no reaction 
of 7a occurred with [Cu(dap)2Cl] (Cu
2+
/Cu*
+ 
= –1.43 V vs. SCE) under the identical reactions 
conditions (Table 5.1, entry 3).
[19]
 By employing even more stronger reducing fac[Ir(ppy)3] 
photocatalyst (Ir
4+
/Ir*
3+ 
= –1.73 V vs. SCE),[20] only resulted a simple E/Z isomerization of 7a, 
however, no C-C bond formation takes place with the vinyl radical which might have generated 
in the reaction media (Table 5.1, entry 4), although the reducing power of the fac[Ir(ppy)3] 
catalyst should have been now sufficient. 
Next, we switched to the reductive quenching cycle: Surprisingly, irradiating 7a in the presence 
of sacrificial electron donor DIPEA (2.2 equiv) and fac[Ir(ppy)3] (5 mol %, Ir
3+
/Ir
2+ 
= –2.13 V 
vs. SCE) in DMF smoothly provided the desired product 8a in 71% yields (Table 5.1, entry 5), 
favoring the direct cyclization over the expected debromination. Notably, the [Ir(ppy)2(dtb-
bpy)]PF6 (Ir
3+
/Ir
2+
 = –1.51 V vs. SCE) is subsequently found to be a suitable photocatalyst in the 
reductive quenching cycle (Table 5.1, entry 6). As expected, lower yield was observed with the 
[Ir{dF(CF3)ppy}2(dtb-bpy)]PF6 photocatalyst since it’s the reduction potential (Ir
3+
/Ir
2+
 = –1.37 
V vs. SCE) apparently too low to allow an efficient conversion of 7a to 8a (Table 5.1, entry 7). 
The cis-diastereomer of 8a was formed predominantly with moderate selectivity (2:1 to 4:1), 
which was nevertheless without consequence of the aimed subsequent aromatization of 8 to 
indoles.  
Having identified the suitable catalyst b [Ir(ppy)2(dtb-bpy)]PF6 for this conversion, further 
optimization enabled the synthesis of 8a with improved yield by switching to the acetonitrile as a 
solvent (Table 5.1, entry 9). To our delight, the catalyst concentration could also be lowered to 
0.3 mol % (Table 5.1, entry 10), though the reaction time needed to be elongated (from 36 h to 
48 h). Whereas, further lowering the catalyst loading to 0.1 mol % gave inferior results even if 
the reaction time was prolonged from 36 h to 72 h (Table 5.1, entries 11, 12). In the absence of 
catalyst or light, no product formation is observed confirming the process is indeed driven by 
visible-light photocatalyst (Table 5.1, entries 13, 14). 
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5.5 Substrate scope 
Having identified the best reaction conditions (Table 5.1, entry 10), we proceeded to expand the 
synthesis of various 2-aryl substituted indolin-3-ylacetic acid derivatives (Table 5.2). 
Gratifyingly, both electron rich and withdrawing substituents in the aryl moiety gave good 
results. However, a nitro substituent in 7k did not provide the desired cyclization product, 
nevertheless, which has already been noted to be incompatible in some photoredox processes 
before.
[13,14] 
Notably,
 
the thiomethyl indoline derivative 8h was smoothly formed in 89% yield 
by the photocatalytic method, contrasting the initiation by classical methods (n-Bu3SnH/AIBN), 
which is known to reduce these type of thioethers.
[21] 
The cis/trans isomers of 8b were separated 
by recrystallization method and the cis diastereomer was clearly analyzed by single crystal X-ray 
analysis (Table 5.2). Evidently, the cis-diastereomers of 8 are kinetically more favoured and thus 
formed preferentially (cis/trans ~3:1) over the thermodynamically more favourable trans-
diastereomers. 
 
Table 5.2: Reaction conditions: [a] Substrate 7 (0.5 mmol), [Ir(ppy)2(dtb-bpy)]PF6 (0.3 mol %), anhydrous MeCN 
(2 mL), LED455, 48 h, rt. [b] 3.0 mmol scale. [c] Complete conversion but expected product was not observed. 
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5.6 Proposed reaction mechanism: 
A plausible reaction mechanism is presented in Figure 5.2. It is known that Ir(III) photoredox 
catalysts efficiently generate the oxidizing excited state *Ir(III) upon blue-light irradiation. Being 
highly oxidizing in nature in the excited state, *Ir(III) undergoes single electron reduction by the 
readily available sacrificial electron donor DIPEA to form even more stronger ground state 
reductant Ir(II). A facile single electron transfer (SET) to 7 from Ir(II) gives rise to the key vinyl 
radical intermediate I with the extrusion of bromide, thus completing the [Ir]-catalytic cycle. The 
resulting vinyl radical I is converted to the nucleophilic α-amino radical species II upon 1,6-H 
atom translocation (HAT). This stable α-amino radical undergoes a facile 5-exo-trig ring closure 
to form α-alkyl radical intermediate III. Subsequent protonation from oxidized DIPEA finally 
provides the desired indoline 8. Evidently, the possibility of a final proton transfer from the 
solvent was excluded by carrying out reactions in deuterated solvents (e.g. MeCN-d
3
 and DMF-
d
7
), for which no deuterium incorporated product was observed, pointing towards the important 
role of the DIPEA besides initiating the reductive quenching cycle.
[22]
 
 
Figure 5.2: Proposed reaction mechanism. 
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5.7 Applications: 
Next, we intended for the manipulation of 8 to show the applications of the title transformation 
(Scheme 5.3). A facile oxidation of indolines 8a and 8b to corresponding 2,3-disubstituted 
indoles took place with DDQ in toluene under microwave irradiation at 120 
o
C.
[11] 
The resulting 
product was directly subjected to the carbamate deprotection with Bu4NF, which provided 9a 
and 9b in 60-63 % yields (over two steps),
[23] 
which also completed the formal synthesis of the 
desired drug candidates 3 and 11.
[5,8]
 In addition, 9a was reduced with LiAlH4 to form 10,
[24]
 
which is a valuable intermediate for the synthesis of a number of other biologically active 
molecules, e.g. tryptamine 2
[25]
 and furoindolines 12.
[26] 
 
Scheme 5.3: Reaction conditions: [a] 8a or 8b (2.0 mmol), DDQ (4.0 mmol), toluene (15 mL), microwave 
irradiation, 120 oC, 10 h; then, [b] Bu4NF (10 mmol), THF (20 mL), rt, 24 h. [c] 9a (0.716 mmol), LiAlH4 (1.04 
mmol), anhydrous THF (4 mL), rt, 10 h. 
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5.8 Conclusions: 
In summary, we have successfully utilized visible-light mediated reductive quenching activation 
mode for the C-C bond formations with vinyl bromides. By using this method, 2,3-disubstituted 
indole derivatives was efficiently synthesized from readily accessed ortho-amino α-
bromocinnamates. Notably, the reaction was also proceeded efficiently even with the very low 
(0.3 mol %) catalyst loading. Thus, this method certainly opens a new door in replacing the 
previously reported procedure that required super-stoichiometric amounts of toxic reagents. 
Furthermore, the resulting 2,3-indolines could be efficiently converted to the biologically active 
indole derivatives. 
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5.9 Experimental section: 
5.9.1 Synthesis of starting material precursor:
[11]
 
 
Reagents and conditions: (i) KOtBu (1.5 equiv), triethyl--bromophosphonoacetate (1.5 equiv), THF, 0 °C - rt, 3 
h, 94% (S2); (ii) Fe-powder (3.5 equiv), EtOH/HCl, reflux, 3 h, 83% (S3); (iii) Methyl chloroformate (1.5 equiv), 
iPr2Et (3.0 equiv), CH2Cl2, 0 °C - rt, 12 h, 87% (S4). 
 
Ethyl 2-bromo-3-(2-nitrophenyl)acrylate (S2): 
Potassium tert-butoxide (22.28 g, 198.5 mmol, 1.50 equiv) was slowly added to 
triethyl--bromophosphonoacetate (60.30 g, 198.5 mmol, 1.50 equiv) in 
anhydrous THF (250 mL) under positive nitrogen atmosphere at 0 
o
C. The 
resulting mixture allowed to stir for 1 h, followed by slow addition of 2-nitrobenzaldehyde S1 
(20.00 g, 132.3 mmol, 1.00 equiv) to the reaction mixture, resulting mixture stirred further for 2 
h at 0 
o
C under inert atmosphere. The progress of the reaction was monitored by TLC analysis 
(staining with 2, 4-DNP / KMnO4); after complete consumption of the starting material, reaction 
was quenched by adding saturated ammonium chloride solution (100 mL), and extracted with 
ethyl acetate (3 x 150 mL). Combined organic phases were washed with brine (100 mL), dried 
over anhydrous Na2SO4, and concentrated in vacuo. Purification of the crude product by column 
chromatography (silica gel, hexanes–EtOAc, 4:1, Rf = 0.49) afforded 2a as a yellow solid (37.33 
g, 94% yield). 
1
H-NMR (300 MHz, CDCl3): δ = 8.46 (s, 1H), 8.19 (dd, J = 8.2, 1.0 Hz, 1H), 7.75 – 7.68 (m, 
1H), 7.65 – 7.54 (m, 2H), 4.36 (q, J = 7.1 Hz, 2H), 1.38 (t, J = 7.1 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3): δ = 162.3, 146.9, 139.2, 133.7, 131.2, 130.9, 129.9, 124.8, 117.3, 
63.1, 14.1. 
The obtained data is in accordance with the literature data.
[11] 
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Ethyl 3-(2-aminophenyl)-2-bromoacrylate (S3): 
Ethyl 2-bromo-3-(2-nitrophenyl)acrylate S2 (35.00 g, 116.62 mmol, 1.00 equiv) 
was dissolved under reflux in EtOH (150 mL) in a three-necked-flask, which 
equipped with a cooling condensor and a dropping funnel. Then Fe-powder 
(22.80 g, 408.1 mmol, 3.5 equiv) and 37% aq. HCl (90 mL) were added by a dropping funnel 
over 2 h under reflux, and the resulting mixture was refluxed for an additional hour. The mixture 
was concentrated on a rotary evaporator. Saturated NaHCO3 (200 mL) was then added to adjust 
the pH of the aqueous layer to 8, and then aqueous layer was extracted with CH2Cl2 (3 × 150 
mL). The combined organic phases were dried over Na2SO4, filtered, and concentrated in vacuo. 
Purification of the crude product by column chromatography (silica gel, hexanes–EtOAc, 9:1, Rf 
= 0.60) afforded S3 as a pale yellow solid (26.00 g, 83% yield). 
1
H-NMR (300 MHz, CDCl3): δ 8.16 (s, 1H), 7.73 – 7.57 (m, 1H), 7.23 – 7.16 (m, 1H), 6.81 (t, J 
= 7.6 Hz, 1H), 6.73 (dd, J = 8.1, 0.6 Hz, 1H), 4.34 (q, J = 7.1 Hz, 2H), 3.70 (bs, 1H), 1.38 (t, J = 
7.1 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 162.2, 143.9, 136.4, 129.9, 128.3, 118.8, 117.2, 115.0, 114.6, 
61.8, 13.2. 
The obtained data is in accordance with the literature data.
[11] 
 
Ethyl 2-bromo-3-(2-((methoxycarbonyl)amino)phenyl)acrylate (S4): 
To a solution of S4 (25.00 g, 92.93 mmol, 1.0 equiv) in CH2Cl2 (150 mL) was 
added 
i
Pr2Et (36.03 g, 278.81 mmol, 3 equiv) followed by methylchloroformate 
(13.17 g, 139.39 mmol, 1.5 equiv) a 0 
o
C. The mixture was then stirred at room 
temperature for 10 h, subsequently diluted with EtOAc (100 mL) and saturated NH4Cl (100 mL). 
This mixture was additionally extracted with EtOAc (2 × 100 mL). And the combined organic 
phases were washed with brine (100 mL), dried over Na2SO4, filtered, and concentrated in 
vacuo. Purification of the crude product by column chromatography (silica gel, hexanes–EtOAc, 
4:1, Rf = 0.60) afforded a pale yellow solid S4 (26.50 g, 87% yield). 
1
H-NMR (300 MHz, CDCl3):  8.15 (s, 1H), 7.85 (d, J = 7.7 Hz, 1H), 7.56 (d, J = 7.7 Hz, 1H,), 
7.39 (dt, J = 7.8, 1.3 Hz, 1H), 7.16 (dt, J = 7.6, 0.9 Hz, 1H,), 7.01 (d, J = 8.0 Hz, 1H), 6.23 (s, 
1H), 4.39 (q, J = 7.1 Hz, 2H), 4.15 (s, 3H), 1.38 (t, J = 7.1 Hz, 3H,). 
13
C-NMR (75 MHz, CDCl3):  162.6, 154.1, 137.5, 135.5, 130.3, 129.0, 125.7, 123.9, 121.9, 
118.4, 63.1, 52.6, 14.2.  
The obtained data is in accordance with the literature data.
[11]
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5.9.2 General procedure (GP-1) for N-benzylation: 
ArCH2Br (1.5 mmol, 1.5 equiv) was added to a solution of S4 (0.328 g, 1.0 mmol, 1.0 equiv), 
K2CO3 (0.415 g, 3.0 mmol, 3.0 equiv) and tetrabutylammonium bromide (0.161 g, 0.5 mmol, 0.5 
equiv) in MeCN (60 mL). The mixture was stirred at room temperature for a further 48 h. Then 
reaction mixture was diluted with EtOAc (50 mL), washed with brine solution (50 mL), and 
extracted with EtOAc (3 × 50 mL). The combined organic phases were dried over Na2SO4, 
filtered, and concentrated in vacuo. Purification of the crude product by column chromatography 
(silica gel, hexanes–EtOAc, 9:1) afforded 7. 
Ethyl 3-(2-(benzyl(methoxycarbonyl)amino)phenyl)-2-bromoacrylate (7a): 
Following GP-1, 7a was prepared from S4 (5 g, 15.23 mmol, 1.00 equiv), 
benzyl bromide or (bromomethyl)benzene (3.90 g, 22.85 mmol, 1.5 equiv), 
K2CO3 (6.30 g, 45.69 mmol, 3.00 equiv), and tetrabutylammonium bromide 
(2.45 g, 7.61 mmol, 0.5 equiv) in MeCN (150 mL). Purification of the crude 
product by column chromatography (silica gel, hexanes–EtOAc, 9:1, Rf = 
0.43) afforded 7a as a pale yellow oil (5.90 g, Z:E = 99:01, 93% yield). 
1
H-NMR (300 MHz, CDCl3, Z-isomer): δ 7.79 (d, J = 5.4 Hz, 1H), 7.70 (s, 1H), 7.40 – 7.29 (m, 
2H), 7.27 – 7.21 (m, 3H), 7.20 (s, 2H), 7.09 – 7.02 (m, 1H), 4.75 (s, 2H), 4.30 (q, J = 7.1 Hz, 
2H), 3.63 (s, 3H), 1.36 (t, J = 7.1 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3, Z-isomer): δ 162.68, 155.98, 140.41, 138.29, 136.85, 133.18, 
130.41, 129.94, 129.08, 128.50, 128.27, 127.82, 127.23, 116.34, 62.80, 54.59, 53.25, 14.21. 
The obtained data is in accordance with the literature data.
[11] 
Ethyl 2-bromo-3-(2-((methoxycarbonyl)(2-methylbenzyl)amino)phenyl)acrylate (7b): 
Following GP-1, 7b was prepared from S4 (5.00 g, 15.23 mmol, 1.00 equiv), 
2-Methylbenzyl bromide (4.23 g, 22.85 mmol, 1.5 equiv), K2CO3 (6.30 g, 
45.69 mmol, 3.00 equiv), and tetrabutylammonium bromide (2.45 g, 7.61 
mmol, 0.5 equiv) in MeCN (150 mL). Purification of the crude product by 
column chromatography (silica gel, hexanes–EtOAc, 9:1, Rf = 0.51) afforded 
7b as a pale yellow solid (6.19 g, Z:E = 89:11, 94% yield).  
1
H-NMR (300 MHz, CDCl3, Z-isomer): δ 7.76 (d, J = 6.5 Hz, 1H), 7.68 (s, 1H), 7.38 – 7.26 (m, 
2H), 7.15 – 6.97 (m, 5H), 5.05 – 4.70 (m, 2H), 4.30 (q, J = 7.1 Hz, 2H), 3.63 (s, 3H), 2.14 (s, 
3H), 1.36 (t, J = 7.1 Hz, 3H). 
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13
C-NMR (75 MHz, CDCl3, Z-isomer): δ 162.66, 155.82, 140.24, 138.09, 136.78, 134.57, 
133.48, 130.46, 130.40, 129.84, 128.25, 127.99, 127.26, 125.99, 116.16, 62.77, 53.27, 51.60, 
19.19, 14.24. 
IR (neat, cm
-1
): 2981, 2951, 1700, 1598, 1569, 1480, 1453, 1438, 1373, 1289, 1265, 1185, 
1126, 1101, 1035, 1011, 977, 910, 893, 866, 781, 756, 736, 663. 
HRMS (ESI): exact m/z calculated for C21H23BrNO4 (M+H)
+
: 432.0805; Found: 432.081 
(M+H)
+
. 
Mp: 64-66 oC (decomposed). 
Ethyl 2-bromo-3-(2-((3,5-dimethylbenzyl)(methoxycarbonyl)amino)phenyl)acrylate (7c): 
Following GP-1, 7c was prepared from S4 (0.328 g, 1.0 mmol, 1.00 equiv), 
1-(bromomethyl)-3,5-dimethylbenzene (0.298 g, 1.5 mmol, 1.5 equiv), 
K2CO3 (0.415 g, 3.0 mmol, 3.00 equiv), and tetrabutylammonium bromide 
(0.161 g, 0.5 mmol, 0.5 equiv) in MeCN (60 mL). Purification of the crude 
product by column chromatography (silica gel, hexanes–EtOAc, 9:1, Rf = 
0.46) afforded 7c as a pale yellow syrup (0.405 g, Z:E = 82:18, 91% yield).  
1
H-NMR (300 MHz, CDCl3, Z-isomer): δ 7.78 (s, 2H), 7.33 (m, 2H), 7.08 (d, J = 7.2 Hz, 1H), 
6.85 (s, 1H), 6.78 (s, 2H), 4.79 – 4.62 (m, 2H), 4.29 (q, J = 7.1, 2H), 3.62 (s, 3H), 2.22 (s, 6H), 
1.35 (t, J = 7.1 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3, Z-isomer): δ 171.09, 162.64, 155.94, 140.62, 138.29, 137.93, 
136.72, 133.18, 130.39, 129.87, 129.43, 128.28, 127.14, 126.79, 115.88, 62.73, 54.54, 53.17, 
21.24, 14.18. 
IR (neat, cm
-1
): 2984, 2953, 1700, 1599, 1485, 1443, 1376, 1288, 1249, 1215, 1136, 1106, 
1021, 991, 849, 761, 715. 
HRMS (ESI): exact m/z calculated for C22H25BrNO4 (M+H)
+
: 446.0961; Found: 446.0968 
(M+H)
+
. 
 
Ethyl 2-bromo-3-(2-((methoxycarbonyl)(4-methylbenzyl)amino)phenyl)acrylate (7d): 
Following GP-1, 7d was prepared from S4 (0.328 g, 1.0 mmol, 1.00 equiv), 1-
(bromomethyl)-4-methylbenzene (0.278 g, 1.5 mmol, 1.5 equiv), K2CO3 (0.415 
g, 3.0 mmol, 3.00 equiv), and tetrabutylammonium bromide (0.161 g, 0.5 
mmol, 0.5 equiv) in MeCN (60 mL). Purification of the crude product by 
column chromatography (silica gel, hexanes–EtOAc, 9:1, Rf = 0.40) afforded 
7d as a colourless viscous oil (0.396 g, Z:E = 99:01, 92% yield).  
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1
H-NMR (300 MHz, CDCl3, Z-isomer): δ 7.77 (d, J = 10.5 Hz, 1H), 7.69 (s, 1H), 7.41 – 7.29 
(m, 2H), 7.04 (s, 4H), 4.72 (m, 2H), 4.29 (q, J = 7.1, 2H), 3.62 (s, 3H), 2.29 (s, 3H), 1.36 (t, J = 
7.1, 3H). 
13
C-NMR (75 MHz, CDCl3, Z-isomer): δ 162.66, 155.93, 140.46, 138.29, 137.46, 133.80, 
133.23, 130.42, 129.90, 129.17, 129.04, 128.31, 127.18, 116.18, 62.75, 54.31, 53.20, 21.17, 
14.20. 
IR (neat, cm
-1
): 2983, 2953, 1702, 1617, 1598, 1514, 1482, 1443, 1376, 1317, 1292, 1234, 
1215, 1188, 1134, 1102, 1036, 990, 902, 844, 711, 761, 660. 
HRMS (ESI): exact m/z calculated for C21H23BrNO4 (M+H)
+
: 432.0805; Found: 432.0811 
(M+H)
+
. 
Ethyl 2-bromo-3-(2-((4-(tert-butyl)benzyl)(methoxycarbonyl)amino)phenyl)acrylate (7e): 
Following GP-1, 7e was prepared from S4 (0.328 g, 1.0 mmol, 1.00 
equiv), 1-(bromomethyl)-4-(tert-butyl)benzene (0.340 g, 1.5 mmol, 1.5 
equiv), K2CO3 (0.415 g, 3.0 mmol, 3.00 equiv), and 
tetrabutylammonium bromide (0.161 g, 0.5 mmol, 0.5 equiv) in MeCN 
(60 mL). Purification of the crude product by column chromatography 
(silica gel, hexanes–EtOAc, 9:1, Rf = 0.43) afforded 7e as a colourless 
viscous oil (0.427 g, Z:E = 99:01, 90% yield).  
1
H-NMR (300 MHz, CDCl3, Z-isomer): δ 7.86 – 7.75 (m, 2H), 7.42 – 7.32 (m, 2H), 7.31 – 7.22 
(m, 3H), 7.14 (m, 2H), 4.72 (s, 2H), 4.30 (q, J = 7.1Hz, 2H), 3.63 (s, 3H), 1.37 (t, J = 7.1Hz, 
3H), 1.28 (s, 9H). 
13
C-NMR (75 MHz, CDCl3, Z-isomer): δ 162.65, 155.93, 150.62, 140.63, 138.24, 133.75, 
133.16, 130.43, 129.88, 128.75, 128.34, 127.18, 126.90, 125.33, 116.16, 62.75, 54.28, 53.20, 
34.50, 31.32, 14.23. 
IR (neat, cm
-1
): 2956, 2906, 2868, 1704, 1617, 1598, 1481, 1444, 1377, 1318, 1293, 1232, 
1189, 1135, 1104, 1038, 983, 904, 850, 760, 671, 657. 
HRMS (ESI): exact m/z calculated for C24H29BrNO4 (M+H)
+
: 474.1274; Found: 474.1282 
(M+H)
+
. 
Ethyl 2-bromo-3-(2-((4-fluorobenzyl)(methoxycarbonyl)amino)phenyl)acrylate (7f): 
Following GP-1, 7f was prepared from S4 (0.328 g, 1.0 mmol, 1.00 equiv), 
1-(bromomethyl)-4-fluorobenzene (0.284 g, 1.5 mmol, 1.5 equiv), K2CO3 
(0.415 g, 3.0 mmol, 3.00 equiv), and tetrabutylammonium bromide (0.161 g, 
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0.5 mmol, 0.5 equiv) in MeCN (60 mL). Purification of the crude product by column 
chromatography (silica gel, hexanes–EtOAc, 9:1, Rf = 0.52) afforde 7f as a colourless viscous oil 
(0.384 g, Z:E = 99:01, 88% yield). 
1
H-NMR (300 MHz, CDCl3, Z-isomer): δ 7.77 (d, J = 6.0 Hz, 1H), 7.67 (s, 1H), 7.38 – 7.27 (m, 
2H), 7.20 – 7.08 (m, 2H), 7.05 – 6.99 (m, 1H), 6.94 – 6.85 (m, 2H), 4.83 – 4.57 (m, 1H), 4.26 (q, 
J = 7.1Hz, 2H), 3.59 (s, 3H), 1.32 (t, J = 7.1Hz, 3H). 
13
C-NMR (75 MHz, CDCl3, Z-isomer): δ 163.98, 162.58, 160.71, 155.92, 140.25, 138.13, 
134.16, 133.14, 132.77 (d, J = 3.2 Hz), 130.87 (d, J = 8.1 Hz), 130.48, 130.01, 128.33, 62.81, 
53.81, 53.24, 14.14. 
19
F-NMR (282 MHz, CDCl3, Z-isomer: δ -114.76, E-isomer: δ -115.25). 
IR (neat, cm
-1
): 2983, 2954, 1702, 1602, 1509, 1482, 1445, 1376, 1215, 1189, 1157, 1135, 
1095, 1035, 1016, 983, 902, 839, 756, 656. 
HRMS (ESI): exact m/z calculated for C20H20BrFNO4 (M+H)
+
: 436.0554; Found: 436.0562 
(M+H)
+
. 
Ethyl 2-bromo-3-(2-((methoxycarbonyl)(4-(trifluoromethyl)benzyl)amino)phenyl)acrylate 
(7g):  
Following GP-1, 7g was prepared from S4 (0.328 g, 1.0 mmol, 1.00 
equiv), 1-(bromomethyl)-4-(trifluoromethyl)benzene (0.359 g, 1.5 
mmol, 1.5 equiv), K2CO3 (0.415 g, 3.0 mmol, 3.00 equiv), and 
tetrabutylammonium bromide (0.161 g, 0.5 mmol, 0.5 equiv) in MeCN 
(60 mL). Purification of the crude product by column chromatography 
(silica gel, hexanes–EtOAc, 9:1, Rf = 0.33) afforded 7g as a pale yellow 
viscous oil (0.418 g, Z:E = 95:05, 86% yield). 
1
H-NMR (300 MHz, CDCl3, Z-isomer): δ 7.81 – 7.72 (m, 2H), 7.49 (d, J = 8.1 Hz, 2H), 7.40 – 
7.27 (m, 4H), 7.05 (d, J = 6.6 Hz, 1H), 4.77 (s, 2H), 4.27 (q, J = 7.1 Hz, 2H), 3.62 (s, 3H), 1.32 
(t, J = 7.1 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3, Z-isomer): δ 162.48, 155.98, 140.91, 140.24, 137.97, 133.03, 
130.55, 130.11, 129.71, 129.32, 128.19, 127.48, 125.43 (q, J = 3.7 Hz), 124.05 (q, J = 272.07 
Hz), 122.25, 116.61, 62.84, 54.15, 53.35, 14.06. 
19
F-NMR (282 MHz, CDCl3, Z-isomer): δ -63.03. 
IR (neat, cm
-1
): 2956, 1704, 1619, 1598, 1483, 1446, 1421, 1378, 1322, 1301, 1253, 1236, 
1190, 1161, 1111, 1064, 1037, 1018, 985, 906, 852, 820, 760, 660. 
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HRMS (ESI): exact m/z calculated for C21H20BrF3NO4 (M+H)
+
: 486.0522; Found: 486.0528 
(M+H)
+
. 
Ethyl 2-bromo-3-(2-((methoxycarbonyl)(4-(methylthio)benzyl)amino)phenyl)acrylate (7h):  
Following GP-1, 7h was prepared from S4 (0.328 g, 1.0 mmol, 1.00 equiv), 
(4-(bromomethyl)phenyl)(methyl)sulfane (0.326 g, 1.5 mmol, 1.5 equiv), 
K2CO3 (0.415 g, 3.0 mmol, 3.00 equiv), and tetrabutylammonium bromide 
(0.161 g, 0.5 mmol, 0.5 equiv) in MeCN (60 mL). Purification of the crude 
product by column chromatography (silica gel, hexanes–EtOAc, 9:1, Rf = 
0.49) afforded 7h as a pale yellow viscous oil (0.441 g, Z:E = 91:09, 95% 
yield). 
1
H-NMR (300 MHz, CDCl3, Z-isomer): δ 7.79 (d, J = 5.9 Hz, 1H), 7.71 (s, 1H), 7.41 – 7.28 (m, 
2H), 7.18 – 6.99 (m, 5H), 4.81 – 4.59 (m, 2H), 4.28 (q, J = 7.1 Hz, 2H), 3.61 (s, 3H), 2.43 (s, 
3H), 1.35 (t, J = 7.1 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3, Z-isomer): δ 162.60, 155.94, 140.38, 138.21, 138.09, 133.56, 
133.14, 130.46, 129.98, 129.62, 128.35, 127.60, 127.28, 126.76, 126.40, 116.34, 62.83, 54.13, 
53.24, 14.20. 
IR (neat, cm
-1
): 2982, 2952, 2922, 1701, 1618, 1597, 1570, 1482, 1442, 1376, 1234, 1215, 
1188, 1135, 1092, 1035, 1016, 983, 840, 804, 759, 656. 
HRMS (ESI): exact m/z calculated for C21H23BrNO4S (M+H)
+
: 464.0526; Found: 464.0536 
(M+H)
+
. 
Ethyl 2-bromo-3-(2-((2-bromobenzyl)(methoxycarbonyl)amino)phenyl)acrylate (7i): 
Following GP-1, 7i was prepared from S4 (0.328 g, 1.0 mmol, 1.00 equiv), 1-
bromo-2-(bromomethyl)benzene (0.375 g, 1.5 mmol, 1.5 equiv), K2CO3 (0.415 
g, 3.0 mmol, 3.00 equiv), and tetrabutylammonium bromide (0.161 g, 0.5 
mmol, 0.5 equiv) in MeCN (60 mL). Purification of the crude product by 
column chromatography (silica gel, hexanes–EtOAc, 9:1, Rf = 0.31) afforded 
7i as a pale yellow solid (0.462 g, Z:E = 99:01, 93% yield).  
1
H-NMR (300 MHz, CDCl3, Z-isomer): δ 7.90 (d, J = 10.5 Hz, 1H), 7.88 – 7.75 (m, 1H), 7.48 
(d, J = 7.9 Hz, 1H), 7.40 – 7.32 (m, 3H), 7.24 (t, J = 7.1 Hz, 1H), 7.19 – 7.07 (m, 2H), 4.99 (s, 
2H), 4.35 (q, J = 7.1 Hz, 2H), 3.79 (s, 3H), 1.40 (t, J = 7.1 Hz, 3H). 
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13
C-NMR (75 MHz, CDCl3, Z-isomer): δ 162.73, 155.92, 140.09, 138.07, 136.03, 133.17, 
132.93, 131.27, 130.41, 129.89, 129.37, 128.20, 127.55, 127.32, 124.19, 116.30, 62.83, 53.68, 
53.40, 14.25. 
IR (neat, cm
-1
): 2976, 2952, 1707, 1614, 1596, 1569, 1440, 1378, 1297, 1250, 1213, 1189, 
1140, 1105, 1026, 983, 896, 875, 782, 752, 653. 
HRMS (ESI): exact m/z calculated for C20H20Br2NO4 (M+H)
+
: 495.9754; Found: 495.9756 
(M+H)
+
.  
Mp: 58-60 
o
C (decomposed). 
 
Ethyl 2-bromo-3-(2-((3-chlorobenzyl)(methoxycarbonyl)amino)phenyl)acrylate (7j): 
Following GP-1, 7j was prepared from S4 (0.328 g, 1.0 mmol, 1.00 equiv), 
1-(bromomethyl)-3-chlorobenzene (0.308 g, 1.5 mmol, 1.5 equiv), K2CO3 
(0.415 g, 3.0 mmol, 3.00 equiv), and tetrabutylammonium bromide (0.161 g, 
0.5 mmol, 0.5 equiv) in MeCN (60 mL). Purification of the crude product by 
column chromatography (silica gel, hexanes–EtOAc, 9:1, Rf = 0.36) afforded 
7j as a pale yellow oil (0.402 g, Z:E = 99:01, 89% yield).  
1
H-NMR (300 MHz, CDCl3, Z-isomer): δ 7.73 (d, J = 6.7 Hz, 1H), 7.69 (s, 1H), 7.36 – 7.23 (m, 
2H), 7.20 – 7.05 (m, 3H), 6.99 (m, 2H), 4.65 (m, 1H), 4.24 (q, J = 7.1 Hz, 2H), 3.56 (s, 3H), 1.29 
(t, J = 7.1 Hz, 1H). 
13
C-NMR (75 MHz, CDCl3, Z-isomer): δ 162.50, 155.90, 140.21, 138.88, 137.95, 134.27, 
133.05, 130.55, 130.03, 129.79, 129.04, 128.21, 128.04, 127.43, 127.19, 116.46, 62.86, 54.07, 
53.32, 14.19. 
The obtained data is in accordance with the literature data.
[11] 
 
Ethyl 2-bromo-3-(2-((methoxycarbonyl)(4-nitrobenzyl)amino)phenyl)acrylate (7k): 
Following GP-1, 7k was prepared from S4 (0.209 g, 0.5 mmol, 1.00 equiv), 
1-(bromomethyl)-4-nitrobenzene (0.324 g, 1.5 mmol, 1.5 equiv), K2CO3 
(0.415 g, 3.0 mmol, 3.00 equiv), and tetrabutylammonium bromide (0.161 g, 
0.5 mmol, 0.5 equiv) in MeCN (60 mL). Purification of the crude product by 
column chromatography (silica gel, hexanes–EtOAc, 9:1, Rf = 0.32) afforded 
7k as a pale yellow oil (0.407 g, Z:E = 99:01, 88% yield).  
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1
H-NMR (300 MHz, CDCl3, Z-isomer): δ 8.07 (d, J = 8.7 Hz, 2H), 7.74 (d, J = 7.4 Hz, 2H), 
7.42 – 7.28 (m, 4H), 7.05 (d, J = 6.8 Hz, 1H), 4.79 (s, 2H), 4.26 (q, J = 7.1 Hz, 2H), 3.62 (s, 3H), 
1.32 (t, J = 7.1 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3, Z-isomer): δ 162.45, 155.99, 147.45, 144.24, 140.04, 137.89, 
132.94, 130.66, 130.21, 129.82, 128.21, 127.68, 123.74, 116.65, 62.98, 53.93, 53.51, 14.12. 
The obtained data is in accordance with the literature data.
[11]
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5.9.3 Reduction potentials: 
Redox potentials of the α-bromocinnamates were measured by cyclic voltammetry in acetonitrile 
(MeCN) containing tetrabutylammonium tetrafluoroborate (0.1 M) as a supporting electrolyte. 
All values are given vs. Saturated Calomel Electrode (SCE). The scan rate was 50 mV S
-1
. 
α-Bromocinnamates Reduction potential (V) 
7a -1.50 
7b -1.48 
7c -1.47 
7d -1.51 
7e -1.52 
7f -1.51 
7g -1.50 
7h -1.48 
7i -1.45 
7j -1.50 
7k -1.19 
Table 5.3: Reduction potentials of the α-bromocinnamate ethyl esters vs SCE. 
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5.9.4. General procedure (GP-2) for photocatalysis: 
 
An oven dried 10 mL schlenk flask was charged with 7 (0.50 mmol, 1.00 equiv) and 
[Ir(ppy)2(dtb-bpy)]PF6 (1.37 mg, 0.003 equiv, 0.3 mol %) in anhydrous MeCN (2.0 mL). Then, 
anhydrous DIPEA (0.191 mL, 1.1 mmol, 2.2 equiv) was added and the resulting suspension was 
deoxygenated by three freeze-pump-thaw cycles. The resulting reaction mixture was irradiated 
with blue light emitting diode (LED, λmax = 455 nm) at room temperature for 48 h. After 
completion of reaction mixture, the crude mixture was filtered and washed with ethyl acetate. 
The crude residue was concentrated in vacuo. Purification of the crude product by column 
chromatography on silica gel by using hexanes and ethyl acetate afforded the pure product 8. 
 
Figure 5.3: Experimental set-up for photochemical reaction. 
Methyl 3-(2-ethoxy-2-oxoethyl)-2-phenylindoline-1-carboxylate (8a): 
Following GP-2, 8a was prepared from 7a (1.254 g, 3.0 mmol, 1.00 equiv), 
[Ir(ppy)2(dtb-bpy)]PF6 (8.22 mg, 0.003 equiv, 0.3 mol %) and DIPEA (1.146 
mL, 1.1 mmol, 2.2 equiv) in MeCN (10 mL). Purification of the crude product 
by column chromatography (silica gel, hexanes–EtOAc, 9:1, Rf = 0.46) 
afforded 8a as a white solid (0.773 g, cis / trans = 78:22, 75% yield).  
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1
H-NMR (300 MHz, CDCl3, cis isomer): δ 7.87 (s, 1H), 7.37 – 7.09 (m, 4H), 7.05 – 6.85 (m, 
4H), 5.58 (d, J = 9.6 Hz, 1H), 4.23 (td, J = 10.0, 4.9 Hz, 1H), 4.09 – 3.99 (dq, J = 7.2 Hz, 2H), 
3.63 (s, 3H), 2.70 – 2.49 (m, 1H), 1.97 (dd, J = 17.4, 10.2 Hz, 1H), 1.16 (t, J = 7.1 Hz, 3H). 
1
H-NMR (300 MHz, CDCl3, trans isomer): δ 7.29 – 7.07 (m, 5H), 7.03 – 6.92 (m, 4H), 5.17 (s, 
1H), 4.23 (ddd, J = 12.1, 8.5, 3.5 Hz, 1H), 4.19 – 4.10 (m, 1H), 4.04 (dq, J = 7.1 Hz, 2H), 2.56 
(d, J = 4.9 Hz, 1H), 1.97 (dd, J = 17.4, 10.2 Hz, 1H), 1.21 (t, J = 7.2 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3, cis isomer): δ 172.23, 153.51, 138.26, 128.63, 128.39, 127.92, 
127.46, 126.93, 125.29, 123.42, 123.11, 114.56, 66.40, 60.67, 52.65, 41.18, 34.20, 14.16. 
13
C-NMR (75 MHz, CDCl3, trans isomer): δ 171.53, 147.41, 141.00, 128.34, 138.21, 130.62, 
128.53, 128.34, 128.12, 127.46, 127.00, 125.29, 115.02, 60.84, 52.71, 41.00, 33.97, 14.24. 
The obtained data is in accordance with the literature data.
[11] 
 
Methyl 3-(2-ethoxy-2-oxoethyl)-2-(o-tolyl)indoline-1-carboxylate (8b): 
Following GP-2, 8b was prepared from 7b (1.296 g, 3.0 mmol, 1.00 equiv), 
[Ir(ppy)2(dtb-bpy)]PF6 (8.22 mg, 0.003 equiv, 0.3 mol %) and DIPEA (1.146 
mL, 1.1 mmol, 2.2 equiv) in MeCN (10 mL). Purification of the crude product 
by column chromatography (silica gel, hexanes–EtOAc, 9:1, Rf = 0.48) 
afforded 8b as a white solid (0.879 g, cis / trans = 55:45, 83% yield). 
1
H-NMR (300 MHz, CDCl3, cis isomer): δ 7.86 (bs, 1H), 7.35 – 7.23 (m, 3H), 7.01 (dt, J = 
11.9, 5.8 Hz, 4H), 5.89 (d, J = 10.1 Hz, 1H), 4.37 (dt, J = 17.3, 8.6 Hz, 1H),, 4.01 (q, J = 7.1 Hz, 
2H), 3.66 (s, 3H), 3.53 (td, J = 7.0, 1.9 Hz, 1H), 2.74 (qd, J = 15.4, 7.1 Hz, 1H), 2.45 (s, 3H), 
1.13 (t, J = 7.2 Hz, 3H). 
1
H-NMR (300 MHz, CDCl3, trans isomer): δ 7.20 – 7.06 (m, 7H), 6.89 (dd, J = 14.8, 7.6 Hz, 
2H), 5.41 (s, 1H), 4.13 (q, J = 7.1 Hz, 2H), 3.69 (s, 3H), 2.54 (dd, J = 17.1, 5.9 Hz, 1H), 2.46 (s, 
3H), 2.25 – 2.12 (m, 1H), 1.31 – 1.25 (m, 1H), 1.20 (t, J = 7.1 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3, cis isomer): δ 172.09, 153.48, 140.59, 136.84, 132.74, 130.63, 
128.28, 127.75, 126.50, 126.23, 125.05, 124.21, 123.08, 114.61, 61.39, 60.60, 52.63, 41.57, 
35.10, 19.49, 14.09. 
13
C-NMR (75 MHz, CDCl3, trans isomer): δ 171.26, 153.61, 142.95, 135.81, 134.44, 130.49, 
128.69, 127.35, 125.97, 125.90, 123.68, 123.26, 122.86, 114.90, 65.06, 61.39, 52.72, 46.01, 
40.42, 19.37, 14.16. 
IR (neat, cm
-1
): 2955, 1705, 1599, 1483, 1461, 1440, 1376, 1346, 1329, 1308, 1274, 1248, 
1156, 1138, 1054, 1020, 746. 
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HRMS (ESI): exact m/z calculated for C21H24NO4 (M+H)
+
: 354.17; Found: 354.1708 (M+H)
+
. 
Mp: 51-53 
o
C (decomposed). 
 
Methyl 2-(3,5-dimethylphenyl)-3-(2-ethoxy-2-oxoethyl)indoline-1-carboxylate (8c): 
Following GP-2, 8c was prepared from 7c (0.223 g, 0.5 mmol, 1.00 equiv), 
[Ir(ppy)2(dtb-bpy)]PF6 (1.37 mg, 0.003 equiv, 0.3 mol %) and DIPEA (0.191 
mL, 1.1 mmol, 2.2 equiv) in MeCN (1.5 mL). Purification of the crude product 
by column chromatography (silica gel, hexanes–EtOAc, 9:1, Rf = 0.53) 
afforded 8c as a pale yellow solid (0.141 g, cis / trans = 71:29, 77% yield). 
1
H-NMR (300 MHz, CDCl3, cis isomer): δ 7.84 (bs, 1H), 7.35 – 7.22 (m, 2H), 7.08 – 6.96 (m, 
2H), 6.87 (dd, J = 25.7, 9.0 Hz, 2H), 5.56 (d, J = 10.0 Hz, 1H), 4.19 (ddd, J = 9.5, 4.7, 1.5 Hz, 
1H), 4.11 (qd, J = 7.2, 1.9 Hz, 2H), 3.69 (s, 3H), 2.71 – 2.62 (m, 1H), 2.19 (s, 6H), 2.09 – 1.97 
(m, 1H), 1.25 – 1.19 (t, J = 7.2 Hz, 3H). 
1
H-NMR (300 MHz, CDCl3, trans isomer): δ 7.51 – 7.39 (m, 1H), 7.14 (d, J = 7.4 Hz, 2H), 
6.60 (s, 4H), 5.18 (d, J = 1.9 Hz, 1H), 4.19 (q, J = 7.1 Hz, 2H), 3.98 (s, 3H), 3.55 (dd, J = 10.5, 
4.0 Hz, 1H), 2.58 (d, J = 4.9 Hz, 1H), 2.27 (d, J = 6.8 Hz, 1H), 2.24 (s, 6H), 1.29 – 1.23 (m, 3H). 
13
C-NMR (75 MHz, CDCl3, cis isomer): δ 172.35, 153.58, 142.44, 138.10, 137.76, 129.63, 
129.20, 128.55, 128.27, 124.55, 123.45, 123.26, 123.03, 114.56, 66.32, 60.63, 52.63, 41.26, 
34.25, 21.35, 14.23.  
13
C-NMR (75 MHz, CDCl3, trans isomer): δ 171.42, 153.84, 143.04, 138.44, 138.20, 132.13, 
131.23, 130.90, 128.16, 124.81, 124.43, 122.93, 122.74, 115.03, 68.07, 61.21, 60.38, 40.99, 
29.74, 21.39, 18.90.  
IR (neat, cm
-1
): 2956, 2920, 1709, 1601, 1484, 1461, 1384, 1338, 1308, 1264, 1248, 1174, 
1138, 1057, 1022, 850, 766, 750, 718, 679.  
HRMS (ESI): exact m/z calculated for C22H26NO4 (M+H)
+
: 368.1856; Found: 368.1864 
(M+H)
+
. 
Mp: 69-71 
o
C (decomposed). 
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Methyl 3-(2-ethoxy-2-oxoethyl)-2-(p-tolyl)indoline-1-carboxylate (8d): 
Following GP-2, 8d was prepared from 7d (0.216 g, 0.5 mmol, 1.00 
equiv), [Ir(ppy)2(dtb-bpy)]PF6 (1.37 mg, 0.003 equiv, 0.3 mol %) and 
DIPEA (0.191 mL, 1.1 mmol, 2.2 equiv) in MeCN (1.5 mL). 
Purification of the crude product by column chromatography (silica gel, 
hexanes–EtOAc, 9:1, Rf = 0.33) afforded 8d as a white solid (0.141 g, 
cis / trans = 92:08, 80% yield). 
1
H-NMR (300 MHz, CDCl3, cis isomer, major): δ 7.82 (bs, 1H), 7.30 – 7.19 (m, 1H), 7.01 – 
6.91 (m, 4H), 6.83 (d, J = 8.0 Hz, 2H), 5.55 (d, J = 9.6 Hz, 1H), 4.19 (ddd, J = 14.3, 9.5, 6.1 Hz, 
1H), 4.06 (q, J = 7.1 Hz, 2H), 3.63 (s, 3H), 2.59 (dt, J = 17.4, 4.1 Hz, 1H), 2.24 (s, 3H), 2.00 (dd, 
J = 17.4, 10.1 Hz, 1H), 1.16 (t, J = 7.1 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3, cis isomer, major): δ 172.28, 153.54, 137.52, 135.19, 129.29, 
129.07, 128.28, 126.82, 123.40, 123.04, 114.56, 66.23, 60.66, 52.65, 41.01, 34.19, 21.17, 14.17. 
IR (neat, cm
-1
): 2955, 2929, 1706, 1598, 1513, 1482, 1460, 1377, 1339, 1304, 1269, 1250, 
1167, 1155, 1136, 1111, 1053, 1021, 999, 809, 766, 743. 
HRMS (ESI): exact m/z calculated for C21H24NO4 (M+H)
+
: 354.17; Found: 354.1709 (M+H)
+
. 
Mp: 93-95 
o
C (decomposed). 
Methyl 2-(4-(tert-butyl)phenyl)-3-(2-ethoxy-2-oxoethyl)indoline-1-carboxylate (8e): 
Following GP-2, 8e was prepared from 7e (0.236 g, 0.5 mmol, 1.00 
equiv), [Ir(ppy)2(dtb-bpy)]PF6 (1.37 mg, 0.003 equiv, 0.3 mol %) and 
DIPEA (0.191 mL, 1.1 mmol, 2.2 equiv) in MeCN (1.5 mL). 
Purification of the crude product by column chromatography (silica gel, 
hexanes–EtOAc, 9:1, Rf = 0.84) afforded 8e as a pale yellow solid 
(0.166 g, cis / trans = 73:27, 84% yield). 
1
H-NMR (300 MHz, CDCl3, cis isomer): δ 7.78 (bs, 1H), 7.30 – 7.12 (m, 3H), 7.03 – 6.91 (m, 
2H), 6.86 (d, J = 8.3 Hz, 2H), 5.56 (d, J = 9.5 Hz, 1H), 4.27 – 4.12 (m, 1H), 4.12 – 3.98 (m, 2H), 
3.64 (s, 3H), 2.74 – 2.48 (m, 1H), 2.01 (dd, J = 17.4, 10.0 Hz, 1H), 1.21 (s, 9H), 1.15 (t, J = 7.1 
Hz, 3H). 
1
H-NMR (300 MHz, CDCl3, trans isomer): δ 7.16 (d, J = 8.4 Hz, 3H), 7.08 (dd, J = 7.4, 5.1 
Hz, 3H), 6.98 – 6.92 (m, 2H), 5.16 (s, 1H), 4.27 – 4.12 (m, 1H), 4.12 – 3.98 (m, 2H), 3.64 (s, 
3H), 3.54 – 3.44 (m, 1H), 2.74 – 2.48 (m, 1H), 1.25 (t, J = 7.1 Hz, 3H), 1.22 (s, J = 1.1 Hz, 9H). 
13
C-NMR (75 MHz, CDCl3, cis isomer): δ 172.33, 153.56, 150.63, 135.01, 128.25, 126.60, 
Chapter 5: Experimental section 
291 
 
125.49, 125.19, 123.37, 123.27, 123.03, 114.60, 66.19, 60.58, 52.64, 41.16, 34.47, 31.30, 29.73, 
14.17. 
13
C-NMR (75 MHz, CDCl3, trans isomer): δ 171.56, 153.87, 150.17, 139.12, 132.19, 128.55, 
126.25, 125.31, 125.27, 124.94, 123.27, 115.09, 67.92, 60.81, 52.73, 41.93, 34.15, 31.37, 29.73, 
14.25. 
IR (neat, cm
-1
): 2958, 2868, 1708, 1600, 1512, 1483, 1440, 1380, 1267, 1159, 1138, 1055, 
1019, 927, 832, 812, 764, 747. 
HRMS (ESI): exact m/z calculated for C24H30NO4 (M+H)
+
: 396.2169; Found: 396.2179 
(M+H)
+
.  
Mp: 43-45 oC (decomposed). 
 
Methyl 3-(2-ethoxy-2-oxoethyl)-2-(4-fluorophenyl)indoline-1-carboxylate (8f): 
Following GP-2, 8f was prepared from 7f (0.218 g, 0.5 mmol, 1.00 
equiv), [Ir(ppy)2(dtb-bpy)]PF6 (1.37 mg, 0.003 equiv, 0.3 mol %) and 
DIPEA (0.191 mL, 1.1 mmol, 2.2 equiv) in MeCN (1.5 mL). 
Purification of the crude product by column chromatography (silica gel, 
hexanes–EtOAc, 9:1, Rf = 0.49) afforded 8f as a white solid (0.128 g, 
cis / trans = 73:27, 72% yield).  
1
H-NMR (300 MHz, CDCl3, cis isomer): δ 7.82 (bs, 1H), 7.25 (ddd, J = 6.2, 3.3, 1.2 Hz, 1H), 
7.05 – 6.81 (m, 5H), 5.59 (d, J = 9.6 Hz, 1H), 4.26 – 4.19 (m, 1H), 4.04 (q, J = 7.1 Hz, 2H), 3.64 
(s, 3H), 2.69 – 2.62 (m, 1H), 1.96 (dd, J = 17.5, 10.5 Hz, 1H), 1.16 (t, J = 7.1 Hz, 3H). 
1
H-NMR (300 MHz, CDCl3, trans isomer): δ 7.56 (s, 1H), 7.28 – 7.23 (m, 1H), 7.13 (dd, J = 
13.6, 6.6 Hz, 1H), 7.05 – 6.81 (m, 5H), 5.15 (s, 1H), 4.15 (q, J = 7.1 Hz, 1H), 3.64 (s, 3H), 3.46 
(t, J = 7.3 Hz, 1H), 2.61 (d, J = 4.7 Hz, 1H), 1.24 (m, 1H), 1.22 (t, J = 7.1 Hz, 3H). 
19
F-NMR (282 MHz, CDCl3): δ -114.71 (cis), -115.70 (trans). 
13
C-NMR (75 MHz, CDCl3, cis isomer): δ 172.11, 163.97, 160.71, 153.42, 134.15 (d, J = 3.63 
Hz), 128.66 (d, J = 8.4 Hz), 128.45, 123.47, 123.23, 115.44, 115.16, 114.63, 65.73, 60.75, 52.70, 
41.04, 34.11, 29.71, 14.16. 
13
C-NMR (75 MHz, CDCl3, trans isomer): δ 171.63, 163.97, 160.71, 153.42, 134.15 (d, J = 
3.63 Hz), 131.65, 128.66 (d, J = 8.4 Hz), 127.03, 124.85, 115.60, 115.32, 115.08, 61.67, 60.88, 
50.20, 40.90, 35.71, 29.67, 14.24. 
IR (neat, cm
-1
): 2956, 2930, 2855, 1705, 1602, 1509, 1483, 1441, 1378, 1309, 1269, 1220, 
1176, 1158, 1096, 1054, 1019, 824, 748. 
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HRMS (ESI): exact m/z calculated for C20H21FNO4 (M+H)
+
: 358.1449; Found: 358.1458 
(M+H)
+
.  
Mp: 46-48 
o
C (decomposed). 
Methyl 3-(2-ethoxy-2-oxoethyl)-2-(4-(trifluoromethyl)phenyl)indoline-1-carboxylate (8g): 
Following GP-2, 8g was prepared from 7g (0.243 g, 0.5 mmol, 1.00 
equiv), [Ir(ppy)2(dtb-bpy)]PF6 (1.37 mg, 0.003 equiv, 0.3 mol %) and 
DIPEA (0.191 mL, 1.1 mmol, 2.2 equiv) in MeCN (1.5 mL). 
Purification of the crude product by column chromatography (silica gel, 
hexanes–EtOAc, 9:1, Rf = 0.37) afforded 8g as a white solid (0.142 g, 
cis / trans = 77:23, 70% yield);  
1
H-NMR (300 MHz, CDCl3, cis isomer): δ 7.83 (bs, 1H), 7.46 (dd, J = 14.2, 8.1 Hz, 1H), 7.34 
– 7.22 (m, 2H), 7.10 (d, J = 8.0 Hz, 2H), 7.06 – 6.95 (m, 2H), 5.66 (d, J = 9.7 Hz, 1H), 4.27 (td, 
J = 10.2, 4.7 Hz, 1H), 4.03 (q, J = 7.1 Hz, 2H), 3.64 (s, 3H), 2.69 – 2.58 (m, 1H), 2.00 – 1.85 (m, 
1H), 1.15 (t, J = 7.1, Hz, 3H). 
1
H-NMR (300 MHz, CDCl3, trans isomer): δ 7.59 (s, 1H), 7.57 – 7.47 (m, 1H), 7.39 – 7.22 (m, 
2H), 7.16 (d, J = 4.7 Hz, 2H), 7.02 – 6.96 (m, 2H), 5.24 (s, 1H), 4.16 (q, J = 7.1 Hz, 2H), 3.95 (s, 
1H), 3.64 (s, 3H), 3.52 – 3.41 (m, 1H), 2.61 (d, J = 4.8 Hz, 1H), 1.23 (t, J = 7.1 Hz, 1H). 
19
F-NMR (282 MHz, CDCl3): δ -63.01 (trans), -63.09 (cis). 
13
C-NMR (75 MHz, CDCl3, cis isomer): δ 171.97, 153.33, 142.35, 130.34, 129.91, 128.61, 
127.44, 125.38 (q, J = 3.8 Hz), 123.85 (q, J = 273.42 Hz), 123.63, 123.50, 123.40, 114.67, 65.91, 
60.83, 52.81, 41.00, 34.17, 29.72, 14.07. 
IR (neat, cm
-1
): 2957, 2930, 2855, 1709, 1619, 1600, 1484, 1442, 1379, 1322, 1274, 1255, 
1163, 1110, 1064, 1017, 839, 818, 748,664. 
HRMS (ESI): exact m/z calculated for C21H21F3NO4 (M+H)
+
: 408.1417; Found: 408.1428 
(M+H)
+
. 
Mp: 49-51 oC (decomposed). 
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Methyl 3-(2-ethoxy-2-oxoethyl)-2-(4-(trifluoromethyl)phenyl)indoline-1-carboxylate (8h): 
Following GP-2, 8h was prepared from 7h (0.232 g, 0.5 mmol, 1.00 
equiv), [Ir(ppy)2(dtb-bpy)]PF6 (1.37 mg, 0.003 equiv, 0.3 mol %) and 
DIPEA (0.191 mL, 1.1 mmol, 2.2 equiv) in MeCN (1.5 mL). 
Purification of the crude product by column chromatography (silica gel, 
hexanes–EtOAc, 9:1, Rf = 0.53) afforded 8h as a white solid (0.171 g, 
cis / trans = 75:25, 89% yield). 
1
H-NMR (300 MHz, CDCl3, cis isomer): δ 7.81 (bs, 1H), 7.17 – 7.08 (m, 2H), 7.07 – 6.96 (m, 
3H), 6.87 (d, J = 8.3 Hz, 2H), 5.55 (d, J = 9.6 Hz, 1H), 4.26 – 4.17 (m, 1H), 4.05 (q, J = 7.1 Hz, 
2H), 3.64 (s, 3H), 2.67 – 2.59 (m, 1H), 2.39 (s, 3H), 2.01 (dd, J = 17.5, 10.2 Hz, 1H), 1.17 (t, J = 
7.1 Hz, 3H). 
1
H-NMR (300 MHz, CDCl3, trans isomer): δ 7.28 – 7.18 (m, 1H), 7.17 – 7.07 (m, 3H), 7.07 – 
6.92 (m, 4H), 5.13 (s, 1H), 4.15 (q, J = 7.1 Hz, 2H), 3.64 (s, 3H), 3.45 (dd, J = 16.9, 10.2 Hz, 
1H), 2.57 (d, J = 4.9 Hz, 1H), 2.42 (s, 3H), 1.26 (dd, J = 9.4, 4.9 Hz, 1H), 1.21 (t, J = 7.1 Hz, 
2H). 
13
C-NMR (75 MHz, CDCl3, cis isomer): δ 172.20, 153.46, 138.05, 135.03, 128.37, 127.46, 
126.83, 126.25, 125.88, 123.43, 123.14, 114.58, 66.05, 60.73, 52.70, 41.08, 34.13, 15.58, 14.18. 
13
C-NMR (75 MHz, CDCl3, trans isomer): δ 171.45, 150.95, 137.36, 134.35, 128.59, 127.40, 
126.77, 126.36, 126.30, 123.37, 122.73, 115.06, 66.52, 60.86, 52.77, 40.95, 29.71, 15.85, 14.25. 
IR (neat, cm
-1
): 2975, 2955, 2922, 1707, 1599, 1483, 1459, 1438, 1378, 1349, 1309, 1270, 
1246, 1181, 1157, 1136, 1090, 1053, 1018, 968, 928, 839, 806, 745, 680. 
HRMS (ESI): exact m/z calculated for C21H24NO4S (M+H)
+
: 386.1421; Found: 386.1424 
(M+H)
+
.  
Mp: 65-67 
o
C (decomposed). 
 
Methyl 2-(2-bromophenyl)-3-(2-ethoxy-2-oxoethyl)indoline-1-carboxylate (8i): 
Following GP-2, 8i was prepared from 7i (0.249 g, 0.5 mmol, 1.00 equiv), 
[Ir(ppy)2(dtb-bpy)]PF6 (1.37 mg, 0.003 equiv, 0.3 mol %) and DIPEA (0.191 
mL, 1.1 mmol, 2.2 equiv) in MeCN (1.5 mL). Purification of the crude product 
by column chromatography (silica gel, hexanes–EtOAc, 9:1, Rf = 0.30) 
afforded 8i as a pale yellow syrup (0.167 g, cis / trans = 79:21, 80% yield). 
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1
H-NMR (300 MHz, CDCl3, cis isomer): δ 7.83 (bs, 1H), 7.28 – 7.12 (m, 4H), 7.03 – 6.91 (m, 
3H), 5.59 (d, J = 9.7 Hz, 1H), 4.33 – 4.19 (m, 1H), 4.04 (q, J = 7.1 Hz, 2H), 3.63 (s, 3H), 2.63 – 
2.53 (m, 1H), 1.97 (dd, J = 17.5, 10.2 Hz, 1H), 1.15 (t, J = 7.1 Hz, 3H). 
1
H-NMR (300 MHz, CDCl3, trans isomer): δ 7.47 (m, 1H), 7.28 – 7.12 (m, 4H), 7.03 – 6.91 
(m, 3H), 4.70 (s, 1H), 4.15 (q, J = 7.1 Hz, 1H), 3.63 (s, 3H), 3.54 – 3.45 (m, 1H), 2.66 – 2.61 (m, 
1H), 1.27 – 1.22 (m, 1H), 1.21 (t, J = 7.1 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3, cis isomer): δ 172.23, 153.51, 138.25, 128.63, 128.38, 127.92, 
127.45, 126.93, 125.29, 123.98, 123.42, 123.11, 114.56, 66.40, 60.67, 52.65, 41.00, 34.20, 
14.16. 
13
C-NMR (75 MHz, CDCl3, trans isomer): δ 171.58, 152.96, 138.14, 131.98, 130.39, 128.87, 
128.08, 128.04, 127.33, 124.53, 123.97, 123.34, 115.05, 66.44, 60.83, 52.77, 41.00, 29.70, 
14.24. 
IR (neat, cm
-1
): 2958, 2922, 2851, 1708, 1596, 1575, 1482, 1439, 1378, 1334, 1307, 1269, 
1252, 1176, 1136, 1080, 1053, 1021, 933, 793, 766, 749, 757. 
HRMS (ESI): exact m/z calculated for C20H21BrNO4 (M+H)
+
: 418.0621; Found: 418.0624 
(M+H)
+
. 
Methyl 2-(3-chlorophenyl)-3-(2-ethoxy-2-oxoethyl)indoline-1-carboxylate (8j):
[11]
 
Following GP-2, 8j was prepared from 7j (0.226 g, 0.5 mmol, 1.00 equiv), 
[Ir(ppy)2(dtb-bpy)]PF6 (1.37 mg, 0.003 equiv, 0.3 mol %) and DIPEA (0.191 
mL, 1.1 mmol, 2.2 equiv) in MeCN (1.5 mL). Purification of the crude product 
by column chromatography (silica gel, hexanes–EtOAc, 9:1, Rf = 0.33) 
afforded 8j as a white solid (0.147 g, cis / trans = 75:25, 79% yield). 
1
H-NMR (300 MHz, CDCl3, cis isomer): δ 7.83 (s, 1H), 7.29 – 7.18 (m, 2H), 7.20 – 7.14 (m, 
1H), 7.10 (dd, J = 10.1, 5.4 Hz, 1H), 7.02 – 6.95 (m, 2H), 6.83 (d, J = 7.4 Hz, 1H), 5.56 (d, J = 
9.6 Hz, 1H), 4.30 – 4.21 (m, 1H), 4.11 – 4.03 (q, J = 7.1 Hz, 2H), 3.65 (s, 3H), 2.66 (dd, J = 9.1, 
3.3 Hz, 1H), 1.94 (dd, J = 17.5, 10.6 Hz, 1H), 1.18 (t, J = 7.1 Hz, 3H). 
1
H-NMR (300 MHz, CDCl3, trans isomer): δ 7.75 (s, 1H), 7.30 – 7.17 (m, 3H), 7.14 – 7.04 (m, 
2H), 7.04 – 6.92 (m, 2H), 5.15 (s, 1H), 4.21 – 4.12 (q, J = 7.1 Hz, 2H), 3.65 (s, 3H), 3.48 (t, J = 
7.3 Hz, 1H), 2.63 (dd, J = 9.0, 2.7 Hz, 1H), 1.25 (dd, J = 7.1, 5.4 Hz, 1H), 1.25 – 1.21 (t, J = 7.1 
Hz, 3H). 
13
C-NMR (75 MHz, CDCl3, cis isomer): δ 172.13, 153.36, 140.43, 134.25, 129.99, 129.79, 
128.54, 128.16, 127.68, 127.26, 125.56, 124.94, 123.32, 114.65, 65.92, 60.91, 52.80, 41.08, 
34.16, 14.17.
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5.9.5 General procedure (GP-3) for aromatization and deprotection of indolines: 
 
A solution of indoline 8 (2 mmol, 1.0 equiv) and DDQ (4 mmol, 2.0 equiv) in toluene (15 mL) 
was placed in a sealed vessel in a microwave and irradiated at 120 °C for 10 h. After completion 
of the reaction, the solvent was removed and the residue was washed with saturated NaHCO3 (15 
mL) solution, and extracted with CH2Cl2 (3 × 20 mL). The combined organic phases were dried 
over Na2SO4, filtered, and concentrated in vacuo. The crude product was dissolved in THF (20 
mL) and treated with Bu4NF (10 mmol, 5 equiv) for 24 h at room temperature. After complete 
conversion of the starting material, the reaction mixture was concentrated in vacuo. Purification 
of the crude product by column chromatography (silica gel, hexanes–EtOAc) afforded 9 as a 
pure compound.  
 
Ethyl 2-(2-phenyl-1H-indol-3-yl)acetate (9a): 
Following GP-3, 9a was prepared from 8a (0.678 g, 2.0 mmol, 1.00 equiv). 
Purification of the crude product by column chromatography (silica gel, 
hexanes–EtOAc, 9:1, Rf = 0.35) afforded 8a as a pale yellow oil (0.335 g, 60% 
   yield). 
1
H-NMR (300 MHz, CDCl3): δ 8.18 (bs, 1H), 7.72 – 7.64 (m, 3H), 7.53 – 7.44 (m, 2H), 7.44 – 
7.34 (m, 2H), 7.27 – 7.12 (m, 2H), 4.19 (q, J = 7.1 Hz, 2H), 3.85 (s, 2H), 1.27 (t, J = 7.1 Hz, 
3H). 
13
C-NMR (75 MHz, CDCl3): δ 172.29, 136.19, 135.75, 132.43, 129.07, 128.97, 128.28, 128.08, 
122.57, 120.05, 119.38, 110.88, 105.76, 60.91, 31.21, 14.26. 
The obtained data is in accordance with the literature data.
[27] 
 
Ethyl 2-(2-(o-tolyl)-1H-indol-3-yl)acetate (9b): 
Following GP-3, 9b was prepared from 8b (0.706 g, 2.0 mmol, 1.00 equiv). 
Purification of the crude product by column chromatography (silica gel, 
hexanes–EtOAc, 9:1, Rf = 0.36) afforded 9b as a pale yellow oil (0.369 g, 63%  
yield). 
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1
H-NMR (300 MHz, CDCl3): δ 8.10 (bs, 1H), 7.69 (dd, J = 11.5, 4.3 Hz, 1H), 7.46 – 7.15 (m, 
7H), 4.10 (q, J = 7.1 Hz, 2H), 3.64 (s, 2H), 2.27 (s, 3H), 1.25 – 1.18 (t, J = 7.1 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 172.12, 137.91, 136.04, 135.61, 131.81, 131.22, 130.36, 128.88, 
128.17, 125.72, 122.14, 119.82, 119.20, 110.87, 106.53, 60.71, 31.01, 20.07, 14.23. 
IR (neat, cm
-1
): 3355; 2978, 2925, 1717, 1486, 1456, 1367, 1306, 1265, 1238, 1175, 1155, 
1110, 1026, 943, 740, 693. 
HRMS (ESI): exact m/z calculated for C19H20NO4 (M+H)
+
: 293.1410 Found: 293.1417 
(M+H)
+
. 
5.9.6 Reduction of indole esters with LiAlH4: 
2-(2-phenyl-1H-indol-3-yl)ethan-1-ol (10): 
To a stirred suspension of LiAlH4 (0.040 g, 1.04 mmol) in dry THF (4 mL) was 
added 9a (0.200 g, 0.716 mmol) slowly at 0 

C. The resulting solution was 
stirred at room temperature for 10 h. The reaction mixture was quenched by 
using wet Na2SO4 and diluted with EtOAc (20 mL), filtered through pad of celite 
and concentrated under reduced pressure to give crude alcohol 10. Purification of the crude 
product by column chromatography (silica gel, hexanes–EtOAc, 9:1, Rf = 0.13) afforded 10 as a 
pale yellow solid (0.206 g, 84% yield).  
1
H-NMR (300 MHz, CDCl3): δ 8.20 (bs, 1H), 7.68 – 7.56 (m, 3H), 7.51 – 7.41 (m, 2H), 7.41 – 
7.32 (m, 2H), 7.17 (m, 2H), 3.95 (t, J = 6.7 Hz, 2H), 3.16 (t, J = 6.7 Hz, 2H). 
13
C-NMR (75 MHz, CDCl3): δ 135.92, 132.87, 129.18, 128.95, 128.18, 127.90, 122.49, 119.84, 
119.16, 110.96, 108.86, 63.01, 28.06. 
The obtained data is in accordance with the literature data.
[28] 
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5.10 NMR spectra: 
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5.11 Crystal data: 8b 
 
 
Figure 5.4: Single-crystal X-ray crystallographic analysis 
of 8b. 
Crystal data. C21H23NO4, Mr = 353.40, monoclinic, P21/c 
(No. 14), a = 10.2857(2) Å, b = 22.5658(4) Å, c = 
7.71479(14) Å,  = 97.8249(18)°,  =  = 90°, V = 
1773.97(6) Å3, T = 123.01(10) K, Z = 4, Z' = 1, (CuK) = 
0.742, 15306 reflections measured, 3706 unique (Rint = 
0.0331) which were used in all calculations. The final wR2 
was 0.1167 (all data) and R1 was 0.0422 (I > 2(I)). 
Compound  8b  
Formula  C21H23NO4  
Dcalc./ g cm-3  1.323  
/mm-1  0.742  
Formula weight  353.40  
Colour  clear colourless  
Shape  irregular  
Size/mm3  0.30×0.14×0.10  
T/K  123.01(10)  
Crystal system  monoclinic  
Space group  P21/c  
a/Å  10.2857(2)  
b/Å  22.5658(4)  
c/Å  7.71479(14)  
/°  90  
/°  97.8249(18)  
/°  90  
V/Å3  1773.97(6)  
Z  4  
Z'  1  
Wavelength/Å  1.54184  
Radiation type  CuK  
min/°  3.918  
max/°  76.327  
Measured refl.  15306  
Independent refl.  3706  
Reflections used  3222  
Rint  0.0331  
Parameters  248  
Restraints  0  
Largest peak  0.602  
Deepest hole  -0.278  
GooF  1.034  
wR2 (all data)  0.1167  
wR2  0.1101  
R1 (all data)  0.0487  
R1  0.0422  
 
Table 5.4: Fractional atomic coordinates (×104) and equivalent isotropic displacement parameters (Å2×103) 
for 8b. Ueq is defined as 1/3 of the trace of the orthogonalised Uij. 
 
Atom x y z Ueq 
O(4) 2038.1(10) 7329.3(4) 2472.2(14) 28.1(2) 
O(2) 3276.6(11) 5048.7(5) 408.5(13) 30.5(2) 
O(3) 3679.0(11) 7940.0(5) 3639.7(15) 31.4(3) 
O(1) 3913.0(19) 4509.9(10) 2840.1(19) 26.5(6) 
N(1) 4081.2(11) 6984.5(5) 2883.9(15) 23.0(2) 
C(7) 2808.4(13) 6117.5(6) 3630.0(18) 21.6(3) 
C(15) 5459.3(14) 6982.9(6) 3221.3(17) 22.6(3) 
C(8) 3399.3(14) 6099.6(6) 5368.2(18) 24.2(3) 
C(20) 3306.9(14) 7462.3(6) 3057.8(18) 23.6(3) 
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Atom x y z Ueq 
C(12) 1541.8(14) 5884.5(6) 3188.7(18) 23.8(3) 
C(6) 3556.6(13) 6395.2(6) 2268.5(17) 21.6(3) 
C(3) 3937.9(14) 4993.7(6) 1817.9(19) 25.5(3) 
C(14) 5935.6(14) 6445.4(6) 2675.8(17) 23.0(3) 
C(4) 4973.4(14) 5419.5(6) 2623.4(18) 23.7(3) 
C(9) 2782.3(15) 5836.9(6) 6660.8(18) 26.0(3) 
C(5) 4817.7(13) 6048.8(6) 1898.4(17) 22.1(3) 
C(16) 6301.2(15) 7422.4(7) 3978.6(19) 27.0(3) 
C(11) 927.3(15) 5629.4(6) 4515(2) 27.7(3) 
C(19) 7273.3(14) 6339.0(7) 2864.5(19) 28.6(3) 
C(10) 1541.4(15) 5596.9(6) 6226.4(19) 28.6(3) 
C(13) 812.5(15) 5911.0(7) 1353(2) 30.6(3) 
C(17) 7646.0(15) 7308.0(7) 4152(2) 32.1(3) 
C(18) 8134.5(15) 6777.9(7) 3601(2) 33.2(3) 
C(21) 1125.6(16) 7803.7(7) 2589(3) 37.9(4) 
C(2) 3024.9(17) 4030.4(7) 2189(2) 36.3(4) 
C(1) 1657.3(18) 4166.4(8) 2492(2) 41.2(4) 
O(1A) 3390(20) 4726(7) 3131(15) 31(4) 
Table 5.5: Anisotropic displacement parameters (×104) 8b. The anisotropic displacement factor exponent 
takes the form: -22[h2a*2 × U11+ ... +2hka* × b* × U12] 
 
Atom U11 U22 U33 U23 U13 U12 
O(4) 24.6(5) 20.4(5) 38.9(6) -0.4(4) 2.8(4) 4.1(4) 
O(2) 39.4(6) 28.6(5) 23.3(5) 2.3(4) 3.7(4) -1.1(4) 
O(3) 34.0(6) 21.1(5) 38.3(6) -4.5(4) 2.0(5) 1.7(4) 
O(1) 29.6(9) 20.6(9) 28.6(6) 4.7(5) 0.9(6) -0.7(7) 
N(1) 22.9(6) 18.7(5) 27.8(6) 0.4(4) 4.3(4) -0.2(4) 
C(7) 23.7(6) 16.9(6) 24.6(6) 0.6(5) 5.1(5) 3.0(5) 
C(15) 24.3(7) 23.3(6) 20.6(6) 3.3(5) 4.5(5) -0.1(5) 
C(8) 25.6(7) 21.5(6) 25.4(7) -0.6(5) 3.3(5) 1.6(5) 
C(20) 27.0(7) 20.8(6) 23.3(6) 1.9(5) 4.4(5) 1.9(5) 
C(12) 24.5(7) 20.7(6) 25.9(7) 0.0(5) 2.7(5) 0.9(5) 
C(6) 23.4(6) 18.2(6) 23.0(6) 0.5(5) 2.6(5) 0.8(5) 
C(3) 31.2(7) 22.4(7) 23.7(6) 0.3(5) 7.0(5) 1.5(5) 
C(14) 24.6(7) 23.3(6) 21.6(6) 2.3(5) 4.7(5) -0.6(5) 
C(4) 26.7(7) 21.3(6) 23.6(6) 0.6(5) 5.1(5) 2.5(5) 
C(9) 33.9(8) 22.4(6) 21.7(6) 0.5(5) 3.7(5) 4.1(5) 
C(5) 24.1(7) 21.5(6) 21.3(6) 1.3(5) 5.1(5) 1.1(5) 
C(16) 30.3(7) 24.5(7) 26.4(7) -0.5(5) 4.2(6) -2.9(5) 
C(11) 27.3(7) 24.5(7) 32.2(7) 0.0(5) 7.2(6) -2.6(5) 
C(19) 26.4(7) 29.1(7) 31.0(7) 2.4(6) 6.6(6) 2.3(6) 
C(10) 36.6(8) 23.5(7) 27.9(7) 2.7(5) 12.4(6) -1.0(6) 
C(13) 26.0(7) 35.5(8) 29.0(7) 2.3(6) -0.4(6) -3.0(6) 
C(17) 28.1(8) 33.6(8) 33.6(8) 0.3(6) 0.5(6) -7.9(6) 
C(18) 22.7(7) 39.2(8) 37.2(8) 4.7(7) 3.0(6) -1.0(6) 
C(21) 27.4(8) 26.7(7) 58.9(10) -3.8(7) 3.3(7) 7.4(6) 
C(2) 41.1(9) 29.7(8) 37.8(8) 1.0(6) 4.1(7) 0.1(7) 
C(1) 40.9(9) 43.3(10) 39.4(9) 6.2(7) 4.9(7) -0.9(7) 
O(1A) 41(9) 17(6) 34(6) -11(4) 5(5) 10(6) 
Table 5.6: Bond lengths in Å for 8b. 
 
Atom Atom Length/Å 
O(4) C(20) 1.3554(18) 
O(4) C(21) 1.4346(17) 
O(2) C(3) 1.2080(18) 
Atom Atom Length/Å 
O(3) C(20) 1.2096(18) 
O(1) C(3) 1.349(2) 
O(1) C(2) 1.460(2) 
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Atom Atom Length/Å 
N(1) C(15) 1.4059(18) 
N(1) C(20) 1.3579(18) 
N(1) C(6) 1.4883(16) 
C(7) C(8) 1.3954(19) 
C(7) C(12) 1.4032(19) 
C(7) C(6) 1.5194(18) 
C(15) C(14) 1.394(2) 
C(15) C(16) 1.392(2) 
C(8) C(9) 1.386(2) 
C(12) C(11) 1.398(2) 
C(12) C(13) 1.5106(19) 
C(6) C(5) 1.5735(18) 
Atom Atom Length/Å 
C(3) C(4) 1.5045(19) 
C(3) O(1A) 1.368(14) 
C(14) C(5) 1.5150(19) 
C(14) C(19) 1.385(2) 
C(4) C(5) 1.5267(18) 
C(9) C(10) 1.385(2) 
C(16) C(17) 1.395(2) 
C(11) C(10) 1.386(2) 
C(19) C(18) 1.397(2) 
C(17) C(18) 1.386(2) 
C(2) C(1) 1.489(2) 
C(2) O(1A) 1.748(14) 
Table 5.7: Bond angles in ° for 8b. 
 
Atom Atom Atom Angle/° 
C(20) O(4) C(21) 114.98(12) 
C(3) O(1) C(2) 117.35(12) 
C(15) N(1) C(6) 111.68(11) 
C(20) N(1) C(15) 125.02(12) 
C(20) N(1) C(6) 123.29(12) 
C(8) C(7) C(12) 119.39(13) 
C(8) C(7) C(6) 118.75(12) 
C(12) C(7) C(6) 121.86(12) 
C(14) C(15) N(1) 109.46(12) 
C(16) C(15) N(1) 129.04(13) 
C(16) C(15) C(14) 121.49(13) 
C(9) C(8) C(7) 121.44(13) 
O(4) C(20) N(1) 110.02(12) 
O(3) C(20) O(4) 124.24(13) 
O(3) C(20) N(1) 125.74(14) 
C(7) C(12) C(13) 122.60(13) 
C(11) C(12) C(7) 118.31(13) 
C(11) C(12) C(13) 119.08(13) 
N(1) C(6) C(7) 110.11(11) 
N(1) C(6) C(5) 103.28(10) 
C(7) C(6) C(5) 115.35(11) 
O(2) C(3) O(1) 123.80(14) 
Atom Atom Atom Angle/° 
O(2) C(3) C(4) 125.90(13) 
O(2) C(3) O(1A) 118.2(6) 
O(1) C(3) C(4) 110.13(12) 
O(1A) C(3) C(4) 108.6(5) 
C(15) C(14) C(5) 110.75(12) 
C(19) C(14) C(15) 120.27(13) 
C(19) C(14) C(5) 128.98(13) 
C(3) C(4) C(5) 114.19(11) 
C(10) C(9) C(8) 119.36(13) 
C(14) C(5) C(6) 103.57(10) 
C(14) C(5) C(4) 111.62(11) 
C(4) C(5) C(6) 116.33(11) 
C(15) C(16) C(17) 117.41(14) 
C(10) C(11) C(12) 121.76(14) 
C(14) C(19) C(18) 119.07(14) 
C(9) C(10) C(11) 119.68(13) 
C(18) C(17) C(16) 121.74(14) 
C(17) C(18) C(19) 120.01(14) 
O(1) C(2) C(1) 110.70(17) 
C(1) C(2) O(1A) 84.3(8) 
C(3) O(1A) C(2) 100.1(10) 
 
Table 5.8: Torsion angles in ° for 8b. 
 
Atom Atom Atom Atom Angle/° 
O(2) C(3) C(4) C(5) 22.3(2) 
O(2) C(3) O(1A) C(2) 60.6(13) 
O(1) C(3) C(4) C(5) -
162.43(16) 
N(1) C(15) C(14) C(5) 0.37(15) 
N(1) C(15) C(14) C(19) 179.68(12) 
N(1) C(15) C(16) C(17) -
179.52(13) 
N(1) C(6) C(5) C(14) 10.34(13) 
N(1) C(6) C(5) C(4) 133.18(12) 
C(7) C(8) C(9) C(10) -1.3(2) 
C(7) C(12) C(11) C(10) -0.7(2) 
C(7) C(6) C(5) C(14) -
109.84(12) 
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Atom Atom Atom Atom Angle/° 
C(7) C(6) C(5) C(4) 13.01(16) 
C(15) N(1) C(20) O(4) 174.21(12) 
C(15) N(1) C(20) O(3) -5.5(2) 
C(15) N(1) C(6) C(7) 112.70(12) 
C(15) N(1) C(6) C(5) -11.00(14) 
C(15) C(14) C(5) C(6) -6.97(14) 
C(15) C(14) C(5) C(4) -
132.88(12) 
C(15) C(14) C(19) C(18) -0.3(2) 
C(15) C(16) C(17) C(18) -0.2(2) 
C(8) C(7) C(12) C(11) -1.4(2) 
C(8) C(7) C(12) C(13) 177.27(13) 
C(8) C(7) C(6) N(1) -49.23(16) 
C(8) C(7) C(6) C(5) 67.14(16) 
C(8) C(9) C(10) C(11) -0.9(2) 
C(20) N(1) C(15) C(14) -
171.75(13) 
C(20) N(1) C(15) C(16) 8.5(2) 
C(20) N(1) C(6) C(7) -68.43(16) 
C(20) N(1) C(6) C(5) 167.87(12) 
C(12) C(7) C(8) C(9) 2.4(2) 
C(12) C(7) C(6) N(1) 130.23(13) 
C(12) C(7) C(6) C(5) -
113.41(14) 
C(12) C(11) C(10) C(9) 1.9(2) 
C(6) N(1) C(15) C(14) 7.09(15) 
C(6) N(1) C(15) C(16) -
172.61(13) 
C(6) N(1) C(20) O(4) -4.51(18) 
C(6) N(1) C(20) O(3) 175.78(13) 
C(6) C(7) C(8) C(9) -
178.12(12) 
C(6) C(7) C(12) C(11) 179.16(12) 
C(6) C(7) C(12) C(13) -2.2(2) 
C(3) O(1) C(2) C(1) -80.0(2) 
C(3) C(4) C(5) C(6) 65.10(15) 
C(3) C(4) C(5) C(14) -
176.36(11) 
C(14) C(15) C(16) C(17) 0.8(2) 
C(14) C(19) C(18) C(17) 0.9(2) 
C(4) C(3) O(1A) C(2) -147.6(5) 
C(5) C(14) C(19) C(18) 178.91(13) 
C(16) C(15) C(14) C(5) -
179.90(12) 
C(16) C(15) C(14) C(19) -0.6(2) 
C(16) C(17) C(18) C(19) -0.6(2) 
C(19) C(14) C(5) C(6) 173.80(14) 
C(19) C(14) C(5) C(4) 47.89(19) 
C(13) C(12) C(11) C(10) -
179.43(13) 
C(21) O(4) C(20) O(3) -0.1(2) 
C(21) O(4) C(20) N(1) -
179.86(13) 
C(2) O(1) C(3) O(2) -0.3(3) 
C(2) O(1) C(3) C(4) -
175.73(18) 
C(1) C(2) O(1A) C(3) -123.4(10) 
O(1A) C(3) C(4) C(5) -126.8(10) 
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Table 5.9: Hydrogen fractional atomic coordinates (×104) and equivalent isotropic displacement parameters 
(Å2×103) for 8b. Ueq is defined as 1/3 of the trace of the orthogonalised Uij. 
 
Atom x y z Ueq 
H(8) 4225 6268 5666 29 
H(6) 2964 6444 1171 26 
H(4A) 5827 5270 2436 28 
H(4B) 4952 5433 3876 28 
H(9) 3198 5822 7809 31 
H(5) 4819 6032 629 27 
H(16) 5980 7779 4354 32 
H(11) 84 5478 4241 33 
H(19) 7594 5980 2506 34 
H(10) 1122 5415 7079 34 
H(13A) 673 6317 1009 46 
H(13B) -19 5715 1321 46 
H(13C) 1320 5717 564 46 
H(17) 8230 7595 4651 39 
H(18) 9036 6715 3721 40 
H(21A) 1303 8119 1819 57 
H(21B) 1216 7948 3769 57 
H(21C) 248 7661 2256 57 
H(2AA) 3311 3664 2781 44 
H(2AB) 3050 3976 947 44 
H(2BC) 3147 4002 967 44 
H(2BD) 3426 3700 2866 44 
H(1A) 1647 4257 3706 62 
H(1B) 1107 3829 2174 62 
H(1C) 1336 4501 1791 62 
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6 One step synthesis of triquinacenes from vinyl-chlorides and acetylenes: A 
surprising discovery in visible-light photocatalysis 
6.1 Abstract: 
The unprecedented synthesis of Triquinacenes is demonstrated from readily available ortho-
alkynylated α-halocinnamates and acetylenes under the visible-light conditions. 
6.2 Introduction: 
The core structure (i.e. the three adjacent five membered rings) is a well-known scaffold called 
Triquinacenes,
[1]
 which was first synthesized by R. B. Woodward in 1964,
[2]
 being suspected for 
quite a long time to have “homoaromatic” properties.[3] Since then, several protocols targeting to 
construct the Triquinacene backbone and its subsequent transformations to the related molecules 
have been appeared.
[4]
 Along these lines, Meijere et al have detailed attempts to prepare the 
strained polyquinene acepentalene from triquinacenes derivatives and has successfully reported 
the preparation of dihydroacepentalenediide.
[5]
 Furthermore, he also studied their ions in gas 
phase.
[6]
  
However, the synthesis of triquinacenes and their derivatives have not been established by 
photochemical methods till date. Having inspired with our previous exciting photochemical 
reaction outcomes with ortho-alkynylated α-halocinnamates and molecular oxygen (Chapter 3), 
which led us to the unprecedented formation of indenones and taiwaniaquinoid related scaffolds 
via a highly reactive vinyl radical species.
[7]
 Herein, we aimed to engage these vinyl radicals in 
simple C-C bond forming reactions with alkynes in the absence of oxygen, which consequently 
provided incredibly complex product structures called Triquinacenes. 
This chapter is unpublished: 
S. K. Pagire, V. Adiyala, J. Yedoyan, O. Reiser, work in progress. 
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6.3 Results and discussion: 
We began our investigations by reacting 1a with 2a by using [Ir{dF(CF3)ppy}2(dtb-bpy)]PF6
[8] 
(EIr(IV)/Ir(III)* = –0.89 V vs. SCE)
[9]
 under blue light in wet DMF. 
6.4 Synthesis of 3a: Catalyst screening and reaction optimization 
 
Entry X Photocatalyst Solvent H2O (equiv) Temp (
o
C) Yield (%)
[b]
 
1 Br Ir-F wet DMF 0 rt 19 
2 Br Ir-F dry DMF 0 rt traces 
3 Br Ir-F wet DMF 2 rt 22 
4 Br Ir-F wet DMSO 2 rt 0 
5 Br Ir-F wet DCM 2 rt 0 
6 Br Ir-F wet MeCN 2 rt traces 
7 Br fac-Ir(ppy)3 wet DMF 2 rt 26 
8 Br fac-Ir(ppy)3 Phenyl acetylene 2 rt 0 
9 Cl fac-Ir(ppy)3 wet MeCN 2 rt 25 
10 Cl fac-Ir(ppy)3 wet DMF 2 rt 33 
11 Cl No catalyst wet DMF 2 rt 0 
12
[c]
 Cl fac-Ir(ppy)3 wet DMF 2 rt 0 
13 Cl fac-Ir(ppy)3 wet DMF 5 rt 17 
14 Cl fac-Ir(ppy)3 wet DMF 10 rt traces 
15
[d]
 Cl fac-Ir(ppy)3 wet DMF 2 rt 29 
16
[e]
 Cl fac-Ir(ppy)3 wet DMF 2 rt 20 
Tables 6.1: Reaction Conditions: [a] Substrate 1a/1b (0.5 mmol, 1.0 equiv), photocatalyst (1 mol %), rt-60 oC, 
solvent(s) (2 mL), H2O (0-40 equiv), 12-72 h, LED455, under N2 [b] isolated. [c] Dark reaction. [d] 1.5 mol % 
photocatalyst. [e] 2.0 mol % photocatalyst, (Note: the extra catalyst was insoluble and blocked the way in the micro-
reactor capillary during the reaction). [f] All these optimizations were done by Santosh K. Pagire and Vidyasagar 
Adiyala. [g] Isolation, crystallization, and single X-ray of 3a were done by Julietta Yedoyan. 
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This indeed gave 3a in 19% yields at room temperature conditions. We later identified the 
product structure by the single X-ray crystal analysis, and immediately realized that the water 
molecule is involved in the process, which should have stem from the wet DMF since we have 
not added any extra water for this attempt. This conclusion is further supported by the dry DMF 
experiment: In absence of water, thus dissolving 1a and 2a in anhydrous DMF solution under 
nitrogen atmosphere provides only traces of product 3a, indicating the need of water as an 
external nucleophile to introduce a hydroxyl group (Table 6.1, entry 2). In a subsequent attempt, 
2 equiv of distilled water was added, which also slightly better results (Table 6.1, entry 3). Other 
solvents, such as DMSO, DCM or MeCN do not provide any products (Table 6.1, entries 4-6). 
Switching to the strong [Ir]-photocatalyst, fac[Ir(ppy)3]
[10]
 (EIr(IV)/Ir(III)* = –1.73 V vs. SCE (Table 
6.1, entry 7) slightly improved the yields (26%). However, no product formation was occurred 
with phenyl acetylene (2 mL) as a neat solvent (Table 6.1, entry 8). 
In all cases, we noted a deep red colouring of the solution in the course of the reaction, probably 
blocking the photo-process, which could explain the incomplete conversion and long reaction 
time of the overall transformation. To our delight, a significant increase in yield was observed 
upon replacing α-bromocinnamates 1a with α-chlorocinnamates 1b, which might be due to the 
higher electronegativity and high oxidising power of chlorine compared to the bromine. Of 
course, this conclusion further needs to be analyzed and confirmed by carrying out several 
control experiments and spectroscopic investigations, such as CV-measurements etc. At the 
moment, we are beginners to utilize vinyl-chlorides as a starting material for organic synthesis, 
thus more studies are desired in this topic. This would probably shine the light into the dark 
corners which are currently invisible.  
For instance, we found (Table 6.1, entry 10) as an optimal condition for further investigations, 
though product yields are still unsatisfactory (33%). In the absence of the iridium catalyst or 
visible-light, no conversion of 1b was observed, which again indicated the process is driven by 
visible-light photocatalysis (Table 6.1, entries 11, 12). To our surprise, increasing the catalyst 
loading does not assist in increasing the yields (Table 6.1, entries 13, 14), which probably due to 
the insolubility of extra catalyst, and in turn, it was also blocking the flow of the reaction mixture 
under the light. 
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6.5 Proposed reaction mechanism: 
We again noticed the unique photochemistry associated with such ortho-alkynylated α-
halocinnamate activation under visible-light. The mechanistic picture of this transformation is 
straightforward, though the compound structure of 3a is complex (Figure 6.1). Initially, a direct 
photoelectron transfer (PET) from the excited Ir(III)*-catalyst to 1a should occur, to generate a 
first vinyl radical I by kicking out a chlorine anion with concurrent oxidation of excited *Ir(III) 
to Ir(IV). The vinyl radical I then undergoes a favorable 5-exo-dig cyclization to form second 
vinyl radical II, which adds to the first phenyl acetylene 2a molecule to form third vinyl radical 
III. This radical then undergoes 5-exo-trig ring closure to access the benzylic radical IV. The 
relatively stable benzylic radical then adds to the second phenyl acetylene molecule to provide 
fourth vinyl radical intermediate V, which ultimately undergoes 5-exo-trig ring closure to access 
another stable benzylic (as well as tertiary and allylic) radical VI. The resulting stable radical VI 
should undergo back electron transfer to Ir(IV), thus completing the catalytic cycle with the 
concurrent formation of the benzylic cation VII. Finally, this carbocation VII gets trapped by the 
nucleophilic water present in the reaction media to access the final triquinacene scaffold 3a. 
 
Figure 6.1: Proposed reaction mechanism for the synthesis of 3a. 
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6.6 Conclusion: 
In summary, we have shown for the first time, a visible-light mediated cascade of C-C bond 
formations with vinyl chlorides and phenyl acetylenes. Noteworthy, this process involves four 
highly reactive vinyl radical intermediates, which was engaged in a productive reaction cascades 
with two phenyl acetylene molecules, leading to complex molecular designs in a single 
photochemical step under the mild reaction conditions. We emphasize here, this reaction could 
also be performed in the micro-flow reactors in the short reaction time. Arguably, the single step 
synthesis of these types of complex architectures is certainly impossible to accomplish by 
employing other methods at this moment. 
Despite the spectacular structure of the obtained product, we found that this reaction is very 
tricky and unfortunately suffers with several reproducibility problems. These compounds are less 
stable on the column which explains the product formation with lower yields although the 
conversion was 100%. This unfortunately put us on the back seat at this moment. In order to 
push this project to the conclusion, further investigations needs to be done. In particular, the acid 
catalyzed ring opening experiments and physical studies might give us some insightful 
information of the overall process. 
Nevertheless, we made a range of electronically differentiated starting materials (See 
experimental section for representative examples) in order to understand the electronic influence 
on the reaction and their outcomes. Thus the broadening of substrate scope, further 
understanding the reaction mechanisms by trapping the carbocation by other nucleophiles (such 
as MeOH or labeled H2O
18
) or changing the trapping reagents is currently underway, and 
hopefully we will see these results in a reputed journal within the next few months. 
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6.7 Experimental Section: 
6.7.1 General procedure (GP-1): Sonogashira coupling 
 
[Note: see the experimental section of Chapter 3 for detailed information about these coupling 
compounds]. 
To a solution of the corresponding 2-bromobenzaldehyde derivative (2.00 mmol, 1.00 equiv), 
PdCl2 (PPh3)2 (2.00 mol %), and CuI (1.00 mol %) in degassed NEt3 (20 mL) was added the 
appropriate acetylene (60 mmol, 1.20 equiv). The resulting mixture was heated under nitrogen 
atmosphere at 60 °C for 6-24 h, gradually the reaction turned dark. The progress of the reaction 
was monitored by TLC. After complete consumption of the starting material, resulting mixture 
was diluted with 15 mL of EtOAc and filtered through the pad of celite. The filtrate was 
evaporated under reduced pressure and the pure compound was isolated through silica gel 
column chromatography using Hexanes/EtOAc as a solvent system.  
6.7.2 General procedure (GP-2) for the preparation of α-chlorocinnamate derivatives:  
This experimental procedure is known in the literature:
[11] 
To a solution of aldehydes S1 (3.0 
mmol, these compounds are directly adopted from chapter 2.1) and α-chloroacetate (3.6 mmol) 
in DCM (20 mL) under a nitrogen atmosphere was added TiCl4 (3.6 mmol, 1.0 M solution in 
DCM) in drops for 10 minutes. The mixture was then stirred at room temperature for 30-45 min. 
To this was added Et3N (6.0 mmol) in drops over a period of 10 minutes while maintaining the 
reaction temperature below 30 °C with external water bath. The resulting brown mixture was 
then stirred at room temperature for next 2–5 h (controlled by TLC). When the reaction was 
completed (Hexanes:EtOAc = 9:1), the mixture was diluted with DCM (30 mL) and washed with 
1.0 N aqueous HCl (20 mL), water, and brine. The organic phase was dried over Na2SO4. The 
solvent was removed under reduced pressure and the crude product was passed through a plug of 
silica to afford the desired (Z)-α-chlorocinnamates 1. 
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Ethyl 2-chloro-3-(2-(phenylethynyl)phenyl)acrylate (1a): 
Following GP-2, 1a was prepared from S1a (618 mg, 3.00 mmol). The 
crude product was purified by column chromatography (Hexanes: EtOAc, 
9:1, Rf = 0.6) afforded 1a as a brown solid (883 mg, 95% yield, Z:E = 
99:01). 
 
1
H-NMR (300 MHz, CDCl3, Z isomer, major):
 δ 8.56 (s, 1H), 8.29 – 8.14 (m, 1H), 7.69 – 7.52 
(m, 3H), 7.47 – 7.30 (m, 5H), 4.39 (q, J = 7.1 Hz, 2H), 1.40 (t, J = 7.1 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3, Z isomer, major): δ 163.35, 135.33, 134.65, 132.29, 131.69, 
129.76, 129.29, 128.86, 128.55, 128.23, 125.03, 123.68, 122.89, 96.28, 87.17, 62.75, 14.35. 
IR (neat, cm
-1
): 2985, 2902, 1712, 1598, 1492, 1467, 1443, 1390, 1363, 1233, 1194, 1111, 
1091, 1043, 1043, 994, 904, 861, 835, 753, 684. 
HRMS (ESI): exact m/z calculated for C19H15ClNaO2 (M+Na)
+
: 333.0653; Found: 333.0654 
(M+Na)
+
. 
Ethyl 2-chloro-3-(5-methoxy-2-(phenylethynyl)phenyl)acrylate (1b): 
Following GP-2, 1b was prepared from S1b (622 mg, 2.63 mmol). 
Purification of the crude product by column chromatography (Hexanes: 
EtOAc, 9:1, Rf = 0.50) afforded 1b as a brown solid (860 mg, 96% yield. 
Z:E = 99:01). 
1
H-NMR (300 MHz, CDCl3, Z isomer, major): δ 8.48 (s, 1H), 7.73 (d, J = 2.6 Hz, 1H), 7.61 – 
7.41 (m, 3H), 7.35 – 7.25 (m, 3H), 6.99 – 6.80 (m, 1H), 4.30 (q, J = 7.1 Hz, 2H), 3.83 (s, 3H), 
1.34 (t, J = 7.1 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3, Z isomer, major): δ 163.35, 159.32, 135.99, 135.27, 133.57, 
131.52, 128.55, 123.82, 123.29, 117.50, 116.20, 114.49, 94.85, 87.19, 62.83, 55.64, 14.39. 
IR (neat, cm
-1
): 2974, 2933, 2839, 1718, 1594, 1560, 1495, 1463, 1442, 1391, 1368, 1319, 
1293, 1276, 1222, 1165, 1097, 1030, 851, 832, 753, 689. 
HRMS (ESI): exact m/z calculated for C20H18ClO3 (M+H)
+
: 341.0939; Found: 341.0941 
(M+H)
+
. 
Ethyl 2-chloro-3-(6-(phenylethynyl)benzo[d][1,3]dioxol-5-yl)acrylate (1c): 
Following GP-2, 1c was prepared from S1c (320 mg, 1.29 mmol). 
Purification of the crude product by column chromatography (Hexanes: 
EtOAc, 9:1, Rf = 0.39) afforded 1c as a brown solid (472 mg, 92% yield, 
Z:E = 99:01). 
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1
H-NMR (300 MHz, CDCl3, Z isomer, major): δ 8.55 (s, 1H), 7.84 (s, 1H), 7.60 – 7.51 (m, 
2H), 7.39 – 7.32 (m, 3H), 7.03 (s, 1H), 6.05 (s, 2H), 4.36 (q, J = 7.1 Hz, 2H), 1.37 (t, J = 7.1 Hz, 
3H). 
13
C-NMR (75 MHz, CDCl3, Z isomer, major): δ 163.58, 148.95, 148.04, 134.89, 131.58, 
129.61, 128.77, 128.58, 122.97, 121.78, 120.45, 111.75, 109.07, 102.21, 95.50, 87.24, 62.71, 
14.41. 
IR (neat, cm
-1
): 2954, 2920, 2852, 1703, 1594, 1497, 1470, 1442, 1392, 1353, 1329, 1271, 
1239, 1221, 1139, 1032, 998, 926, 904, 860, 756, 721, 693, 671. 
HRMS (ESI): exact m/z calculated for C20H15ClNaO4 (M+Na)
+
: 377.0551; Found: 377.0553 
(M+Na)
+
. 
 
Ethyl 2-chloro-3-(5-nitro-2-(phenylethynyl)phenyl)acrylate (1d): 
Following GP-2, 1d was prepared from S1g (419 mg, 1.67 mmol). 
Purification of the crude product by column chromatography (Hexanes: 
EtOAc, 9:1, Rf = 0.49) afforded 1d as a yellow solid (533 mg, 90% yield, 
Z:E = 95:05). 
1
H-NMR (300 MHz, CDCl3, Z isomer, major): δ 9.00 (d, J = 2.3 Hz, 1H), 8.43 (s, 1H), 8.17 
(dt, J = 9.0, 4.5 Hz, 1H), 7.73 – 7.66 (m, 1H), 7.58 – 7.51 (m, 2H), 7.42 – 7.32 (m, 3H), 4.36 (q, 
J = 7.1 Hz, 2H), 1.40 – 1.33 (t, J = 7.1 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3, E isomer, major): δ 162.73, 146.88, 135.88, 133.10, 132.98, 
132.08, 131.14, 129.96, 128.82, 126.39, 124.32, 124.20, 121.85, 101.45, 85.89, 63.19, 14.37. 
IR (neat, cm
-1
): 2923, 2851, 2209, 1739, 1713, 1598, 1516, 1492, 1461, 1442, 1367, 1338, 1267, 
1229, 1072, 1035, 995, 911, 847, 827, 753, 740, 684. 
HRMS (ESI): exact m/z calculated for C19H14ClNNaO4 (M+Na)
+
: 378.0504; Found: 378.0504 
(M+Na)
+
.  
 
Ethyl 2-chloro-3-(4-methyl-2-(phenylethynyl)phenyl)acrylate (1e): 
Following GP-2, 1e was prepared from S1h (412 mg, 1.87 mmol). 
Purification of the crude product by column chromatography (Hexanes: 
EtOAc, 9:1, Rf = 0.44) afforded 1e as a yellow solid (582 mg, 96% yield, 
Z:E = 92:08). 
1
H-NMR (300 MHz, CDCl3, Z isomer, major): δ δ 8.53 (s, 1H), 8.17 – 8.10 (m, 1H), 7.59 – 
7.49 (m, 2H), 7.42 (d, J = 7.3 Hz, 1H), 7.38 – 7.30 (m, 3H), 7.26 – 7.16 (m, 1H), 4.35 (q, J = 7.1 
Hz, 2H), 2.35 (s, 3H), 1.39 – 1.33 (t, J = 7.1 Hz, 3H). 
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13
C-NMR (75 MHz, CDCl3, Z isomer, major): δ 163.53, 140.27, 135.22, 132.85, 131.87, 
131.70, 129.26, 129.23, 128.81, 128.56, 125.16, 123.00, 122.75, 95.91, 87.34, 62.68, 21.43, 
14.38. 
IR (neat, cm
-1
): 2977, 2928, 2907, 1711, 1595, 1491, 1474, 1439, 1393, 1367, 1282, 1233, 
1198, 1151, 1114, 1043, 993, 910, 867, 817, 750, 685. 
HRMS (ESI): exact m/z calculated for C20H17ClNaO2 (M+Na)
+
: 347.0809; Found: 347.0812 
(M+Na)
+
. 
6.7.3 General procedure (GP-3) for the preparation of Triquinacenes: 
To a oven dried 10 mL Schlenk flask was charged with 1 (0.50 mmol, 1.00 equiv) and fac-
[Ir(ppy)3] (3.3 mg, 0.01 equiv, 1.00 mol %) in 2 mL anhydrous DMF. The reaction mixture was 
degassed with freeze-pump thaw cycles (3x), then the phenyl acetylene (2.5 mmol, 5 equiv) was 
added under the positive nitrogen atmosphere, and the reaction mixture was vigorously stirred 
(~1000 rpm) at rt with an internal irradiation of blue light (LED 455 nm). After 72 h, distilled 
water (20 mL) was added to dilute the reaction mixture, the resulting dark red coloured mixture 
then transferred to the separatory funnel and extracted with ethyl acetate (3 x 10 mL). The 
combined organic layer was washed with brine (15 ml) and dried over Na2SO4. The residue was 
purified by flash column chromatography (SiO2) with Hexanes/EtOAc as a solvent system. 
Ethyl (2a
1
R,4aR,8bR)-8b-hydroxy-1,2a,3-triphenyl-4a,8b-dihydropentaleno[1,6-ab]indene-
2a
1
(2aH)-carboxylate (3a): 
Following GP-3, 3a was prepared from 1a (155 mg, 0.50 mmol). 
Purification of the crude product by column chromatography (Hexanes: 
EtOAc, 4:1, Rf = 0.42) afforded 3a as a yellow solid (80 mg, 29% yield). 
 
1
H-NMR (400 MHz, CDCl3): δ 7.79 – 7.74 (m, 2H), 7.33 (ddd, J = 10.1, 7.7, 2.3 Hz, 5H), 7.29 
– 7.21 (m, 6H), 7.16 (dt, J = 7.0, 3.3 Hz, 3H), 7.11 (dd, J = 6.6, 3.6 Hz, 3H), 7.05 – 6.99 (m, 
2H), 6.46 – 6.30 (m, 2H), 5.31 (d, J = 2.7 Hz, 1H), 4.90 (s, 1H), 3.60 – 3.38 (m, 2H), 1.07 – 0.90 
(t, J = 7.1 Hz, 3H). 
13
C-NMR (101 MHz, CDCl3): δ 171.28, 147.10, 142.76, 142.29, 141.16, 134.41, 133.20, 
132.25, 128.38, 128.27, 128.02, 127.29, 127.25, 126.57, 126.47, 126.39, 124.20, 123.00, 96.72, 
80.63, 73.84, 60.54, 55.79, 12.90. 
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6.8 NMR spectra:  
1
H-NMR: 1a 
 
13
C-NMR: 1a 
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1
H-NMR: 1b  
 
13
C-NMR: 1b 
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H-NMR: 1c  
 
 
13
C-NMR: 1c 
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1
H-NMR: 1d 
 
13
C-NMR: 1d 
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1
H-NMR: 1e  
 
13
C-NMR: 1e 
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H-NMR: 3a  
 
13
C-NMR: 3a 
 
 
 
Chapter 6: Crystal data 
347 
 
6.9 Crystal data of 3a: 
 
 
Figure: 6.3: Single crystal structure of 3a 
Experimental: Single clear yellow prism-shaped crystals 
of (3A) were obtained by recrystallisation from 
DCM/Pentane diffusion method. A suitable crystal 
(0.22×0.15×0.09) mm3 was selected and mounted on a 
MITIGEN holder oil on a SuperNova, Single source at 
offset, Atlas diffractometer. The crystal was kept at T = 
297.77(10) K during data collection. Using Olex2 
(Dolomanov et al., 2009), the structure was solved with 
the ShelXT (Sheldrick, 2015) structure solution program, 
using the Intrinsic Phasing solution method. The model 
was refined with version 2016/6 of ShelXL (Sheldrick, 
2015) using Least Squares minimisation. 
Crystal Data. C35H28O3, Mr = 496.57, triclinic, P-1 (No. 2), 
a = 9.2067(3) Å, b = 10.1106(4) Å, c = 15.1256(5) Å,  = 
79.025(3)°,  = 86.455(2)°,  = 65.654(3)°, V = 
1259.08(8) Å3, T = 297.77(10) K, Z = 2, Z' = 1, (CuK) = 
0.648, 33922 reflections measured, 5040 unique (Rint = 
0.0527) which were used in all calculations. The final wR2 
was 0.1051 (all data) and R1 was 0.0387 (I > 2(I)). 
Compound  3a  
    
Formula  C35H28O3  
Dcalc./ g cm-3  1.310  
/mm-1  0.648  
Formula Weight  496.57  
Colour  clear yellow  
Shape  prism  
Size/mm3  0.22×0.15×0.09  
T/K  297.77(10)  
Crystal System  triclinic  
Space Group  P-1  
a/Å  9.2067(3)  
b/Å  10.1106(4)  
c/Å  15.1256(5)  
/°  79.025(3)  
/°  86.455(2)  
/°  65.654(3)  
V/Å3  1259.08(8)  
Z  2  
Z'  1  
Wavelength/Å  1.54184  
Radiation type  CuK  
min/°  4.882  
max/°  73.705  
Measured Refl.  33922  
Independent Refl.  5040  
Reflections Used  4210  
Rint  0.0527  
Parameters  345  
Restraints  0  
Largest Peak  0.273  
Deepest Hole  -0.191  
GooF  1.030  
wR2 (all data)  0.1051  
wR2  0.0981  
R1 (all data)  0.0481  
R1  0.0387  
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Table 6.2: Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement Parameters (Å2×103) 
for 3a. Ueq is defined as 1/3 of the trace of the orthogonalised Uij. 
 
Atom x y z Ueq 
O(3) 4471.6(11) 8349.4(10) 6783.9(7) 28.2(2) 
O(1) 2641.2(10) 5712.3(10) 8144.4(6) 28.1(2) 
O(2) 2914.2(11) 6677.4(11) 6714.0(6) 30.8(2) 
C(5) 5430.2(15) 5577.8(13) 8775.2(8) 22.3(3) 
C(3) 3451.1(15) 6136.7(14) 7473.1(9) 24.2(3) 
C(6) 5937.7(14) 6778.5(14) 8889.0(9) 23.3(3) 
C(11) 6341.8(15) 4328.5(13) 7424.6(8) 26(3) 
C(4) 5136.4(14) 5808.6(13) 7747.3(8) 22.0(3) 
C(7) 6171.2(14) 7543.2(13) 8064.5(9) 23.3(3) 
C(9) 7052.3(15) 6291.6(14) 6676.9(8) 23.6(3) 
C(12) 5502.6(15) 3527.9(13) 7037.3(9) 24.5(3) 
C(19) 8769.4(15) 2033.5(14) 8276.7(9) 24.7(3) 
C(18) 7322.6(15) 3416.5(13) 8281.4(9) 23.2(3) 
C(25) 6782.1(15) 4079.7(14) 8991.8(9) 23.4(3) 
C(10) 7347.2(15) 4869.1(14) 6756.4(8) 23.4(3) 
C(26) 7944.4(16) 7039.4(15) 6088.9(9) 25.8(3) 
C(13) 4806.7(16) 2705.9(14) 7609.7(10) 28.6(3) 
C(8) 5690.7(15) 7066.6(13) 7277.0(9) 22.8(3) 
C(32) 6715.8(17) 8644.4(15) 8038.3(10) 29.9(3) 
C(17) 5347.8(17) 3658.4(15) 6112.1(10) 30.6(3) 
C(27) 7284.0(18) 8566.4(16) 5764.0(9) 30.8(3) 
C(35) 6205.9(16) 7118.2(15) 9691.9(9) 28.6(3) 
C(20) 9106.4(17) 1263.0(15) 7560.7(10) 31.5(3) 
C(24) 9871.0(16) 1470.2(15) 8992.6(10) 30.4(3) 
C(31) 9491.2(17) 6207.6(17) 5833.3(9) 30.7(3) 
C(22) 11558.4(17) -543.9(16) 8280.3(11) 35.7(3) 
C(34) 6732.0(18) 8230.4(16) 9663.3(10) 33.9(3) 
C(21) 10492.6(19) -9.0(16) 7563.3(11) 37.6(3) 
C(14) 3944.4(18) 2063.6(16) 7265.8(11) 35.2(3) 
C(33) 7006(19) 8971.9(16) 8843.7(10) 34.9(3) 
C(15) 3789.3(19) 2209.7(16) 6345.0(11) 37.6(3) 
C(28) 8156(2) 9216.8(18) 5200.7(10) 37.5(3) 
C(23) 11241.8(17) 190.2(16) 8999.5(11) 34.9(3) 
C(16) 4501.0(19) 2997.2(17) 5767.5(10) 36.8(3) 
C(30) 10351.7(19) 6865.2(19) 5276(1) 37.5(4) 
C(29) 9682(2) 8372.7(19) 4957.7(10) 40.0(4) 
C(2) 1073.9(17) 5834.1(18) 7902.3(11) 38.5(4) 
C(1) 416(2) 5233(2) 8717.2(14) 54.5(5) 
Table 6.3: Anisotropic Displacement Parameters (×104) 3a. The anisotropic displacement factor exponent 
takes the form: -22[h2a*2 × U11+ ... +2hka* × b* × U12] 
 
Atom U11 U22 U33 U23 U13 U12 
O(3) 27.3(5) 24.7(5) 30.5(5) -0.8(4) -6(4) -10.0(4) 
O(1) 22.8(4) 33.7(5) 30.4(5) -5.0(4) 6(4) -14.9(4) 
O(2) 29.8(5) 35.9(5) 28.6(5) -4.6(4) -3.0(4) -15.3(4) 
C(5) 23.8(6) 24.9(6) 21.3(6) -5.5(5) 3.7(5) -12.8(5) 
C(3) 24.8(6) 22.2(6) 27.4(7) -7.2(5) 2.2(5) -10.5(5) 
C(6) 21.3(6) 23.2(6) 26.5(7) -7.1(5) 2.6(5) -9.5(5) 
C(11) 24.8(6) 22.6(6) 21.5(6) -6.0(5) 3.7(5) -10.9(5) 
C(4) 23.1(6) 22.8(6) 22.8(6) -6.0(5) 3.1(5) -11.5(5) 
C(7) 22.0(6) 21.3(6) 26.3(7) -6.1(5) 6(5) -8.1(5) 
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Atom U11 U22 U33 U23 U13 U12 
C(9) 24.6(6) 28.7(6) 20.1(6) -4.7(5) 0.4(5) -13.3(5) 
C(12) 26.5(6) 21.6(6) 26.9(7) -6.8(5) 1.8(5) -10.5(5) 
C(19) 26.2(6) 22.2(6) 27.5(7) -3.6(5) 4.6(5) -12.7(5) 
C(18) 25.7(6) 23.2(6) 24.2(6) -3.6(5) 2.9(5) -14.2(5) 
C(25) 25.9(6) 24.5(6) 22.2(6) -3.1(5) 1.6(5) -13.3(5) 
C(10) 24.6(6) 26.9(6) 20.3(6) -6.1(5) 3.4(5) -11.8(5) 
C(26) 31.6(7) 33.1(7) 19.8(6) -5.9(5) 1.5(5) -20.1(6) 
C(13) 34.5(7) 26.7(6) 27.5(7) -5.7(5) 6(5) -15.3(6) 
C(8) 23.1(6) 21.4(6) 24.1(6) -2.7(5) 1.0(5) -10.1(5) 
C(32) 36.1(7) 26.0(6) 30.5(7) -4.1(5) 2.7(6) -16.4(6) 
C(17) 38.2(7) 30.9(7) 27.2(7) -6.1(5) 0.6(6) -18.2(6) 
C(27) 36.3(7) 34.3(7) 27.8(7) -3.5(6) 0.3(6) -21.4(6) 
C(35) 33.9(7) 29.4(7) 25.8(7) -6.6(5) 2.8(5) -15.8(6) 
C(20) 34.7(7) 29.5(7) 26.7(7) -5.8(5) 2.5(6) -9.7(6) 
C(24) 31.8(7) 27.2(7) 34.4(8) -8.8(6) 0.3(6) -12.6(6) 
C(31) 34.9(7) 38.9(7) 26.8(7) -11.3(6) 5.7(6) -21.9(6) 
C(22) 30.2(7) 26.2(7) 44.9(9) -6.9(6) 4.7(6) -6.3(6) 
C(34) 45.2(8) 34.5(7) 30.3(8) -10.9(6) -0.2(6) -22.3(7) 
C(21) 41.2(8) 30.4(7) 34.5(8) -10.8(6) 7.2(6) -6.8(6) 
C(14) 40.3(8) 30.9(7) 42.1(9) -7.1(6) 2.1(6) -22.1(6) 
C(33) 47.2(8) 30.8(7) 37.0(8) -8.7(6) 1.1(7) -25.0(7) 
C(15) 42.8(8) 34.1(8) 44.2(9) -12.5(6) -5.8(7) -20.8(7) 
C(28) 52.1(9) 42.3(8) 28.9(8) 1.0(6) -3.4(7) -32.7(7) 
C(23) 31.4(7) 29.6(7) 42.7(9) -4.6(6) -5.5(6) -11.7(6) 
C(16) 47.3(9) 37.5(8) 30.0(8) -8.7(6) -5.4(6) -19.7(7) 
C(30) 39.5(8) 57.8(10) 30.5(8) -18.8(7) 11.1(6) -31.9(7) 
C(29) 53.7(9) 60.9(10) 26.0(7) -8.1(7) 8.0(7) -44.6(9) 
C(2) 24.4(7) 47.7(9) 46.1(9) -2.9(7) -3.8(6) -19.3(6) 
C(1) 29.2(8) 65.3(11) 65.6(12) 13.5(9) -3.2(8) -26.4(8) 
Table 6.4: Bond Lengths in Å for 3a. 
 
Atom Atom Length/Å 
O(3) C(8) 1.4259(15) 
O(1) C(3) 1.3325(15) 
O(1) C(2) 1.4606(16) 
O(2) C(3) 1.2124(16) 
C(5) C(6) 1.5096(17) 
C(5) C(4) 1.5512(18) 
C(5) C(25) 1.5026(17) 
C(3) C(4) 1.5141(18) 
C(6) C(7) 1.3913(18) 
C(6) C(35) 1.3855(19) 
C(11) C(4) 1.5972(16) 
C(11) C(12) 1.5322(18) 
C(11) C(18) 1.5325(18) 
C(11) C(10) 1.5060(17) 
C(4) C(8) 1.5906(16) 
C(7) C(8) 1.5186(18) 
C(7) C(32) 1.3906(18) 
C(9) C(10) 1.3315(18) 
C(9) C(26) 1.4842(17) 
C(9) C(8) 1.5263(17) 
C(12) C(13) 1.3954(18) 
C(12) C(17) 1.391(2) 
Atom Atom Length/Å 
C(19) C(18) 1.4821(17) 
C(19) C(20) 1.3987(19) 
C(19) C(24) 1.396(2) 
C(18) C(25) 1.3359(18) 
C(26) C(27) 1.4032(19) 
C(26) C(31) 1.3976(19) 
C(13) C(14) 1.388(2) 
C(32) C(33) 1.389(2) 
C(17) C(16) 1.392(2) 
C(27) C(28) 1.3929(19) 
C(35) C(34) 1.3889(19) 
C(20) C(21) 1.389(2) 
C(24) C(23) 1.385(2) 
C(31) C(30) 1.3851(19) 
C(22) C(21) 1.379(2) 
C(22) C(23) 1.382(2) 
C(34) C(33) 1.387(2) 
C(14) C(15) 1.382(2) 
C(15) C(16) 1.386(2) 
C(28) C(29) 1.380(2) 
C(30) C(29) 1.385(2) 
C(2) C(1) 1.477(2) 
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Table 6.5: Bond Angles in ° for 3a. 
 
Atom Atom Atom Angle/° 
C(3) O(1) C(2) 115.85(11) 
C(6) C(5) C(4) 104.86(10) 
C(25) C(5) C(6) 111.21(10) 
C(25) C(5) C(4) 104.23(10) 
O(1) C(3) C(4) 112.91(11) 
O(2) C(3) O(1) 123.48(12) 
O(2) C(3) C(4) 123.55(11) 
C(7) C(6) C(5) 111.92(11) 
C(35) C(6) C(5) 127.07(12) 
C(35) C(6) C(7) 120.98(12) 
C(12) C(11) C(4) 113.39(10) 
C(12) C(11) C(18) 112.79(10) 
C(18) C(11) C(4) 102.95(10) 
C(10) C(11) C(4) 102.53(9) 
C(10) C(11) C(12) 114.01(10) 
C(10) C(11) C(18) 110.19(10) 
C(5) C(4) C(11) 106.55(10) 
C(5) C(4) C(8) 107.13(10) 
C(3) C(4) C(5) 115.07(10) 
C(3) C(4) C(11) 109.35(10) 
C(3) C(4) C(8) 112.17(10) 
C(8) C(4) C(11) 106.05(9) 
C(6) C(7) C(8) 112.00(11) 
C(32) C(7) C(6) 119.99(12) 
C(32) C(7) C(8) 127.94(12) 
C(10) C(9) C(26) 124.58(12) 
C(10) C(9) C(8) 111.71(11) 
C(26) C(9) C(8) 123.70(11) 
C(13) C(12) C(11) 120.35(12) 
C(17) C(12) C(11) 121.13(11) 
C(17) C(12) C(13) 118.45(12) 
C(20) C(19) C(18) 122.17(12) 
C(24) C(19) C(18) 120.28(12) 
C(24) C(19) C(20) 117.54(12) 
C(19) C(18) C(11) 1265(11) 
C(25) C(18) C(11) 111.80(11) 
C(25) C(18) C(19) 125.56(12) 
C(18) C(25) C(5) 114.23(12) 
C(9) C(10) C(11) 115.54(11) 
C(27) C(26) C(9) 122.36(12) 
C(31) C(26) C(9) 119.63(12) 
C(31) C(26) C(27) 118.00(12) 
C(14) C(13) C(12) 120.91(13) 
O(3) C(8) C(4) 115.08(10) 
O(3) C(8) C(7) 106.74(10) 
O(3) C(8) C(9) 112.17(10) 
C(7) C(8) C(4) 103.55(10) 
C(7) C(8) C(9) 115.33(10) 
C(9) C(8) C(4) 103.91(10) 
C(33) C(32) C(7) 118.96(13) 
C(12) C(17) C(16) 120.61(13) 
C(28) C(27) C(26) 120.35(14) 
C(6) C(35) C(34) 118.88(13) 
C(21) C(20) C(19) 120.94(14) 
C(23) C(24) C(19) 121.43(13) 
C(30) C(31) C(26) 121.23(14) 
C(21) C(22) C(23) 119.74(13) 
Atom Atom Atom Angle/° 
C(33) C(34) C(35) 120.35(13) 
C(22) C(21) C(20) 120.33(14) 
C(15) C(14) C(13) 120.09(13) 
C(34) C(33) C(32) 120.81(13) 
C(14) C(15) C(16) 119.70(14) 
C(29) C(28) C(27) 120.59(15) 
C(22) C(23) C(24) 120.02(14) 
C(15) C(16) C(17) 120.22(14) 
C(29) C(30) C(31) 120.11(14) 
C(28) C(29) C(30) 119.72(13) 
O(1) C(2) C(1) 107.64(13) 
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Table 6.6: Hydrogen Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement 
Parameters (Å2×103) for 3a. Ueq is defined as 1/3 of the trace of the orthogonalised Uij. 
 
Atom x y z Ueq 
H(3) 3929.5 8101.39 6496.57 42 
H(5) 4477.29 5631.33 9120.53 27 
H(25) 7206.1 3651.12 9570.53 28 
H(10) 81262 4250.49 6421.57 28 
H(13) 4922.14 2586.78 8229.98 34 
H(32) 6885.36 9153.66 7490.06 36 
H(17) 5814.08 4192.14 5720.01 37 
H(27) 6258.63 9147.34 5925.67 37 
H(35) 6036.49 6610.12 10240.64 34 
H(20) 8391.86 1607.5 7076.1 38 
H(24) 9679.82 1965.28 9475.11 37 
H(31) 9951.3 5193.7 6041.13 37 
H(22) 12486.49 -1395.34 8279.72 43 
H(34) 6903.82 8479.11 10196.65 41 
H(21) 10703.46 -502.66 7079.11 45 
H(14) 3470.46 1534.19 7655.52 42 
H(33) 7380.39 9697.53 8833.23 42 
H(15) 3209.95 1781.52 6114.03 45 
H(28) 7705.68 10229.09 4986.49 45 
H(23) 11949.53 -175.37 9488.33 42 
H(16) 4412.75 3084.34 5147.9 44 
H(30) 11381.28 6293.42 5115.46 45 
H(29) 10257.25 8814.21 4581.66 48 
H(2A) 1169.51 5279.93 7428.03 46 
H(2B) 375.72 6858.99 7687.54 46 
H(1A) -613.69 5291.41 8576.23 82 
H(1B) 314.49 5796.87 9179.34 82 
H(1C) 1118.67 4221.43 8925.79 82 
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7 Shining visible-light on sulfonyl chlorides: Versatile applications in organic 
synthesis 
7.1 Introduction: 
Recently, sulfonyl chlorides have been recognized as cheapest, commercially available, 
biocompatible, and stable starting materials in the construction of C-C or C-S bonds.
[1]
 In 
principle, the sulfonyl chlorides known to undergo the loss of SO2 group to trigger the C-C bond 
formation in visible-light photocatalysis.
[2,3–5]
 For instance, trifluoromethyl sulfonyl chloride or 
aryl sulfonyl chloride directly forms a trifluoromethyl
[3,5]
 or aryl radicals
[4]
 upon SO2 extrusion 
under the oxidative quenching cycle providing corresponding C-CF3 or C-aryl products, 
respectively. For aryl radical generations, diazonium salts used as alternative coupling partners in 
visible-light photocatalysis.
[6]
 However, diazonium salts suffer from various disadvantages, such 
as: explosive in nature, unstable at ambient conditions, expensive, difficult to store for longer 
periods of time even at low temperatures, functionalized derivatives are not commercially 
available, and it should be freshly prepared prior to use.  
Secondly, a few examples concerning the construction of C-S bond are also known.
[7,8]
 Oxidative 
quenching is one of the principal SET processes in the activation of sulfonyl chlorides. In this 
process, the excited-state photocatalyst is quenched by the sulfonyl chloride, giving rise to 
sulfonyl radical with the extrusion of a chloride.
[7]
 Notably, other sulfonyl sources such as aryl or 
alkyl sulfinates,
[9]
 sulfonyl hydrazides
[10]
 or sulfinic acids
[11]
 are also known to provide the 
identical sulfonyl radicals; however, most of these reagents are commercially not available, thus 
it needs to synthesize in the laboratory before starting the desired reaction, which ultimately calls 
for additional synthetic/purification steps. 
All in all, having identified the advantage of using sulfonyl chlorides over aryl diazonium salts or 
other sulfonyl sources, synthetic community turned their attention towards sulfonyl chlorides, 
and indeed, a number of  synthetic methods have been established over the period of time, which 
are recently summarized by Natarajan et al in their excellent review article.
[12]
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8 Synthesis of β-hydroxysulfones from sulfonyl chlorides and alkenes utilizing 
visible-light photocatalytic sequences 
8.1 Abstract:  
The synthesis of β-hydroxysulfones from sulfonyl chlorides and styrenes has been achieved in 
high yields by a visible light mediated Atom Transfer Radical Addition (ATRA)-like process 
utilizing fac[Ir(ppy)3] as photoredox catalyst. Moreover, this process could also be combined 
with the visible light mediated synthesis of trifluoromethylated sulfonyl chlorides via an ATRA 
reaction between unactivated alkenes and CF3SO2Cl utilizing [Cu(dap)2Cl] as photoredox 
catalyst, signifying the opportunity of sequential photoredox processes. 
8.2 Introduction: 
The β-hydroxysulfone is a privileged scaffold that has been utilized for numerous pharmaceutical 
drug candidates, fine chemicals, and as a valuable precursor in the synthesis of a variety of 
biologically active molecules.
[1]
 For example, the anticancer drug bicalutamide and antifungal 
agents, for instance, Sch42427 and SSY726 attribute a β-hydroxysulfone moiety.[2] Recently, 
quite a lot of advancements for the synthesis of β-hydroxysulfones have been reported.  
 
Scheme 8.1: Sequential [Cu]- and [Ir] catalyzed method for the synthesis of β-hydroxysulfones. 
This Chapter has been published: 
S. K. Pagire, S. Paria, O. Reiser, Org. Lett. 2016, 18, 2106-2109. 
S.K.P. and O.R. wrote the manuscript. 
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For instance, the opening of epoxides with sulfinate salts,
[3]
 chemical or bio-reduction of β-
ketosulfones,
[4]
 and the addition of organometallic reagents to carbonyl compounds.
[5]
  
A range of techniques utilizing the addition of sulfonic acid derivatives to styrenes have been 
particularly developed towards the intention compounds.
[6,7]
 Given the broad accessibility of 
sulfonyl chlorides, a few of them like p-toluenesulfonyl chloride (TsCl) being industrially 
produced on ton scale, this compound set appears to be striking for the direct synthesis of β-
hydroxysulfones. However, to the best of our information, this has not been accessed yet by 
photochemical methods.
[8]
 Almost from a last decade, visible-light induced photoredox catalysis 
has been proved a fascinating field in organic synthesis, offering a non-polluting, endlessly clean 
source of energy, naturally abundant, with exceptional applications in organic synthesis.
[9,10]
  
We present here the [Ir]-catalyzed, visible-light mediated ATRA-like reaction for the synthesis 
of β-hydroxysulfone from sulfonyl chlorides and styrenes, featuring sustainable and cost-
effective reaction conditions, high yields and superb regioselectivity. Moreover, since 
trifluoromethylated sulfonyl chlorides can be achieved by a copper-catalyzed, visible light 
mediated ATRA reaction between CF3SO2Cl and alkenes (vide infra),
[11]
 we showcase the 
sequential exploitation of two photoredox processes for the synthesis of the aimed compounds, 
fetching together two diverse photo-reactions. 
As a first step, we tested the viability of developing a photochemical ATRA-like reaction 
between sulfonyl chlorides to β-hydroxysulfones. Sulfinic acid salts[12] and especially sulfonyl 
chlorides
[13]
 have been utilized previously in photoredox processes signifying that the generation 
of sulfonyl radicals by single electron transfer (SET) should be possible. 
8.3 Results and discussion: 
Consequently, using α-methyl styrene 1a and 4-nitrobenzenesulfonyl chloride 2a as model, we 
screened various photoredox catalysts under visible light irradiation in aqueous solvents, targeted 
the formation of hydroxysulfone 3a. Starting with [Ru(bpy)3Cl2] (bpy = bipyridine; E = -0.81 V 
versus SCE) as catalyst under blue light irradiation (λmax = 455 nm), we quickly realized that a 
mixture of acetonitrile and water, ensuring both, solubility of reagents and catalyst as well as 
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having a supply for introduction of the hydroxyl group is necessary (Table 8.1, entries 1-6). The 
best ratio of acetonitrile / water was found to be 5:1 (Table 8.1, entry 5) giving rise to 3a in 90% 
yield. Substituting [Ru(bpy)3Cl2] with [Cu(dap)2Cl]
[14]
 (dap = 2,9-bis(p-anisyl)-1,10-
phenanthroline; E = –1.43 V versus SCE), being an even stronger reductant in its excited state 
than [Ru(bpy)3Cl2] also gave rise to 3a, though, in lower yields (Table 1, entry 7).  
8.4 synthesis of 3a and 3b: Catalyst screening and reaction optimization 
 
Entry R
1
 in 
R
1
SO2Cl 
Photocatalyst  
(1 mol %) 
Solvent(s) Yield (%)
[b]
 
1 4-NO2Ph [Ru(bpy)3Cl2] H2O 6 
2 4-NO2Ph [Ru(bpy)3Cl2] MeCN:H2O (1:3) 40 
3 4-NO2Ph [Ru(bpy)3Cl2] MeCN:H2O (1:1) 51 
4 4-NO2Ph [Ru(bpy)3Cl2] MeCN:H2O (3:1) 63 
5 4-NO2Ph [Ru(bpy)3Cl2] MeCN:H2O (5:1) 90 
6 4-NO2Ph [Ru(bpy)3Cl2] MeCN:H2O (7:1) 69 
7 4-NO2Ph [Cu(dap)2Cl] MeCN:H2O (5:1) 61 
8 4-NO2Ph fac[Ir(ppy)3] MeCN:H2O (5:1) 95 
9 4-NO2Ph no catalyst MeCN:H2O (5:1) trace
[c]
 
10 4-NO2Ph fac[Ir(ppy)3] 
no light 
MeCN:H2O (5:1) trace
[c]
 
11
[d] 
Me [Cu(dap)2Cl] MeCN:H2O (5:1) 21 
12
[d] 
Me [Ru(bpy)3Cl2] MeCN:H2O (5:1) 7 
Table 8.1: Reaction conditions: [a] 1a (1.0 mmol, 1.0 equiv), sulfonyl chloride 2 (1.5 mmol, 1.5 equiv), 
photocatalyst (1 mol %), solvent(s) (2 mL), LED455. [b] Isolated yields. [c] Detected by TLC analysis, starting 
materials remain unchanged. [d] 24 h irradiation time. [e] 10 h irradiation time. 
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Finally, fac[Ir(ppy)3]
[15]
 (ppy = 2-phenylpyridine; E = –1.73 V versus SCE) having the strongest 
reducing power after excitation of all other catalysts tested, allowed the isolation of 3a in 95% 
yield (Table 8.1, entry 8). Control experiments further confirmed both, light and a photoredox 
catalyst is required to the reaction to proceed effectively (Table 8.1, entry 9-10). Switching from 
the aromatic 4-nitrosulfonyl chloride (E = -0.44 V versus SCE) to the aliphatic mesyl chloride 
2b, having more negative reduction potential (E = -1.39 V versus SCE, see experimental 
section), only catalyst fac[Ir(ppy)3] gave the hydroxysulfone 3b in good yields (Table 8.1, entry 
11-13). As a result, the scope and limitations for the synthesis of β-hydroxysulfones 3 was 
subsequently explored using the fac[Ir(ppy)3] photocatalyst. 
8.5 Scope for sulfonyl chlorides 
 
Table 8.2: Reaction conditions: α-methyl styrene 1a (1.0 mmol, 1.0 equiv), sulfonyl chloride 2 (1.5 mmol, 1.5 
equiv), fac[Ir(ppy)3] (1 mol %), MeCN (1.67 mL), water (0.33 mL), LED455 at room temperature. 
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Various sulfonyl chlorides could be efficiently coupled with α-methyl styrene 1a (Table 8.2), 
demonstrating the broad functional group compatibility for the photochemical process. A series 
of aryl sulfonyl chlorides bearing strong or weak electron-donating groups and electron-
withdrawing groups afforded the desired hydroxysulfones in excellent yields. 
Notably, a nitro substituent, which is typically a limitation for photochemical
[16]
 or radical 
processes,
[17]
 was fully compatible under current conditions. Moreover, sterically bulkier groups 
at the sulfonyl chloride such as 2-naphthyl, pentafluorophenyl, mesityl, or ortho-bromophenyl 
efficiently reacted with styrenes to afford the corresponding tertiary hydroxysulfones 3j-3m in 
78-92% yield. Furthermore, the identity of the β-hydroxysulfones 3 was further explained by the 
X-ray crystal structure of ortho-bromo hydroxysulfone derivative 3m (Table 8.2). 
8.6 Scope for alkenes 
 
Table 8.3: Reaction conditions: Alkene 1 (1.0 mmol, 1.0 equiv), tosyl chloride 2f (1.5 mmol, 1.5 equiv), 
fac[Ir(ppy)3] (1 mol %), MeCN (1.67 mL), distilled water (0.33 mL), LED455 at room temperature. 
Furthermore, using tosyl chloride as a common sulfonyl source (Table 8.3), a range of styrene 
type alkenes also gave the corresponding β-hydroxysulfones in good to excellent yields, 
tolerating 1,1- and 1,2-disubstitution as well as a variety of functional groups in the aromatic 
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moiety. The limitation of the reaction was found with aliphatic alkenes that did not react at all, 
which is probably due to the less efficient oxidation of the alkyl radical formed after addition of 
RSO2• to the alkene (vide infra, see mechanism). 
From the last few years, our group has engaged in the development of [Cu(dap)2Cl] catalyzed, 
visible light mediated ATRA reactions.
[18] 
Recently, we have shown unprecedented 
trifluoromethylsulfochlorination of unactivated alkenes utilizing CF3SO2Cl (E = -0.18 V versus 
SCE)
[19]
 as a sulfonyl partner.
[11]
 This surprising reaction contrasts the [Ru] or [Ir] catalyzed 
processes that resulted only in chlorinated products (Scheme 8.2).
[19]
 In this reaction, it is 
assumed that [Cu(dap)2Cl] plays a dual role, i.e. acting both as an electron transfer reagent as 
well as coordinating the reactants in the bond forming processes.
[11]
  
 
Scheme 8.2: Catalyst selective Sulfonylation vs. chlorination of unactivated alkenes 
8.7 Sequential photocatalysis (One or two flask synthesis)  
We thought this method could also be used as a starting point for further developments since 
fluorine containing compounds are valuable building blocks in pharmaceutical chemistry.
[20]
 
Therefore, along with the process towards β-hydroxysulfones developed here, we also explored 
the possibility to stitch two photocatalytic sequences together. Indeed, sulfonyl chlorides could 
be achieved by the [Cu(dap)2Cl] catalyzed ATRA process, followed by their fac[Ir(ppy)3] 
catalyzed addition to styrenes to yield 7a-7d (Table 8.4). Noteworthy, each specific 
photocatalyst is necessary for the individual steps of the sequence: When fac[Ir(ppy)3] is used in 
to synthesize the sulfonyl chlorides 6a-6d, direct addition of trifluoromethyl and chloride instead 
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of sulfonylchloride is observed, on the other hand [Cu(dap)2Cl] was not redox-efficient
[10]
 for the 
activation of 6a-6d to engage in the coupling with styrenes to provide the desired 
hydroxysulfones 7a-7d (Table 8.4). 
 
Table 8.4: Reaction conditions: (1
st
 step) Alkene 5 (1.0 mmol, 1.0 equiv), CF3SO2Cl (2.0 mmol, 2.0 equiv), 
K2HPO4 (2.0 mmol, 2.0 equiv), [Cu(dap)2Cl] (1 mol %), MeCN (2 mL), LED455 at room temperature for 24 h. (2
nd
 
step): α-methyl styrene 1a (1.0 mmol, 1.0 equiv), sulfonyl chloride 6 (1.5 mmol, 1.5 equiv), fac[Ir(ppy)3] (1 mol %), 
MeCN (1.67 mL), distilled water (0.33 mL), LED455 at room temperature for 24 h. 
 
Scheme 8.3: Reaction conditions: 1-hexene 5a (1.0 mmol, 1.0 equiv), CF3SO2Cl (2.0 mmol, 2.0 equiv), 
[Cu(dap)2Cl] (1 mol %), MeCN (1.67 mL), LED455 at room temperature for 24 h then α-methyl styrene 1a (1.0 
mmol, 1.0 equiv, fac[Ir(ppy)3] (1 mol %), distilled water (0.33 mL), LED455 at room temperature for 24 h. 
This sequence can also be carried out in a single flask without the requirement to isolate the 
intermediate sulfonyl chlorides: e.g., 7d could be directly obtained by first irradiating 5a and 
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CF3SO2Cl in the presence of [Cu(dap)2Cl] (1 mol %) photocatalyst followed by the addition of 
distilled water, α-methylstyrene (1a) and fac[Ir(ppy)3] (1 mol %) (Scheme 8.3). 
The resulting trifluoromethylated sulfones obtained from sequential photocatalysis as equimolar 
mixture of diastereomers, reflecting the nature of the two chronological radical addition 
processes. In order to arrive at diastereomerically pure compounds, the obtained hydroxysulfones 
can be further converted to vinylsulfones by a literature known procedure,
[21]
 which is 
demonstrated with the conversion of 7b to 8a (Scheme 8.4). 
8.8 Synthesis of vinyl Sulfones 
 
Scheme 8.4: Reaction conditions: 7b (0.5 mmol, 1.0 equiv), Ac2O (1.0 mmol, 2.0 equiv), DMAP (1.0 mmol, 2.0 
equiv), DCM (7 mL), at room temperature for 60 h. 
8.9 Proposed reaction mechanism 
We propose here a plausible reaction mechanism for the hydroxysulfonylation reaction. It is 
known that, the initial excitement of the Ir(III) photoredox catalyst should occur by irradiation 
with blue light to generate excited *Ir(III). Followed by single electron transfer (SET) to sulfonyl 
chloride 2 form the resultant sulfonyl radical I simultaneous with oxidation to Ir(IV). The 
regioselective sulfonyl radical I addition to styrene 1 takes place to arrive at the carbon cantered 
radical intermediate II, which subsequently undergoes oxidation to corresponding carbocation 
III by back electron transfer processes regenerating the Ir(III)-catalyst. The consequential 
carbocation III is trapped by water as a nucleophile (Figure 8.1). 
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In order to understand the reaction mechanism in more details, oxygen isotope labeling 
experiment was conducted. Indeed, it was found from the HRMS data that, the oxygen atom of 
the hydroxyl group in compound 3fa was only originated from H2O
18
 (See SI). 
 
Figure 8.1: Proposed reaction mechanism for the synthesis of 3 and 3fa. 
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8.10 Conclusion: 
To conclude, we have developed a visible light mediated, Ir(III)-catalyzed ATRA-like reaction 
for the synthesis of β-hydroxysulfone derivatives from commercially available alkenes and 
sulfonyl chlorides. Moreover, in combination with the visible light mediated Cu(I)-catalyzed 
synthesis of trifluoromethyl containing sulfonyl chlorides, two different photochemical processes 
can be connected together in a logical way to access the β-hydroxysulfones demonstrating the 
possibility of sequential photochemical reactions. 
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8.11 Experimental section: 
8.11.1 General procedure (GP-1): Scope for sulfonyl chloride 
 
To an oven-dried Schlenk tube (10 ml size) equipped with a stir bar was added aryl sulfonyl 
chloride 2 (1.5 mmol, 1.5 equiv.) and fac[Ir(ppy)3] (6.6 mg, 1.0 mol %). Then, acetonitrile (1.67 
mL) and distilled water (0.33 mL) was added; the resulting suspension was deoxygenated by 
three freeze-pump-thaw cycles followed by the addition of the prop-1-en-2-ylbenzene (or α-
methyl styrene) 1a (118 mg, 1.0 mmol, 1.0 equiv.) under positive nitrogen atmosphere. The 
reaction mixture was irradiated with blue light emitting diode (LED, λmax = 455 nm) at room 
temperature. After complete conversion of starting materials (judged by TLC analysis), the 
reaction mixture was saturated with brine solution (15 mL) and the product was extracted with 
ethyl acetate (3x15 mL), the combined organic layers were dried over Na2SO4 and concentrated, 
the residue was purified by column chromatography on silica gel by using hexanes and ethyl 
acetate as eluents to afford the desired product 3. 
 
Figure 8.2: Experimental set-up for photochemical reaction 
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1-((4-nitrophenyl)sulfonyl)-2-phenylpropan-2-ol (3a): 
Following GP-1, 3a was prepared from 4-nitrobenzenesulfonyl chloride 
2a (332 mg, 1.5 mmol). The crude product was purified by column 
chromatography (Hexanes: EtOAc, 4:1, Rf = 0.18) to afford 3a as a 
colorless solid (305 mg, 95% yield). 
1
H-NMR (300 MHz, DMSO): δ 8.29 (d, J = 8.6 Hz, 2H), 7.97 (d, J = 8.6 Hz, 2H), 7.35 (d, J = 
7.6 Hz, 2H), 7.23 – 7.07 (m, 3H), 5.45 (s, 1H), 4.00 (ABq, J = 15.1 Hz, 2H), 1.60 (s, 3H). 
3
C-NMR (75 MHz, DMSO): δ 149.70, 146.65, 146.30, 129.44, 127.52, 126.41, 124.89, 123.73, 
71.55, 65.64, 29.92. 
The obtained data is in accordance with the literature data.
[22]
 
 
1-(methylsulfonyl)-2-phenylpropan-2-ol (3b): 
Following GP-1, 3b was prepared from methanesulfonyl chloride 2b (172 mg, 
1.5 mmol). The crude product was purified by column chromatography 
(Hexanes: EtOAc, 4:1, Rf = 0.20) to afford 3b as a colorless viscous oil (174 
mg, 81% yield). 
1
H-NMR (300 MHz, CDCl3): δ 7.47 (dt, J = 3.2, 1.8 Hz, 2H), 7.43 – 7.37 (m, 2H), 7.34 – 7.27 
(m, 1H), 3.52 (ABq, J = 14.9 Hz, 2H), 2.40 (s, 3H), 1.73 (s, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 144.50, 128.81, 127.82, 124.81, 72.55, 65.58, 43.04, 30.61. 
The obtained data is in accordance with the literature data.
[23]
 
 
2-phenyl-1-(phenylsulfonyl)propan-2-ol (3c): 
Following GP-1, 3c was prepared from benzenesulfonyl chloride 2c 
(265 mg, 1.5 mmol). The crude product was purified by column 
chromatography (Hexanes : EtOAc, 9:1, Rf = 0.19) to afford 3c as a 
colorless solid (242 mg, 88% yield). 
1
H-NMR (300 MHz, CDCl3): δ 7.60 – 7.56 (m, 2H), 7.55 – 7.49 (m, 1H), 7.40 – 7.33 (m, 2H), 
7.30 – 7.25 (m, 2H), 7.20 – 7.14 (m, 3H), 4.35 (bs, 1H), 3.68 (ABq, 14.7 Hz, 2H), 1.70 (s, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 144.25, 140.20, 133.47, 129.12, 128.29, 127.51, 127.28, 124.65, 
787, 66.62, 30.85. 
The obtained data is in accordance with the literature data.
[22]
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1-(4-((2-hydroxy-2-phenylpropyl)sulfonyl)phenyl)ethan-1-one (3d): 
Following GP-1, 3d was prepared from 4-acetylbenzenesulfonyl 
chloride 2d (328 mg, 1.5 mmol). The crude product was purified by 
column chromatography (Hexanes : EtOAc, 4:1, Rf = 0.15) to afford 3d 
as a colorless solid (285 mg, 89% yield). 
1
H-NMR (300 MHz, CDCl3): δ 7.86 (d, J = 8.6 Hz, 2H), 7.61 (d, J = 8.6 Hz, 2H), 7.22 (dd, J = 
6.7, 3.0 Hz, 2H), 7.15 – 7.09 (m, 3H), 4.21 (bs, 1H), 3.72 (ABq J = 14.8 Hz, 2H), 2.61 (s, 3H), 
1.67 (s, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 196.69, 143.97, 143.66, 140.33, 128.71, 128.30, 127.95, 127.30, 
124.72, 73.08, 66.59, 31.03, 26.97. 
IR (neat, cm
-1
): 3493, 2969, 2915, 1677, 1596, 1574, 1494, 1448, 1428, 1398, 1359, 1312, 
1296, 1263, 1189, 1147, 1120, 1085, 1072, 1012, 944, 916, 863, 826, 781, 764, 749, 717, 699. 
HRMS (ESI): exact m/z calculated for C17H22F5NO4S (M+NH4)
+
: 336.1264; Found: 336.1268 
(M+ NH4)
+
. 
Mp: 137-139 
o
C (decomposed). 
 
1-((4-methoxyphenyl)sulfonyl)-2-phenylpropan-2-ol (3e): 
Following GP-1, 3e was prepared from 4-methoxybenzenesulfonyl 
chloride 2e (310 mg, 1.5 mmol). The crude product was purified by 
column chromatography (Hexanes: EtOAc, 4:1, Rf = 0.29) to afford 3e 
as a colorless crystals (284 mg, 93% yield). 
1
H-NMR (300 MHz, CDCl3): δ 7.53 – 7.44 (m, 2H), 7.27 (dt, J = 8.5, 2.3 Hz, 2H), 7.23 – 7.14 
(m, 3H), 6.84 – 6.77 (m, 2H), 4.54 (bs, 1H), 3.82 (s, 3H), 3.63 (ABq, J = 14.8 Hz, 2H), 1.68 (s, 
3H). 
13
C-NMR (75 MHz, CDCl3): δ 163.52, 144.44, 131.75, 129.75, 128.28, 127.17, 124.67, 114.29, 
784, 66.74, 55.72, 30.91. 
The obtained data is in accordance with the literature data.
[22]
 
 
2-phenyl-1-tosylpropan-2-ol (3f): 
Following GP-1, 3f was prepared from 4-methylbenzenesulfonyl 
chloride (tosyl chloride) 2f (285 mg, 1.5 mmol). The crude product was 
purified by column chromatography (Hexanes: EtOAc, 4:1, Rf = 0.28) 
to afford 3f as a colorless solid (278 mg, 96% yield). 
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1
H-NMR (300 MHz, CDCl3): δ 7.50 – 7.44 (m, 2H), 7.31 – 7.25 (m, 2H), 7.22 – 7.13 (m, 5H), 
4.32 (bs, 1H), 3.65 (ABq, 14.6 Hz, 2H), 2.38 (s, 3H), 1.70 (s, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 144.55, 144.47, 137.31, 129.72, 128.26, 127.55, 127.15, 124.65, 
787, 66.66, 30.78, 21.60. 
The obtained data is in accordance with the literature data.
[22]
 
 
1-((4-fluorophenyl)sulfonyl)-2-phenylpropan-2-ol (3g): 
Following GP-1, 3g was prepared from 4-fluorobenzenesulfonyl 
chloride 2g (292 mg, 1.5 mmol). The crude product was purified by 
column chromatography (Hexanes: EtOAc, 4:1, Rf = 0.25) to afford 3g 
as a colorless solid (236 mg, 80% yield). 
1
H-NMR (300 MHz, CDCl3): 
1
H-NMR (300 MHz, CDCl3) δ 7.57 – 7.48 (m, 2H), 7.27 – 7.20 
(m, 2H), 7.20 – 7.14 (m, 3H), 7.05 – 6.96 (m, 2H), 4.57 (bs, 1H), 3.72 (ABq, 14.7 Hz, 2H), 1.67 
(s, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 167.20, 163.80, 144.01, 136.09, 130.53, 130.40, 128.33, 127.33, 
124.70, 116.48, 116.18, 73.08, 66.75, 31.11. 
19
F-NMR (282 MHz, CDCl3): δ -103.97. 
The obtained data is in accordance with the literature data.
[7]
 
 
1-((4-chlorophenyl)sulfonyl)-2-phenylpropan-2-ol (3h): 
Following GP-1, 3h was prepared from 4-chlorobenzenesulfonyl 
chloride 2h (316 mg, 1.5 mmol). The crude product was purified by 
column chromatography (Hexanes: EtOAc, 4:1, Rf = 0.26) to afford 3h 
as a colorless solid (301 mg, 97% yield). 
1
H-NMR (300 MHz, CDCl3): δ 7.47 – 7.41 (m, 2H), 7.33 – 7.27 (m, 2H), 7.25 – 7.21 (m, 2H), 
7.20 – 7.15 (m, 3H), 4.53 (bs, 1H), 3.70 (ABq, J = 14.8 Hz, 2H), 1.67 (s, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 143.96, 140.20, 138.45, 129.32, 129.03, 128.34, 127.32, 124.70, 
73.07, 66.70, 31.11. 
The obtained data is in accordance with the literature data.
[7]
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1-((4-bromophenyl)sulfonyl)-2-phenylpropan-2-ol (3i): 
Following GP-1, 3i was prepared from 4-bromobenzenesulfonyl 
chloride 2i (383 mg, 1.5 mmol). The crude product was purified by 
column chromatography (Hexanes: EtOAc, 4:1, Rf = 0.28) to afford 3i 
as a colorless solid (300 mg, 84% yield). 
1
H-NMR (300 MHz, CDCl3): δ 7.49 – 7.44 (m, 2H), 7.39 – 7.33 (m, 2H), 7.22 (dt, J = 5.4, 2.1 
Hz, 2H), 7.20 – 7.15 (m, 3H), 4.53 (bs, 1H), 3.69 (ABq, J = 14.8 Hz, 2H), 1.67 (s, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 143.93, 138.96, 132.31, 129.07, 128.81, 128.35, 127.31, 124.70, 
73.06, 66.68, 31.12. 
The obtained data is in accordance with the literature data.
[22]
 
1-(naphthalen-2-ylsulfonyl)-2-phenylpropan-2-ol (3j): 
Following GP-1, 3j was prepared from naphthalene-2-sulfonyl chloride 
2j (340 mg, 1.5 mmol). The crude product was purified by column 
chromatography (Hexanes: EtOAc, 4:1, Rf = 0.24) to afford 3j as a 
colorless solid (290 mg, 89% yield). 
1
H-NMR (300 MHz, CDCl3): δ 8.04 (d, J = 1.6 Hz, 1H), 7.90 – 7.78 (m, 3H), 7.69 – 7.54 (m, 
3H), 7.28 – 7.21 (m, 3H), 7.08 – 6.99 (m, 2H), 6.94 (ddd, J = 7.2, 3.7, 1.3 Hz, 1H), 4.70 (bs, 1H), 
3.75 (ABq, J = 14.7 Hz, 2H), 1.70 (s, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 144.04, 136.82, 135.04, 131.91, 129.79, 129.57, 129.46, 129.37, 
128.11, 127.84, 127.56, 127.29, 124.59, 121.90, 73.20, 66.47, 30.97. 
The obtained data is in accordance with the literature data.
[7]
 
 
1-((perfluorophenyl)sulfonyl)-2-phenylpropan-2-ol (3k): 
Following GP-1, 3k was prepared from 2,3,4,5,6-
pentafluorobenzenesulfonyl chloride 2k (400 mg, 1.5 mmol). The crude 
product was purified by column chromatography (Hexanes: EtOAc, 
4:1, Rf = 0.22) to afford 3k as a colorless solid (319 mg, 87% yield).  
1
H-NMR (600 MHz, CDCl3): δ 7.31 – 7.28 (m, 2H), 7.20 (dd, J = 10.1, 4.8 Hz, 2H), 7.17 – 7.13 
(m, 1H), 4.14 (s, 1H), 3.89 (ABq, J = 15.4 Hz, 2H), 1.69 (s, 3H). 
13
C-NMR (151 MHz, CDCl3): δ 145.42 (m), 143.64 (m), 142.91, 138.42 (m), 136.68 (m), 
128.18, 127.65, 124.61, 72.60, 67.62, 31.20. 
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19
F-NMR (282 MHz, CDCl3): δ -135.52 – -135.78 (m, 2F), -144.00 (tt, J = 21.1, 7.9 Hz, 1F), -
158.73 – -159.11 (m, 2F). 
IR (neat, cm
-1
): 3525, 2972, 2916, 1740, 1646, 1519, 1489, 1446, 1369, 1337, 1292, 1261, 
1229, 1216, 1150, 1118, 1095, 1071, 982, 943, 921, 866, 769, 753, 703. 
HRMS (ESI): exact m/z calculated for C15H15F5NO3S (M+NH4)
+
: 384.0687; Found: 384.0688 
(M+ NH4)
+
. 
Mp: 150-152 
o
C. 
1-(mesitylsulfonyl)-2-phenylpropan-2-ol (3l): 
Following GP-1, 3l was prepared from 2,4,6-trimethylbenzenesulfonyl 
chloride 2l (328 mg, 1.5 mmol). The crude product was purified by 
column chromatography (Hexanes: EtOAc, 4:1, Rf = 0.66) to afford 3l 
as a colorless solid (247 mg, 78% yield). 
1
H-NMR (300 MHz, CDCl3): δ 7.42 – 7.36 (m, 2H), 7.29 – 7.16 (m, 3H), 6.92 – 6.80 (m, 2H), 
4.33 (bs, 1H), 3.59 (ABq, J = 14.4 Hz, 2H), 2.59 (s, 6H), 2.27 (s, 3H), 1.80 (s, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 145.10, 143.64, 139.47, 134.39, 132.33, 128.30, 127.24, 124.46, 
73.61, 66.12, 30.40, 22.82, 21.00. 
IR (neat, cm
-1
): 3498, 2978, 2941, 1738, 1600, 1561, 1492, 1443, 1401, 1379, 1299, 1268, 
1242, 1151, 1111, 1075, 1034, 936, 850, 755, 721, 700. 
HRMS (ESI): exact m/z calculated for C18H15NO3S (M+NH4)
+
: 336.1628; Found: 336.1633 
(M+ NH4)
+
.  
Mp: 66-68 
o
C (decomposed). 
1-((2-bromophenyl)sulfonyl)-2-phenylpropan-2-ol (3m): 
Following GP-1, 3m was prepared from 2-bromobenzenesulfonyl 
chloride 2m (383 mg, 1.5 mmol). The crude product was purified by 
column chromatography (Hexanes : EtOAc, 4:1, Rf = 0.40) to afford 
3m as a colorless needles (329 mg, 92% yield).  
1
H-NMR (300 MHz, CDCl3): δ 7.62 (dd, J = 7.9, 1.1 Hz, 1H), 7.51 (dd, J = 7.9, 1.7 Hz, 1H), 
7.33 – 7.20 (m, 3H), 7.15 (td, J = 7.8, 1.2 Hz, 1H), 7.11 – 6.99 (m, 3H), 4.59 (bs, 1H), 4.07 
(ABq, J = 15.1 Hz, 2H), 1.65 (s, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 143.63, 138.84, 134.90, 134.33, 131.42, 128.11, 127.93, 127.33, 
124.50, 120.21, 73.02, 63.80, 31.24. 
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IR (neat, cm
-1
): 3493, 2973, 2944, 1740, 1568, 1494, 1444, 1426, 1378, 1363, 1305, 1241, 
1154, 1109, 1090, 1042, 1020, 942, 914, 845, 757, 698. 
HRMS (ESI): exact m/z calculated for C15H15BrNaO3S (M+Na)
+
: 376.9817; Found: 376.9818 
(M+ Na)
+
.  
Mp: 147-149 
o
C. 
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8.11.2 General procedure (GP-2): Scope for Alkenes 
 
To an oven-dried Schlenk tube (10 ml size) equipped with a stir bar was added tosyl chloride 2f 
(285mg, 1.5 mmol, 1.5 equiv.) and fac[Ir(ppy)3] (6.6 mg, 1.0 mol %). Then, acetonitrile (1.67 
mL) and distilled water (0.33 mL) was added; the resulting suspension was deoxygenated by 
three freeze-pump-thaw cycles followed by the addition of the corresponding alkene 1 (1.0 
mmol, 1.0 equiv.) under positive nitrogen atmosphere. The reaction mixture was irradiated with 
blue light emitting diode (LED, λmax = 455 nm) at room temperature. After complete conversion 
of starting materials (judged by TLC analysis), the reaction mixture was saturated with brine 
solution (15 mL) and the product was extracted with ethyl acetate (3x15 mL), the combined 
organic layers were dried over Na2SO4 and concentrated, the residue was purified by column 
chromatography on silica gel by using hexanes and ethyl acetate as eluents to afford the desired 
product 4. 
 
2-(4-chlorophenyl)-1-tosylpropan-2-ol (4a): 
Following GP-2, 4a was prepared from 1-chloro-4-(prop-1-en-2-
yl)benzene (152 mg, 1.0 mmol). The crude product was purified by 
column chromatography (Hexanes: EtOAc, 4:1, Rf = 0.30) to afford 4a 
as a colorless solid (280 mg, 86% yield).  
1
H-NMR (300 MHz, CDCl3): δ 7.42 (d, J = 8.3 Hz, 2H), 7.16 (dt, J = 4.3, 1.6 Hz, 4H), 7.12 – 
7.06 (m, 2H), 4.71 (bs, 1H), 3.64 (ABq, J = 14.7 Hz, 2H), 2.41 (s, 3H), 1.63 (s, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 144.83, 142.75, 136.88, 1387, 129.74, 128.23, 127.52, 126.25, 
72.79, 66.32, 31.04, 21.62. 
IR (neat, cm
-1
): 3487, 2970, 2917, 1596, 1489, 1398, 1380, 1353, 1299, 1282, 1265, 1189, 
1145, 1118, 1082, 1013, 948, 863, 824, 811, 763, 749, 702. 
HRMS (ESI): exact m/z calculated for C16H21ClNO3S (M+NH4)
+
: 342.0925; Found: 342.0929 
(M+ NH4)
+
.  
Mp: 139-141 
o
C (decomposed). 
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1-phenyl-2-tosylethan-1-ol (4b): 
Following GP-2, 4b was prepared from styrene (104 mg, 1.0 mmol). The crude 
product was purified by column chromatography (Hexanes : EtOAc, 4:1, Rf = 
0.28) to afford 4b as a colorless oil (218 mg, 79% yield). 
1
H-NMR (300 MHz, CDCl3): δ 7.82 (d, J = 8.0 Hz, 2H), 7.37 (d, J = 8.0 Hz, 2H), 7.32 – 7.24 
(m, 5H), 5.24 (dd, J = 10.0, 1.8 Hz, 1H), 3.53 – 3.27 (m, 2H), 2.45 (s, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 145.29, 140.79, 136.16, 130.13, 128.77, 128.32, 128.06, 125.71, 
68.50, 63.99, 21.73. 
The obtained data is in accordance with the literature data.
[22]
 
1-(p-tolyl)-2-tosylethan-1-ol (4c): 
Following GP-2, 4c was prepared from 1-methyl-4-vinylbenzene (118 mg, 1.0 
mmol). The crude product was purified by column chromatography (Hexanes: 
EtOAc, 4:1, Rf = 0.33) to afford 4c as a colorless solid (221 mg, 76% yield). 
1
H-NMR (300 MHz, CDCl3): δ 7.77 (dd, J = 18.2, 8.3 Hz, 2H), 7.34 (d, J = 8.1 Hz, 2H), 7.12 
(dd, J = 18.2, 8.1 Hz, 4H), 5.18 (dd, J = 9.8, 1.7 Hz, 1H), 3.73 (bs, 1H), 3.54 – 3.23 (m, 2H), 
2.43 (s, 3H), 2.29 (s, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 145.16, 138.02, 137.99, 136.27, 130.07, 129.38, 128.07, 125.69, 
68.38, 63.95, 21.71, 21.16. 
The obtained data is in accordance with the literature data.
[7]
 
 
1-(4-fluorophenyl)-2-tosylethan-1-ol (4d): 
Following GP-2, 4d was prepared from 1-fluoro-4-vinylbenzene (122 mg, 1.0 
mmol). The crude product was purified by column chromatography (Hexanes : 
EtOAc, 4:1, Rf = 0.23) to afford 4d as a colorless solid (221 mg, 75% yield). 
1
H-NMR (300 MHz, CDCl3): δ 7.81 (d, J = 8.0 Hz, 2H), 7.38 (d, J = 8.0 Hz, 2H), 7.32 – 7.20 
(m, 2H), 7.05 – 6.92 (m, 2H), 5.23 (dd, J = 9.9, 1.7 Hz, 1H), 3.65 (bs, 1H), 3.36 (m, 2H), 2.46 (s, 
3H). 
13
C-NMR (75 MHz, CDCl3): δ 164.13, 160.86, 145.42, 136.58, 136.53, 136.02, 130.17, 128.03, 
127.55, 127.44, 115.79, 115.50, 67.88, 63.94, 21.72. 
19
F-NMR (282 MHz, CDCl3): δ -114.09. 
The obtained data is in accordance with the literature data.
[7] 
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2-tosyl-2,3-dihydro-1H-inden-1-ol (4e): 
Following GP-2, 4e was prepared from 1H-indene (116 mg, 1.0 mmol). The 
crude product was purified by column chromatography (Hexanes: EtOAc, 4:1, 
Rf = 0.28) to afford 4e as a colorless viscous oil (190 mg, 66% yield, trans/cis 
95:05). 
1
H-NMR (300 MHz, CDCl3, major isomer): δ 7.83 (d, J = 8.3 Hz, 2H), 7.37 (d, J = 8.3 Hz, 
2H), 7.35 – 7.31 (m, 1H), 7.28 (dd, J = 6.4, 2.2 Hz, 2H), 7.22 – 7.17 (m, 1H), 5.70 (d, J = 4.9 Hz, 
1H), 4.16 (ddd, J = 8.9, 6.2, 4.9 Hz, 1H), 3.65 – 3.39 (m, 2H), 2.46 (s, 3H). 
13
C-NMR (75 MHz, CDCl3, major isomer): δ 145.40, 140.28, 138.89, 134.75, 130.08, 129.66, 
128.81, 128.05, 125.26, 124.59, 72.63, 60.62, 31.91, 21.75. 
The obtained data is in accordance with the literature data.
[24]
 
 
2-tosyl-1,2,3,4-tetrahydronaphthalen-1-ol (4f): 
Following GP-2, 4f was prepared from 1,2-dihydronaphthalene (130 mg, 1.0 
mmol). The crude product was purified by column chromatography (Hexanes: 
EtOAc, 4:1, Rf = 0.36) to afford 4f as a colorless solid (265 mg, 88% yield, 
trans/cis 9:1). 
1
H-NMR (300 MHz, CDCl3, major isomer): δ 7.85 (d, J = 7.9 Hz, 2H), 7.61 (d, J = 7.6 Hz, 
1H), 7.40 (d, J = 7.9 Hz, 2H), 7.29 – 7.14 (m, 2H), 7.02 (d, J = 7.1 Hz, 1H), 5.21 (d, J = 9.2 Hz, 
1H), 3.81 (bs, 1H), 3.38 (ddd, J = 12.5, 9.2, 3.5 Hz, 1H), 2.92 – 2.70 (m, 2H), 2.47 (s, 3H), 2.16 
(ddd, J = 13.0, 8.1, 3.5 Hz, 1H), 1.74 (tdd, J = 13.0, 11.0, 6.3 Hz, 1H). 
13
C-NMR (75 MHz, CDCl3, major isomer): δ 145.55, 135.82, 134.84, 133.38, 130.06, 129.24, 
128.06, 127.72, 127.68, 126.92, 67.54, 67.01, 27.97, 22.99, 21.73. 
The obtained data is in accordance with the literature data.
[24]
 
 
1-(naphthalen-2-yl)-2-tosylethan-1-ol (4g):
[24]
 
Following GP-2, 4g was prepared from 2-vinylnaphthalene (154 mg, 1.0 
mmol). The crude product was purified by column chromatography (Hexanes: 
EtOAc, 4:1, Rf = 0.19) to afford 4g as a colorless solid (253 mg, 77% yield). 
1
H-NMR (300 MHz, CDCl3): δ 7.87 – 7.75 (m, 6H), 7.51 – 7.44 (m, 2H), 7.39 – 7.32 (m, 3H), 
5.42 (dd, J = 9.8, 1.8 Hz, 1H), 3.49 (m, 2H), 2.45 (s, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 145.33, 137.96, 136.11, 1389, 1385, 130.13, 128.71, 128.06, 
128.03, 127.71, 126.46, 126.33, 124.81, 123.32, 68.65, 63.90, 21.72. 
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8.11.3 General procedure (GP-3): Trifluoromethylsulfochlorination 
 
To an oven-dried Schlenk tube (10 ml size) equipped with a stir bar was charged with alkene 5 
(3.0 mmol, 1 equiv), [Cu(dap)2Cl] (26.4 mg, 0.03 mmol, 1.0 mol %), K2HPO4 (1032 mg, 6 
mmol, 2 equiv) and MeCN (2.5 mL); the resulting suspension was degassed by three freeze-
pump-thaw cycles followed by the addition of the triflyl chloride (1008 mg, 6 mmol, 2 equiv). 
The reaction mixture was irradiated for 24 hours with blue light emitting diode (LED, λmax = 455 
nm) at room temperature. Afterwards, the reaction mixture was quenched with water and the 
product was extracted with DCM (3x10 mL), the combined organic layers were dried over 
Na2SO4 and concentrated, the residue was purified by silica gel column chromatography to 
afford pure 6. 
 
4,4,4-trifluoro-1-phenylbutane-2-sulfonyl chloride (6a): 
Following GP-3, 6a was prepared using allylbenzene (354 mg, 3.0 mmol). 
Chromatography on silica (hexanes: EtOAc, 9:1, Rf = 0.73) afforded 6a as a 
colorless oil (724 mg, 84% yield). 
1
H-NMR (300 MHz, CDCl3): δ 7.37 (m, 3H), 7.27 (m, 2H), 4.07 (m, 1H), 3.57 (dd, J = 14.9, 
5.6 Hz, 1H), 3.26 (dd, J = 14.9, 6.9 Hz, 1H), 3.04 (ddd, J = 15.8, 10.3, 3.4 Hz, 1H), 2.66 (ddd, J 
= 15.8, 9.8, 7.3 Hz, 1H). 
13
C-NMR (75 MHz, CDCl3): 133.85, 129.49, 129.11, 128.05, 124.05, (q, J = 276 Hz), 70.93, 
36.17, 34.16, 33.9 (q, J = 31.5 Hz). 
19
F-NMR (282 MHz, CDCl3):
 δ -63.95. 
The obtained data is in accordance with the literature data.
[11] 
1,1,1-trifluoro-5-phenylpentane-3-sulfonyl chloride (6b): 
Following GP-3, 6b was prepared using but-3-en-1-ylbenzene (397 mg, 
3.0 mmol) Chromatography on silica (hexanes: EtOAc, 9:1, Rf = 0.8) 
afforded 6b as a colorless oil (717 mg, 79% yield). 
Chapter 8: Experimental section 
376 
 
1
H-NMR (300 MHz, CDCl3): δ 7.37 – 7.32 (m, 2H), 7.30 – 7.18 (m, 3H), 3.79 (ddd, J = 8.9, 
7.8, 2.8 Hz, 1H), 81 (dqd, J = 15.5, 10.6, 2.7 Hz, 1H), 2.94 (t, J = 7.9 Hz, 2H), 2.74 – 2.47 (m, 
2H), 2.41 – 2.26 (m, 1H);  
13
C-NMR (75 MHz, CDCl3): δ 138.88, 128.87, 128.65, 128.47, 126.90, 126.70, 126.37 (q, J = 
274 Hz), 123.02, 68.86 (dd, J = 5.0, 2.5 Hz), 34.90 (q, J = 30.7 Hz), 32.13. 
19
F-NMR (282 MHz, CDCl3):
 δ -63.90. 
IR (neat, cm
-1
): 1603, 1696, 1455, 1372, 1317, 1260, 1245, 1148, 1119, 1072, 1024, 911, 844, 
744, 698. 
HRMS (ESI): exact m/z calculated for C11H12ClF3O2S (M)
+
: 300.01953; Found: 300.01949 
(M)
+
. 
 
2-(trifluoromethyl)cyclohexane-1-sulfonyl chloride (6c): 
Following GP-3, 6c was prepared using cyclohexene (243 mg, 3.0 mmol, 1 
equiv.). Chromatography on silica (hexanes-EtOAc, 9:1, Rf = 0.38) afforded 6c 
as a mixture of two non-separable diastereomers (60:40), colorless oil (375 mg, 
49% yield). 
1
H-NMR (300 MHz, CDCl3): δ 4.01 (m, 1H), 87 (m, 1H), 2.53 (m, 1H), 2.04 (m, 3H), 1.69 (m, 
4H). 
13
C-NMR (75 MHz, CDCl3,): 126.59 (q, J = 270 Hz), 71.03, 38.26 (q, J = 27.7 Hz), 23.94, 
20.61, 20.43, 20.31. 
19
F-NMR (282 MHz, CDCl3): δ -67.63.  
The obtained data is in accordance with the literature data.
[11]
 
 
1,1,1-trifluoroheptane-3-sulfonyl chloride (6d): 
Following GP-3, 6d was prepared using 1-hexene (252 mg, 3.0 mmol, 1 
equiv.). Chromatography on silica (hexanes: EtOAc, 9:1, Rf = 0.42) afforded 
6d as a pale yellow oil (499 mg, 66% yield).  
1
H-NMR (300 MHz, CDCl3): δ 3.76 (dtd, J = 8.5, 5.7, 2.8 Hz, 1H), 3.07 (dqd, J = 15.5, 10.6, 
2.8 Hz, 1H), 2.71 – 2.47 (m, 1H), 2.29 – 2.11 (m, 1H), 2.09 – 1.92 (m, 1H), 1.56 (tdd, J = 12.0, 
6.7, 2.5 Hz, 2H), 1.39 (dq, J = 14.4, 7.2 Hz, 2H), 0.95 (dd, J = 8.9, 5.6 Hz, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 124.94 (q, J = 277.4 Hz), 69.90 (m), 34.58 (q, J = 30.8 Hz), 
30.11 , 27.97, 22.25, 13.53. 
19
F-NMR (282 MHz, CDCl3):
 δ -64.30. 
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IR (neat, cm
-1
): 2964, 2937, 2876, 1466, 1437, 1370, 1308, 1258, 1151, 1086, 1014, 993, 917, 
843, 742, 709. 
HRMS (ESI): exact m/z calculated for C7H12ClF3O2S (M)
+
: 252.01948; Found: 252.01945 
(M)
+
. 
 
2-phenyl-1-((4,4,4-trifluoro-1-phenylbutan-2-yl)sulfonyl)propan-2-ol (7a): 
Following GP-1, 7a was prepared from 6a (430 mg, 1.5 mmol). The 
crude product was purified by column chromatography (Hexanes: 
EtOAc, 4:1, Rf = 0.5) to afford 7a as a 2 non-separable diastereomers 
(1:1), colorless oil (343 mg, 89% yield). 
1
H-NMR (300 MHz, CDCl3): δ 7.42 – 7.28 (m, 7H), 7.23 (m, 2H), 7.19 – 7.13 (m, 1H), 4.22 
(bs, 1H), 3.36 – 3.26 (m, 1H), 3.25 – 3.09 (m, 2H), 3.09 – 3.00 (m, 2H), 2.91 (qdd, J = 10.6, 4.4, 
2.2 Hz, 1H), 2.46 – 2.14 (m, 1H), 1.67 (s, 3H), 1.62 (s, 3H – other diastereomer). 
13
C-NMR (75 MHz, CDCl3, diastereomers: 1:1): δ 144.53, 144.46, 135.79, 135.64, 129.82, 
129.49, 129.10, 129.02, 128.60, 128.62, 127.79, 127.78, 127.71, 127.64, 125.66 (q, J = 278.09 
Hz), 125.60 (q, J = 2888 Hz), 124.65, 124.63, 72.99, 72.86, 63.90, 63.59, 60.21 (d, J = 1.9 Hz), 
59.91, 35.61, 34.41, 31.98 (q, J = 30.3 Hz), 31.02 (q, J = 30.4 Hz), 30.11, 30.00. 
19
F-NMR (282 MHz, CDCl3, diastereomers: 1:1):
 δ -63.60 and -63.77. 
IR (neat, cm
-1
): 3492, 2983, 1494, 1447, 1387, 1302, 1258, 1181, 1115, 1071, 1029, 999, 946, 
917, 880, 846, 748, 697. 
HRMS (ESI): exact m/z calculated for C19H25F3NO3S (M+NH4)
+
: 404.1502; Found: 404.1504 
(M+NH4)
+
. 
 
2-phenyl-1-((1,1,1-trifluoro-5-phenylpentan-3-yl)sulfonyl)propan-2-ol (7b): 
Following GP-1, 7b was prepared from 6b (450 mg, 1.5 mmol). The crude 
product was purified by column chromatography (Hexanes: EtOAc, 4:1, Rf = 
0.58) to afford 7b as a two non-separable diastereomers (0.91:1), colorless oil 
(344 mg, 86% yield). 
1
H-NMR (300 MHz, CDCl3): δ 7.51 – 7.39 (m, 4H), 7.38 – 7.22 (m, 4H), 7.23 – 7.16 (m, 2H), 
4.28 (bs, 1H), 3.57 (dd, J = 25.0, 10.3 Hz, 1H), 3.32 (dd, J = 14.8, 4.2 Hz, 1H), 2.98 – 2.52 (m, 
4H), 2.52 – 2.30 (m, 1H), 2.29 – 2.09 (m, 1H), 2.02 (qd, J = 10.5, 5.5 Hz, 1H), 1.78 (s, 3H). 
13
C-NMR (75 MHz, CDCl3, diastereomers: 0.91:1): δ 144.71, 144.67, 140.04, 139.90, 128.82, 
128.79, 128.75, 128.60, 128.48, 128.43, 127.89, 127.87, 127.84 (q, J = 270.18 Hz), 126.72, 
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126.60, 125.63 (q, J = 277.11 Hz), 124.65, 124.57, 73.02, 72.93, 62.04, 61.58, 57.56, 57.51, 
32.88 (q, J = 30.3 Hz), 32.39, 31.92, 31.26 (q, J = 30.4 Hz), 30.79, 30.16, 29.97, 29.67. 
19
F-NMR (282 MHz, CDCl3, diastereomers: 1:0.91): δ -63.54 and -63.96. 
IR (neat, cm
-1
): 3493, 2935, 1602, 1495, 1448, 1386, 1303, 1259, 1117, 1113, 1071, 1027, 945, 
916, 880, 843, 766, 748, 698. 
HRMS (ESI): exact m/z calculated for C20H27F3NO3S (M+NH4)
+
: 418.1658; Found: 418.1661 
(M+NH4)
+
. 
 
2-phenyl-1-((2-(trifluoromethyl)cyclohexyl)sulfonyl)propan-2-ol (7c): 
Following GP-1, 7c was prepared from 6c (375 mg, 1.5 mmol). The 
crude product was purified by column chromatography (Hexanes : 
EtOAc, 4:1, Rf = 0.62) to afford 7c as a two non-separable 
diastereomers (1:1), colorless oil (294 mg, 84% yield). 
1
H-NMR (300 MHz, CDCl3): δ 7.46 (m, 2H), 7.38 (m, 2H), 7.33 – 7.25 (m, 1H), 4.47 (s, 1H – 
OH, 1
st
 isomer), 4.43 (s, 1H – OH, 2nd isomer), 3.69 (dd, J = 41.1, 14.7 Hz, 1H), 3.38 (dd, J = 
17.5, 14.7 Hz, 1H), 3.04 – 2.72 (m, 2H), 1.98 (dd, J = 23.6, 9.7 Hz, 2H), 1.91 – 1.80 (m, 2H), 
1.76 (s, 3H 1
st
 isomer), 1.76 (s, 3H 2
nd
 isomer), 1.72 (d, J = 1.6 Hz, 1H), 1.60 – 1.43 (m, 3H). 
13
C-NMR (75 MHz, CDCl3, diastereomers: 1:1): δ 144.69, 144.57, 128.91, 128.71, 128.59, 
127.77, 127.69, 127.23 (q, J = 278.53 Hz), 127.03 (q, J = 280.63 Hz), 125.19, 124.75, 124.49, 
780, 72.90, 62.97, 61.60, 57.85, 56.70, 37.31 (q, J = 26.5 Hz), 35.10 (q, J = 26.8 Hz), 30.28, 
30.05, 22.08, 21.63, 21.17, 21.15, 21.09, 20.78, 20.19, 19.95. 
19
F-NMR (282 MHz, CDCl3, diastereomers: 1:1): δ -67.40 and -67.53. 
IR (neat, cm
-1
): 3492, 2944, 2876, 1709, 1494, 1448, 1386, 1363, 1304, 1250, 1178, 1104, 
1069, 1035, 1009, 946, 913, 873, 766, 699. 
HRMS (ESI): exact m/z calculated for C16H25F3NO3S (M+NH4)
+
: 368.1502; Found: 368.1507 
(M+NH4)
+
. 
 
2-phenyl-1-((1,1,1-trifluoroheptan-3-yl)sulfonyl)propan-2-ol (7d): 
Following GP-1, 7d was prepared from 6d (378 mg, 1.5 mmol). The 
crude product was purified by column chromatography (Hexanes : 
EtOAc, 4:1, Rf = 0.6) to afford 7d as a two non-separable diastereomers 
(1:1), pale yellow viscous oil (323 mg, 92% yield). 
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1
H-NMR (300 MHz, CDCl3): δ 7.45 – 7.31 (m, 4H), 7.27 (m, 1H), 4.27 (s, 1H), 3.67 – 3.46 (m, 
1H), 3.31 (dd, J = 14.7, 5.5 Hz, 1H), 2.89 – 2.51 (m, 1H), 2.39 – 2.05 (m, 1H), 1.73 (s, 3H), 1.64 
– 1.56 (m, 1H), 1.38 – 1.08 (m, 6H), 0.90 – 0.79 (m, 3H). 
13
C-NMR (75 MHz, CDCl3, diastereomers: 1:1): δ 144.60, 144.50, 128.78, 128.75, 127.84, 
127.81, 125.5 (q, J = 278.21 Hz), 124.62, 124.52, 123.9 (q, J = 277.01 Hz), 73.05, 72.88, 62.10, 
61.46, 58.26, 58.06, 32.89 (q, J = 30.1 Hz), 31.11 (q, J = 30.5 Hz), 30.29, 30.23, 28.63, 28.22, 
27.78, 27.29, 22.56, 22.40, 13.69, 13.66. 
19
F-NMR (282 MHz, CDCl3, diastereomers: 1:1): δ -63.96 and -64.47. 
IR (neat, cm
-1
): 3489, 2961, 2936, 1739, 1494, 1446, 1377, 1302, 1259, 1231, 1121, 946, 916, 
843, 766, 699.  
HRMS (ESI): exact m/z calculated for C16H27F3NO3S (M+NH4)
+
: 370.1658; Found: 370.1662 
(M+NH4)
+
. 
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8.11.4 General procedure (GP-4): One pot photocatalysis  
To an oven-dried Schlenk tube (10 ml size) equipped with a stir bar was charged with 1-Hexene 
5a (84.16 mg, 1.0 mmol, 1.0 equiv), [Cu(dap)2Cl] (8.8 mg, 0.01 mmol, 1.0 mol %), and MeCN 
(1.67 mL); the resulting suspension was degassed by three freeze-pump-thaw cycles followed by 
the addition of the triflyl chloride (336 mg, 2.0 equiv). The reaction mixture was irradiated for 24 
hours with blue light emitting diode (LED, λmax = 455 nm) at room temperature, followed by the 
addition of the prop-1-en-2-ylbenzene (or α-methyl styrene) 1a (118 mg, 1.0 mmol, 1.0 equiv), 
distilled water (0.33 mL), and fac[Ir(ppy)3] (6.6 mg, 0.01 mmol, 1.0 mol %) under positive 
nitrogen atmosphere to the reaction mixture. The resulting suspension was further irradiated with 
blue light emitting diode (LED, λmax = 455 nm) at room temperature for 24 h. Then reaction 
mixture was saturated with brine solution (15 mL) and the product was extracted with ethyl 
acetate (3x15 mL), the combined organic layers were dried over Na2SO4 and concentrated, the 
residue was purified by column chromatography on silica gel by using hexanes and ethyl acetate 
as eluents to afford the desired product 7d (183 mg, 52%). 
 
 
 
(E)-(5,5,5-trifluoro-3-((2-phenylprop-1-en-1-yl)sulfonyl)pentyl)benzene (8a): 
To an oven-dried round bottomed flask (25 mL size) equipped with a stir bar 
was charged with 7b (200 mg, 0.5 mmol, 1.0 equiv), Ac2O (102 mg, 1.0 
mmol, 2.0 equiv), DMAP (122 mg, 1.0 mmol, 2.0 equiv), and DCM (7 mL); 
the resulting suspension was stirred for 60 hours at room temperature. Then 
reaction mixture was saturated with brine solution (15 mL) and the product was extracted with 
ethyl acetate (3x15 mL), the combined organic layers were dried over Na2SO4 and concentrated, 
the residue was purified by column chromatography on silica gel by using hexanes and ethyl 
acetate as eluents to afford the desired product 8a as a colorless oil (142 mg, 74%). 
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1
H-NMR (400 MHz, CDCl3): δ 7.47 (s, 5H), 7.36 – 7.30 (m, 2H), 7.25 (t, J = 8.8 Hz, 3H), 6.41 
(s, 1H), 3.29 (d, J = 5.1 Hz, 1H), 3.08 – 2.96 (m, 2H), 2.94 – 2.83 (m, 1H), 2.56 (s, 3H), 2.55 – 
2.40 (m, 2H), 2.32 – 2.10 (m, 1H). 
13
C-NMR (101 MHz, CDCl3): δ 157.25, 139.86, 139.79, 134.18, 130.25, 129.94, 128.83, 
128.60, 128.41, 127.18, 126.42, 126.25, 122.73, 121.67, 57.45 (d, J = 1.9 Hz), 32.83 (q, J = 30.1 
Hz), 32.31, 30.33, 17.35. 
19
F-NMR (282 MHz, CDCl3):
 δ -63.90. 
IR (neat, cm
-1
): 2929, 1604, 1573, 1495, 1444, 1385, 1302, 1261, 1129, 1073, 1027, 826, 800, 
750, 698. 
HRMS (ESI): exact m/z calculated for C20H25F3NO2S (M+NH4)
+
: 400.1554; Found: 400.1553 
(M+NH4)
+
. 
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8.11.5 Reduction potentials: 
Redox potentials of the sulfonyl chlorides were measured by cyclic voltammetry in acetonitrile 
containing tetrabutylammonium tetrafluoroborate (0.1 M) as a supporting electrolyte. All values 
are given versus Saturated Calomel Eletrode (SCE). Potential sweep rate was 50 mV S
-1
. 
Sulfonyl chlorides Reduction potential (V) 
4-nitrobenzenesulfonyl chloride (2a) -0.44 
methanesulfonyl chloride (2b) -1.39 
benzenesulfonyl chloride (2c) -0.95 
4-acetylbenzenesulfonyl chloride (2d) -0.66 
4-methoxybenzenesulfonyl chloride (2e) -0.99 
4-methylbenzenesulfonyl chloride (2f) -0.94 
4-fluorobenzenesulfonyl chloride (2g) -0.90 
4-chlorobenzenesulfonyl chloride (2h) -0.79 
4-bromobenzenesulfonyl chloride (2i) -0.82 
naphthalene-2-sulfonyl chloride (2j) -0.74 
2,3,4,5,6-pentafluorobenzenesulfonyl 
chloride (2k) 
-0.56 
2,4,6-trimethylbenzenesulfonyl chloride (2l) -0.81 
2-bromobenzenesulfonyl chloride (2m) -0.82 
Table 8.5: Redox potential of the sulfonyl chlorides versus SCE.  
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8.11.6 Isotope labelling experiment with H2O
18
: 
To an oven-dried Schlenk tube (10 ml size) equipped with a stir bar was added tosyl chloride 2f 
(143mg, 0.75 mmol, 1.5 equiv) and fac[Ir(ppy)3] (6.6 mg, 1.0 mol %). Then, acetonitrile (0.83 
mL) and H2
18
O (0.17 mL) was added; the resulting suspension was deoxygenated by three 
freeze-pump-thaw cycles followed by the addition of the prop-1-en-2-ylbenzene (or α-methyl 
styrene) 1a (59 mg, 0.5 mmol, 1.0 equiv) under positive nitrogen atmosphere. The reaction 
mixture was irradiated with blue light emitting diode (LED, λmax = 455 nm) at room temperature 
for 18 h. The resulting reaction mixture was saturated with brine solution (10 mL) and the 
product was extracted with ethyl acetate (3x10 mL), the combined organic layers were dried over 
Na2SO4 and concentrated, the residue was purified by column chromatography on silica gel by 
using hexanes and ethyl acetate as eluents to afford the desired product 3fa (137 mg, 94%). The 
O
18
 incorporated mass of the compound 3fa was clearly detected by HRMS analysis. 
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8.12 NMR spectra:  
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H-NMR: 3a (DMSO-d
6
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8.13 Crystal data: 3m 
 
 
Figure 8.3: Crystal structure of 3m 
Crystal Data: C15H15BrO3S, Mr = 355.24, 
monoclinic, P21 (No. 4), a = 5.92604(15) Å, b = 
12.2676(3) Å, c = 9.9444(2) Å, = 103.755(2)°, = 
 = 90°, V = 702.21(3) Å3, T = 123.0(2) K, Z = 2, Z' = 
1, (CuK) = 5.423, 5956 reflections measured, 2628 
unique (Rint = 0.0348) which were used in all 
calculations. The final wR2 was 0.1082 (all data) and 
R1 was 0.0419 (I > 2(I)). 
Compound  3m 
    
Formula  C15H15BrO3S  
Dcalc./ g cm
-3
  1.680  
mm-1  5.423  
Formula Weight  355.24  
Color  clear colorless  
Shape  prism  
Max Size/mm  0.21  
Mid Size/mm  0.18  
Min Size/mm  0.10  
T/K  123.0(2)  
Crystal System  monoclinic  
Flack Parameter  0.06(4)  
Hooft Parameter  0.076(12)  
Space Group  P21  
a/Å  5.92604(15)  
b/Å  12.2676(3)  
c/Å  9.9444(2)  
°  90  
°  103.755(2)  
 90  
V/Å
3
  702.21(3)  
Z  2  
Z'  1  
min/
°
  4.578  
max/
°
  73.353  
Measured Refl.  5956  
Independent Refl.  2628  
Reflections Used  2616  
Rint  0.0348  
Parameters  183  
Restraints  1  
Largest Peak  1.071  
Deepest Hole  -0.978  
GooF  1.032  
wR2 (all data)  0.1082  
wR2  0.1079  
R1 (all data)  0.0421  
R1  0.0419  
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Images of the Crystal on the Diffractometer 
 
Table 8.6: Fractional Atomic Coordinates (×10
4
) and Equivalent Isotropic Displacement 
Parameters (Å
2
×10
3
) for 3m. Ueq is defined as 1/3 of the trace of the orthogonalised Uij. 
 
Atom x y z Ueq 
Br1 10142.8(9) 1539.7(6) 1408.2(6) 26.3(2) 
S1 6240(3) 2321.5(13) 3254.6(16) 24.0(4) 
O1 6148(10) 1165(4) 3079(6) 35.1(13) 
O2 4354(9) 2844(5) 3721(5) 33.0(11) 
C1 7852(10) 2631(5) 845(6) 22.5(12) 
C3 6152(14) 3951(6) -884(7) 32.2(16) 
C2 7777(12) 3144(6) -408(6) 25.8(13) 
C10 8368(12) 4707(5) 4126(6) 24.1(13) 
C15 6543(12) 5411(5) 4046(6) 25.3(13) 
C7 8877(11) 2667(5) 4467(6) 25.2(13) 
C11 9815(12) 4847(6) 3183(7) 26.2(13) 
C8 8901(13) 3775(6) 5180(6) 30.8(15) 
C13 7418(12) 6322(5) 2085(7) 29.3(15) 
C6 6302(11) 2930(5) 1651(6) 21.7(12) 
C14 6044(12) 6216(6) 3033(7) 28.1(14) 
C4 4576(12) 4238(6) -112(7) 30.1(15) 
C5 4657(13) 3736(6) 1142(7) 28.2(14) 
C12 9303(13) 5646(6) 2178(7) 30.5(14) 
O3 7205(12) 3750(5) 6048(5) 44.0(14) 
C9 11238(18) 3920(7) 6131(10) 55(3) 
Table 8.7: Anisotropic Displacement Parameters (×10
4
) 3m. The anisotropic displacement factor 
exponent takes the form: -22[h2a*2 × U11+ ... +2hka* × b* × U12] 
 
Atom U11 U22 U33 U23 U13 U12 
Br1 25.3(3) 24.8(3) 27.9(3) -4.4(3) 4.8(2) 4.4(3) 
S1 24.9(8) 24.1(8) 23.9(7) 1.7(6) 7.7(6) -0.7(6) 
O1 44(3) 24(3) 39(3) 0(2) 13(2) -5(2) 
O2 25(2) 43(3) 35(2) -1(2) 16(2) 1(2) 
C1 19(3) 21(3) 26(3) -1(2) 3(2) -1(2) 
C3 43(4) 29(4) 21(3) 1(3) 1(3) -3(3) 
C2 32(3) 27(3) 18(3) -3(2) 5(2) -3(3) 
C10 30(3) 22(3) 20(3) -6(2) 5(2) 3(3) 
C15 30(3) 23(3) 22(3) -1(2) 6(3) 1(3) 
C7 31(3) 21(3) 20(3) -1(2) -1(2) 5(3) 
C11 25(3) 30(4) 24(3) -3(3) 7(2) 4(3) 
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Atom U11 U22 U33 U23 U13 U12 
C8 42(4) 26(3) 21(3) -5(3) 0(3) 12(3) 
C13 32(3) 26(4) 28(3) 5(3) 3(2) 0(3) 
C6 21(3) 18(3) 23(3) -3(2) 0(2) -1(2) 
C14 28(3) 24(3) 31(3) 1(2) 5(3) 6(2) 
C4 32(4) 26(4) 25(3) 1(3) -7(3) 6(3) 
C5 27(3) 29(4) 25(3) -4(3) -2(3) 3(3) 
C12 35(4) 32(4) 27(3) 2(3) 11(3) -3(3) 
O3 68(4) 40(3) 32(3) 2(2) 27(3) 6(3) 
C9 63(6) 21(4) 55(5) -4(4) -37(5) 0(4) 
Table 8.8: Bond Lengths in Å for 3m. 
 
Atom Atom Length/Å 
Br1 C1 1.894(6) 
S1 O1 1.429(6) 
S1 O2 1.457(5) 
S1 C7 1.783(6) 
S1 C6 1.769(6) 
C1 C2 1.387(9) 
C1 C6 1.404(9) 
C3 C2 1.384(11) 
C3 C4 1.388(11) 
C10 C15 1.372(10) 
C10 C11 1.424(9) 
Atom Atom Length/Å 
C10 C8 1.533(10) 
C15 C14 1.390(9) 
C7 C8 1.531(9) 
C11 C12 1.382(10) 
C8 O3 1.472(9) 
C8 C9 1.490(10) 
C13 C14 1.391(10) 
C13 C12 1.377(10) 
C6 C5 1.396(10) 
C4 C5 1.381(10) 
 
Table 8.9: Bond Angles in 
°
 for 3m. 
 
Atom Atom Atom Angle/
°
 
O1 S1 O2 117.8(4) 
O1 S1 C7 108.7(3) 
O1 S1 C6 108.5(3) 
O2 S1 C7 107.2(3) 
O2 S1 C6 106.5(3) 
C6 S1 C7 107.8(3) 
C2 C1 Br1 117.0(5) 
C2 C1 C6 120.6(6) 
C6 C1 Br1 122.4(5) 
C2 C3 C4 119.8(6) 
C3 C2 C1 120.2(6) 
C15 C10 C11 118.4(6) 
C15 C10 C8 122.8(6) 
C11 C10 C8 118.8(6) 
C10 C15 C14 121.2(6) 
C8 C7 S1 115.8(5) 
C12 C11 C10 119.9(6) 
C7 C8 C10 111.5(5) 
O3 C8 C10 111.0(6) 
Atom Atom Atom Angle/
°
 
O3 C8 C7 108.7(7) 
O3 C8 C9 107.0(7) 
C9 C8 C10 110.7(7) 
C9 C8 C7 107.8(6) 
C12 C13 C14 119.7(6) 
C1 C6 S1 124.1(5) 
C5 C6 S1 117.6(5) 
C5 C6 C1 118.2(6) 
C15 C14 C13 119.9(6) 
C5 C4 C3 120.2(6) 
C4 C5 C6 120.9(7) 
C13 C12 C11 120.7(6) 
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Table 8.10: Hydrogen Fractional Atomic Coordinates (×10
4
) and Equivalent Isotropic 
Displacement Parameters (Å
2
×10
3
) for 3m. Ueq is defined as 1/3 of the trace of the 
orthogonalised Uij. 
 
Atom x y z Ueq 
H3 6116 4301 -1719 39 
H2 8821 2945 -929 31 
H15 5624 5350 4681 30 
H7A 9206 2106 5174 30 
H7B 10127 2656 3990 30 
H11 11104 4400 3244 31 
H13 7066 6847 1392 35 
H14 4792 6682 2990 34 
H4 3462 4769 -440 36 
H5 3601 3938 1655 34 
H12 10243 5728 1557 37 
H3A 6001 3461 5617 66 
H9A 12384 3991 5597 82 
H9B 11597 3299 6730 82 
H9C 11239 4566 6677 82 
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9 Temperature controlled selective C-S or C-C bond formations: First 
photocatalytic sulfonylation of unactivated heterocycles utilizing aryl sulfonyl 
chlorides 
9.1 Abstract:  
A facile method for heterocyclic sulfonylation has been developed by employing visible-light-
induced photocatalysis at room temperature conditions. This strategy provides a direct access to 
the novel class of sulfonyl substituted heterocycles in excellent yields. The synthetic utility of 
this reaction attributed to the direct use of commercially available sulfonyl chlorides and 
unactivated heterocycles under mild reaction conditions. Furthermore, this reaction offers a 
simple route for the synthesis of related sulfonyl-containing biologically active molecules. On 
the other hand, the C-C bond formation reaction occurs with the extrusion of the SO2 group at 
elevated temperature conditions, giving rise to arylated heterocycles. 
 
Scheme 9.1: Temperature dependent sulfonylation vs. arylation of heterocycles. 
9.2 Introduction: 
Sulfur-containing organic compounds have been documented as essential building blocks in 
synthetic as well as in medicinal chemistry.
[1]
 The substitution of a sulfur group on the aryl or 
heteroaryl moiety either in the form of sulfanyl, a sulfinyl, or a sulfonyl form, which immensely  
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enhances the synthetic utility and biological activity of the resultant organic compounds.
[2]
 In 
particular, sulfonyl-containing heterocycles have extensive applications in synthesis, 
agrochemical industries, and pharmaceuticals.
[3]
 For example, compounds A and B are very 
selective and potent human immunodeficiency virus type 1 (HIV-1) reverse transcriptase 
inhibitors (Figure 9.1).
[4]
 While, SR 33805 (C) is a potent Ca
2+
 channel antagonist, which binds 
allosterically to the a1-subunit of L-type Ca
2+
 channels (Kd = 20 pM), it also inhibits PDGF-
stimulated smooth muscle cell proliferation.
[5]
 The bis-sulfone derivative D has been established 
as a cannabinoid CB2 receptor ligands.
[6]
 Whereas, Serotonin E is a 5-HT6 receptor antagonist.
[3]
 
 
Figure 9.1: Representative biologically active molecules consisting aryl sulfonyl moiety. 
As a result, the various and elegant synthetic methods have been developed in the direction of C-
S bond formation by classical
[7]
 as well as photochemical methods.
[8,9]
 Despite the highly 
important several biologically active sulfonyl derivatives, the sulfonylation of desired 
heteroaromatics is surprisingly under-developed by straightforward routes (Figure 9.1). 
Therefore, direct and selective C-H sulfonylation of heterocyclic compounds has remained an 
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elementary challenge in organic synthesis till date. Though, there are quite a few indirect routes 
available for the synthesis of sulfonylated heteroarenes. Which mainly includes preactivation of 
heterocycles,
[10,11]
 or need a activated (or modified) sulfonyl sources, which unfortunately 
limited to the specific substrates.
[12,13]
 Furthermore, to control undesired desulfonylation
[14]
 and 
over-reduction of sulfonyl groups is a challenging task.
[8,15]
 In those cases, the re-oxidation of 
obtained sulfides needs to be conducted in order to recover the desired sulfonyl moiety.
[16]
 As a 
consequence, these methods calls for supplementary oxidation steps,
[17]
 which frequently require 
strong oxidants and suffer from harsh reaction conditions: for example, use of strong acids and 
organometallic reagents at elevated temperature conditions, eventually does not tolerate a variety 
of functional groups.
[18]
  
In recent times, we have introduced a convenient method for the synthesis of -hydroxysulfones 
from styrenes and sulfonyl chlorides utilizing visible-light-induced sequential photocatalytic 
strategy (Chapter 3.1).
[19]
 As stated earlier, the aryl sulfonyl chlorides typically exist as bench-
stable solids, which are commercially available, cheap, and mild sulfonylation source.
[20]
 Despite 
of the sulfonylation reactions, they are also known for C-C bond formation reactions at elevated 
temperature conditions.
[21]
 Therefore, obtaining temperature controlled selectivity particularly in 
the C-S bond formation using such reagents is another challenge.  
 
Scheme 9.2: Comparison between Natarajan’s method and our method. 
Within our constant interest of visible-light triggered photocatalyst controlled selective C-S bond 
formations with unactivated alkenes,
[22]
 herein, we unexpectedly arrive at temperature controlled 
C-H functionalization of heteroaromatics utilizing sulfonyl chlorides. To our surprise, at room 
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temperature conditions, we observed that the sulfonyl group remained intact, though on the other 
hand, we were aware that, the Natarajan group
[14]
 already showed the direct arylation under the 
identical conditions (Scheme 9.2). Our results therefore calls to revise the previous method and 
to rewrite the “exact reaction conditions” used, in particular the “reaction temperature” they 
employed. Rest of the parameters do not interfere with the SO2 extrusion, which we have proved 
later in our group (vide infra). 
9.3 Results and discussion: 
Having all this information in mind, we began our investigations by shining blue light on 
benzenesulfonyl chloride 1a, N-methyl pyrrole 2a using [Ru(bpy)3Cl2]
[23]
 (E1/2 (III/*II) = -0.81 V vs 
SCE) catalyst with the addition of Na2CO3 in dry MeCN (Table 9.1, entry 1). Indeed, we 
predominantly found C2-sulfonylation product 3a over C2-arylation 4a (20 
o
C - 23 
o
C) in 67% 
yields at room temperature conditions. 
In order to confirm our reasoning, we gradually raised the reaction temperature to 30 
o
C; indeed, 
the non-polar compound 4a started to emerge (Table 9.1, entry 2). Further raising the reaction 
temperature to 60 
o
C, considerably provides C2-arylated product 4a (Table 9.1, entries 3-5) in 
65-66% yields without the formation of 3a. The yield of 3a was enhanced to 79% (Table 9.1, 
entry 6) by the execution of fac[Ir(ppy)3]
[24]
 (E1/2 (IV/*III)  –1.73 V vs SCE, ppy = 2-
phenylpyridine) photocatalyst. To our delight, lowering the [Ir]-photocatalyst loading (from 3 
mol % to 1 mol %), also provided almost the identical results (Table 9.1, entries 6-7). Further 
optimization exposed that, in absence Na2CO3, the starting materials remained unreacted, while 
reaction color was completely black after 48 h of irradiation (Table 9.1, entry 9). The addition of 
other inorganic bases such as K2CO3, K2HPO4, Na2HPO4 were found to be less effective (Table 
9.1, entries 10-12). The controlled experiments revealed that the combination of visible-light and 
the photocatalyst are together necessary to accomplish the desired sulfonylation (Table 9.1, 
entries 13-14). In literature, there are a number of impressive methods already known for the 
construction of C-C bonds, which mainly includes palladium catalyzed cross-coupling 
reactions,
[25,26]
 photoredox catalysis,
[14,27]
 or dual Cu and photocatalysis.
[28]
 Thus, we mostly 
focused on the synthesis of sulfonylated products. Nevertheless, we have also shown few 
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representative arylated examples in Table 9.2 for the direct comparison and to confirm our 
reasoning. 
9.4 Synthesis of 3a and 4a: Catalyst screening and reaction optimization 
 
Entry 
Photocatalyst 
(mol %) 
Additive 
Temperature 
(
o
C) 
Yield (%)
[b]
 
3a 4a 
01 [Ru(bpy)3Cl2] (3) Na2CO3 rt
[c]
 67 - 
02 [Ru(bpy)3Cl2] (3) Na2CO3 30 49 7 
03 [Ru(bpy)3Cl2] (3) Na2CO3 35 27 31 
04 [Ru(bpy)3Cl2] (3) Na2CO3 45 - 66 
05 [Ru(bpy)3Cl2] (3) Na2CO3 60 - 65 
06 fac[Ir(ppy)3] (3) Na2CO3 rt 79 - 
07 fac[Ir(ppy)3] (1) Na2CO3 rt 80 - 
08 fac[Ir(ppy)3] (1) Na2CO3 45 - 75 
09
e
 fac[Ir(ppy)3] (1) - rt 28 - 
10 fac[Ir(ppy)3] (1) K2CO3 rt 74 - 
11 fac[Ir(ppy)3] (1) K2HPO4 rt 71 - 
12 fac[Ir(ppy)3] (1) Na2HPO4 rt 69 - 
13 No Catalyst Na2CO3 rt - - 
14 
fac[Ir(ppy)3] (1), 
no light 
Na2CO3 rt - - 
Table 9.1: Reaction conditions:
 [a] Benzenesulfonylchloride 1a (1.0 mmol, 1 equiv), N-methylpyrrole 2a (1.5 
mmol, 1.5 equiv), Photocatalyst (1-3 mol %), additive (1.5 mmol, 1.5 equiv), dry MeCN (3 mL), LED455, 48 h.
 [b] 
Isolated yields. [c] room temperature (20 oC - 23 oC, maintained with external water bath). 
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9.5 Substrate scope: 
By applying the optimal conditions (Table 9.1, entries 7 and 8), we turned our attention to 
enhance the scope of the substrates. Initially, veriety of aryl sulfonyl chlorides 1 having a range 
of electronic substituents were investigated with N-methyl pyrrole 2a as a trapping reagent 
(Table 9.2). Sulfonyl chlorides 1 possessing electron donating substituents (e.g. Me, MeO) as 
well as electron deficient functionalities (e.g. acetyl, NO2) were well tolerated.  
 
Table 9.2: Reaction conditions:
 [a] Aryl sulfonyl chloride 1 (1.0 mmol, 1 equiv), N-methylpyrrole 2a (1.5 mmol, 
1.5 equiv), fac[Ir(ppy)3] (1 mol %), Na2CO3 (1.5 mmol, 1.5 equiv), dry MeCN (3 mL), LED455, 48 h, rt (20 
oC - 23 
oC, maintained with external water bath). [b] Reaction done at 45oC. [c] Reaction done at 60 oC. 
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Moreover, the halogen family (F, Cl, Br) and also ortho-substituted bromo derivative (3g) were 
worked well under the employed conditions, providing sulfonylated products predominantly in 
high yields (Table 9.2). The presence of SO2 group was already confirmed by the HRMS and 
NMR analysis (see experimental section). Pleasingly, structures of 3b and 3m were 
unambiguously characterized by the single X-ray crystal analysis (Table 9.2). 
Furthermore, we decided to examine a scope for heterocycles 2 with Tosyl chloride 1b as a usual 
coupling partner (Table 9.2). The range of heterocycles such as 2-acetyl thiophene (3m), thiazole 
(3l), and 2- or 3-substituted indoles (3n, 3o) were regioselectively sulfonylated in good yields 
(Table 9.2). In particular, the selective sulfonylation of indoles was a challenging task under the 
similar photochemical conditions, which was earlier reported by the group of Zheng.
[8]
 They 
notice a partial reduction of sulfonyl to sulfide group at >30 
o
C. To our great delight, under the 
employed controlled conditions, only desired sulfonylated products could be isolated (see 
experimental section). In contrast, direct arylation reactions are also achieved at 60 
o
C for indoles 
without the formation of any of partially reduced intermediates (Table 9.2). At 45 
o
C, the 
undesired products (may be partially reduced) were observed. 
9.6 Applications: 
Having established the sulfonylation protocol, we aimed to demonstrate the utility of this new 
strategy for the construction of representative valuable biologically active sulfonyl containing 
drug candidates which are already described in Figure 9.1. By employing the standard 
conditions, the direct C3-sulfonylation of indole derivative 2g was productively achieved 
utilizing benzenesulfonylchloride 1a in 72% yields (Scheme 9.3).  
 
Scheme 9.3: Formal synthesis of HIV-1 RT (L-737, 126). 
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From the resulting 3-sulfonylated indoles 3p, further synthesis of corresponding biologically 
active HIV-1 RT (L-737, 126) A is already established in few steps.
[29]
 Next, we have also 
implement our method for the direct C2-sulfonylation of 3-substituted indole derivative 2e which 
gives a key precursor 3q in 74% yields in a single step. To our surprise, this has never done 
before in single step (Scheme 9.4). From intermediate 3q, the following synthesis of a Ca
2+
 
channel blocker C (SR 33805) was already achieved in literature.
[30]
 
 
Scheme 9.4: Formal synthesis of Ca
2+
 channel blocker C (SR 33805). 
9.7 Proposed reaction mechanism: 
As reported earlier,
[19]
 we propose the reaction mechanism utilizing the oxidative quenching 
cycle: Initial excitation of the Ir(III) to Ir (III)* occurs by irradiation with blue light. From this 
Ir(III)*, the subsequent single electron transfer (SET) to benzenesulfonylchloride 1a occurs to 
generate the corresponding sulfonyl radical I upon chloride extrusion, concurrent with oxidation 
to Ir(IV). Regioselective sulfonyl radical I addition to N-methyl pyrrole 2a takes place to form a 
stable carbon-centered -amino radical intermediate II, which subsequently undergoes oxidation 
to the corresponding carbocation III by back electron transfer processes. The resultant 
carbocation III rapidly undergoes rearomatization triggered by sodium carbonate give rise to 3a 
(Figure 3). 
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Figure 9.2: Proposed reaction mechanism. 
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9.8 Conclusion: 
To conclude, we have developed a first visible-light photocatalyzed method for the direct 
sulfonylation or arylation of heterocycles at different temperature conditions without pre-
activating a sulfonyl source and a heterocyclic ring. In addition, the utility of this transformation 
has been demonstrated via the formal synthesis of relevant biologically active molecules using 
readily available starting materials under sustainable reaction conditions. 
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9.9 Experimental section: 
9.9.1 Reduction potentials: 
Redox potentials of the sulfonyl chlorides were measured by cyclic voltammetry in acetonitrile 
containing tetrabutylammonium tetrafluoroborate (0.1 M) as a supporting electrolyte. All values 
are given versus Saturated Calomel Electrode (SCE). Potential sweep rate was 50 mV S
-1
. 
Sulfonyl chlorides Reduction potential (V) 
benzenesulfonyl chloride (1a) -0.95 
4-methylbenzenesulfonyl chloride (1b) -0.94 
4-methoxybenzenesulfonyl chloride (1c) -0.99 
4-fluorobenzenesulfonyl chloride (1d) -0.90 
4-chlorobenzenesulfonyl chloride (1e) -0.79 
4-bromobenzenesulfonyl chloride (1f) -0.82 
2-bromobenzenesulfonyl chloride (1g) -0.82 
4-acetylbenzenesulfonyl chloride (1h) -0.66 
4-nitrobenzenesulfonyl chloride (1i) -0.44 
methanesulfonyl chloride (1j) -1.39 
Table 9.3: Redox potentials of the sulfonyl chlorides versus SCE.  
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9.9.2 General Procedure (GP-1) for C, H-Sulfonylation: 
 
An oven dried 10 mL Schleck flask was charged with 1 (1.0 mmol, 1.00 equiv), Na2CO3 (159 
mg, 1.50 mmol, 1.00 equiv), and fac[Ir(ppy)3] (6.54 mg, 0.01 equiv, 1.00 mol %) in 3.0 mL dry 
MeCN. The resulting suspension was deoxygenated by three freeze-pump-thaw cycles. Then 
desired heterocyclic compound 2 (1.50 mmol, 1.5 equiv) was added under positive nitrogen 
atmosphere). The reaction mixture was exposed to the blue light emitting diode (LED, λmax = 
455 nm) at room temperature for 48 h. After complete conversion of aryl sulfonyl chloride 
(judged by TLC), the reaction mixture was saturated by addition of brine solution (20 mL). The 
aqueous phase was washed with ethyl acetate (3 x 20 mL). The combined organic fractions were 
dried over Na2SO4, concentrated in vacuo, and the crude residue was purified by column 
chromatography on silica gel by using hexanes and ethyl acetate as eluents to afford the pure 
product 3. 
 
Figure 9.3: Experimental set-up for photochemical reaction. 
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1-methyl-2-(phenylsulfonyl)-1H-pyrrole (3a): 
Following GP-1, 3a was prepared from benzenesulfonylchloride 1a (176 mg, 
1.0 mmol, 1.00 equiv) and N-Methylpyrrole 2a (122 mg, 133 µL, 1.50 mmol, 
1.5 equiv). The crude product was purified by column chromatography (silica 
gel, hexanes–EtOAc, 7:3, Rf = 0.34) to afford 3b as a light yellow viscous 
(sticky) solid (177 mg, 80% yield). 
1
H-NMR (300 MHz, CDCl3): δ 7.97 – 7.76 (m, 2H), 7.66 – 7.38 (m, 3H), 7.03 (dd, J = 4.0, 1.9 
Hz, 1H), 6.76 (t, J = 2.2 Hz, 1H), 6.16 (dd, J = 4.0, 2.6 Hz, 1H), 3.69 (s, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 142.22, 133.03, 129.87, 129.34, 127.92, 127.26, 118.97, 108.46, 
35.75. 
IR (neat, cm
-1
): 2923, 1704, 1581, 1515, 1475, 1442, 1420, 1363, 1303, 1222, 1148, 1120, 
1080, 1017, 994, 749, 724, 688. 
EI-MS: exact m/z calculated for C11H11NO2S (M)
+
: 221.05050; Found: 221.05052 (M)
+
. 
 
1-methyl-2-tosyl-1H-pyrrole (3b): 
Following GP-1, 3b was prepared from tosyl chloride 1b (191 mg, 1.0 mmol, 
1.00 equiv) and N-Methylpyrrole 2a (122 mg, 133 µL, 1.50 mmol, 1.5 equiv). 
The crude product was purified by column chromatography (silica gel, 
hexanes–EtOAc, 4:1, Rf = 0.39) to afford 3b as a white solid (183 mg, 78% 
yield).  
1
H-NMR (300 MHz, CDCl3): δ 7.78 – 7.74 (m, 2H), 7.29 (d, J = 8.5 Hz, 2H), 7.00 (dd, J = 4.1, 
1.9 Hz, 1H), 6.79 – 6.61 (m, 1H), 6.15 (dd, J = 4.1, 2.5 Hz, 1H), 3.69 (s, 3H), 2.40 (s, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 143.94, 139.32, 129.97, 129.59, 128.41, 127.40, 118.63, 108.36, 
35.74, 21.71. 
IR (neat, cm
-1
): 3126, 2921, 1740, 1591, 1513, 1491, 1443, 1314, 1287, 1229, 1159, 1125, 
1096, 1076, 1047, 1006, 882, 845, 818, 801, 745, 695, 658. 
HRMS (ESI): exact m/z calculated for C12H14NO2S (M+H)
+
: 236.074; Found: 236.0747 
(M+H)
+
.  
Mp: 100-102 oC (decomposed). 
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2-((4-methoxyphenyl)sulfonyl)-1-methyl-1H-pyrrole (3c): 
Following GP-1, 3c was prepared from 4-methoxybenzenesulfonyl chloride 1c 
(206 mg, 1.0 mmol, 1.00 equiv) and N-Methylpyrrole 2a (122 mg, 133 µL, 
1.50 mmol, 1.5 equiv). The crude product was purified by column 
chromatography (silica gel, hexanes–EtOAc, 4:1, Rf = 0.13) to afford 3c as a 
pale yellow solid (211 mg, 84% yield).  
1
H-NMR (300 MHz, CDCl3): δ 7.89 – 7.76 (m, 2H), 7.02 – 6.90 (m, 3H), 6.76 – 6.69 (m, 1H), 
6.14 (dd, J = 4.0, 2.6 Hz, 1H), 3.84 (s, 3H), 3.69 (s, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 1691, 133.75, 129.57, 129.41, 128.77, 118.24, 114.51, 108.23, 
55.80, 35.68. 
IR (neat, cm
-1
): 2924, 2854, 1704, 1592, 1573, 1458, 1397, 1364, 1315, 1290, 1259, 1154, 
1128, 1079, 1022, 966, 831, 800, 749, 716, 697, 665. 
EI-MS: exact m/z calculated for C12H13NO3S (M)
+
: 251.06107; Found: 251.06090 (M)
+
.  
Mp: 87-89 oC (decomposed). 
 
2-((4-fluorophenyl)sulfonyl)-1-methyl-1H-pyrrole (3d): 
Following GP-1, 3d was prepared from 4-fluorobenzenesulfonyl chloride 1d 
(194 mg, 1.0 mmol, 1.00 equiv) and N-Methylpyrrole 2a (122 mg, 133 µL, 
1.50 mmol, 1.5 equiv). The crude product was purified by column 
chromatography (silica gel, hexanes–EtOAc, 9:1, Rf = 0.23) to afford 3d as a 
brown solid (184 mg, 77% yield).  
1
H-NMR (300 MHz, CDCl3): δ 7.93 – 7.85 (m, 2H), 7.22 – 7.12 (m, 2H), 7.01 (dd, J = 4.0, 1.9 
Hz, 1H), 6.77 (t, J = 2.1 Hz, 1H), 6.17 (dd, J = 4.0, 2.6 Hz, 1H), 3.70 (s, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 166.98, 163.60, 138.37 (d, J = 9 Hz), 130.10 (d, J = 9.7 Hz), 
127.77, 119.05, 116.63 (d, J = 22.6 Hz), 108.58, 35.77. 
19
F-NMR (282 MHz, CDCl3): δ -105.22. 
IR (neat, cm
-1
): 2921, 1586, 1511, 1489, 1460, 1403, 1359, 1318, 1286, 1220, 1155, 1126, 
1093, 1076, 1046, 1004, 835, 813, 740, 711, 692, 663. 
EI-MS: exact m/z calculated for C11H10NO2FS (M)
+
: 239.4108; Found: 239.04077 (M)
+
.  
Mp: 61-63 oC (decomposed). 
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2-((4-chlorophenyl)sulfonyl)-1-methyl-1H-pyrrole (3e): 
Following GP-1, 3e was prepared from 4-chlorobenzenesulfonyl chloride 1e 
(211 mg, 1.0 mmol, 1.00 equiv) and N-Methylpyrrole 2a (122 mg, 133 µL, 
1.50 mmol, 1.5 equiv). The crude product was purified by column 
chromatography (silica gel, hexanes–EtOAc, 7:3, Rf = 0.37) to afford 3e as a 
pale yellow solid (227 mg, 89% yield). 
1
H-NMR (300 MHz, CDCl3): δ 7.84 – 7.79 (m, 2H), 7.48 – 7.45 (m, 2H), 7.04 (ddd, J = 5.9, 
3.6, 1.8 Hz, 1H), 6.91 – 6.71 (m, 1H), 6.29 – 6.10 (m, 1H), 3.70 (s, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 140.86, 139.61, 130.18, 129.70, 128.82, 127.55, 119.34, 108.73, 
35.84. 
IR (neat, cm
-1
): 2923, 1702, 1579, 1512, 1474, 1392, 1313, 1290, 1228, 1159, 1130, 1086, 
1048, 1006, 826, 752, 705, 690. 
EI-MS: exact m/z calculated for C11H10NO2SCl (M)
+
: 255.01153; Found: 255.01133 (M)
+
. 
Mp: 73-75 
o
C (decomposed). 
 
2-((4-bromophenyl)sulfonyl)-1-methyl-1H-pyrrole (3f): 
Following GP-1, 3f was prepared from 4-bromobenzenesulfonyl chloride 1f 
(255 mg, 1.0 mmol, 1.00 equiv) and N-Methylpyrrole 2a (122 mg, 133 µL, 
1.50 mmol, 1.5 equiv). The crude product was purified by column 
chromatography (silica gel, hexanes–EtOAc, 7:3, Rf = 0.31) to afford 3f as a 
pale yellow solid (243 mg, 81% yield). 
1
H-NMR (300 MHz, CDCl3): δ 7.75 – 7.72 (m, 2H), 7.65 – 7.62 (m, 2H), 7.03 (dd, J = 4.1, 1.9 
Hz, 1H), 6.78 (t, J = 2.2 Hz, 1H), 6.18 (dd, J = 4.0, 2.6 Hz, 1H), 3.70 (s, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 141.25, 132.53, 130.07, 128.75, 127.99, 127.33, 119.22, 108.60, 
35.70. 
IR (neat, cm
-1
): 2923, 1701, 1570, 1512, 1467, 1385, 1363, 1313, 1292, 1225, 1159, 1128, 
1066, 1047, 1002, 818, 740, 700. 
EI-MS: exact m/z calculated for C11H10NO2SBr (M)
+
: 298.96101; Found: 298.96068 (M)
+
.  
Mp: 90-92 
o
C (decomposed). 
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2-((2-bromophenyl)sulfonyl)-1-methyl-1H-pyrrole (3g): 
Following GP-1, 3g was prepared from 2-bromobenzenesulfonyl chloride 1g 
(255 mg, 1.0 mmol, 1.00 equiv) and N-Methylpyrrole 2a (122 mg, 133 µL, 
1.50 mmol, 1.5 equiv). The crude product was purified by column 
chromatography (silica gel, hexanes–EtOAc, 4:1, Rf = 0.42) to afford 3g as a 
pale yellow solid (234 mg, 78% yield). 
1
H-NMR (300 MHz, CDCl3): δ 8.22 (dd, J = 7.8, 1.7 Hz, 1H), 7.69 (dd, J = 7.8, 1.3 Hz, 1H), 
7.49 (td, J = 7.7, 1.4 Hz, 1H), 7.40 (td, J = 7.6, 1.8 Hz, 1H), 7.17 (dd, J = 4.1, 1.9 Hz, 1H), 6.79 
(t, J = 2.1 Hz, 1H), 6.20 (dd, J = 4.1, 2.6 Hz, 1H), 3.66 (s, 3H). 
13
C-NMR (75 MHz, CDCl3): 140.86, 136.05, 134.29, 130.80, 130.02, 127.87, 125.86, 122.07, 
121.40, 108.29, 35.96. 
IR (neat, cm
-1
): 2921, 1704, 1571, 1511, 1434, 1397, 1359, 1314, 1292, 1229, 1162, 1136, 
1117, 1048, 1021, 755, 737, 700. 
EI-MS: exact m/z calculated for C11H10NO2SBr (M)
+
: 298.96101; Found: 298.96068 (M)
+
. 
Mp: 107-109 
o
C (decomposed). 
 
1-(4-((1-methyl-1H-pyrrol-2-yl)sulfonyl)phenyl)ethan-1-one (3h): 
Following GP-1, 3h was prepared from 4-acetylbenzenesulfonyl 
chloride 1h (219 mg, 1.0 mmol, 1.00 equiv) and N-Methylpyrrole 2a 
(122 mg, 133 µL, 1.50 mmol, 1.5 equiv). The crude product was 
purified by column chromatography (silica gel, hexanes–EtOAc, 1:1, Rf 
= 0.50) to afford 3h as a pale yellow viscous (sticky) solid (199 mg, 
76% yield). 
1
H-NMR (300 MHz, CDCl3): δ 8.07 – 8.03 (m, 2H), 7.72 – 7.56 (m, 2H), 6.77 (dd, J = 2.4, 1.9 
Hz, 1H), 6.61 (dt, J = 4.2, 2.0 Hz, 1H), 6.25 – 6.06 (m, 1H), 3.53 (s, 3H), 2.64 (s, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 197.35, 148.64, 138.56, 129.75, 128.99, 125.46, 125.05, 118.32, 
108.65, 34.96, 26.98. 
IR (neat, cm
-1
): 2923, 1682, 1589, 1514, 1420, 1393, 1357, 1293, 1258, 1146, 1120, 1083, 
1033, 1009, 957, 827, 793, 722, 676. 
EI-MS: exact m/z calculated for C13H13NO3S (M)
+
: 263.0699; Found: 263.0748 (M)
+
. 
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1-methyl-2-((4-nitrophenyl)sulfonyl)-1H-pyrrole (3i): 
Following GP-1, 3i was prepared from 4-nitrosulfonyl chloride 1i (221 
mg, 1.0 mmol, 1.00 equiv) and N-Methylpyrrole 2a (122 mg, 133 µL, 
1.50 mmol, 1.5 equiv). The crude product was purified by column 
chromatography (silica gel, hexanes–EtOAc, 4:1, Rf = 0.12) to afford 3i 
as a pale yellow solid (213 mg, 80% yield).  
1
H-NMR (300 MHz, CDCl3): δ 8.36 – 8.30 (m, 2H), 8.09 – 8.03 (m, 2H), 7.11 (dd, J = 4.1, 1.9 
Hz, 1H), 6.83 (t, J = 2.1 Hz, 1H), 6.23 (dd, J = 4.1, 2.6 Hz, 1H), 3.74 (s, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 150.08, 148.03, 130.96, 128.42, 126.16, 124.55, 120.37, 109.17, 
35.87. 
IR (neat, cm
-1
): 3102, 2924, 1702, 1605, 1527, 1462, 1395, 1343, 1291, 1223, 1162, 1126, 
1076, 1009, 853, 763, 735, 679. 
EI-MS: exact m/z calculated for C11H10N2O4S (M)
+
: 266.03558; Found: 266.03629 (M)
+
. 
Mp: 95-97oC (decomposed). 
1-methyl-2-(methylsulfonyl)-1H-pyrrole (3j): 
Following GP-1, 3j was prepared from Methanesulfonylchloride 1j (115 mg, 
1.0 mmol, 1.00 equiv) and N-Methylpyrrole 2a (122 mg, 133 µL, 1.50 mmol, 
1.5 equiv). The crude product was purified by column chromatography (silica 
gel, hexanes–EtOAc, 4:1, Rf = 0.19) to afford 3j as a pale yellow oil (116 mg, 
73% yield). 
1
H-NMR (400 MHz, CDCl3): δ 6.90 (dd, J = 4.0, 1.9 Hz, 1H), 6.82 (t, J = 2.2 Hz, 1H), 6.18 (dd, 
J = 4.0, 2.6 Hz, 1H), 3.89 (s, 3H), 3.09 (s, 3H). 
13
C-NMR (101 MHz, CDCl3): δ 129.64, 128.28, 118.40, 108.47, 45.70, 35.89. 
IR (neat, cm
-1
): 2956, 2924, 1514, 1469, 1399, 1363, 1290, 1224, 1161, 1110, 1007, 952, 762, 
738. 
EI-MS: exact m/z calculated for C6H9NO2S (M)
+
: 159.03485; Found: 159.03519 (M)
+
. 
 
1-phenyl-2-tosyl-1H-pyrrole (3k): 
Following GP-1, 3k was prepared from tosyl chloride 1b (191 mg, 1.0 mmol, 
1.00 equiv) and N-phenylpyrrole 2b (214 mg, 1.50 mmol, 1.5 equiv). The 
crude product was purified by column chromatography (silica gel, hexanes–
EtOAc, 4:1, Rf = 0.32) to afford 3k as a white solid (208 mg, 70% yield).  
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1
H-NMR (300 MHz, CDCl3): δ 7.42 – 7.32 (m, 2H), 7.32 – 7.18 (m, 4H), 7.15 (dt, J = 4.9, 2.5 
Hz, 1H), 7.09 – 6.99 (m, 3H), 6.81 (dd, J = 4.7, 2.4 Hz, 1H), 6.26 (dt, J = 7.1, 3.6 Hz, 1H), 2.30 
(s, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 143.68, 138.79, 138.19, 130.83, 129.97, 129.37, 128.98, 128.63, 
128.07, 127.79, 119.14, 108.84, 21.70. 
IR (neat, cm
-1
): 2921, 2852, 1738, 1719, 1495, 1441, 1391, 1304, 1287, 1209, 1168, 1138, 
1088, 1076, 1034, 1018, 967, 814, 777, 757, 693, 667. 
EI-MS: exact m/z calculated for C17H15NO2S (M)
+
: 297.08180; Found: 297.08092 (M)
+
. 
Mp: 99-101 
o
C (decomposed). 
 
2-tosylthiazole (3l): 
Following GP-1, 3l was prepared from tosyl chloride 1b (191 mg, 1.0 mmol, 
1.00 equiv) and thiazole 2d (128 mg, 1.50 mmol, 1.5 equiv). The crude product 
was purified by column chromatography (silica gel, hexanes–EtOAc, 4:1, Rf = 
0.37) to afford 3l as a white solid (186 mg, 78% yield). 
1
H-NMR (300 MHz, CDCl3): δ 7.98 (d, J = 8.4 Hz, 2H), 7.94 (d, J = 3.0 Hz, 1H), 7.65 (d, J = 
3.0 Hz, 1H), 7.36 (d, J = 8.4 Hz, 2H), 2.42 (s, 2H). 
13
C-NMR (75 MHz, CDCl3): δ 166.66, 144.83, 144.39, 134.89, 129.30, 127.87, 124.86, 20.89. 
The obtained data is in accordance with the literature data.
[10] 
 
1-(5-tosylthiophen-2-yl)ethan-1-one (3m): 
Following GP-1, 3m was prepared from tosyl chloride 1b (191 mg, 1.0 
mmol, 1.00 equiv) and 1-(thiophen-2-yl)ethan-1-one 2c (189 mg, 1.50 
mmol, 1.5 equiv). The crude product was purified by column 
chromatography (silica gel, hexanes–EtOAc, 4:1, Rf = 0.16) to afford 
3m as a pale yellow solid (221 mg, 79% yield). 
1
H-NMR (300 MHz, CDCl3): δ 7.84 (d, J = 8.3 Hz, 2H), 7.60 (d, J = 4.0 Hz, 1H), 7.55 (d, J = 
4.0 Hz, 1H), 7.31 (d, J = 8.1 Hz, 2H), 2.52 (s, 3H), 2.39 (s, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 190.59, 150.25, 150.21, 145.28, 137.97, 132.79, 131.57, 130.28, 
127.73, 26.94, 21.72. 
The obtained data is in accordance with the literature data.
[10] 
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3-isopropyl-1-methyl-2-tosyl-1H-indole (3n): 
Following GP-1, 3n was prepared from tosyl chloride 1b (191 mg, 1.0 
mmol, 1.00 equiv) and 3-isopropyl-1-methyl-1H-indole 2e (259 mg, 
1.50 mmol, 1.5 equiv). The crude product was purified by column 
chromatography (silica gel, hexanes–EtOAc, 9:1, Rf = 0.37) to afford 
3n as a viscous (sticky) white solid (251 mg, 77% yield). 
1
H-NMR (300 MHz, CDCl3): δ 7.92 (d, J = 8.2 Hz, 1H), 7.84 – 7.75 (m, 2H), 7.40 – 7.21 (m, 
4H), 7.18 – 7.07 (m, 1H), 4.36 (hept, J = 7.1 Hz, 1H), 3.91 (s, 3H), 2.40 (s, 3H), 1.49 (d, J = 7.1 
Hz, 6H). 
13
C-NMR (75 MHz, CDCl3): δ 144.22, 140.11, 139.10, 130.99, 130.03, 128.61, 126.78, 125.63, 
124.62, 123.47, 120.03, 110.65, 31.90, 25.43, 23.11, 21.72. 
IR (neat, cm
-1
): 2960, 2929, 2872, 1732, 1596, 1509, 1460, 1367, 1327, 1299, 1180, 1155, 
1089, 825, 744, 705, 687. 
HRMS (ESI): exact m/z calculated for C19H21NO2S (M+H)
+
: 328.1366; Found: 328.1368 
(M+H)
+
. 
 
2-methyl-3-tosyl-1H-indole (3o): 
Following GP-1, 3o was prepared from tosyl chloride 1b (191 mg, 1.0 mmol, 
1.00 equiv) and 2-methyl-1H-indole 2f (196 mg, 1.50 mmol, 1.5 equiv). The 
crude product was purified by column chromatography (silica gel, hexanes–
EtOAc, 4:1, Rf = 0.13) to afford 3o as a brown solid (210 mg, 74% yield).  
1
H-NMR (300 MHz, CDCl3): δ 9.54 (s, 1H), 7.91 (d, J = 8.3 Hz, 2H), 7.62 (t, J = 8.4 Hz, 1H), 
7.42 (d, J = 8.3 Hz, 1H), 7.33 (dd, J = 7.0, 1.1 Hz, 1H), 7.30 – 7.23 (m, 2H), 7.19 – 7.12 (m, 1H), 
2.57 (s, 3H), 2.37 (s, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 144.41, 139.06, 136.16, 130.04, 129.47, 128.28, 127.04, 126.12, 
120.70, 118.51, 112.50, 21.66, 9.04. 
IR (neat, cm
-1
): 3285, 2922, 2853, 1594, 1582, 1537, 1493, 1451, 1410, 1386, 1281, 1141, 
1121, 1099, 1067, 1012, 925, 809, 735, 685, 657. 
Mp: 160-162 
o
C (decomposed). 
The obtained data is in accordance with the literature data.
[13] 
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5-chloro-2-methyl-3-(phenylsulfonyl)-1H-indole (3p): 
Following GP-1, 3p was prepared from benzenesulfonylchloride 1a (176 mg, 
1.0 mmol, 1.00 equiv) and 5-chloro-2-methyl-1H-indole 2g (247 mg, 1.50 
mmol, 1.5 equiv). The crude product was purified by column chromatography 
(silica gel, hexanes–EtOAc, 5:1, Rf = 0.25) to afford 3p as a white solid (219 
mg, 72% yield). 
1
H-NMR (300 MHz, CDCl3): δ 9.41 (s, 1H), 8.01 – 7.90 (m, 3H), 7.55 – 7.41 (m, 3H), 7.19 (d, 
J = 8.6 Hz, 1H), 7.11 (dd, J = 8.6, 2.0 Hz, 1H), 2.65 (s, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 143.64, 143.05, 132.96, 132.94, 129.38, 128.27, 126.51, 126.11, 
123.74, 118.84, 112.62, 110.90, 13.17. 
IR (neat, cm
-1
): 3290, 1529, 1575, 1446, 1400, 1281, 1143, 1107, 1069, 1020, 999, 946, 870, 
804, 735, 712, 686. 
Mp: 179-181 
o
C (decomposed). 
The obtained data is in accordance with the literature data.
[29]
 
3-isopropyl-2-((4-methoxyphenyl)sulfonyl)-1-methyl-1H-indole (3q): 
Following GP-1, 3q was prepared from 4-methoxybenzenesulfonyl 
chloride 1c (206 mg, 1.0 mmol, 1.00 equiv) and 3-isopropyl-1-methyl-
1H-indole 2e (259 mg, 1.50 mmol, 1.5 equiv). The crude product was 
purified by column chromatography (silica gel, hexanes–EtOAc, 9:1, Rf 
= 0.14) to afford 3q as a viscous (sticky) white solid (253 mg, 74% 
yield). 
1
H-NMR (300 MHz, CDCl3): δ 7.89 – 7.84 (m, 1H), 7.82 – 7.74 (m, 2H), 7.32 – 7.21 (m, 2H), 
7.12 – 7.03 (m, 1H), 6.95 – 6.88 (m, 2H), 4.30 (hept, J = 7.1 Hz, 1H), 3.86 (s, 3H), 3.79 (s, 3H), 
1.43 (d, J = 7.1 Hz, 6H). 
13
C-NMR (75 MHz, CDCl3): δ 163.38, 139.12, 134.69, 130.51, 129.02, 125.56, 124.65, 123.47, 
120.01, 114.61, 110.63, 55.85, 31.89, 25.44, 23.15. 
IR (neat, cm
-1
): 2958, 2922, 2869, 2850, 1733, 1592, 1577, 1495, 1459, 1365, 1323, 1295, 
1258, 1178, 1148, 1129, 1088, 1021, 821, 801, 741, 686, 653; C19H21NO3S (M+H)
+
: 344.1315; 
Found: 344.1318 (M+H)
+
. 
The obtained data is in accordance with the literature data.
[30]
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9.9.3 General Procedure (GP-2) for C, H-Arylation: 
 
An oven dried 10 mL Schleck flask was charged with 1 (1.0 mmol, 1.00 equiv), Na2CO3 (159 
mg, 1.50 mmol, 1.00 equiv), and fac[Ir(ppy)3] (6.54 mg, 0.01 equiv, 1.00 mol %) in 3.0 mL dry 
MeCN. The resulting suspension was deoxygenated by three freeze-pump-thaw cycles. Then 
desired heterocyclic compound 2 (1.50 mmol, 1.5 equiv) was added under positive nitrogen 
atmosphere). The reaction mixture was exposed to the blue light emitting diode (LED, λmax = 
455 nm) at 45 (or 60 
o
C) for 48 h. After complete conversion of aryl sulfonyl chloride (judged by 
TLC), the reaction mixture was saturated by addition of brine solution (20 mL). The aqueous 
phase was washed with ethyl acetate (3 x 20 mL). The combined organic fractions were dried 
over Na2SO4, concentrated in vacuo, and the crude residue was purified by column 
chromatography on silica gel by using hexanes and ethyl acetate as eluents to afford the pure 
product 4. 
1-methyl-2-phenyl-1H-pyrrole (4a): 
Following GP-2, 4a was prepared from benzenesulfonylchloride 1a (176 mg, 
1.0 mmol, 1.00 equiv) and N-Methylpyrrole 2a (122 mg, 133 µL, 1.50 mmol, 
1.5 equiv). The crude product was purified by column chromatography (silica 
gel, hexanes–EtOAc, 3:1, Rf = 0.35) to afford 4a as a colorless solid (117 mg, 
75% yield). 
1
H-NMR (300 MHz, CDCl3): δ 7.53 – 7.41 (m, 5H), 6.83 – 6.72 (m, 1H), 6.34 – 6.30 (m, 1H), 
6.30 – 6.25 (m, 1H), 3.72 (s, 3H). 
13
C-NMR (75 MHz, CDCl3): δ 134.72, 133.48, 128.77, 128.49, 126.86, 123.78, 108.78, 107.90, 
35.17. 
The obtained data is in accordance with the literature data.
[14,26]
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1-methyl-2-(p-tolyl)-1H-pyrrole (4b): 
Following GP-2, 4b was prepared from tosyl chloride 1b (191 mg, 1.0 mmol, 
1.00 equiv) and N-Methylpyrrole 2a (122 mg, 133 µL, 1.50 mmol, 1.5 equiv). 
The crude product was purified by column chromatography (silica gel, 
hexanes–EtOAc, 3:1, Rf = 0.37) to afford 4b as a pale yellow oil (119 mg, 70% 
yield). 
1
H-NMR (300 MHz, CDCl3): δ 7.76 – 7.70 (m, 2H), 7.25 (m, 2H), 6.97 – 6.88 (m, 1H), 6.72 (t, 
J = 4.7 Hz, 1H), 6.29 (dd, J = 4.2, 2.6 Hz, 1H), 3.97 (s, 3H), 2.42 (s, 3H). 
13
C-NMR (75 MHz, CDCl3):
 δ 151.82, 146.59, 139.81, 129.78, 126.59, 122.13, 110.20, 99.69, 
33.54, 21.56. 
The obtained data is in accordance with the literature data.
[14,26]
 
 
2-(4-methoxyphenyl)-1-methyl-1H-pyrrole (4c): 
Following GP-2, 4c was prepared from 4-methoxybenzenesulfonyl chloride 1c 
(206 mg, 1.0 mmol, 1.00 equiv) and N-Methylpyrrole 2a (122 mg, 133 µL, 
1.50 mmol, 1.5 equiv). The crude product was purified by column 
chromatography (silica gel, hexanes–EtOAc, 3:1, Rf = 0.32) to afford 4c as a 
pale yellow oil (153 mg, 82% yield). 
1
H-NMR (300 MHz, CDCl3): δ 7.87 – 7.73 (m, 2H), 7.04 – 6.93 (m, 2H), 6.93 – 6.86 (m, 1H), 
6.67 (dd, J = 4.1, 1.5 Hz, 1H), 6.28 (dd, J = 4.2, 2.6 Hz, 1H), 3.95 (s, 3H), 3.87 (s, 3H). 
13
C-NMR (75 MHz, CDCl3):
 δ 160.97, 148.01, 146.54, 126.26, 123.80, 114.34, 110.11, 99.22, 
55.74, 33.52. 
The obtained data is in accordance with the literature data.
[14,26] 
 
2-(4-fluorophenyl)-1-methyl-1H-pyrrole (4d): 
Following GP-2, 4d was prepared from 4-fluorobenzenesulfonyl chloride 1d 
(194 mg, 1.0 mmol, 1.00 equiv) and N-Methylpyrrole 2a (122 mg, 133 µL, 
1.50 mmol, 1.5 equiv). The crude product was purified by column 
chromatography (silica gel, hexanes–EtOAc, 3:1, Rf = 0.39) to afford 4d as a 
white solid (138 mg, 79% yield). 
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1
H-NMR (300 MHz, CDCl3): δ 7.39 – 7.28 (m, 2H), 7.13 – 7.02 (m, 2H), 6.69 (t, J = 2.2 Hz, 
1H), 6.22 – 6.13 (m, 2H), 3.61 (s, 3H). 
3
C-NMR (75 MHz, CDCl3):
 δ 162.08 (d, J = 246.3 Hz), 133.70, 130.50 (d, J = 8.0 Hz), 129.61 
(d, J = 3.3 Hz), 123.70, 115.46 (d, J = 21.4 Hz), 108.78, 107.91, 35.08. 
19
F-NMR (282 MHz, CDCl3): δ -116.05. 
The obtained data is in accordance with the literature data.
[14,26]
 
1-(4-(1-methyl-1H-pyrrol-2-yl)phenyl)ethan-1-one (4h): 
Following GP-2, 4h was prepared from 4-acetylbenzenesulfonyl 
chloride 1h (219 mg, 1.0 mmol, 1.00 equiv) and N-Methylpyrrole 2a 
(122 mg, 133 µL, 1.50 mmol, 1.5 equiv). The crude product was 
purified by column chromatography (silica gel, hexanes–EtOAc, 3:1, Rf 
= 0.29) to afford 4h as a brown solid (145 mg, 73% yield). 
1
H-NMR (300 MHz, CDCl3): δ 8.08 – 7.87 (m, 2H), 7.59 – 7.43 (m, 2H), 6.77 (dd, J = 7.7, 5.2 
Hz, 1H), 6.35 (dt, J = 5.8, 2.9 Hz, 1H), 6.29 – 6.15 (m, 1H), 3.73 (s, 3H), 2.63 (s, 3H). 
13
C-NMR (75 MHz, CDCl3):
 δ 197.78, 138.07, 135.06, 133.56, 128.76, 128.11, 125.49, 110.38, 
108.52, 35.62, 26.76. 
The obtained data is in accordance with the literature data.
[28]
 
1-methyl-2-(4-nitrophenyl)-1H-pyrrole (4i): 
Following GP-2, 4i was prepared from 4-nitrosulfonyl chloride 1i (221 mg, 
1.0 mmol, 1.00 equiv) and N-Methylpyrrole 2a (122 mg, 133 µL, 1.50 mmol, 
1.5 equiv). The crude product was purified by column chromatography (silica 
gel, hexanes–EtOAc, 3:1, Rf = 0.30) to afford 4i as a pale yellow solid (153 
mg, 76% yield). 
1
H-NMR (300 MHz, CDCl3): δ 8.32 – 8.12 (m, 2H), 7.58 – 7.43 (m, 2H), 6.85 – 6.68 (m, 1H), 
6.39 (dd, J = 3.7, 1.8 Hz, 1H), 6.22 (dd, J = 3.7, 2.7 Hz, 1H), 3.72 (s, 3H). 
13
C-NMR (75 MHz, CDCl3):
 δ 144.92, 138.74, 131.35, 127.07, 125.60, 123.01, 110.53, 107.88, 
34.73. 
The obtained data is in accordance with the literature data.
[14,26]
 
3-isopropyl-1-methyl-2-(p-tolyl)-1H-indole (4n): 
Following GP-2, 4n was prepared from tosyl chloride 1b (191 mg, 1.0 mmol, 
1.00 equiv) and 3-isopropyl-1-methyl-1H-indole 2e (259 mg, 1.50 mmol, 1.5 
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equiv). The crude product was purified by column chromatography (silica gel, hexanes–EtOAc, 
95:05, Rf = 0.70) to afford 4n as a colorless solid (186 mg, 71% yield).  
1
H-NMR (300 MHz, CDCl3): δ 7.90 – 7.83 (m, 1H), 7.41 – 7.25 (m, 6H), 7.18 (ddd, J = 8.0, 
7.0, 1.1 Hz, 1H), 3.58 (s, 3H), 94 – 3.04 (m, 1H), 2.51 (s, 3H), 1.46 (d, J = 7.1 Hz, 6H). 
13
C-NMR (75 MHz, CDCl3): δ 137.98, 137.52, 136.76, 130.90, 129.71, 129.16, 126.22, 121.34, 
120.59, 119.34, 118.82, 109.65, 30.76, 26.55, 23.64, 21.54. 
IR (neat, cm
-1
): 2962, 2921, 2868, 1460, 1428, 1400, 1362, 1338, 1314, 1248, 1221, 1125, 
1014, 990, 827, 703. 
EI-MS: exact m/z calculated for C19H21N (M)
+
: 263.16685; Found: 263.16657 (M)
+
.  
Mp: 89-91 
o
C (decomposed). 
 
2-methyl-3-(p-tolyl)-1H-indole (4o): 
Following GP-2, 4o was prepared from tosyl chloride 1b (191 mg, 1.0 mmol, 
1.00 equiv) and 2-methyl-1H-indole 2f (196 mg, 1.50 mmol, 1.5 equiv). The 
crude product was purified by column chromatography (silica gel, hexanes–
EtOAc, 9:1, Rf = 0.25) to afford 4o as a brown solid (166 mg, 75% yield). 
1
H-NMR (300 MHz, CDCl3): δ 8.16 (bs, 1H), 7.64 – 7.53 (m, 1H), 7.38 – 7.28 (m, 1H), 7.29 – 
7.10 (m, 2H), 6.99 (s, 4H), 2.51 (s, 3H), 2.27 (s, 3H). 
13
C-NMR (75 MHz, CDCl3):
 δ 141.12, 135.81, 135.54, 134.46, 130.45, 129.64, 125.88, 122.25, 
120.78, 119.12, 110.78, 99.90, 21.00, 12.27. 
The obtained data is in accordance with the literature data.
[31]
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9.11 Crystal data: 3b 
 
 
Figure 9.4: Single X-ray crystal structure of 3b 
Experimental: Single clear colorless needle-shaped 
crystals of (3b) were obtained by recrystallization from 
DCM/pentane (diffusion method). A suitable crystal 
(0.27×0.08×0.05) mm3 was selected and mounted on a 
MITIGEN holder with inert oil on a SuperNova, Single 
source at the offset, Atlas diffractometer. The crystal was 
kept at T = 123.00(10) K during data collection. Using 
Olex2 (Dolomanov et al., 2009), the structure was solved 
with the ShelXT (Sheldrick, 2015) structure solution 
program, using the Intrinsic Phasing solution method. 
The model was refined with a version of olex2.refine 
(Bourhis et al., 2015) using Gauss-Newton minimisation. 
Crystal Data. C12H13NO2S, Mr = 235.31, orthorhombic, 
Fdd2 (No. 43), a = 26.8040(7) Å, b = 21.6398(5) Å, c = 
7.7705(2) Å,  =  =  = 90°, V = 4507.1(2) Å3, T = 
123.00(10) K, Z = 16, Z' = 1, (Cu K) = 2.428, 6092 
reflections measured, 1989 unique (Rint = 0.0377) which 
were used in all calculations. The final wR2 was 0.0822 
(all data) and R1 was 0.0306 (I≥(I)). 
Compound  3b  
Formula  C12H13NO2S  
Dcalc./ g cm-3  1.3870  
/mm-1  2.428  
Formula Weight  235.31  
Colour  clear colourless  
Shape  needle  
Size/mm3  0.27×0.08×0.05  
T/K  123.00(10)  
Crystal System  orthorhombic  
Flack Parameter  -0.049(14)  
Hooft Parameter  -0.033(9)  
Space Group  Fdd2  
a/Å  26.8040(7)  
b/Å  21.6398(5)  
c/Å  7.7705(2)  
/°  90  
/°  90  
/°  90  
V/Å3  4507.1(2)  
Z  16  
Z'  1  
Wavelength/Å  1.54184  
Radiation type  Cu K  
min/°  5.25  
max/°  73.42  
Measured Refl.  6092  
Independent Refl.  1989  
Reflections Used  1950  
Rint  0.0377  
Parameters  146  
Restraints  0  
Largest Peak  0.2255  
Deepest Hole  -0.2312  
GooF  1.0527  
wR2 (all data)  0.0822  
wR2  0.0807  
R1 (all data)  0.0316  
R1  0.0306  
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Table 9.4: Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement Parameters (Å2×103) 
for 3b. Ueq is defined as 1/3 of the trace of the orthogonalised Uij. 
 
Atom x y z Ueq 
S(1) 4168.74(16) 4658.49(19) 3472.3(6) 26.04(13) 
O(1) 4346.3(6) 4999.7(7) 2004(2) 35.5(3) 
O(2) 4337.1(5) 4036.0(6) 3739(2) 33.0(3) 
N(1) 4282.1(6) 4914.1(7) 6940(2) 27.4(3) 
C(4) 2472.4(8) 4624.5(8) 3100(2) 28.6(4) 
C(2) 3256.8(8) 5174.0(9) 2865(3) 31.1(4) 
C(1) 3509.7(7) 4639.2(8) 3344(3) 25.6(4) 
C(9) 4448.1(8) 5721.4(8) 5234(3) 29.7(4) 
C(5) 2734.4(7) 4095.2(8) 3574(3) 29.5(4) 
C(8) 4311.3(7) 5106.4(8) 5245(3) 25.6(4) 
C(10) 4502.6(8) 5905.6(9) 6948(3) 32.8(4) 
C(6) 3251.1(7) 4097.9(8) 3680(3) 27.3(4) 
C(11) 4403.6(8) 5397.8(9) 7958(3) 32.2(4) 
C(7) 1912.4(9) 4623(1) 2973(3) 37.8(5) 
C(3) 2742.2(8) 5158.9(9) 2732(3) 32.7(4) 
C(12) 4169(8) 4299.2(9) 7577(3) 34.4(5) 
Table 9.5: Anisotropic Displacement Parameters (×104) 3b. The anisotropic displacement factor exponent 
takes the form: -22[h2a*2 × U11+ ... +2hka* × b* × U12] 
 
Atom U11 U22 U33 U23 U13 U12 
S(1) 25.4(2) 27.5(2) 25.2(2) -0.08(16) 3.70(18) 0.75(17) 
O(1) 36.8(8) 42.9(8) 26.8(7) -6.6(6) 4.9(6) 1.9(6) 
O(2) 27.9(7) 32.3(7) 38.7(8) 4.1(5) 2.9(6) -1.8(6) 
N(1) 25.6(8) 30.1(8) 26.5(8) 0.7(6) 1.1(7) 3.1(7) 
C(4) 29(1) 33.9(8) 22.8(10) 1.6(7) -1.7(7) 0.3(7) 
C(2) 33.1(10) 24.5(8) 35.6(11) -1.6(7) 0.9(8) 3.5(8) 
C(1) 27.1(9) 27.4(8) 22.4(9) 1.7(7) 3.0(8) 0.8(6) 
C(9) 26.6(10) 29.2(9) 33.5(11) -1.5(7) -0.6(8) 6.2(8) 
C(5) 30.5(10) 27.8(8) 30.1(10) -2.3(7) 0.7(8) 4.5(8) 
C(8) 22.0(9) 29.2(9) 25.7(9) 1.0(7) 1.1(7) 2.8(7) 
C(10) 31.5(11) 31.3(9) 35.5(11) -3.8(8) -3.4(9) 1.1(8) 
C(6) 30.5(9) 24.4(8) 27.2(10) 2.0(7) 0.5(8) 4.2(7) 
C(11) 30.3(10) 37.5(10) 28.7(11) -0.7(8) -2.6(8) -1.0(8) 
C(7) 30.4(11) 43.7(11) 39.4(13) 4.0(8) -4.0(9) -0.7(9) 
C(3) 34.7(11) 28.0(8) 35.4(11) 8.3(8) -2.5(9) 2.6(8) 
C(12) 40.8(12) 30.8(9) 31.7(12) -0.7(8) 2.9(9) 7.1(8) 
Table 9.6: Bond Lengths in Å for 3b. 
 
Atom Atom Length/Å 
S(1) O(1) 1.4398(17) 
S(1) O(2) 1.4356(14) 
S(1) C(1) 1.7698(19) 
S(1) C(8) 1.727(2) 
N(1) C(8) 1.383(3) 
N(1) C(11) 1.352(3) 
N(1) C(12) 1.455(2) 
C(4) C(5) 1.393(3) 
C(4) C(7) 1.504(3) 
Atom Atom Length/Å 
C(4) C(3) 1.394(3) 
C(2) C(1) 1.392(3) 
C(2) C(3) 1.383(3) 
C(1) C(6) 1.386(3) 
C(9) C(8) 1.380(3) 
C(9) C(10) 1.398(3) 
C(5) C(6) 1.387(3) 
C(10) C(11) 1.376(3) 
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Table 9.7: Bond Angles in ° for 3b. 
 
Atom Atom Atom Angle/° 
O(2) S(1) O(1) 119.44(9) 
C(1) S(1) O(1) 107.30(10) 
C(1) S(1) O(2) 107.45(8) 
C(8) S(1) O(1) 105.73(9) 
C(8) S(1) O(2) 109.99(10) 
C(8) S(1) C(1) 106.19(9) 
C(11) N(1) C(8) 108.09(16) 
C(12) N(1) C(8) 127.68(17) 
C(12) N(1) C(11) 124.19(19) 
C(7) C(4) C(5) 121.24(18) 
C(3) C(4) C(5) 118.35(18) 
C(3) C(4) C(7) 120.41(18) 
C(3) C(2) C(1) 119.07(18) 
C(2) C(1) S(1) 118.79(14) 
C(6) C(1) S(1) 120.57(14) 
C(6) C(1) C(2) 120.63(18) 
C(10) C(9) C(8) 107.24(18) 
C(6) C(5) C(4) 121.03(17) 
N(1) C(8) S(1) 125.31(14) 
C(9) C(8) S(1) 126.48(17) 
C(9) C(8) N(1) 108.13(18) 
C(11) C(10) C(9) 107.21(17) 
C(5) C(6) C(1) 119.45(16) 
C(10) C(11) N(1) 109.3(2) 
C(2) C(3) C(4) 121.44(18) 
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Table 9.8: Hydrogen Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement 
Parameters (Å2×103) for 3b. Ueq is defined as 1/3 of the trace of the orthogonalized Uij. 
 
Atom x y z Ueq 
H(2) 3431.2(8) 5536.3(9) 2637(3) 37.3(5) 
H(3) 2572.7(8) 5519(9) 2390(3) 39.2(5) 
H(5) 2560.2(7) 3734.4(8) 3823(3) 35.4(5) 
H(6) 3422.5(7) 3739.5(8) 3974(3) 32.8(5) 
H(9) 4495.2(8) 5967.4(8) 4266(3) 35.7(5) 
H(10) 4589.5(8) 6298.0(9) 7333(3) 39.3(5) 
H(11) 4418.0(8) 5388.9(9) 9154(3) 38.6(5) 
H(7a) 1778.7(9) 4947(6) 3680(19) 56.8(7) 
H(7b) 1815.0(9) 4689(9) 1798(5) 56.8(7) 
H(7c) 1786(1) 4232(3) 3360(20) 56.8(7) 
H(12c) 4408(4) 4010.3(17) 7170(20) 51.6(7) 
H(12b) 4164(7) 4302(2) 8812(3) 51.6(7) 
H(12a) 3839(3) 4179(4) 7170(20) 51.6(7) 
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9.12 Crystal data: 3m 
 
 
Figure 9.5: Single X-ray crystal structure of 3m 
Experimental: Single clear colorless prism-shaped 
crystals of (3m) were obtained by recrystallization from 
DCM/pentane diffusion method. A suitable crystal 
(0.26×0.20×0.17) mm3 was selected and mounted on a 
SuperNova, a Single source at the offset, Atlas 
diffractometer. The crystal was kept at T = 123.00(10) K 
during data collection. Using Olex2 (Dolomanov et al., 
2009), the structure was solved with the ShelXT 
(Sheldrick, 2015) structure solution program, using the 
Intrinsic Phasing solution method. The model was refined 
with version 2016/6 of ShelXL (Sheldrick, 2015) using 
Least Squares minimisation. 
Crystal Data. C13H12O3S2, Mr = 280.35, monoclinic, P21/c 
(No. 14), a = 10.1074(2) Å, b = 16.4523(3) Å, c = 
7.8081(2) Å,  = 101.625(2)°,  =  = 90°, V = 
1271.77(5) Å3, T = 123.00(10) K, Z = 4, Z' = 1, (CuK) = 
3.783, 13789 reflections measured, 2536 unique (Rint = 
0.0242) which were used in all calculations. The final wR2 
was 0.0744 (all data) and R1 was 0.0273 (I > 2(I)). 
Compound  3m 
    
Formula  C13H12O3S2  
Dcalc./ g cm-3  1.464  
/mm-1  3.783  
Formula Weight  280.35  
Colour  clear colourless  
Shape  prism  
Size/mm3  0.26×0.20×0.17  
T/K  123.00(10)  
Crystal System  monoclinic  
Space Group  P21/c  
a/Å  10.1074(2)  
b/Å  16.4523(3)  
c/Å  7.8081(2)  
/°  90  
/°  101.625(2)  
/°  90  
V/Å3  1271.77(5)  
Z  4  
Z'  1  
Wavelength/Å  1.54184  
Radiation type  CuK  
min/°  5.214  
max/°  73.712  
Measured Refl.  13789  
Independent Refl.  2536  
Reflections Used  2443  
Rint  0.0242  
Parameters  165  
Restraints  0  
Largest Peak  0.396  
Deepest Hole  -0.327  
GooF  1.033  
wR2 (all data)  0.0744  
wR2  0.0737  
R1 (all data)  0.0282  
R1  0.0273  
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Table 9.9: Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement Parameters (Å2×103) 
for 3m. Ueq is defined as 1/3 of the trace of the orthogonalized Uij. 
 
Atom x y z Ueq 
S2 3653.7(3) 3175.0(2) 6292.5(4) 16.66(10) 
S1 6205.3(3) 3947.3(2) 8233.5(4) 15.81(11) 
O1 5284.1(10) 4625.3(6) 7939.0(13) 21.4(2) 
O2 6993.1(11) 3795.4(7) 9947.2(13) 22.7(2) 
O3 1330.6(11) 2234.9(6) 4445.0(15) 27.6(3) 
C2 6949.8(14) 4478.4(8) 5258.2(18) 17.5(3) 
C10 4633.8(14) 1742.5(8) 7045.9(18) 18.7(3) 
C8 5239.8(14) 3078.3(8) 7557.8(17) 16.1(3) 
C11 3504.0(14) 2132.0(8) 6155.4(17) 16.8(3) 
C9 5641.5(15) 2288.4(8) 7859.0(18) 18.9(3) 
C12 2236.5(14) 1787.9(8) 5142.5(18) 19.0(3) 
C3 7784.8(15) 4486.6(9) 4048.8(18) 20.0(3) 
C4 8977.3(15) 4038.1(8) 4325.8(19) 19.1(3) 
C1 7307.6(14) 4013.1(8) 6756.3(18) 15.8(3) 
C6 8499.3(15) 3563.6(9) 7080.5(19) 21.0(3) 
C5 9322.0(15) 3581.1(9) 5859.5(19) 22.0(3) 
C13 2141.5(16) 879.6(9) 5024(2) 24.7(3) 
C7 9877.2(16) 4048.8(10) 3005(2) 25.2(3) 
Table 9.10: Anisotropic Displacement Parameters (×104) 3m. The anisotropic displacement factor exponent 
takes the form: -22[h2a*2 × U11+ ... +2hka* × b* × U12] 
 
Atom U11 U22 U33 U23 U13 U12 
S2 15.47(17) 14.51(17) 19.09(18) -0.85(11) 1.30(12) 1.26(11) 
S1 15.81(18) 16.22(18) 15.15(17) -2.19(11) 2.52(13) -0.86(11) 
O1 20.8(5) 17.4(5) 26.6(5) -3.8(4) 6.3(4) 0.8(4) 
O2 23.1(5) 28.9(5) 15.1(5) -2.0(4) 1.6(4) -3.4(4) 
O3 21.0(5) 23.7(5) 34.3(6) -4.6(4) -3.3(5) 2.9(4) 
C2 14.6(6) 16.8(6) 20.1(7) 1.1(5) 0.9(5) 1.6(5) 
C10 20.5(7) 16.0(6) 19.9(7) 1.3(5) 5.0(5) 1.1(5) 
C8 16.5(6) 17.4(6) 14.4(6) -0.4(5) 2.8(5) -0.4(5) 
C11 19.4(7) 15.7(6) 16.4(6) -1.4(5) 6.0(5) -1.0(5) 
C9 18.4(7) 18.8(7) 18.9(7) 2.1(5) 1.9(5) 1.8(5) 
C12 18.4(7) 20.9(7) 18.6(7) -2.7(5) 5.6(5) 0.4(5) 
C3 21.1(7) 20.2(7) 17.7(6) 3.4(5) 1.4(5) -0.5(5) 
C4 17.8(7) 20.0(7) 19.1(7) -2.0(5) 3.1(5) -2.1(5) 
C1 14.4(6) 15.9(6) 16.7(6) -1.7(5) 2.3(5) -2.2(5) 
C6 20.3(7) 22.9(7) 18.8(7) 4.5(5) 1.8(5) 3.9(6) 
C5 16.9(7) 24.9(7) 23.8(7) 2.0(6) 3.0(6) 6.0(6) 
C13 29(7) 20.2(7) 29.5(8) -4.7(6) 2.9(6) -2.2(6) 
C7 29(8) 30.8(8) 22.8(7) 0.9(6) 7.9(6) 1.3(6) 
Table 9.11: Bond Lengths in Å for 3m. 
 
Atom Atom Length/Å 
S2 C8 1.7127(14) 
S2 C11 1.7240(14) 
S1 O1 1.4414(10) 
S1 O2 1.4344(11) 
S1 C8 1.7514(14) 
Atom Atom Length/Å 
S1 C1 1.7610(14) 
O3 C12 1.2144(18) 
C2 C3 1.388(2) 
C2 C1 1.3837(19) 
C10 C11 1.370(2) 
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Atom Atom Length/Å 
C10 C9 1.409(2) 
C8 C9 1.3677(19) 
C11 C12 1.4761(19) 
C12 C13 1.499(2) 
C3 C4 1.392(2) 
Atom Atom Length/Å 
C4 C5 1.397(2) 
C4 C7 1.507(2) 
C1 C6 1.392(2) 
C6 C5 1.386(2) 
Table 9.12: Bond Angles in ° for 3m. 
 
Atom Atom Atom Angle/° 
C8 S2 C11 90.20(7) 
O1 S1 C8 106.31(6) 
O1 S1 C1 108.76(6) 
O2 S1 O1 120.20(6) 
O2 S1 C8 108.04(6) 
O2 S1 C1 108.43(6) 
C8 S1 C1 103.92(6) 
C1 C2 C3 119.30(13) 
C11 C10 C9 112.53(13) 
S2 C8 S1 119.86(8) 
C9 C8 S2 113.48(11) 
C9 C8 S1 126.57(11) 
C10 C11 S2 112.35(10) 
C10 C11 C12 129.57(13) 
C12 C11 S2 118.09(10) 
C8 C9 C10 111.44(13) 
O3 C12 C11 120.17(13) 
O3 C12 C13 122.87(14) 
C11 C12 C13 116.96(13) 
C2 C3 C4 121.02(13) 
C3 C4 C5 118.48(13) 
C3 C4 C7 120.70(13) 
C5 C4 C7 120.82(13) 
C2 C1 S1 119.71(11) 
C2 C1 C6 121.11(13) 
C6 C1 S1 119.11(10) 
C5 C6 C1 118.74(13) 
C6 C5 C4 121.34(13) 
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Table 9.12: Hydrogen Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement 
Parameters (Å2×103) for 3m. Ueq is defined as 1/3 of the trace of the orthogonalized Uij. 
 
Atom x y z Ueq 
H2 6157.95 4782.49 5063.84 21 
H10 4725.46 1180.19 7106.95 22 
H9 6474.25 2131.33 8517.01 23 
H3 7544.28 4796.35 3037.58 24 
H6 8738.48 3257.33 8096.95 25 
H5 10119.81 3282.71 6065.07 26 
H13A 2164.76 657.14 6166.02 37 
H13B 2888.8 671.34 4569.56 37 
H13C 1310.22 728.74 4259.56 37 
H7A 9345.7 3946.51 1860.36 38 
H7B 10556.33 3635.62 3292.29 38 
H7C 10302.94 4571.05 3019.04 38 
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10 Summary: 
This thesis demonstrates the development of new and unprecedented activation methods in 
visible-light mediated photoredox catalysis. The established transformations not only unlocked 
new avenues in organic synthesis but holds enormous potential for the future advancements and 
sustainable developments in this field. 
In chapter 1, I have outlined a short overview of visible-light-mediated processes that have been 
established over the years, starting with Ciamician’s idea of using sunlight as a clean and 
unlimited energy source for organic synthesis. Therein, I have also highlighted four principal 
activation modes associated with visible-light photocatalysis (i.e, oxidative quenching, reductive 
quenching, energy transfer, and a photocascade process). Accordingly, I stated the diversity of 
various synthetic methods relies upon the ability of photoredox catalysts such as [Ru(bpy)3]Cl2, 
[Ir{dF(CF3)ppy}2(dtbbpy)]PF6, [Ir(ppy)2(dtbbpy)]PF6, or fac-Ir(ppy)3 to undergo a number of 
productive quenching pathways from the excited state. The flexibility of these catalysts has 
allowed for the development of a series of transformations such as diradical formation by triplet 
photosensitization, cycloaddition reactions, vinyl radical formation by reductive radical 
dehalogenations, 1,6-HAT process or α-amino functionalization, sulfonylation as well as 
arylation reactions, etc. Notably, these photocatalysts certainly possess a series of advantages 
over the classical radical chemistry in light of sustainable developments. 
In chapter 2, we have summarized the visible-light mediated activation of C-X bonds, generation 
of vinyl radical as a key intermediate, and its applications in organic synthesis that are developed 
in last few years, mostly from our group. 
In chapter 3, I have presented the unprecedented activation of vinyl-bromides with molecular 
oxygen utilizing dual energy and electron transfer modes: Ortho-alkynylated α-bromocinnamates 
can be converted by a visible-light-mediated photocascade reaction with molecular oxygen into 
either indenones or dihydroindeno[1,2-c]chromenes. The one-step process features key 
photochemical steps; thus, the initial activation of vinyl bromides through energy transfer to give 
α-ketoradicals in a reaction with molecular oxygen, followed by α-oxidation of an arene moiety 
by 6-π electrocyclization, and subsequent hydroxylation by an electron-transfer process from the 
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same photocatalyst leads to the dihydroindeno[1,2-c]chromenes. For this chapter, I have 
conducted a series of experiments in attempts of understanding the detailed reaction mechanism. 
While finding the mechanistic details, some of the attempts also ended up in disclosing the new 
reactions; for examples, visible-light mediated [2+2]-photocycloaddition of cinnamates with 
visible-light was unknown. As a consequence, we have subsequently developed the latter method 
and extended the scope of the stated transformation, which is separately described in chapter 4. 
In chapter 4, an efficient method for the synthesis of substituted cyclobutanes from cinnamates, 
chalcones, and styrenes utilizing a visible-light triplet sensitization mode was described. This 
reaction provided a diverse range of substituted cyclobutanes in high yields under mild 
conditions without the need of external additives. Good regioselectivity was obtained due to 
strong π–π-stacking of arene moieties, whereas diastereoselectivity relied on the electronic 
effects or ortho-substitution of the arene substrate. Furthermore, we have also shown the utility 
of this transformation by formal synthesis of the lignane natural product (±)-Tanegool. 
In chapter 5, a tin-free method for the synthesis of substituted indolines was described generating 
vinyl radicals by visible-light-promoted photocatalysis in a reductive quenching cycle. This 
method offered a mild, robust, and high yielding pathway to a wide range of indolines containing 
diverse electronic substituents. The resulting 2,3-disubstituted indolines serve as valuable 
precursors for the synthesis of biologically active molecules, which was demonstrated with the 
formal synthesis of Tryptamines and Furoindolines. Notably, we have replaced the hazardous 
reagents and harsh reaction conditions with the mild reaction conditions. 
In chapter 6, the unprecedented discovery of Triquinacenes was outlined: We have shown for the 
first time, a visible-light mediated cascade of C-C bond formations with vinyl chlorides and 
phenyl acetylenes. Noteworthy, this process involves four highly reactive vinyl radical 
intermediates, which was engaged in a productive reaction cascades with two phenyl acetylene 
molecules, leading to the complex molecular designs in a single photochemical step under the 
mild reaction conditions. This reaction could also be performed in the micro-flow reactors in the 
short reaction time. Arguably, the single step synthesis of these types of complex architectures is 
certainly impossible to accomplish by employing other methods at this stage. 
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In chapter 7, I have highlighted the applications of sulfonyl chlorides. This has been found a 
cheap, biocompatible, readily available reagent for sulfonylation, trifluoromethylation or 
arylation reactions under visible-light conditions. 
In chapter 8, the sequential [Cu] and [Ir] photocatalyzed method for the synthesis of β-
hydroxysulfones from sulfonyl chlorides and styrenes in the presence of water was 
demonstrated. We showed here the importance of each specific catalyst that is employed in the 
title transformation. In turn, this paper has already received a remarkable attention from the 
synthetic community. 
Finally, in chapter 9, I further extended the scope of sulfonyl chlorides for arylation or 
sulfonylation of heterocycles at different temperature conditions. We showed for the first time a 
comparative study on the selective C-C and C-S bond formations just by adjusting the 
appropriate reaction temperature.  
Overall, in my PhD work, I had a chance to work in the fascinating field of visible-light 
photoredox catalysis. As shown, I have come across several unique reaction pathways and 
closely witnessed these surprising discoveries. Undoubtedly, further discovery and development 
of new methods utilizing visible light-mediated photoredox catalysis will continue to grow in the 
next years, particularly due to the redox flexibility of photocatalysts to be employed with a range 
of reactions. However, a detailed study of how factors such as temperature, solvent choice, 
catalyst choice, or additives, etc…affect the reaction outcome. Such studies will be necessary to 
understand how to better improve existing methods and develop new methods. More 
importantly, these studies may also provide answers to many of the existing anomalous results 
that have been observed in this field. One example of an observation that could possibly be 
explained by more rigorous mechanistic studies involves the specific role of oxygen for the vinyl 
bromide activation (Chapter 3) or the high reactivity of vinyl chlorides over vinyl bromides in 
Triquinacene synthesis (Chapter 6), and so on. Another observation pertains to the unexpected 
C-S bond formation in the trifluoromethylsulfochlorination reaction in the presence of selected 
[Cu]-catalyst in contrast to the [Ir]- or [Ru]-photocatalysts (Chapter 8).  
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Last, but not least, to understand the detailed reaction mechanism of new photoredox methods is 
still a challenging task. Preliminary results in our group, especially for the activation of vinyl 
halides indicate that particular reactions are prone to a high level of selectivity and reactivity via 
different reaction pathways based on the specific substituents present on the starting materials or 
the photocatalyst employed. The design of special substrates or identification of key 
intermediates involved could open new chapters along with understanding the mode of action of 
a photocatalyst in the overall process. 
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11 Zusammenfassung: 
Diese Arbeit beschreibt die Entwicklung neuer Aktivierungsmethoden in der Photoredoxkatalyse 
mit sichtbarem Licht. Die hier beschriebenen Umwandlungen eröffnen nicht nur Wege in der 
organischen Synthese, sondern bergen auch enormes Potential für zukünftige Untersuchungen 
und nachhaltige Entwicklungen in diesem Bereich.  
In Kapitel 1 wurde ein kurzer Überblick über die verschiedenen, von sichtbarem Licht 
getriebenen Prozesse gegeben, welche sich über die Jahre etabliert haben, angefangen mit 
Ciamicians Idee Sonnenlicht als saubere, unbegrenzt zur Verfügung stehende Energiequelle für 
die organische Synthese zu nutzen. In diesem Kapitel wurden zudem die vier grundlegen 
Aktivierungsmethoden der Photokatalyse mit sichtbarem Licht näher betrachtet (d.h. oxidatives 
Quenching, reduktives Quenching, Energietransfer und Photoredoxkaskaden). Dementsprechend 
wurde beschrieben, dass die Bandbreite an chemischen Transformationen von 
Photoredoxkatalysatoren wie [Ru(bpy)3]Cl2, [Ir{dF(CF3)ppy}2(dtbbpy)]PF6, 
[Ir(ppy)2(dtbbpy)]PF6, oder fac-Ir(ppy)3, von deren Fähigkeit abhängt ausgehend vom 
angeregten Zustand produktive Quenchingschritte durchführen zu können. Die vielseitige 
Einsetzbarkeit dieser Katalysatoren ermöglichte die Entwicklung diverser Umwandlungen, wie 
z.B. die Diradikalbildung durch Triplett-Photosensitizer, Cycloadditionsreaktionen, 
Vinylradikalbildung durch reduktive, radikalische Dehalogenierung, der 1,6-HAT-Prozess, α-
Aminofunktionalisierung, Sulfonylierungs- sowie Arylierungsreaktionen und viele mehr. Diese 
Photokatalysatoren besitzen eine bemerkenswerte Reihe an Vorteilen gegenüber der klassischen 
Radikalchemie in Hinblick auf nachhaltige Entwicklungen.  
In Kapitel 2 wurden die Aktivierung von C-X-Bindungen, die Generierung von Vinylradikalen 
als Schlüsselintermediate und deren Anwendung in der organischen Synthese der letzten Jahre 
zusammengefasst. 
In Kapitel 3 wurde eine neuartige Aktivierung von Vinylbromiden mit molekularem Sauerstoff 
unter Verwendung von Energie- und Elektronenentransfer beschrieben. Ortho-alkynylierte α-
Bromzimtsäuren konnten mit sichtbarem Licht in einer Photokaskadenreaktion mit molekularem 
Sauerstoff in Indenone sowie Dihydroindeno[1,2-c]chromene umgewandelt werden. Dieser 
einstufige Prozess beinhaltet photochemische Schlüsselschritte: die anfängliche Aktivierung der 
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Vinylbromide zu α-Ketoradikalen durch Energietransfer mit molekularem Sauerstoff, gefolgt 
von α-Oxidierung einer Arengruppe durch 6-π-Elektrozykliesierung und anschließender 
Hydroxylierung durch einen Elektronentrasferprozess desselben Katalysators, was zur Bildung 
von Dihydroindeno[1,2-c]chromene führt. Hierfür wurden eine Reihe an Experimenten 
durchgeführt um den genauen Reaktionsmechanismus zu ermitteln und zu verstehen. Diese 
Experimente führten auch zur Entdeckung neuer Reaktionen, z.B. die zuvor unbekannte [2+2]-
Photocycloaddition von Zimtsäuren mit sichtbarem Licht. Diese wurde als Folge später genauer 
untersucht und das Anwendungsspektrum erweitert, was in Kapitel 4 näher beschrieben wird. 
In Kapitel 4 wurde eine effiziente Methode zur Synthese von substituierten Cyclobutanen, 
ausgehend von Zimtsäuren, Chalconen und Styrolen und mithilfe von Triplett-Sensitizern sowie 
sichtbarem Licht, beschrieben. Eine Vielzahl an substituierten Cyclobutanen konnte mit dieser 
Methode in hohen Ausbeuten unter milden Bedingungen ohne zusätzliche Additive hergestellt 
werden. Die gute Regioselektivität konnte aufgrund des starken π-π-Stackings der Arengruppen 
erreicht werden, die Diastereoselektivität basierte auf elektronischen Effekten oder der ortho-
Substitution des Arensubstrats. Der Nutzen dieser Transformation konnte durch die 
Formalsynthese des in Lignan vorkommenden Naturstoffs (±)-Tanegool aufgezeigt werden.  
In Kapitel 5 wurde eine Zinn-freie Methode zur Synthese von substituierten Indolinen durch 
Generierung von Vinylradikalen mittels Photokatalyse unter sichtbarem Licht und reduktiven 
Quenching beschrieben. Diese Methode bot einen milden, robusten Weg zur Darstellung einer 
Vielzahl an substituierten Indolinen in hohen Ausbeuten. Die entstanden 2,3-disubstitueirten 
Indoline dienen als nützliche Vorstufen für die Synthese von biologisch aktiven Verbindungen. 
Dies wurde durch die Formalsynthese von Tryptaminen und Furoindolinen demonstriert. Hier 
konnten gefährliche Reagenzien und harsche Reaktionsbedingungen durch mildere ersetzt 
werden. 
In Kapitel 6 wurde die Entdeckung einer neuartigen Methode zur Darstellung von Triquinacenen 
erörtert: durch eine zuvor unbekannte Kaskade von C-C-Bindungsknüpfungen von 
Vinylchloriden und Phenylacetlyenen unter sichtbarem Licht. Hier ist zu bemerken, dass dieser 
Prozess insgesamt vier reaktive Vinyradikallintermediate beinhaltete, welche in einer 
Reaktionskaskade mit zwei Molekülen Phenylacetylen reagierten was zur Bildung der 
komplexen Verbindung unter milden, photochemischen Bedingungen in einem Schritt führte. 
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Diese Reaktion konnte zudem auch in einem Mikroreaktor im Flow mit kurzen Reaktionszeiten 
durchgeführt werden. Die Einstufensynthese dieser komplexen Verbindungen ist zurzeit 
vermutlich durch keine andere Methode möglich. 
In Kapitel 7 wurden die Anwendungen von Sulfonylchloriden näher betrachtet. Diese stellen 
günstige, biokompatible Reagenzien zur Sulfonylierung, Trifluoromethylierung oder Arylierung 
für Reaktionen unter sichtbarem Licht dar. 
In Kapitel 8 wurde die sequenzielle [Cu]- und [Ir]-photokatalysierte Methode zur Synthese von 
β-Hydroxysulfonen ausgehend von Sulfonylchloriden und Styrolen in Anwesenheit von Wasser 
beschrieben. Dabei wurde die Wichtigkeit jedes verwendeten Katalysators für die Reaktion 
aufgezeigt. Die resultierende Publikation hat schon jetzt Aufmerksamkeit in der chemischen 
Gemeinschaft bekommen. 
Im abschließenden 9. Kapitel wurde die Anwendungsbreite der nutzbaren Sulfonylchloride für 
die Arylierung oder Sulfonylierung von Heterozyklen bei verschieden Temperaturen erweitert. 
Eine Vergleichsstudie wurde angefertigt, welche den Einfluss der Temperatur auf die 
konkurrierende selektive C-C bzw. C-S-Bindungsknüpfung aufzeigt. 
Während meiner Studien zu dieser Doktorarbeit hatte ich die Chance im faszinierenden Feld der 
Photoredoxkatalyse mit sichtbarem Licht zu arbeiten. Wie aufgezeigt war ich in der Lage über 
verschiedene, einzigartige Reaktionswege zu stolpern und diese überraschenden Entdeckungen 
näher zu untersuchen. Ohne Zweifel werden auch in den nächsten Jahren weitere Entdeckungen 
im Feld der Photoredoxkatalyse mit sichtbarem Licht gemacht werden und neue Methoden 
entwickelt werden, insbesondere aufgrund der Flexibilität der Redoxeigenschaften der 
Photokatalysatoren welche in vielen Reaktionen ausgenutzt werden wird. Dies erfordert jedoch 
die genaue Untersuchung von Reaktionsparametern, welche einen Einfluss auf den Ausgang der 
Reaktion haben, wie z.B. Temperatur, Lösungsmittel, Katalysator oder Additive. Diese 
Untersuchungen sind wichtig um bereits existierende Methoden zu verbessern und neue 
Methoden zu entwickeln. Zudem können diese auch Antworten auf viele ungeklärte 
Beobachtungen liefern welche in diesem Gebiet gemacht wurden. Ein Beispiel für eine 
Beobachtung welche durch genauere mechanistische Studien geklärt werden könnte ist die 
genaue Rolle des Sauerstoffs in der Vinylbromidaktivierung (Kapitel 3) oder die hohe Aktivität 
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der Vinylchloride im Vergleich zu den –bromiden in der Triquinacensynthese (Kapitel 6). Eine 
weitere untersuchenswerte Beobachtung ist die unerwartete C-S-Bindungsknüpfung in der 
Trifluoromethylsulfochlorierung, welche mit ausgewählten [Cu]-Katalysatoren, jedoch nicht mit 
[Ir]- oder [Ru]-Photokatalysatoren stattfindet (Kapitel 8). 
Das Unterfangen den detaillierten Reaktionsmechanismus für neue Photoredoxmethoden zu 
verstehen ist noch immer sehr herausfordernd. Vorläufige Ergebnisse in unserer Arbeitsgruppe, 
speziell für die Aktivierung von Vinylhalogen, ergeben, dass hohe Selektivität und Reaktivität in 
bestimmten Reaktionen abhängig vom Substitutionsmuster der verwendeten Startmaterialien 
oder von der Wahl des Photokatalysators sind. Das Entwerfen von speziellen Substraten oder die 
Identifizierung der Schlüsselintermediate könnte neue Möglichkeiten eröffnen und zum 
Verständnis des Wirkmechanismus des Photokatalysators im gesamten Prozess beitragen. 
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